Sentence,class,file
"However, the favorable speedof the algorithm does not compromise its accuracy.The SETTER web server together with thestand-alone implementation of the SETTER algo-rithm are freely accessible at http://siret.cz/setter.",Non-OADS,/arxiv_data1/oa_pdf/6d/e3/gks560.PMC3394248.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6d/e3/gks560.PMC3394248.pdf
The SETTER web server as well as the accompanied binary package are freely avail-able at http://siret.cz/setter.,OADS,/arxiv_data1/oa_pdf/6d/e3/gks560.PMC3394248.pdf
SUMMARY A web server for the RNA 3D pairwise structural align- ment was developed and is available at http://siret.cz/ setter.,OADS,/arxiv_data1/oa_pdf/6d/e3/gks560.PMC3394248.pdf
"http://www.jmol.org/ (4 June 2012, date last accessed).W48 Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/6d/e3/gks560.PMC3394248.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/2a/a8/gks487.PMC3394249.pdf
accessible at http://www.homozygositymapper.org/ and there is no login requirement.,Non-OADS,/arxiv_data1/oa_pdf/2a/a8/gks487.PMC3394249.pdf
"A TAL effector-nucleotide binding codethat links repeat type to specified nucleotideenables prediction of genomic binding sites for TAL effectors and customization of TAL effectors for use in DNA targeting, in particular as customtranscription factors for engineered gene regulationand as site-specific nucleases for genome editing.We have developed a suite of web-based toolscalled TAL Effector-Nucleotide Targeter 2.0(TALE-NT 2.0; https://boglab.plp.iastate.edu/) thatenables design of custom TAL effector repeat arrays for desired targets and prediction of TAL effector binding sites, ranked by likelihood, in agenome, promoterome or other sequence ofinterest.",OADS,/arxiv_data1/oa_pdf/72/bd/gks608.PMC3394250.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/72/bd/gks608.PMC3394250.pdf
Target Finder is written in C and uses Kseq.h (http://lh3lh3.users.sourceforge.net/ parsefastq.shtml) for sequence parsing.,OADS,/arxiv_data1/oa_pdf/72/bd/gks608.PMC3394250.pdf
"Genome sequences were obtained from Ensembl (www.ensembl.org), except for the rice genome, which was downloaded from the MSU Rice GenomeAnnotation Project (http://rice.plantbiology.msu.edu, Version 6.1).",OADS,/arxiv_data1/oa_pdf/72/bd/gks608.PMC3394250.pdf
"Promoteromes were downloaded from the UCSC Genome Bioinformatics Site (http://genome.ucsc.edu/index.html), except for the rice promoterome, which was downloaded from the Rice Genome Annotation Project and the Arabidopsis promoterome, which wasdownloaded from The Arabidopsis Information Resource (TAIR; http://www.arabidopsis.org/).",OADS,/arxiv_data1/oa_pdf/72/bd/gks608.PMC3394250.pdf
"CONCLUSION TALEN Targeter and TAL Effector Targeter are versatile tools that allow design of custom RVD arrays for geneediting, engineered gene regulation and other applications.Although other TALEN design tools exist (TALEN Hit,http://talen-hit.cellectis-bioresearch.com/search; ZiFitTargeter 4.0 (16), http://ziﬁt.partners.org/ZiFiTBeta/Introduction.aspx and idTALE (29), http://idtale.kaust.edu.sa/index.html), TALEN Targeter is the only toolthat works with any architecture by allowing users tospecify ranges for both spacer size and number ofrepeats.",OADS,/arxiv_data1/oa_pdf/72/bd/gks608.PMC3394250.pdf
Three independent predictors are usedto increase the rate of successful predictions.Careful evaluation shows that there is nearly 80%chance that the query sequence belongs to thesame SCOP family as the top scoring template.The Bioshell Threader server is freely available at:http://www.bioshell.pl/threader/.,OADS,/arxiv_data1/oa_pdf/a5/eb/gks555.PMC3394251.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a5/eb/gks555.PMC3394251.pdf
The NetAligner web server is publicly avail- able at http://netaligner.irbbarcelona.org/.INTRODUCTION Genome sequencing projects are providing nearly complete repertoires of the genes and proteins present inmany species.,OADS,/arxiv_data1/oa_pdf/12/8c/gks446.PMC3394252.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/12/8c/gks446.PMC3394252.pdf
"The web server is publicly available at http://netaligner.irbbarcelona.org/.THE NetAligner WEB SERVER Alignment tasks Our web server implementation of the NetAligner algo- rithm (12) features three different alignment tasks:‘Complex to interactome’, ‘Pathway to interactome’ and ‘Interactome to interactome’ alignments.",OADS,/arxiv_data1/oa_pdf/12/8c/gks446.PMC3394252.pdf
Available at:http://www.beaconlab.it/cscan.,Non-OADS,/arxiv_data1/oa_pdf/fb/ab/gks483.PMC3394253.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/fb/ab/gks483.PMC3394253.pdf
"Monte Carlo simulations of peptide–membrane interactions with the MCPep web servery Yana Gofman1,2, Turkan Haliloglu3,4and Nir Ben-Tal2,* 1Helmholtz-Zentrum, Department of Structure Research on Macromolecules, 21502 Geesthacht, Germany, 2Department of Biochemistry and Molecular Biology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv 69978, Israel,3Polymer Research Center and Chemical Engineering Department and 4Life Sciences and Technologies Research Center, Bogazici University, Bebek-Istanbul 34342, Turkey Received March 8, 2012; Revised May 16, 2012; Accepted May 22, 2012 ABSTRACT The MCPep server (http://bental.tau.ac.il/MCPep/) is designed for non-experts wishing to perform MonteCarlo (MC) simulations of helical peptides in associ-ation with lipid membranes.",Non-OADS,/arxiv_data1/oa_pdf/b0/fd/gks577.PMC3394254.pdf
"Here, we present MCPep (http://bental.tau.ac.il/ MCPep/): a web implementation of the MC simulationmodel.",OADS,/arxiv_data1/oa_pdf/b0/fd/gks577.PMC3394254.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b0/fd/gks577.PMC3394254.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ce/e4/gks427.PMC3394255.pdf
The webserver-based tool is freely available at http://gpsy.genouest.org.,OADS,/arxiv_data1/oa_pdf/b4/cf/gks380.PMC3394256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b4/cf/gks380.PMC3394256.pdf
"378–387, http://www.bioconductor.org/help/publications/tech-reports/.",Non-OADS,/arxiv_data1/oa_pdf/b4/cf/gks380.PMC3394256.pdf
"We present here a web-service that automates the primer design process, along with a user interface that includesa number of useful tools for managing both theinput sequences and the resulting outputs.RF-Cloning is free and open to all users, and canbe accessed at http://www.rf-cloning.org.",OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
"The algorithm then returns hybrid primers with the correct orientationand compatible T m. The service can be accessed through our web based user interface at http://www.rf-cloning.org, or through direct XML requests with the Simple ObjectAccess Protocol (SOAP).",OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
"A number of useful sequence manipulation tools (some of which have been adapted from those found at Sequence Massager, http://www.attotron.com/cybertory/analysis/seqMassager.htm)are also included to perform common tasks, such as removal of numbers and whitespace or converting a sequence to its reverse complement.",Non-OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
Savvy is a scalable vector graphics (SVG) plasmid mapdrawing software adapted from the original version 0.1source code kindly provided by Dr Malay Basu (http://www.bioinformatics.org/savvy/).,OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
"Adobe Illustrator and CorelDRAW) as well as the open source SVG editor, Inkscape (http://inkscape.org/).",Non-OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
"For those wishing to access the RF-Cloningdesign algorithm directly from custom scripts, we have included a SOAP server to accept incoming XML requests (http://www.rf-cloning.org/classes/rf_cloning_server.php).",OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
The afﬁliated WSDL ﬁle and sample SOAP clients can be downloaded from http://www.rf-cloning .org/soap_server.php.,OADS,/arxiv_data1/oa_pdf/cd/eb/gks396.PMC3394257.pdf
This web server can be freely accessed at http://cmbi.bjmu.edu.cn/huac.,OADS,/arxiv_data1/oa_pdf/e4/9e/gks437.PMC3394258.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/e4/9e/gks437.PMC3394258.pdf
It is freely accessible at http://tmsoc.bii.,Non-OADS,/arxiv_data1/oa_pdf/9d/ea/gks379.PMC3394259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/9d/ea/gks379.PMC3394259.pdf
The WWW server is available via http://tmsoc.bii.a-star.edu.sg or http://mendel.bii.a-star.edu.sg/METHODS/TMSOC/cgi-bin/.,OADS,/arxiv_data1/oa_pdf/9d/ea/gks379.PMC3394259.pdf
The server is available at: http://bioserv.rpbs.univ-paris-diderot.fr/PEP-FOLD.,Non-OADS,/arxiv_data1/oa_pdf/29/4e/gks419.PMC3394260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/29/4e/gks419.PMC3394260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/70/06/gks485.PMC3394261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/fe/7d/gks364.PMC3394262.pdf
The UCSC annotationdata sets are built from MySQL tables available from theUCSC human genome annotation database (http://hgdownload.cse.ucsc.edu/downloads.html#human).Reference human genome sequence and public domain SNP details are collected from BioMart release 63 for hg19 (ftp://ftp.ensembl.org/pub/release-63/mysql/) andrelease 54 for hg18 (ftp://ftp.ensembl.org/pub/release-54/mysql/).,OADS,/arxiv_data1/oa_pdf/fe/7d/gks364.PMC3394262.pdf
Pre-computed SIFT predictions fornon-synonymous amino acid substitutions in Ensembl proteins are available from the SIFT Human Protein DB release 63 (ftp://ftp.jcvi.org/pub/data/sift/Human_db_37_ensembl_63/).,OADS,/arxiv_data1/oa_pdf/fe/7d/gks364.PMC3394262.pdf
COSMIC and miRBase data are downloaded from theircorresponding FTP sites (ftp://ftp.sanger.ac.uk/pub/CGP/cosmic and http://mirbase.org/ftp.shtml).,OADS,/arxiv_data1/oa_pdf/fe/7d/gks364.PMC3394262.pdf
PICR can be accessed at http://www.ebi.ac.uk/Tools/picr/.,Non-OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"CaBIG GeneConnect (https://cabig.nci.nih.gov/ tools/GeneConnect/), from the National Cancer Institute,provides mappings both programmatically and inter- actively, but has not been updated since 2007, and maps between a limited number of databases.",OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
ProteinInformation Resource’s (PIR) ID-mapping service allowsdirect identiﬁer mapping between a small numbers of databases (http://pir.georgetown.edu/pirwww/search/ idmapping.shtml).,OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
Wayne State’sOnto-Translate (http://vortex.cs.wayne.edu/projects.htm#Onto-Translate) is gene focused and requires a login touse.,Non-OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"‘The Synergizer’ supports both gene and protein IDmapping, but has a limited set of databases and no pro-grammatic access is provided (http://llama.mshri.on.ca/ synergizer/translate/).",Non-OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"Finally, the UniProt ID-mapping system (http://www.uniprot.org/mapping/) supports identiﬁer mappingamong a high number of resources.",OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"PICR is a web application,accessible at http://www.ebi.ac.uk/Tools/picr/, whichmaps active and deprecated protein and gene identiﬁers,complete amino acid sequences and protein subsequences to the corresponding identiﬁers in over 100 different data- bases.",OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
Anonline user guide is available at http://www.ebi.ac.uk/Tools/picr/userguide.do.,Non-OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"To achieve this goal, we used the existing BLAST web service provided by the EBI (15) (http://www.ebi.ac.uk/Tools/webservices/services/sss/ncbi_blast_soap).",OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
BLAST support was added to the SOAP and REST interfaces by updating the web service descriptor (http://www.ebi.ac.uk/Tools/picr/service?wsdl) to handle new messages as required by the service ( getUPIForBlastSequence and getUPIForBlastSequenceResponse ) and to enhance the object model to be able to capture all the required BLAST parameters.,OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
Full documentation and some template code are available at http://www.ebi.ac.uk/Tools/picr/WSDLDocumentation .do (for the SOAP web service) and http://www.ebi.ac.uk/Tools/picr/RESTDocumentation.do (for the REST web service).,OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"(2012) UniProt Knowledgebase User Manual, http://www.uniprot.org/manual/.W280 Nucleic Acids Research, 2012, Vol.",Non-OADS,/arxiv_data1/oa_pdf/20/40/gks338.PMC3394263.pdf
"This coordinated effort has resulted in a comprehensive public repository ofbioinformatics tools and databases, annotated with con- textual information and organized by functional relevance (http://bioinformatics.ca/links_directory).",OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
Detailed explanations and examples of searching within the Links Directory areprovided on the tutorials page at http://www.bioinfor matics.ca/links_directory/tutorial.,Non-OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
"The complete listing of URLscited in the 2012 Web Server Issue can be accessed online at the Nucleic Acids Research website, http://nar.oxfordjournals.org/, and at http://bioinformatics.ca/ links_directory/narweb2012/.",OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
Number of NAR Web Servers from selected subcategories of the Bioinformatics Links Directory (http://bioinformatics.ca/links_directory/).,OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
"Continued Name 2005 Total2006 Total2007 Total2008 Total2009 Total2010 Total2011 2012a Resources Databases Tools Total Resources Databases Tools Total Fly 12 16 17 17 17 21 2 8 13 23 1 7 16 24 General resources 20 23 27 28 29 32 3 12 16 31 3 11 16 30 Microbes 19 31 38 45 53 60 3 12 49 64 2 9 51 62 Mouse and rat 28 32 35 35 36 42 4 17 21 42 4 11 24 39 Other organisms 13 18 21 21 21 22 3 6 13 22 3 4 13 20 Other vertebrates 10 10 10 10 10 11 1 3 7 11 1 3 7 11Plants 11 16 19 21 25 28 2 10 18 30 2 9 20 31 Worm 9 9 9 9 9 10 1 4 6 11 1 4 8 13 Yeast 11 15 18 18 18 21 2 9 10 21 2 7 12 21 Other molecules Carbohydrates 5 6 6 6 6 7 7 7 5 5Compounds 2 6 12 1 14 15 1 15 16 Databases 26 26 25 1 26 Enzymes 2 Metabolites 3 4 7 12 1 12 13 1 13 14 Peptides 11 Small molecules 1 3 6 6 9 13 2 13 15 2 15 17 Protein 2D Structure prediction 29 51 58 60 63 65 1 65 66 56 56 3D Structural features 53 70 75 85 100 1 2 103 106 1 2 107 110 3D Structure comparison 78 35 45 50 59 71 1 6 68 75 1 6 62 69 3D Structure prediction 48 59 60 70 83 4 1 85 90 2 1 83 86 3D Structure retrieval, viewing 28 45 51 52 56 58 4 7 47 58 3 8 42 53Annotation and function 26 35 44 47 53 57 5 57 62 5 56 61 Biochemical features 25 37 40 41 46 46 2 2 43 47 2 2 41 45 Databases 116 1 117 115 2 117 Do-it-all tools for protein 6 8 8 13 14 15 3 12 15 3 11 14 Domains and motifs 50 86 112 115 121 124 14 115 129 14 109 123Identiﬁcation, presentation and format 12 13 14 14 14 14 1 13 14 1 14 15 Networks & Interactions, pathways, enzymes 48 66 88 94 107 125 3 21 113 137 2 19 113 134 Localization and targeting 19 30 38 38 39 41 3 39 42 3 34 37 Molecular dynamics and docking 19 21 27 34 40 1 44 45 1 48 49 Phylogeny reconstruction 28 36 44 45 53 54 4 5 47 56 4 4 48 56 Protein expression 7 8 8 8 10 10 1 2 7 10 1 2 8 11 Proteomics 21 25 27 33 37 39 3 4 32 39 3 4 26 33Sequence comparison 7 14 17 18 18 18 18 Sequence data 7 7 8 9 10 10 1 6 3 10 1 5 3 9 Sequence features 14 25 31 33 38 46 2 2 46 50 2 3 47 52 Sequence retrieval 21 27 29 29 31 29 1 6 21 28 1 7 20 28 RNA Databases 0 24 1 25 23 2 25 Functional RNAs 9 14 19 26 32 37 0 5 39 44 5 41 46 General resources 8 10 10 10 10 11 4 3 4 11 5 2 4 11 Motifs 9 19 21 22 23 25 0 1 26 27 1 25 26 Sequence retrieval 11 11 10 11 11 9 0 2 7 9 2 7 9 Structure prediction, visualization and design 24 38 47 54 58 62 0 3 65 68 3 64 67 Sequence comparison Alignment editing and visualization 14 20 21 21 23 25 0 0 25 25 23 23 Analysis of aligned sequences 27 43 59 60 62 64 0 0 65 65 1 57 58 Comparative genomics 19 26 33 35 37 48 2 7 40 49 2 6 33 41 Multiple sequence alignments 19 38 50 56 57 65 1 0 67 68 1 1 62 64 Other alignment tools 6 11 11 11 11 12 0 0 13 13 12 12Pairwise sequence alignments 11 22 23 26 33 35 1 0 34 35 1 30 31 Similarity searching 13 31 47 47 49 50 1 2 49 52 1 3 45 49 Total unique resources, databases and tools in Bioinformatics Links Directory700 + 1000 + 1100 + 1200 + 1400 1500 144 480 1250 1874 134 455 1205 1794 aA complete listing of all URLs listed in the Nucleic Acids Research 2012 Web Server Issue can be accessed online at: http://bioinformatics.ca/links_directory/narweb2012.Nucleic Acids Research, 2012, Vol.",Non-OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
"In particular, the authors acknowledge all the contributors to the Bioinformatics Links Directory for their valuableinput and suggestions for improvements to the directory; these individuals are listed on the Acknowledgements page at http://bioinformatics.ca/links_directory/acknowledgements/.",OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
"http://scholar.google.ca/ (10 June 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
"http://www.google.com/ + 1/button/ (10 June 2012, date last accessed).W12 Nucleic Acids Research, 2012, Vol.",Non-OADS,/arxiv_data1/oa_pdf/73/2c/gks632.PMC3394264.pdf
"As the output,SurvNet will generate a list of network biomarkersand display them through a user-friendly interface.SurvNet can be accessed at http://bioinformatics.mdanderson.org/main/SurvNet.",OADS,/arxiv_data1/oa_pdf/15/12/gks386.PMC3394266.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/15/12/gks386.PMC3394266.pdf
The network ﬁles are in a ‘.dot’ format that can bevisualized by GraphViz (http://www.graphviz.org).,OADS,/arxiv_data1/oa_pdf/15/12/gks386.PMC3394266.pdf
The DichroMatchserver is freely available at http://dichromatch.cryst.,Non-OADS,/arxiv_data1/oa_pdf/49/7c/gks449.PMC3394267.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/49/7c/gks449.PMC3394267.pdf
"By default, it uses the Protein Circular Dichroism Data Bank(PCDDB), a publicly accessible repository for the storage of validated CD/SRCD spectra together with their associated metadata, as its reference data set (3,4).Alternatively, the user can create a custom reference data set of selected protein spectra (either using an associated website http://createrds.cryst.bbk.ac.uk or byuploading a compressed collection of ﬁles) to perform a more focused matching of a query spectrum.",OADS,/arxiv_data1/oa_pdf/49/7c/gks449.PMC3394267.pdf
"This might bedesirable, for instance, if the user had a series of spectra of related proteins produced by their own laboratory and not yet deposited in the PCDDB or if the user only wantedto consider a subset of all proteins present in the PCDDB.User-deﬁned reference data sets can be produced using theCreateRDS tool (http://createrds.cryst.bbk.ac.uk).",OADS,/arxiv_data1/oa_pdf/49/7c/gks449.PMC3394267.pdf
"Likewise, the referencedata set formatting server located at http://createrds.cryst.bbk.ac.uk is freely accessible to all users.",OADS,/arxiv_data1/oa_pdf/49/7c/gks449.PMC3394267.pdf
"Toidentify such molecules and their most likelybound positions, we extend the functionality ofFTMAP (http://ftmap.bu.edu/param) to accept any small molecule as an additional probe.",Non-OADS,/arxiv_data1/oa_pdf/c5/b0/gks441.PMC3394268.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c5/b0/gks441.PMC3394268.pdf
"The com- putational chemistry toolset RDKIT (RDKIT: Open-source chemoinformatics; http://www.rdkit.org) is used to generate 3D coordinates based on the submitted SMILES strings, and the program OpenBabel (18) performs all required chemical ﬁle format translations.The tool Confab (10) is then used to generate multiple conformations of the small molecules.",OADS,/arxiv_data1/oa_pdf/c5/b0/gks441.PMC3394268.pdf
"Subsequent to the generation of 3D coordinates, the quantum chemistry system GAMESS (18) is used to compute AM1 atomic charges; the information is then piped through molecule manipulation scripts from the Sarnoff Corporation (http://charles.karney.info/ b2d-scripts/) using the molecular mechanics suite ANTECHAMBER (11) to perform BCCs and to generate the ﬁnal AM1-BCC atomic charges.",OADS,/arxiv_data1/oa_pdf/c5/b0/gks441.PMC3394268.pdf
Using the server The updated server is accessible online (http://ftmap.bu .edu/param) and has been tested using Google Chrome and Mozilla Firefox.,OADS,/arxiv_data1/oa_pdf/c5/b0/gks441.PMC3394268.pdf
"Our earlier implementation of the FTMAP algorithm (4), using only the 16 standard probes, is still available at http://ftmap.bu.edu/.",Non-OADS,/arxiv_data1/oa_pdf/c5/b0/gks441.PMC3394268.pdf
"ExPASy: SIB bioinformatics resource portal Panu Artimo1, Manohar Jonnalagedda1,2, Konstantin Arnold3, Delphine Baratin4, Gabor Csardi5, Edouard de Castro4,S e´verine Duvaud4, Volker Flegel1, Arnaud Fortier1, Elisabeth Gasteiger4, Aure ´lien Grosdidier2,C e´line Hernandez1, Vassilios Ioannidis1, Dmitry Kuznetsov1, Robin Liechti1,S e´bastien Moretti1,6, Khaled Mostaguir4, Nicole Redaschi4, Gre´goire Rossier1, Ioannis Xenarios1,4,7and Heinz Stockinger1,* 1Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland,2Molecular Modelling Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland,3Computational Structural Biology Group, University of Basel, SIB Swiss Institute of Bioinformatics, Basel, Switzerland,4Swiss-Prot Group, SIB Swiss Institute of Bioinformatics, Geneva, Switzerland,5Department of Statistics, Harvard University, Cambride, USA,6Department of Ecology and Evolution, University of Lausanne, Lausanne, Switzerland and7Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland Received December 16, 2011; Revised April 10, 2012; Accepted April 17, 2012 ABSTRACT ExPASy (http://www.expasy.org) has worldwide reputation as one of the main bioinformatics re-sources for proteomics.",Non-OADS,/arxiv_data1/oa_pdf/7c/c1/gks400.PMC3394269.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/7c/c1/gks400.PMC3394269.pdf
"Following thisidea, a REST-based cross-resource search protocol (The detailed speciﬁcation of the interface can be found at: http://wiki.isb-sib.ch/web-team/Sib-resource_query-interface) (Figure 3) has been designed.",OADS,/arxiv_data1/oa_pdf/7c/c1/gks400.PMC3394269.pdf
Example of a new URL: http://web.expasy.org/translate instead of http://www .expasy.org/tools/dna.html.,Non-OADS,/arxiv_data1/oa_pdf/7c/c1/gks400.PMC3394269.pdf
The DSP server is avail- able at both http://cheminfo.tongji.edu.cn/dsp/ andits main mirror http://chemcenter.tongji.edu.cn/dsp/.,OADS,/arxiv_data1/oa_pdf/58/54/gks361.PMC3394270.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/58/54/gks361.PMC3394270.pdf
The actual corresponding shape strings are retrieved from http://www.fos.su.se/ /C24pdbdna/ according to their tertiary structures.,OADS,/arxiv_data1/oa_pdf/58/54/gks361.PMC3394270.pdf
The program can befreely downloaded via (http://cheminfo.tongji.edu.cn/dsp/Home/Downloads).,Non-OADS,/arxiv_data1/oa_pdf/58/54/gks361.PMC3394270.pdf
"ZINCPharmer: pharmacophore search of the ZINC database David Ryan Koes* and Carlos J. Camacho Department of Computational and Systems Biology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15260, USA Received January 16, 2012; Revised April 4, 2012; Accepted April 12, 2012 ABSTRACT ZINCPharmer (http://zincpharmer.csb.pitt.edu) is an online interface for searching the purchasable com- pounds of the ZINC database using the Pharmer pharmacophore search technology.",OADS,/arxiv_data1/oa_pdf/25/c7/gks378.PMC3394271.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/25/c7/gks378.PMC3394271.pdf
ZINC compounds are converted into 3D con- formations using omega2 from OpenEye Scientiﬁc Software (http://eyesopen.com).,OADS,/arxiv_data1/oa_pdf/25/c7/gks378.PMC3394271.pdf
"The graphical user interface (Figure 1) for deﬁning, reﬁning and visualizing pharmacophore queries and their results is implemented using JavaScript and theJava-based Jmol (http://www.jmol.org/) molecular viewer.",OADS,/arxiv_data1/oa_pdf/25/c7/gks378.PMC3394271.pdf
"Alternatively, if there aremany known binders then a consensus pharmacophorecan be elucidated (1,4) using software such as ChemicalComputing Group’s MOE (http://www.chemcomp.com/), Inte:Ligand’s LigandScout (http://www.inteligand.com/), or PharmaGist (5) and the result can be imported intoZINCPharmer.",OADS,/arxiv_data1/oa_pdf/25/c7/gks378.PMC3394271.pdf
ZINCPharmer is a fully open access resource and is avail- able at http://zincpharmer.csb.pitt.edu.ACKNOWLEDGEMENTS The ZINC database is incorporated into ZINCPharmer by permission.,OADS,/arxiv_data1/oa_pdf/25/c7/gks378.PMC3394271.pdf
Free access: http://xxmotif.genzentrum.lmu.de.,Non-OADS,/arxiv_data1/oa_pdf/f9/03/gks602.PMC3394272.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f9/03/gks602.PMC3394272.pdf
RENATO also offers an interactive advanced graphical interface that allows exploring the regulatory networkfound.RENATO is available at: http://renato.bioinfo.cipf.es/.,OADS,/arxiv_data1/oa_pdf/7e/fb/gks573.PMC3394273.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/7e/fb/gks573.PMC3394273.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/21/a3/gks515.PMC3394274.pdf
The Java applet is part of Jmol applet molecu- lar viewer distribution (http://jmol.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/21/a3/gks515.PMC3394274.pdf
"Prediction performace for Astex diverse set (34,36) Docking method For RMSD <2A˚(%)For RMSD <1A˚(%) Quantum.Ligand.Dock 78 59 AutoDock (35) 81.7 NAChemPLPa(34,36) 81 59 GoldScorea(34,36) 69 50 ChemScorea(34,36) 76 48 ASPa(36) 72 44 LigDockCSA (35) 84.7 NAMolGroVirtual Docker (37) 74 NA ahttp://www.ccdc.cam.ac.uk/case_studies/life_science/workcase_ posepred.pdf (Cambridge crystallographic data centre).W420 Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/21/a3/gks515.PMC3394274.pdf
It is available at http://csa.project.cwi.nl.,Non-OADS,/arxiv_data1/oa_pdf/c0/51/gks362.PMC3394275.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c0/51/gks362.PMC3394275.pdf
"In the output layer, structures and their superpos- itions are visualized in Jmol (http://www.jmol.org) and images are generated using the PHP package pChart(http://www.pchart.net/).",OADS,/arxiv_data1/oa_pdf/c0/51/gks362.PMC3394275.pdf
"However, the limited nature of this information has fostered therecent development of tools speciﬁcally designed for theannotation and functional assessment of Single Nucleotide Variants (SNVs) such as ANNOVAR (7), snpEff (http://snpeff.sourceforge.net/) or Variant EffectPredictor (8).",OADS,/arxiv_data1/oa_pdf/47/83/gks572.PMC3394276.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/47/83/gks572.PMC3394276.pdf
"Annotated SNPs are taken from Ensembl’sApplication Programming Interface (API) which inte-grates distinct databases such as: HGMD-PUBLIC (19),NHGRI GWAS catalog (20), OMIM (http://omim.org/) and Open Access GWAS Database (21).",OADS,/arxiv_data1/oa_pdf/47/83/gks572.PMC3394276.pdf
We also include pathologic mutations collected from COSMIC (http://www.sanger.ac.uk /genetics /CGP /cosmic/) and UniProt (22).,Non-OADS,/arxiv_data1/oa_pdf/47/83/gks572.PMC3394276.pdf
For example: http://ws.bioinfo.cipf.es/cellbase/rest/latest/hsa/genomic/ variant/13:32906982:T/consequence_type returns the consequence type of a substitution of the ref- erence base by a T in the position 32906982 of the chromosome 13.,Non-OADS,/arxiv_data1/oa_pdf/47/83/gks572.PMC3394276.pdf
Theﬁrst and probably the most popular tools are Annovar (7) and snpEff (http://snpeff.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/47/83/gks572.PMC3394276.pdf
"According to the information given in the respective publications, runtimes are quite similar (approximately one exome, assuming 30–40,000 variants per exome in half hour), except for the snpEff, which claims to makeover a million predictions per minute (according to http://snpeff.sourceforge.net/).",Non-OADS,/arxiv_data1/oa_pdf/47/83/gks572.PMC3394276.pdf
GeneView can besearched at http://bc3.informatik.hu-berlin.de/.,OADS,/arxiv_data1/oa_pdf/41/73/gks563.PMC3394277.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/41/73/gks563.PMC3394277.pdf
The DR_bind server is freely available with nologin requirement at http://dnasite.limlab.ibms.sinica.edu.tw.,OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
"In thiswork, we have implemented our DNA-residue predictionmethod for public use in a web server, DR_bind (http://dnasite.limlab.ibms.sinica.edu.tw).",OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
"This yielded 83 DNA-bound proteins that are sequentially and structurally non-homologous with conservation data (Supplementary Table S1), whereas the remaining 12 proteins had no conservation proﬁles from the ConSurf- DB database (http://consurfdb.tau.ac.il/) (32).",OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
"Data set II was derived from Data set I by searching each of the 83 DNA-bound proteins with conservationdata for highly homologous proteins (sharing /C2190% sequence identity) with DNA-free structure(s) using the SAS tool (http://www.ebi.ac.uk/thornton-srv/databases/sas/); if multiple DNA-free structures were found, the structure that showed the largest root-mean-square devi- ation (RMSD) from the DNA-bound structure usingthe SSAP program (33) was chosen as the representative one.",OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
"Performance measures To evaluate the performance of DR_bind, the numbers of correctly predicted binding residues (TP) and non-bindingresidues (TN), as well as the numbers of incorrectly pre-dicted binding residues (FP) and non-binding residues(FN) were computed and used to determine: sensitivity ¼TP=ðTP + FN Þð 4Þ specificity ¼TN=ðFP + TN Þ, ð5Þ precision ¼TP=ðTP + FP Þð 6Þ accuracy ¼ðTP + TN Þ=ðTP + FP + TN + FN Þð 7Þ Matthew 0s correlation coefficient or MCC ¼ðTP/C2TNÞ/C0ðFP/C2FNÞ= TP + FPðÞ TP + FNðÞ TN + FPðÞ TN + FNðÞ ½/C1381=2ð8Þ DR_bind web server Input On the DR_bind web page http://dnasite.limlab.ibms .sinica.edu.tw/, users are given two options: For optionA, users upload their own ﬁle in PDB format and theevolutionary data for their protein in ConSurf format orask DR_bind to retrieve the evolutionary data fromConSurf.",OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
"This 3D representation is created using Jmol (http://www.jmol.org/) and can be rotated and zoomed in/out on the results page itself.DR_bind currently runs on an Apple Mac Mini quad-core i7 server and the time taken to yield a predic-tion depends on the number of residues in the PDB chain.A prediction takes /C245 min for 50 residues, /C241.5 h for 200 residues, /C244.5 h for 350 residues and /C2410 h for 450 residues.",OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
Helppages with instructions on how to use the server are avail-able at http://dnasite.limlab.ibms.sinica.edu.tw/examples/ help.html.,OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
"Comparisons with other servers that predict DNA-binding residues Using our bound and free data sets, the performance of DR_bind was compared with that of three recentweb servers, BINDN + (http://bioinfo.ggc.org/bindn + /),NAPS (http://proteomics.bioengr.uic.edu/NAPS) andDNABINDPROT (http://www.prc.boun.edu.tr/appserv/prc/dnabindprot/).",OADS,/arxiv_data1/oa_pdf/d0/03/gks481.PMC3394278.pdf
The RPF server is availableat: http://nmr.cabm.rutgers.edu/rpf.,OADS,/arxiv_data1/oa_pdf/a4/db/gks373.PMC3394279.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/gks373.PMC3394279.pdf
Available online at http://www.jmol.org.,Non-OADS,/arxiv_data1/oa_pdf/a4/db/gks373.PMC3394279.pdf
The CPred is accessible at http://sarst.life.nthu.edu.tw/CPred.,Non-OADS,/arxiv_data1/oa_pdf/43/f7/gks529.PMC3394280.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/43/f7/gks529.PMC3394280.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/96/29/gks550.PMC3394281.pdf
The NFBC1966 GWAS data were provided bythe database of Genotype and Phenotype (dbGaP; http://www.ncbi.nlm.nih.gov/gap) via speciﬁc Data UseCertiﬁcation.,OADS,/arxiv_data1/oa_pdf/96/29/gks550.PMC3394281.pdf
"BiForce Toolbox is free and thebinary ﬁles compiled for the three operating systems (Mac OSX, Windows and Linux) can be downloaded from http://bioinfo.utu.ﬁ/BiForceToolbox/.",OADS,/arxiv_data1/oa_pdf/96/29/gks550.PMC3394281.pdf
"We are grateful for assistance from the authors of the BOOST software.We acknowledge data access to NHLBI STAMPEED study (Northern Finland Birth Cohort 1966, phs000276.v1.p1) via dbGaP (http://www.ncbi.nlm.nih .gov/gap).",Non-OADS,/arxiv_data1/oa_pdf/96/29/gks550.PMC3394281.pdf
"IMP currently supportsseven organisms ( Homo sapiens ,Mus musculus , Rattus novegicus ,Drosophila melanogaster ,Danio rerio ,Caenorhabditis elegans and Saccharomyces cerevisiae ), does not require any registration or installation and is freely available for use at http://imp.princeton.edu.",Non-OADS,/arxiv_data1/oa_pdf/a3/16/gks458.PMC3394282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a3/16/gks458.PMC3394282.pdf
The complete list of data sources is accessible directly on the web server (http://imp.princeton.edu/networks/data/).,OADS,/arxiv_data1/oa_pdf/a3/16/gks458.PMC3394282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/90/af/gks561.PMC3394284.pdf
GBlocks was run at lower and higher stringency using the web server version (http://molevol.cmima.csic.es/castresana/Gblocks_server.html).,OADS,/arxiv_data1/oa_pdf/90/af/gks561.PMC3394284.pdf
"Seq2Logo is available at http://www.cbs.dtu.dk/biotools/Seq2Logo (14 May2012, date last accessed).INTRODUCTION The idea of generating a logo from aligned sets of sequences was introduced in 1990 by Schneider and Stephens (1).",OADS,/arxiv_data1/oa_pdf/45/98/gks469.PMC3394285.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/45/98/gks469.PMC3394285.pdf
"An instruction of how to implement this transfer can befound at: http://www.cbs.dtu.dk/biotools/Seq2Logo-1.0/ bin/easytransferbutton.html (14 May 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/45/98/gks469.PMC3394285.pdf
SPRITE is availableat http://mfrlab.org/grafss/sprite/ while ASSAM canbe accessed at http://mfrlab.org/grafss/assam/.,OADS,/arxiv_data1/oa_pdf/c1/57/gks401.PMC3394286.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c1/57/gks401.PMC3394286.pdf
All of the output browsingoptions listed also allow for visualization of the hits in aJmol (http://www.jmol.org/) molecular viewer window.,OADS,/arxiv_data1/oa_pdf/c1/57/gks401.PMC3394286.pdf
"We havedeveloped a web resource, dbCAN (http://csbl.bmb.uga.edu/dbCAN/annotate.php), to provide a cap-ability for automated CAZyme signature domain-based annotation for any given protein data set (e.g.",OADS,/arxiv_data1/oa_pdf/f3/e1/gks479.PMC3394287.pdf
"The CAZy database (short asCAZyDB hereafter) represents the currently most compre- hensive database (http://www.cazy.org) for CAZyme proteins, which consists of 308 CAZyme families as ofApril 2011 (excluding nine deprecated ones and ﬁve un- classiﬁed families, e.g.",OADS,/arxiv_data1/oa_pdf/f3/e1/gks479.PMC3394287.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f3/e1/gks479.PMC3394287.pdf
"To fully address the issues outlined above, we developed a web resource, dbCAN (http://csbl.bmb.uga.edu/dbCAN/),based on the classiﬁcation scheme of CAZyDB.",OADS,/arxiv_data1/oa_pdf/f3/e1/gks479.PMC3394287.pdf
"Immune epitope database analysis resource Yohan Kim1, Julia Ponomarenko2, Zhanyang Zhu3, Dorjee Tamang1, Peng Wang4, Jason Greenbaum1, Claus Lundegaard5, Alessandro Sette1, Ole Lund5, Philip E. Bourne2, Morten Nielsen5and Bjoern Peters1,* 1La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037,2San Diego Supercomputer Center, MC 0505, 10100 Hopkins Drive, La Jolla, CA 92093,3Sequenom, 3595 John Hopkins Court, San Diego, CA 92121, USA,4Shanghai Advanced Research Institute, No.99 Haike Road, Zhangjiang Hi-Tech Park, Pudong Shanghai, 201210, China and5Technical University of Denmark, Building 208, 2800, Lyngby, Denmark Received March 2, 2012; Revised April 19, 2012; Accepted April 25, 2012 ABSTRACT The immune epitope database analysis resource (IEDB-AR: http://tools.iedb.org) is a collection oftools for prediction and analysis of moleculartargets of T- and B-cell immune responses (i.e.",OADS,/arxiv_data1/oa_pdf/36/1c/gks438.PMC3394288.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/36/1c/gks438.PMC3394288.pdf
Details on the use of IEDB-API as well as examplesare provided at the IEDB-AR website (http://tools.iedb.,OADS,/arxiv_data1/oa_pdf/36/1c/gks438.PMC3394288.pdf
TheParatome web server is freely available at http://www.ofranlab.org/paratome/.,OADS,/arxiv_data1/oa_pdf/39/69/gks480.PMC3394289.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/39/69/gks480.PMC3394289.pdf
"For the full list of train and test sets is available at http://ofranservices.biu.ac.il/site/services/paratome/ABRs_train_pdb.txt, 23 May2012, date last accessed http://ofranservices.biu.ac.il/site/ services/paratome/ABRs_test_pdb.txt, 23 May 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/39/69/gks480.PMC3394289.pdf
"CDRs according to Kabat and Chothia wereobtained by coupling the Abnum tool (http://www.bioinf.org.uk/abs/abnum/, 23 May 2012, date last accessed) with a table of CDRs deﬁnitions (http://www.bioinf.org.uk/abs/#cdrdef, 23 May 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/39/69/gks480.PMC3394289.pdf
"To obtain the CDRs according to IMGT, we applied the IMGT-gap tool (http://www.imgt.org/3Dstructure-DB/cgi/DomainGapAlign.cgi, 23 May 2012,date last accessed).",OADS,/arxiv_data1/oa_pdf/39/69/gks480.PMC3394289.pdf
"Structure visualization is enabled using the Jmol Java applet (http://jmol.sourceforge.net/, 23 May 2012, date last accessed).The web server and computations run on a Red-hat Enterprise Linux 5.7 (Tikanga) with 3.00 GHz 8 CPUs and 16 GB primary memory.",OADS,/arxiv_data1/oa_pdf/39/69/gks480.PMC3394289.pdf
Available at http://www.facweb.iitkgp.ernet.in/ /C24rbahadur/prince/home.html.,Non-OADS,/arxiv_data1/oa_pdf/fb/77/gks535.PMC3394290.pdf
"In order to calculate all these interface parameters for a given protein–RNA complex, we have automatized the methodand implemented it into a web server named PRince (P rotein-R NA in terface ; http://www.facweb.iitkgp.ernet.",OADS,/arxiv_data1/oa_pdf/fb/77/gks535.PMC3394290.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/fb/77/gks535.PMC3394290.pdf
It is freely available at http://intscore.molgen.mpg.de.,Non-OADS,/arxiv_data1/oa_pdf/b4/eb/gks492.PMC3394291.pdf
"To provide the research community with a tool for interaction conﬁdence scoring, we have developed IntScore (http://intscore.molgen.mpg.de).",Non-OADS,/arxiv_data1/oa_pdf/b4/eb/gks492.PMC3394291.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b4/eb/gks492.PMC3394291.pdf
The NASSAMprogram is freely accessible without any loginrequirement at http://mfrlab.org/grafss/nassam/.,OADS,/arxiv_data1/oa_pdf/c1/71/gks513.PMC3394293.pdf
"In recent years, theProtein Data Bank (PDB; http://www.rcsb.org/pdb/) (1) has seen a signiﬁcant increase in the availability of RNA crystallographic structures.",OADS,/arxiv_data1/oa_pdf/c1/71/gks513.PMC3394293.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c1/71/gks513.PMC3394293.pdf
Users have a further option of selecting hit patterns for visual examin- ation in a Jmol molecular visualization Java plug-inwindow (http://www.jmol.org/).,OADS,/arxiv_data1/oa_pdf/c1/71/gks513.PMC3394293.pdf
METAGENassist is available athttp://www.metagenassist.ca.,OADS,/arxiv_data1/oa_pdf/39/3c/gks497.PMC3394294.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/39/3c/gks497.PMC3394294.pdf
"Brieﬂy, the web interface was developed using Java Server Faces (http://java.sun.com/javaee/javaserverfaces, JSF) technol-ogy.",OADS,/arxiv_data1/oa_pdf/39/3c/gks497.PMC3394294.pdf
The integrationbetween Java and R was established through the Rservepackage (http://www.rforge.net/Rserve).,OADS,/arxiv_data1/oa_pdf/39/3c/gks497.PMC3394294.pdf
idTarget is freely available as a web-basedserver at http://idtarget.rcas.sinica.edu.tw.,OADS,/arxiv_data1/oa_pdf/9e/b3/gks496.PMC3394295.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/9e/b3/gks496.PMC3394295.pdf
Marvin Sketch applet (http://www.chemaxon.com/products/marvin/marvinsketch/) was embedded inthe idTarget job submission page so that users can drawtheir interested ligand online.,OADS,/arxiv_data1/oa_pdf/9e/b3/gks496.PMC3394295.pdf
"In the result page, userscan inspect the binding poses and manipulate theresulting 3D structures interactively via the embeddedOpenAstexViewer applet (http://openastexviewer.net/web/).",OADS,/arxiv_data1/oa_pdf/9e/b3/gks496.PMC3394295.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ad/86/gks375.PMC3394296.pdf
The application isfreely available at http://genecodis.cnb.csic.es.,OADS,/arxiv_data1/oa_pdf/2f/64/gks402.PMC3394297.pdf
"A good compendium of available tools can befound at http://www.geneontology.org/GO.tools.shtml (accessed April 30, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2f/64/gks402.PMC3394297.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/2f/64/gks402.PMC3394297.pdf
"The inclusion of biomedical literature data from Pubmed identiﬁers (http://www.ncbi.nlm.nih.gov/ pubmed/, accessed April 30, 2012) facilitates the ﬁndingof articles related with a group of genes.",OADS,/arxiv_data1/oa_pdf/2f/64/gks402.PMC3394297.pdf
Thisapproach gives a global view of the studiedprocess and makes it possible to highlight specificinteractions that have so far been understudied.DroPNet is freely available at http://dropnet.isima.fr.,OADS,/arxiv_data1/oa_pdf/65/0b/gks434.PMC3394298.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/65/0b/gks434.PMC3394298.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/fa/4c/gks528.PMC3394299.pdf
"For example, FLAN was de-veloped at NCBI to annotate inﬂuenza viral genomes (2).In order to efﬁciently validate genome sequence data andaccurately annotate the viral genomes sequenced by MSC,a homology-based viral gene prediction program calledVIGOR (Vi ral G enome O RF R eader, http://www.jcvi .org/vigor) was developed at J. Craig Venter Institute(JCVI) for inﬂuenza virus, coronavirus, SARS corona- virus, rhinovirus and rotavirus (3).",OADS,/arxiv_data1/oa_pdf/fa/4c/gks528.PMC3394299.pdf
The gene feature table can be used to create GenBank submission ﬁles bySequin (http://www.ncbi.nlm.nih.gov/Sequin/index) or tbl2asn (http://www.ncbi.nlm.nih.gov/GenBank/tbl2asn2 .html).,OADS,/arxiv_data1/oa_pdf/fa/4c/gks528.PMC3394299.pdf
"To overcome these problems, we have developed O-miner (http://www.o-miner.org), which can analyse themost popular, and widely used Affymetrix genomics and transcriptomics array types on the ﬂy starting from raw standard Affymetrix ﬁle format (CEL image ﬁlesobtained from the scanner) or partially processed format (normalized, segmented and/or binary) with minimal set-up efforts.",Non-OADS,/arxiv_data1/oa_pdf/52/3a/gks432.PMC3394300.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/52/3a/gks432.PMC3394300.pdf
CellBase documentation can be found athttp://docs.bioinfo.cipf.es/projects/cellbase.,OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"In order to provide a high availability and load balancing to the MySQL replication cluster, a Keepalived (http://www.keepalived.org) and HAProxy (http://haproxy.1wt.eu) services have been conﬁgured.",OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"To achieve a higher performance, Java was chosen for the server implementation to both (i) connect to MySQLusing JBoss Hibernate (http://www.hibernate.org) and(ii) to implement RESTful web services API using Jerseylibrary (http://jersey.java.net).",OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"To provide a high availability and loadbalancing to these web services, a HAProxy (http://haproxy.1wt.eu) was set up to balance Apache Tomcatinstances.",OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
Detailed and up-to-date information of currently available methods can be accessed by visiting the docu-mentation page at http://docs.bioinfo.cipf.es/projects/cellbase/wiki.,OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"chromosome 16 from 3698105 to 3701105), we usethe genomic category since the speciﬁed inputs aregenomic coordinates: http://ws.bioinfo.cipf.es/cellbase/rest/latest/hsa/genomic/ region/16:3698105-3701105/snp Example 2 .",Non-OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
Retrieving all transcripts for a gene is straightforward using the feature category: http://ws.bioinfo.cipf.es/cellbase/rest/latest/hsa/feature/ gene/BRCA2/transcript Table 1.,OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"Theresulting query will look like this: http://ws.bioinfo.cipf.es/cellbase/rest/latest/hsa/feature/id/ ENSG00000011478,ENSG00000008382/xref?dbname=hgnc_symbol Example 4 .",OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
To fetch the target genes for a particular miRNA like hsa-mir-150: http://ws.bioinfo.cipf.es/cellbase/rest/latest/hsa/regulatory /mirna_gene/hsa-mir-150/target Example 5 .,OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
To download a diagram of a speciﬁc pathway: http://ws.bioinfo.cipf.es/cellbase/rest/latest/hsa/network/ pathway/Triacylglycerol%20biosynthesis/image Example 6.,Non-OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"To obtain all available species, codes and genome assemblies: http://ws.bioinfo.cipf.es/cellbase/rest/latest/species Using CellBase RESTful web services CellBase RESTful web services have been implemented using HTTP GET method, so they can be accesseddirectly from any web browser.",OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
"CellBase web services are also available throughsome applications developed in our department such asGenome Maps (http://genomemaps.org), RENATO(http://renato.bioinfo.cipf.es) or VARIANT (http://variant.bioinfo.cipf.es), what proves the beneﬁts andpotential of this implementation.",OADS,/arxiv_data1/oa_pdf/1d/cf/gks575.PMC3394301.pdf
The freely avail- able service and documentation can be accessed at http://gurkan.case.edu/software or http://magnet.case.edu.,Non-OADS,/arxiv_data1/oa_pdf/44/c8/gks526.PMC3394302.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/44/c8/gks526.PMC3394302.pdf
PredyFlexy can be accessed at http://www.dsimb.inserm.fr/dsimb_tools/predyflexy/.INTRODUCTION X-ray experiments have been valuable tools to understand the intimate relation between protein structures and bio- logical functions.,OADS,/arxiv_data1/oa_pdf/9b/ff/gks482.PMC3394303.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/9b/ff/gks482.PMC3394303.pdf
The method is implemented in a useful web serverPredyFlexy (http://www.dsimb.inserm.fr/dsimb_tools/ predyﬂexy/) which is able to give different type of predic- tions as well a CI with outputs and ﬂat ﬁle.,OADS,/arxiv_data1/oa_pdf/9b/ff/gks482.PMC3394303.pdf
"Theuse of DBD2BS to predict PWMs can beincorporated with sequence-based methods todiscover binding sites in genome-wide studies.Available at: http://dbd2bs.csie.ntu.edu.tw/, http://dbd2bs.csbb.ntu.edu.tw/, and http://dbd2bs.ee.ncku.edu.tw.",OADS,/arxiv_data1/oa_pdf/ba/42/gks564.PMC3394304.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ba/42/gks564.PMC3394304.pdf
Clicking the ‘3D’ buttons of sequence logos loads the corresponding tem-plates into the Jmol (available at http://www.jmol.org/) panel on the right side of the result page.,Non-OADS,/arxiv_data1/oa_pdf/ba/42/gks564.PMC3394304.pdf
DIANA-miRPath v2.0 is an efficient and yet easy to use tool that can be incorporated success-fully into miRNA-related analysis pipelines.It provides for the first time a series of highly specific tools for miRNA-targeted pathway analysis via a web interface and can be accessed at http://www.microrna.gr/miRPathv2.,OADS,/arxiv_data1/oa_pdf/42/e5/gks494.PMC3394305.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/42/e5/gks494.PMC3394305.pdf
"The directory, at http://bioinformatics.ca/links_directory, is a searchable compilation of web servers published in this and previous Web Server issues together with other useful tools, databases and resources for life sciences research.",OADS,/arxiv_data1/oa_pdf/4d/1a/gks607.PMC3394306.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4d/1a/gks607.PMC3394306.pdf
EvolView is freely available at: http://www.evolgenius.info/evolview.html.,Non-OADS,/arxiv_data1/oa_pdf/43/59/gks576.PMC3394307.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/43/59/gks576.PMC3394307.pdf
"The second tutorial provides even more detailed step-by-step instruction for new users, and is available online (http://code.google.com/p/evolgenius/wiki/EvolViewQuickStart).All datasets for the two tutorials can be directly copy-pasted into our web tool.",Non-OADS,/arxiv_data1/oa_pdf/43/59/gks576.PMC3394307.pdf
"Full documentation,including detailed instructions for dataset preparation,can also be found online (http://code.google.com/p/ evolgenius/wiki/EvolView).",OADS,/arxiv_data1/oa_pdf/43/59/gks576.PMC3394307.pdf
"For more details about the datasets and more examples, please see our online documentation on datasets at http://code.google .com/p/evolgenius/wiki/EvolViewIntroductionToDatasets.Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/43/59/gks576.PMC3394307.pdf
ACKNOWLEDGEMENTS We are thankful to Lukas Laag and other developers for their wonderful open-source libraries used by this project; see here for a complete list (http://code.google.com/p/ evolgenius/wiki/EvolViewAcknowledgements).,Non-OADS,/arxiv_data1/oa_pdf/43/59/gks576.PMC3394307.pdf
Thewebserver is fully open access and can be foundat http://homingendonuclease.net.,OADS,/arxiv_data1/oa_pdf/ac/9f/gks365.PMC3394308.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ac/9f/gks365.PMC3394308.pdf
The MOLE online 2.0 application is freely available via the Internet at http://ncbr.muni.cz/mole or http://mole.upol.cz.,OADS,/arxiv_data1/oa_pdf/87/8a/gks363.PMC3394309.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/gks363.PMC3394309.pdf
http://mole.upol.cz/documentation/).,Non-OADS,/arxiv_data1/oa_pdf/87/8a/gks363.PMC3394309.pdf
"Results visualization and analysis Proﬁles of the channels found are presented in three ways: (i) plots of channel radii against length (visualized using gnuplot—http://www.gnuplot.info—as PNG images); (ii)an interactive table summarizing the set of lining residues and physicochemical properties; and (iii) the channel isosurface along its centerline, which is visualized in the Jmol plugin (36).",OADS,/arxiv_data1/oa_pdf/87/8a/gks363.PMC3394309.pdf
Channel centerline positions with radii of max- imally inscribed balls values can also be downloaded in two formats for further analysis and storage: (i) as ageneric PDB ﬁle or (ii) as a python script for visualizationin PyMol (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/87/8a/gks363.PMC3394309.pdf
"CONCLUSIONS In this article, we described MOLE online 2.0 (http://ncbr .muni.cz/mole or http://mole.upol.cz), a new web-based interactive tool for the analysis of molecular channelsand pores.",OADS,/arxiv_data1/oa_pdf/87/8a/gks363.PMC3394309.pdf
KOMODO is freely available at http://komodotool.org.,Non-OADS,/arxiv_data1/oa_pdf/f5/ad/gks490.PMC3394310.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f5/ad/gks490.PMC3394310.pdf
KOMODO isfreely available for use at http://komodotool.org.,Non-OADS,/arxiv_data1/oa_pdf/f5/ad/gks490.PMC3394310.pdf
Theweb server can be freely accessed at http://galaxy.seoklab.org/.,OADS,/arxiv_data1/oa_pdf/ed/aa/gks493.PMC3394311.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ed/aa/gks493.PMC3394311.pdf
The JMol (http://www.jmol.org) is used for visualization of predicted structures.,OADS,/arxiv_data1/oa_pdf/ed/aa/gks493.PMC3394311.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/19/54/gks372.PMC3394312.pdf
"To this end, a secondlibrary of protein structures that have known GO termswas created using PDB-GO mapping taken from the Gene Ontology Annotation database (http://www.ebi.ac.uk/ GOA/) and SIFTS project (http://www.ebi.ac.uk/pdbe/docs/sifts/).",OADS,/arxiv_data1/oa_pdf/19/54/gks372.PMC3394312.pdf
Allthe libraries are freely downloadable at http://zhanglab.ccmb.med.umich.edu/COFACTOR/library.html.,OADS,/arxiv_data1/oa_pdf/19/54/gks372.PMC3394312.pdf
http://www.jmol.org/.,Non-OADS,/arxiv_data1/oa_pdf/19/54/gks372.PMC3394312.pdf
The Rtips web server along with the stand-alone programs is freely accessibleat http://rna.naist.jp/.,OADS,/arxiv_data1/oa_pdf/82/a2/gks412.PMC3394313.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/82/a2/gks412.PMC3394313.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/7a/14/gks374.PMC3394314.pdf
"For MetaboAnalyst 2.0, all the images arenow anti-aliased using the Cairo graphics library (http://cairographics.org).",OADS,/arxiv_data1/oa_pdf/7a/14/gks374.PMC3394314.pdf
The iELM server supports single protein queries as well as large-scale proteomic submissions and isfreely available at http://i.elm.eu.org.,OADS,/arxiv_data1/oa_pdf/a2/51/gks444.PMC3394315.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a2/51/gks444.PMC3394315.pdf
USER INTERFACE The iELM web server is freely available at http://i.elm.eu .org with no login required.,OADS,/arxiv_data1/oa_pdf/a2/51/gks444.PMC3394315.pdf
"The server can be queried in two ways: ‘protein iELM’ searches theprecalculated high-quality associations (score >0.6) from the STRING resource for SLiM-mediated interactions, whereas ‘proteomic iELM’ allows users to explore their own protein–protein interactome of interest for SLiMs.The server also provides a list of all 835 annotated linear motif-binding domains that can be freely downloaded at http://i.elm.eu.org/domains.",OADS,/arxiv_data1/oa_pdf/a2/51/gks444.PMC3394315.pdf
The web server is freely available at http://i.elm.eu.org.,OADS,/arxiv_data1/oa_pdf/a2/51/gks444.PMC3394315.pdf
BIPS is freely accessible at http://sbi.imim.es/BIPS.php.,Non-OADS,/arxiv_data1/oa_pdf/8a/56/gks553.PMC3394316.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/8a/56/gks553.PMC3394316.pdf
"The models enable us to analyze macro-molecular dynamics with the maximum degrees offreedom by combining a variety of ENMs from full-atom to coarse-grained, backbone and hybrid models with one connection rule, such asdistance-cutoff, number-cutoff or chemical-cutoff.KOSMOS is available at http://bioengineering.skku.ac.kr/kosmos.",OADS,/arxiv_data1/oa_pdf/d3/46/gks525.PMC3394317.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d3/46/gks525.PMC3394317.pdf
ConoDictoris freely accessible at http://conco.ebc.ee.,Non-OADS,/arxiv_data1/oa_pdf/f4/ee/gks337.PMC3394318.pdf
"The precursors generally contain an N-terminalsignal sequence, a central propeptide region and a C-terminal hypervariable mature toxin (4,5).The Conoserver database (http://www.conoserver.org/) is a repository of nucleic acid and protein sequences, and of structural information on conopeptides (4).",Non-OADS,/arxiv_data1/oa_pdf/f4/ee/gks337.PMC3394318.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f4/ee/gks337.PMC3394318.pdf
A detailed help page provides clear explanations and screen shots of the most important tables of the analysis (http://conco.ebc.ee/ConoDictor_help.html).,OADS,/arxiv_data1/oa_pdf/f4/ee/gks337.PMC3394318.pdf
"RegPrecise web services interface: programmatic access to the transcriptional regulatory interactions in bacteria reconstructed by comparative genomics Pavel S. Novichkov1,*, Thomas S. Brettin2, Elena S. Novichkova1, Paramvir S. Dehal1, Adam P. Arkin1, Inna Dubchak1and Dmitry A. Rodionov3,4,* 1Lawrence Berkeley National Laboratory, Berkeley, CA 94720,2Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831-6420, USA,3Institute for Information Transmission Problems, Russian Academy of Sciences, Moscow 127994 and4Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA Received March 19, 2012; Revised May 10, 2012; Accepted May 18, 2012 ABSTRACT Web services application programming interface (API) was developed to provide a programmaticaccess to the regulatory interactions accumulatedin the RegPrecise database (http://regprecise.lbl.gov), a core resource on transcriptional regulationfor the microbial domain of the Department of Energy (DOE) Systems Biology Knowledgebase.",OADS,/arxiv_data1/oa_pdf/9d/15/gks562.PMC3394319.pdf
TheRegPrecise web services API is freely accessible at http://regprecise.lbl.gov/RegPrecise/services.jsp with no login requirements.,OADS,/arxiv_data1/oa_pdf/9d/15/gks562.PMC3394319.pdf
"In 2009–10, with a goal of building collections of taxonomy-speciﬁc reference regulons, we developed twoweb resources for large-scale inference and analysis of regulatory interactions in prokaryotes: the RegPrecise database (http://regprecise.lbl.gov) to capture and visual-ize manually curated regulons (9) and the RegPredict web *To whom correspondence should be addressed.",OADS,/arxiv_data1/oa_pdf/9d/15/gks562.PMC3394319.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/9d/15/gks562.PMC3394319.pdf
server (http://regpredict.lbl.gov) for fast and accurate regulon reconstruction (8).,OADS,/arxiv_data1/oa_pdf/9d/15/gks562.PMC3394319.pdf
The base Uniform ResourceLocator (URL) for all web services is http://regprecise.lbl.gov/Services/rest/.,OADS,/arxiv_data1/oa_pdf/9d/15/gks562.PMC3394319.pdf
The complete documentation on the listed resources can be found at http://regprecise.lbl.gov/RegPrecise/services.jsp.,OADS,/arxiv_data1/oa_pdf/9d/15/gks562.PMC3394319.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/97/81/gks514.PMC3394320.pdf
The user interface was built as a web application using GWT development toolkit (http://code.google.com/webtoolkit/).,OADS,/arxiv_data1/oa_pdf/97/81/gks514.PMC3394320.pdf
The MoNetFamily sever is available at http://monetfamily.life.nctu.edu.tw.INTRODUCTION A module is a fundamental unit forming with highly connected proteins and often possesses speciﬁc biologicalfunctions.,Non-OADS,/arxiv_data1/oa_pdf/80/64/gks541.PMC3394321.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/80/64/gks541.PMC3394321.pdf
The pKNOT v.2 is available from http://pknot.life.nctu.edu.tw/.,Non-OADS,/arxiv_data1/oa_pdf/81/aa/gks592.PMC3394322.pdf
"Currently, there are two web servers available for analysis of knotted protein—pKNOT (12) (http://pknot.life.nctu.edu.tw) and KNOTS (13) (http://knots.mit.edu).",OADS,/arxiv_data1/oa_pdf/81/aa/gks592.PMC3394322.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/81/aa/gks592.PMC3394322.pdf
The QGRS-H Predictor can be freely accessedat: http://quadruplex.ramapo.edu/qgrs/app/start.,OADS,/arxiv_data1/oa_pdf/05/88/gks422.PMC3394323.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/05/88/gks422.PMC3394323.pdf
The MFEprimer-2.0 server does notrequire a login and is freely available at http://biocompute.bmi.ac.cn/CZlab/MFEprimer-2.0.,OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
"Moreover, the MFEprimer-2.0 command-line version and local server version are open source and can be downloaded at https://github.com/quwubin/MFEprimer/wiki/Manual/.",Non-OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
"A Python (http://www.python .org) script (see Supplementary Scripts) was used to cal- culate all of the k-mer values, with k ranging from 5 to 9.",OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
"Detailed infor-mation for the output is provided in the FAQ list (http://code.google.com/p/mfeprimer/wiki/FAQ).W206 Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
"The ‘‘MultiAlign’’ function can help the user identify the rela-tionship between these amplicons (for detailed informa-tion, see https://github.com/quwubin/MFEprimer/wiki/HowTo).",Non-OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
We experimentally validated the primer pair and obtainedhigh-quality results (see https://github.com/quwubin/MFEprimer/wiki/HowTo for detailed results).,Non-OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
Some of them are listed on our ‘‘Thanks’’ page: https://github.com/quwubin/MFEprimer/wiki/iThank.,Non-OADS,/arxiv_data1/oa_pdf/05/3a/gks552.PMC3394324.pdf
The CMWeb is freely accessible at http://cmweb.enzim.hu.,Non-OADS,/arxiv_data1/oa_pdf/9a/fb/gks488.PMC3394325.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/9a/fb/gks488.PMC3394325.pdf
We suggest to utilize at the client browser the most commonly used Oracle Java JRE (http://java.com).,Non-OADS,/arxiv_data1/oa_pdf/9a/fb/gks488.PMC3394325.pdf
Super web server is freely accessible from: http://lcb.infotech.monash.edu.au/super.,OADS,/arxiv_data1/oa_pdf/10/e9/gks436.PMC3394326.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/10/e9/gks436.PMC3394326.pdf
"Super automatic- ally synchronizes its database with the wwPDB server(http://www.wwpdb.org), on a weekly basis, to ensure itis always up-to-date.",OADS,/arxiv_data1/oa_pdf/10/e9/gks436.PMC3394326.pdf
A detailed online help pageon how to use all features of the server is available at http://lcb.infotech.monash.edu.au/super/help.,Non-OADS,/arxiv_data1/oa_pdf/10/e9/gks436.PMC3394326.pdf
Thesource code of the C program driving the web server is available for download from http://gitorious.org/super.,OADS,/arxiv_data1/oa_pdf/10/e9/gks436.PMC3394326.pdf
The web server is available at http://decrypthon.igbmc.fr/kd4v.,OADS,/arxiv_data1/oa_pdf/eb/1b/gks474.PMC3394327.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/eb/1b/gks474.PMC3394327.pdf
"PocketQuery: protein–protein interaction inhibitor starting points from protein–protein interaction structure David Ryan Koes* and Carlos J. Camacho Department of Computational and Systems Biology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15260, USA Received January 16, 2012; Revised March 20, 2012; Accepted April 4, 2012 ABSTRACT PocketQuery (http://pocketquery.csb.pitt.edu) is a web interface for exploring the properties ofprotein–protein interaction (PPI) interfaces with afocus on the discovery of promising starting pointsfor small-molecule design.",OADS,/arxiv_data1/oa_pdf/b8/09/gks336.PMC3394328.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b8/09/gks336.PMC3394328.pdf
The PocketQuery interface is implemented using JavaScript and the Java-based Jmol (http://www.jmol.org/) molecular viewer.,OADS,/arxiv_data1/oa_pdf/b8/09/gks336.PMC3394328.pdf
This functionality is providedunder the Export tab of the molecular viewer panel.Export is available for two online virtual screeningsearch engines: AnchorQuery (http://anchorquery.csb.pitt.edu) and ZINCPharmer (http://zincpharmer.csb.pitt.edu).,OADS,/arxiv_data1/oa_pdf/b8/09/gks336.PMC3394328.pdf
PocketQuery is freely available at http://pocketquery.csb .pitt.edu FUNDING National Institutes of Health (NIH) [R01GM097082].,Non-OADS,/arxiv_data1/oa_pdf/b8/09/gks336.PMC3394328.pdf
"It is freely available at http://probis.cmm.ki.si/old-version, and the new ProBiS web server is athttp://probis.cmm.ki.si.",OADS,/arxiv_data1/oa_pdf/1f/9b/gks435.PMC3394329.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/gks435.PMC3394329.pdf
Details regarding the new ProBiSare available at http://probis.cmm.ki.si.,Non-OADS,/arxiv_data1/oa_pdf/1f/9b/gks435.PMC3394329.pdf
"Speciﬁcation of the web servicesinterface input data, a full set of commands and usefulexamples can be found at the ‘ProBiS-Web serverRESTful Web Services’ instructions page at http://probis.cmm.ki.si/?what=webservices.",OADS,/arxiv_data1/oa_pdf/1f/9b/gks435.PMC3394329.pdf
A complete list of new features is available in the User’s Guide at http://probis.cmm.ki.si.,Non-OADS,/arxiv_data1/oa_pdf/1f/9b/gks435.PMC3394329.pdf
"SOFTWARE REQUIREMENTS The ProBiS web server requires Sun Java plugin Version 6 Update 26 or higher ( http://www.java.com), and has been shown to function correctly with Firefox, IE8, Chrome 14.0, Safari 5.1 and Opera 11.5 web browsers.",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/gks435.PMC3394329.pdf
"Installer packages for Mac OS X,Windows and Linux are available under the LGPLlicence from http://mapman.gabipd.org/web/guest/robin.INTRODUCTION Next-generation high-throughput sequencing (NGS) is leading to the accumulation of a wealth of genomic and high-throughput mRNA sequencing (RNA-Seq) data is enabling increasingly comprehensive transcriptomicstudies.",Non-OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
"Several software tools have been developed to perform single steps in this workﬂow: FastQC is an excellent tool for generating quality over-views (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc), while FASTX provides a collection of command line programs to process and ﬁlter raw sequence data (http://hannonlab.cshl.edu/fastx_toolkit/).",OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
"The packages, manual and demo datasets are available for download from http://mapman.gabipd.org/web/guest/robin.RNA-SEQ WORKFLOW Data import Raw Illumina/Solexa short read data can be imported in FastQ format.",OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
A choice of MapMan functional anno-tation packages is provided in the RobiNA package.More mapping ﬁles can be freely downloaded fromhttp://mapman.gabipd.org/web/guest/mapmanstore.,OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
"Speciﬁcally, the NetBeans visual API (http://graph.netbeans.org/) was used to develop the visual experimentdesigner, and Apache commons (http://commons.apache.org/) was used to facilitate generic string operations.To achieve an improved user experience and betterintegration into the Mac OS X platform, we used theAppleJavaExtensions provided by Apple, Inc., and the‘QuaQua look and feel’ (http://www.randelshofer.ch/quaqua/).",OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
"The SAM JDK library (http://picard.sourceforge.net/) is used for import of SAM/BAM ﬁles,and libraries developed by the biojava project (27) areused for working with GFF3 annotation ﬁles.",OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
Bzip2support is provided by http://code.google.com/p/jbzip2/.Generation of plots is based on JFreeChart (http://www.,OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
jfree.org/jfreechart/) and PDF output is provided by iTextPDF (http://itextpdf.com/).,OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
Installer packages for different operating systems were created using the free IzPack installer generator (http://izpack.org/).,OADS,/arxiv_data1/oa_pdf/74/18/gks540.PMC3394330.pdf
The webserver can be usedby biologists to derive novel PWMs for transcription factors lacking known binding sites and is freely ac- cessible at http://www.gene-regulation.com/pub/programs/3dtf/.,OADS,/arxiv_data1/oa_pdf/ed/7a/gks551.PMC3394331.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ed/7a/gks551.PMC3394331.pdf
The system is hosted at http://pbs.rnet.missouri.edu.,Non-OADS,/arxiv_data1/oa_pdf/ed/1d/gks527.PMC3394332.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ed/1d/gks527.PMC3394332.pdf
"ACKNOWLEDGEMENTS The authors are grateful to the researchers and groups who made the following software packages and databases available for us to use in PBSword: the Jmol package(http://jmol.sourceforge.net/) for generating view of proteins, the SCOP for constructing database, MSMS/ NACESS/HBPLUS/SURFNET software for generating surface and properties of binding sites and the PDB (http://www.pdb.org) for maintaining the tertiary struc-tures.",Non-OADS,/arxiv_data1/oa_pdf/ed/1d/gks527.PMC3394332.pdf
"GGRNA: an ultrafast, transcript-oriented search engine for genes and transcripts Yuki Naito and Hidemasa Bono* Database Center for Life Science, Research Organization of Information and Systems, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032 Japan Received February 25, 2012; Revised April 23, 2012; Accepted April 29, 2012 ABSTRACT GGRNA (http://GGRNA.dbcls.jp/) is a Google-like, ultrafast search engine for genes and transcripts.",OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
"http://blast.ncbi.nlm.nih.gov/) (4), but the searches are usually queued instead of returning the results immediately.",OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
"For searching genomic sequences,faster web services have been proposed, such as BLAT (http://genome.ucsc.edu/) (5) and TDSE (http://www .dnasoso.com/) (6), but no web services are available forsearching gene and transcript sequences very quickly.",Non-OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
"The search results can be retrieved through the following URI: http://GGRNA.dbcls.jp/api/ SPECIES /QUERY [.FORMAT ] SPECIES :‘ h s ’( Homo sapiens ), ‘mm’ ( Mus musculus ), etc.",OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
"(optional) Currently available SPECIES andFORMAT types are listed in the following URI: http://GGRNA.dbcls.jp/api/ For example, a search for the string ‘caagaagagattg’ in human is represented as follows: http://GGRNA.dbcls.jp/api/hs/caagaagagattg A JSON formatted output is retrieved by adding ‘.json’ sufﬁx in URI: http://GGRNA.dbcls.jp/api/hs/caagaagagattg.json For a phrase search, note that a double quote is encoded as ‘%22’, and a space character is encoded as ‘+’ in the URI.",Non-OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
"A search for the phrase ‘‘RNA interfer- ence’’ in Caenorhabditis elegans is represented as follows: http://GGRNA.dbcls.jp/api/ ce/%22RNA + interference%22Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
( A) Top page (http://GGRNA.dbcls.jp/).,Non-OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
"A video tutorial introducing more uses of GGRNA (http://GGRNA.dbcls.jp/en/togotv/) is available at TogoTV (http://togotv.dbcls.jp/en/) (10), a collection offreely available tutorial videos for bioinformatics resources maintained by Database Center for Life Science, Japan.",OADS,/arxiv_data1/oa_pdf/a6/0d/gks448.PMC3394333.pdf
SPEER-SERVER is available at http://www.hpppi.iicb.res.in/ss/.,OADS,/arxiv_data1/oa_pdf/d4/eb/gks559.PMC3394334.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d4/eb/gks559.PMC3394334.pdf
We believe that SteinerNet will beuseful for researchers who would like to integrate their high-throughput data fora specific condition orcellular response and to find biologicallymeaningful pathways.SteinerNet is accessible at http://fraenkel.mit.edu/steinernet.,Non-OADS,/arxiv_data1/oa_pdf/3c/67/gks445.PMC3394335.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/3c/67/gks445.PMC3394335.pdf
SteinerNet isaccessible at http://fraenkel.mit.edu/steinernet.,Non-OADS,/arxiv_data1/oa_pdf/3c/67/gks445.PMC3394335.pdf
GENIES (http://www.genome.jp/tools/ genies/) is publicly available as one of the genome analysis tools in GenomeNet.,OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"Here, we present gene network inference engine based on supervised analysis (GENIES: http://www.genome.jp/ tools/genies/), a web server to predict unknown part ofgene network from various types of genome-wide data (e.g.",OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"Thepresence or absence of each orthologous gene is codedas 1 or 0, respectively, across the different organisms.KEGG gene IDs are accepted for the input data so thatthe genes can be mapped onto the KEGG PATHWAYmaps, and some input examples are provided in the helppage (http://www.genome.jp/tools/genies/help.html (9May 2012, date last accessed)).",OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"The output of GENIES is a weighted graph with genes as nodes and prediction scores as edges, provided in the following ways (Figure 2): Pathway list, Inferred list, Search and Download (An example can beseen at http://www.genome.jp/tools-bin/genies?mode=path&id=example (9 May 2012, date last accessed)).The ﬁrst option, Pathway list, outputs the predicted inter-actions grouped into KEGG PATHWAY (20) maps.When one of the pathways is selected by the user, thegenes that are predicted to interact with the other genesin the selected pathway will be highlighted.",OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"The last option, Details & Download, providesthe list of the predicted gene pairs downloadable as atab-delimited text ﬁle, which can be viewed usingvisualizing software like Cytoscape (http://www.cytoscape.org/ (9 May 2012, date last accessed)) (21).",OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"Figure 4 shows the distributions of the computed self-ranks for 668 pathway genes, where the left panel corresponds to the random prediction (see Supplementary Materials, http://web.kuicr.kyoto-u.ac.jp/supp/kot/nar2012/ (9 May 2012, date last accessed)), the middle panel corresponds to the direct approach and the right panel corresponds to the supervised approach.",OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"Additional cross- validation experiments show the similar tendency (see Supplementary Materials, http://web.kuicr.kyoto-u.",Non-OADS,/arxiv_data1/oa_pdf/22/77/gks459.PMC3394336.pdf
"MAGIA2: from miRNA and genes expression data integrative analysis to microRNA–transcription factor mixed regulatory circuits (2012 update) Andrea Bisognin1, Gabriele Sales2, Alessandro Coppe3, Stefania Bortoluzzi1,* and Chiara Romualdi1,* 1Department of Biology, University of Padova, Padova 35131,2Department of Statistical Science, University of Padova, Padova 35121 and3Department of Comparative Biomedicine and Food Sciences, University of Padova, Padova 35020, Italy Received March 1, 2012; Revised April 23, 2012; Accepted April 30, 2012 ABSTRACT MAGIA2(http://gencomp.bio.unipd.it/magia2) is an update, extension and evolution of the MAGIA webtool.",OADS,/arxiv_data1/oa_pdf/d8/f9/gks460.PMC3394337.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d8/f9/gks460.PMC3394337.pdf
"Here, we present MAGIA 2(miRNA and genes integrated analysis 2012 update, freely available athttp://gencomp.bio.unipd.it/magia2) an updated and fully redesigned release of MAGIA (21), a web application for the integrative analysis of in silico target prediction, miRNA and gene expression data.",OADS,/arxiv_data1/oa_pdf/d8/f9/gks460.PMC3394337.pdf
"Regarding TFs, we used experimentally validated TF– miRNA interactions reported in mirGen2.0 (17) and TransmiR (42), whereas TF–gene interactions were obtained from ECRbase database (43) (http://ecrbase.dcode.org/) for mouse organism and from the ‘TFBS conserved’ track of the UCSC genome annotation for human (version hg19).",OADS,/arxiv_data1/oa_pdf/d8/f9/gks460.PMC3394337.pdf
"The URL is http://sift-dna.org(24 May 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e9/58/gks539.PMC3394338.pdf
"We mapped the HumVar and HumDiv data to Ensembl,RefSeq and UCSC Known ids using the UniProtKB id mapping tool (http://www.uniprot.org/help/uniprotkb).",OADS,/arxiv_data1/oa_pdf/e9/58/gks539.PMC3394338.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/e9/58/gks539.PMC3394338.pdf
COMPARISON TO JCVI WEB SERVER The current web server supported by the original authors of SIFT can be found at http://sift-dna.org.,OADS,/arxiv_data1/oa_pdf/e9/58/gks539.PMC3394338.pdf
DISCUSSION The SIFT web server (http://sift-dna.org) offers tools to predict the effects of nonsynonymous single nucleotide variants (nsSNVs) and frameshifting indels on protein function.,OADS,/arxiv_data1/oa_pdf/e9/58/gks539.PMC3394338.pdf
"Thesmaller database greatly improves run times (up to98%) and memory usage, not only of similarity searching (BLAST), but also of chimera checking (UCHIME) and of clustering the reads (UCLUST).TaxMan is available at http://www.ibi.vu.nl/programs/taxmanwww/.",OADS,/arxiv_data1/oa_pdf/13/a4/gks418.PMC3394339.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/gks418.PMC3394339.pdf
CORE The Excel ﬁle was downloaded [http://microbiome.osu .edu/ (19)] and the taxonomic categories wereconcatenated.,OADS,/arxiv_data1/oa_pdf/13/a4/gks418.PMC3394339.pdf
Greengenes The Greengenes PROKMSA_id and GenBank accession in the Greengenes FASTA ﬁle [current_GREENGENES_ gg16S_unaligned.fasta; http://greengenes.lbl.gov/ (15)]were merged with an underscore and the lineage(Greengenes/Hugenholtz) format was changed.,OADS,/arxiv_data1/oa_pdf/13/a4/gks418.PMC3394339.pdf
SILVA Files were downloaded from http://www.arb-silva.de/ (14).,OADS,/arxiv_data1/oa_pdf/13/a4/gks418.PMC3394339.pdf
Vaginal 16S reference The sequences were taken from the alignment ﬁle and gaps were removed (vaginal_aln.fasta; http://microbiome.fhcrc.,Non-OADS,/arxiv_data1/oa_pdf/13/a4/gks418.PMC3394339.pdf
"This tree data is used for the HTML Tree viewer, pie-chart plotting (using jqPlot, an open source project by Chris Leonello;http://www.jqplot.com/) and for the FASTA headers in the downloadable ﬁle.",OADS,/arxiv_data1/oa_pdf/13/a4/gks418.PMC3394339.pdf
The PepSite web server is available at http://pepsite2.russelllab.org.,OADS,/arxiv_data1/oa_pdf/4b/21/gks398.PMC3394340.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4b/21/gks398.PMC3394340.pdf
Proteinsurface atoms are deﬁned as those with positive solventaccessibility scores calculated with NACCESS 2.1.1 (http://www.bioinf.manchester.ac.uk/naccess/).,Non-OADS,/arxiv_data1/oa_pdf/4b/21/gks398.PMC3394340.pdf
"Molecular visualizations are generated by default usingJmol (http://www.jmol.org/), a popular Java viewer.",OADS,/arxiv_data1/oa_pdf/4b/21/gks398.PMC3394340.pdf
"In addition, experimental support for WebGL-based visualizations generated using VMD (37) and X3DOM(http://www.x3dom.org/) will be added in the near future.",Non-OADS,/arxiv_data1/oa_pdf/4b/21/gks398.PMC3394340.pdf
"The iELM webserver (http://i.elm.eu.org; Weatheritt et al., 2012, in this special edition), which predicts protein–peptide interactions involving linear motifs annotated in ELM (14), makes use of the PepSite API.",OADS,/arxiv_data1/oa_pdf/4b/21/gks398.PMC3394340.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/fa/ba/gks554.PMC3394341.pdf
The repetitive sequence regions of the 26 preloaded genomes were identiﬁed by the RepeatMasker program (http://repeatmasker.org) and stored in the backgrounddatabase.,OADS,/arxiv_data1/oa_pdf/fa/ba/gks554.PMC3394341.pdf
We apply the method to genomic sequencesof HBV and visualize its output in a circular form.jpHMM is available online at http://jphmm.gobics.de for download and as a web server for HIV-1 and HBV sequences.,OADS,/arxiv_data1/oa_pdf/25/d0/gks414.PMC3394342.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/25/d0/gks414.PMC3394342.pdf
Web server jpHMM is available online at http://jphmm.gobics.de/.,OADS,/arxiv_data1/oa_pdf/25/d0/gks414.PMC3394342.pdf
"To simulate previously unobserved se-quences, the two parental sequences of each testsequence are removed from the multiple alignment thatis used to build the model in the respective program run.The test data sets can be downloaded from http://jphmm.gobics.de/download.",OADS,/arxiv_data1/oa_pdf/25/d0/gks414.PMC3394342.pdf
SAVoR is freely availableat http://tesla.pcbi.upenn.edu/savor.,OADS,/arxiv_data1/oa_pdf/91/c3/gks310.PMC3394343.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/91/c3/gks310.PMC3394343.pdf
"Alternatively, the user can upload a text ﬁle of custom annotation values using the UCSC Genome Browser BEDformat, a ﬂexible tabular ﬁle format for genomic locationsand associated data (http://genome.ucsc.edu/FAQ/FAQformat.html#format1).",OADS,/arxiv_data1/oa_pdf/91/c3/gks310.PMC3394343.pdf
The web server can be freely accessed at http://proline.biochem.iisc.ernet.in/ pocketannotate/.,Non-OADS,/arxiv_data1/oa_pdf/63/1d/gks421.PMC3394344.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/63/1d/gks421.PMC3394344.pdf
It resulted in average PMAX score of 0.59 and PMIN score of 0.63 (http://proline.biochem.iisc.ernet.in/ pocketannotate/info/Cluster_similarity.htm).,OADS,/arxiv_data1/oa_pdf/63/1d/gks421.PMC3394344.pdf
"A total of 329 of the predicted sites gave signiﬁcant hits against its native ligand-binding sites with PMAX >0.25, PMIN >0.4 and at least 200 matching distance elements (http://proline.biochem.iisc.ernet.in/pocketannotate/php/Across_different_structures.htm).",OADS,/arxiv_data1/oa_pdf/63/1d/gks421.PMC3394344.pdf
Similar analysis was carried out on a data set of 124 pairs of apo-holo structures that identiﬁed correct hits in 75cases (http://proline.biochem.iisc.ernet.in/pocketannotate/info/apo_holo.htm) and 6166 pairs of homologousapo-holo protein structures that identiﬁed 4400 pairs with correct ligand having <60% identity obtained through BUDDY-system (32) and BindingDB (33)database (http://proline.biochem.iisc.ernet.in/pocketannotate/info/homologous_pairs.htm).,OADS,/arxiv_data1/oa_pdf/63/1d/gks421.PMC3394344.pdf
"This data set included diverse (completely differentbinding sites) and analogues or inhibitors (same bindingsite) of the ligands, and hence, a classiﬁer (0 for different site and 1 for same site) was manually generated to test the speciﬁcity and sensitivity of the PMS MAX scores obtained (http://proline.biochem.iisc.ernet.in/pocketannotate/info/classiﬁer.htm).",OADS,/arxiv_data1/oa_pdf/63/1d/gks421.PMC3394344.pdf
"Here, we describe the implementa-tion of these ideas in a webserver freely available atthe National EMBNet node—Argentina, at URL: http://lfp.qb.fcen.uba.ar/embnet/.",Non-OADS,/arxiv_data1/oa_pdf/13/bf/gks447.PMC3394345.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/13/bf/gks447.PMC3394345.pdf
MATERIALS AND METHODS Input ﬁles The main input ﬁle contains a set of protein structure co- ordinates in the standard format of the Protein Data Bank (http://www.rcsb.org).,OADS,/arxiv_data1/oa_pdf/13/bf/gks447.PMC3394345.pdf
"The most common 20amino acids are taken into account and if backbone or C-beta atoms are missing, they are automatically built into the ﬁle using an automodel option of Modeller suite (http://salilab.org/modeller/).",Non-OADS,/arxiv_data1/oa_pdf/13/bf/gks447.PMC3394345.pdf
CombFunc is available at http://www.sbg.bio.ic.ac.uk/combfunc.,OADS,/arxiv_data1/oa_pdf/d4/51/gks489.PMC3394346.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/gks489.PMC3394346.pdf
THE COMBFUNC WEB SERVER CombFunc is available at http://www.sbg.bio.ic.ac.uk/ combfunc.,OADS,/arxiv_data1/oa_pdf/d4/51/gks489.PMC3394346.pdf
"TheCyber-T web server, with R source code and data sets, is publicly available at http://cybert.ics.uci.",OADS,/arxiv_data1/oa_pdf/c5/58/gks420.PMC3394347.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c5/58/gks420.PMC3394347.pdf
IMPLEMENTATION The current version of Cyber-T is composed of a backend written in R (http://www.r-project.org/) made accessiblevia a web server interface.,OADS,/arxiv_data1/oa_pdf/c5/58/gks420.PMC3394347.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/cercor/bhr265 Advance Access publication October 6, 2011Cerebral Cortex August 2012;22:1923– 1934",Non-OADS,/arxiv_data1/oa_pdf/b5/98/bhr265.PMC3394369.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original wo rk is properly cited.J Antimicrob Chemother 2012; 67: 1948–1960 doi:10.1093/jac/dks161 Advance Access publication 25 May 2012 1948",Non-OADS,/arxiv_data1/oa_pdf/ec/d7/dks161.PMC3394442.pdf
"http://www.who.int/mediacentre/factsheets/fs104/ en/index.html (23 September 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/ec/d7/dks161.PMC3394442.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Annals of Botany 110: 349–360, 2012 doi:10.1093/aob/mcs069, available online at www.aob.oxfordjournals.org",Non-OADS,/arxiv_data1/oa_pdf/13/e5/mcs069.PMC3394645.pdf
http://dx.doi.org/10.1371/journal.pbio.0060307 .Mironova et al.,OADS,/arxiv_data1/oa_pdf/13/e5/mcs069.PMC3394645.pdf
BMC Systems Biology 4: 98. http://dx.doi:10.1186/1752-0509-4-98 .,OADS,/arxiv_data1/oa_pdf/13/e5/mcs069.PMC3394645.pdf
Molecular Systems Biology 6: 447. http://dx.doi.org/10.1038/msb.,OADS,/arxiv_data1/oa_pdf/13/e5/mcs069.PMC3394645.pdf
http://dx.doi.or/10.1101/cshperspect.a001552 .Mironova et al.,OADS,/arxiv_data1/oa_pdf/13/e5/mcs069.PMC3394645.pdf
"2012;44(2):104-112 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.104  Moonkyoo Kong, MD 1 Seong Eon Hong, MD 1 Woo Suk Choi, MD 2 Si-Young Kim, MD 3 Jinhyun Choi, MD 1 Departments of 1Radiation Oncology,  2Diagnostic Radiology, and 3Internal  Medicine, Kyung Hee University School of  Medicine, Seoul, Korea  Correspondence: Seong Eon Hong, MD  Department of Radiation Oncology,  Kyung Hee University Medical Center,  26 Kyungheedae-ro, Dongdaemun-gu,  Seoul 130-701, Korea  Tel: 82-2-958-8661  Fax: 82-2-958-9469  E-mail: anjdixn@naver.com  Received  January 26, 2012  Accepted  March 19, 2012 Purpose  This study was designed to investigate the long-term oncologic outcomes for locally advanced  rectal cancer patients after treatment with preoperative concurrent chemoradiotherapy followed  by total mesorectal excision, and to identify prognostic factors that affect survival and pathologic  response.",Non-OADS,/arxiv_data1/oa_pdf/23/26/crt-44-104.PMC3394859.pdf
"Encouraging results have also been achieved in terms of recurrence rate,  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │104 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/26/crt-44-104.PMC3394859.pdf
"2012;44(2):113-120 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.113  Boyoung Park, MD, PhD  Kui Son Choi, PhD  Yoon Young Lee, MPH  Jae Kwan Jun, MD, PhD  Hong Gwan Seo, MD, PhD  Natlona Canegr Contro Instltutg,  Natlona Canegr Cgntgr, Goyani, Korga  Correspondence: Jae Kwan Jun, MD, PhD  National Cancer Control Institute,  National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 410-769, Korea  Tel: 82-31-920-2184  Fax: 82-31-920-2189  E-mail: jkjun@ncc.re.kr  Received  February 6, 2012  Accepted  April 19, 2012 Purpose  The Korean National Cancer Screening Survey (KNCSS) is a nationwide survey conducted  annually, since 2004.",Non-OADS,/arxiv_data1/oa_pdf/1f/34/crt-44-113.PMC3394860.pdf
"Key words  Early detection of cancer, Trends, Health-care surveys Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treat - ment Outcomes and Analysis of Prognostic Factors Original Article Open Access  Trends in Cancer Screening Rates among Korean Men and  Women: Results from the Korean National Cancer Screening  Survey (KNCSS), 2004-2011  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │113 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/34/crt-44-113.PMC3394860.pdf
Available from: http://www.cancer.go.kr/  ncic/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/34/crt-44-113.PMC3394860.pdf
Avail - able from: http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2009&chid=92&coid  =916&mid=#trends.,Non-OADS,/arxiv_data1/oa_pdf/1f/34/crt-44-113.PMC3394860.pdf
Avail - able from: http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2009&chid=92&coid  =917&mid=#trends.,Non-OADS,/arxiv_data1/oa_pdf/1f/34/crt-44-113.PMC3394860.pdf
Avail - able from: http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2009&chid=92&  coid=918&mid=.,Non-OADS,/arxiv_data1/oa_pdf/1f/34/crt-44-113.PMC3394860.pdf
"2012;44(2):121-126 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.121  Mostafa Saadat, PhD  Department of Biology, Shiraz University  College of Sciences, Shiraz, Iran  Correspondence: Mostafa Saadat, PhD  Department of Biology,  Shiraz University College of Sciences,  Shiraz 71454, Iran  Tel: 98-711-6137432  Fax: 98-711-6286421  E-mail: msaadat41@yahoo.com  Received  March 1, 2012  Accepted  April 30, 2012 Purpose  Apolipoprotein E (APOE, MIM: 107741) has three functionally distinct isoforms of the protein (E2,  E3, and E4), encoded by corresponding alleles ε2, ε3, and ε4, which have been well described.",Non-OADS,/arxiv_data1/oa_pdf/5e/0d/crt-44-121.PMC3394861.pdf
"Key words  Apolipoproteins E, Breast neoplasms, Meta-analysis,  Disease susceptibility Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treat - ment Outcomes and Analysis of Prognostic Factors Original Article Open Access  Apolipoprotein E ( APOE ) Polymorphisms and Susceptibility to  Breast Cancer: A Meta-Analysis  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │121 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/0d/crt-44-121.PMC3394861.pdf
"2012;44(2):127-132 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.127  Jong Gwon Choi, MD, PhD  Jae Hong Seo, MD, PhD  Sang Cheul Oh, MD, PhD  Chul Won Choi, MD, PhD  Jun Suk Kim, MD, PhD  Division of Oncology-Hematology,  Department of Internal Medicine,  Korea University Guro Hospital,  Korea University College of Medicine,  Seoul, Korea  Correspondence: Jun Suk Kim, MD, PhD  Division of Oncology-Hematology,  Department of Internal Medicine,  Korea University Guro Hospital,  148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea  Tel: 82-2-2626-3057  Fax: 82-2-2626-4453  E-mail: kjs6651@kumc.or.kr  Received  March 7, 2012  Accepted  May 22, 2012 Purpose  The purpose of this study was to determine the efficacy and safety of treatment using gemcitabine  and capecitabine for patients with advanced pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/11/a2/crt-44-127.PMC3394862.pdf
"Key words  Gemcitabine, Capecitabine, Pancreatic neoplasms Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treat - ment Outcomes and Analysis of Prognostic Factors Original Article Open Access  A Phase II Trial of Gemcitabine plus Capecitabine for Patients  with Advanced Pancreatic Cancer  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │127 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/a2/crt-44-127.PMC3394862.pdf
"2012;44(2):133-141 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.133  John T. Reynolds, MD 1 John M. Watkins, MD 2 Tarek A. Dufan, MD 2 Shrikant S. Kubsad, PhD 2 1MedCenter One Health Systems,  Department of Hematology & Oncology,  2Bismarck Cancer Center, Bismarck,  ND , USA  Correspondence: John T. Reynolds, MD  MedCenter One Health Systems,  Department of Hematology & Oncology,  300 N. 7th Street, Bismarck, ND 58501, USA  Tel: 1-701-323-5741  Fax: 1-701-323-8506  E-mail: jreyno@mohs.org  Received  March 8, 2012  Accepted  June 12, 2012 Purpose  Chemotherapy has demonstrated ability to generate tumor antigens secondary to induction of  apoptosis, against which human leukocyte antigen-compatible, irradiated, related donor mononu - clear cells may be administered with immune stimulation to activate antigen presenting and  cytotoxic T cells, while minimizing risk of graft-versus-host disease (GVHD).",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/crt-44-133.PMC3394863.pdf
"Key words  Residual neoplasm, Mononuclear leukocytes, Immunomodulation Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treat - ment Outcomes and Analysis of Prognostic Factors Original Article Open Access  Irradiation of Donor Mononuclear Cells for Treatment of  Chemorefractory Metastatic Solid Cancers:  A Community-Based Immune Transplant Pilot Study  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │133 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/crt-44-133.PMC3394863.pdf
"2012;44(2):142-145 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.142  Moon-Kyung Kim, MD  Seo-Hee Kim, MD  Yoo-Young Lee, MD  Chel Hun Choi, MD  Tae-Joong Kim, MD  Jeoung-Won Lee, MD, PhD  Je-Ho Lee, MD, PhD  Duk-Soo Bae, MD, PhD  Byoung-Gie Kim, MD, PhD  Department of Obstetrics and Gynecology,  Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea  Correspondence: Byoung-Gie Kim, MD, PhD  Department of Obstetrics and Gynecology,  Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea  Tel: 82-2-3410-3513  Fax: 82-2-3410-0630  E-mail: bgkim@skku.edu  Received  October 26, 2010  Accepted  December 22, 2010 Clinical observation of skin metastasis in ovarian cancer cases is relatively uncommon.",Non-OADS,/arxiv_data1/oa_pdf/22/f3/crt-44-142.PMC3394864.pdf
"Key words  Drug therapy, Neoplasm metastasis, Ovarian neoplasms,  Palliative care, Skin neoplasms Case Report Open Access  Metastatic Skin Lesions on Lower Extremities in a Patient with  Recurrent Serous Papillary Ovarian Carcinoma:  A Case Report and Literature Review  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │142 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/f3/crt-44-142.PMC3394864.pdf
"2012;44(2):146-150 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.146  Hyun Jung Lee, MD 1 Kyoung Yul Lee, MD 2 Dong-Yeop Shin, MD 1 Yun Gyoo Lee, MD 1 Se Youn Choi, MD 1 Kyung Chul Moon, MD 2 Il-Kyu Han, MD 3 Tae Min Kim, MD 1 Departments of 1Internal Medicine,  2Pathology, and 3Orthopedic Surgery,  Seoul National University Hospital,  Seoul National University College of  Medicine, Seoul, Korea  Correspondence: Tae Min Kim, MD  Department of Internal Medicine,  Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel: 82-2-2072-3559  Fax: 82-2-764-2199  E-mail: gabriel9@snu.ac.kr  Received  September 26, 2010  Accepted  February 9, 2011 Erdheim-Chester disease is a rare non-Langerhans-cell histiocytosis involving bones and multiple  organs.",Non-OADS,/arxiv_data1/oa_pdf/be/d1/crt-44-146.PMC3394865.pdf
"Key words  Non-Langerhans-cell histiocytosis,  Osteosclerosis, Retroperitoneal fibrosis Case Report Open Access  A Case of Erdheim-Chester Disease with  Asymptomatic Renal Involvement  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │146 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/d1/crt-44-146.PMC3394865.pdf
"2012;44(2):73 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.73  Editorial  New Step of Joint Publication with the Korean Association for Clinical Oncology  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │73 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/91/crt-44-73.PMC3394866.pdf
"2012;44(2):74-84 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.74  D. Nathan Kim, MD, PhD 1 Taek-Keun Nam, MD 1,2  Kevin S. Choe, MD, PhD 1 Hak Choy, MD 1 1Department of Radiation Oncology,  University of Texas Southwestern Medical  Center, Dallas, TX, USA, 2Department of  Radiation Oncology, Chonnam National  University Medical School, Gwangju, Korea  Correspondence: Hak Choy, MD  Department of Radiation Oncology, University of  Texas Southwestern Medical Center, 5801 Forest  Park Road, Dallas, TX 75390-9183, USA  Tel: 1-214-645-7656  Fax: 1-214-645-7622  E-mail: hak.choy@utsouthwestern.edu  Received  December 8, 2011  Accepted  December 20, 2011 Locally advanced non-small cell lung cancer (NSCLC) is a heterogeneous disease, and we have  embarked on an era where patients will benefit from individualized therapeutic strategies based  on identifiable molecular characteristics of the tumor.",Non-OADS,/arxiv_data1/oa_pdf/33/60/crt-44-74.PMC3394867.pdf
"Key words  Lung neoplasms, Individualized medicine,  Tyrosine kinase inhibitor,  Epidermal growth factor receptor, Combined modality therapy Review Article Open Access  Personalized Combined Modality Therapy for  Locally Advanced Non-small Cell Lung Cancer  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │74 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/60/crt-44-74.PMC3394867.pdf
http://dx.doi.org/10.1007/82_2011_164.,Non-OADS,/arxiv_data1/oa_pdf/33/60/crt-44-74.PMC3394867.pdf
"2012;44(2):85-96 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.85  Yoon-Koo Kang, MD, PhD 1 Hye Jin Kang, MD, PhD 2 Kyoung-Mee Kim, MD, PhD 3 Taesung Sohn, MD, PhD 4 Dongil Choi, MD, PhD 5 Min-Hee Ryu, MD, PhD 1 Woo Ho Kim, MD, PhD 6 Han-Kwang Yang, MD, PhD 7 On Behalf of the Korean GIST Study  Group (KGSG)  1Department of Oncology, Asan Medical  Center, University of Ulsan College of  Medicine, 2Division of Hematology/  Oncology, Department of Internal Medicine,  Korea Cancer Center Hospital,  Korea Institute Radiological and Medical  Sciences, Departments of 3Pathology,  4Surgery, and 5Radiology, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, 6Department of Pathology,  7Department of Surgery & Cancer Research  Institute, Seoul National University College  of Medicine, Seoul, Korea  Correspondence: Y oon-Koo Kang, MD, PhD  Department of Oncology, Asan Medical Center,  University of Ulsan College of Medicine,  88 Olympic-ro 43-gil, Songpa-gu,  Seoul 138-736, Korea  Tel: 82-2-3010-3210  Fax: 82-2-3010-8772  E-mail: ykkang@amc.seoul.kr  Received  March 5, 2012  Accepted  April 25, 2012 Despite their rarity in incidence and prevalence, gastrointestinal stromal tumors (GISTs) have  emerged as a distinct and noteworthy pathogenetic entity.",Non-OADS,/arxiv_data1/oa_pdf/81/67/crt-44-85.PMC3394868.pdf
"Key words  Guideline, Gastrointestinal stromal tumors, Diagnosis, Surgery,  Drug therapy, Molecular targeted therapy, Imatinib, Sunitinib Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treat - ment Outcomes and Analysis of Prognostic Factors Special Article Open Access  Clinical Practice Guideline for Accurate Diagnosis and Effective  Treatment of Gastrointestinal Stromal Tumor in Korea  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │85 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/67/crt-44-85.PMC3394868.pdf
Available from: http://www.nccn.org/professionals/  physician_gls/pdf/sarcoma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/81/67/crt-44-85.PMC3394868.pdf
Available from: http://www.nccn.org/professionals/ physician_gls/  f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/81/67/crt-44-85.PMC3394868.pdf
"2012;44(2):97-103 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2012.44.2.97  Hee Seung Kim, MD 1 Mi-Kyung Kim, MD 1 Hak Jae Kim, MD 2 Seung-Su Han, MD 3 Jae Weon Kim, MD, PhD 1 Departments of 1Obstetrics and  Gynecology and 2Radiation Oncology,  Seoul National University College of  Medicine, 3Department of Obstetrics and  Gynecology, Chung-Ang University College  of Medicine, Seoul, Korea  Correspondence: Jae Weon Kim, MD, PhD  Department of Obstetrics and Gynecology,  Seoul National University College of Medicine,  101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel: 82-2-2072-3511  Fax: 82-2-762-3599  E-mail: kjwksh@snu.ac.kr  Received  October 10, 2011  Accepted  March 7, 2012 Purpose  This study investigated the efficacy and toxicity associated with consolidation chemotherapy  using paclitaxel and carboplatin after concurrent chemoradiation (CCR) in cervical cancer pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/89/67/crt-44-97.PMC3394869.pdf
"Key words  Consolidation chemotherapy, Chemoradiotherapy, Paclitaxel,  Carboplatin, Uterine cervical neoplasms Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treat - ment Outcomes and Analysis of Prognostic Factors Original Article Open Access  Phase II Study of Consolidation Chemotherapy after Adjuvant or  Primary Concurrent Chemoradiation Using Paclitaxel and Carboplatin to  Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │97 Copyright ⓒ2012 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/67/crt-44-97.PMC3394869.pdf
Available from: http://www.Nccn.Org.,Non-OADS,/arxiv_data1/oa_pdf/89/67/crt-44-97.PMC3394869.pdf
"153Korean J Physiol Pharmacol Vol 16: 153 －158, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.153 ABBREVIATIONS: MTT, 3-(4,5-Dimethylthizol-2-yl)-2,5-diphenylte- trazolium bromide; BCA, bicinchoninic acid; FACS, fluorescence  activated cell sorter; PARP, Poly (ADP-ribose) polymerase; PMSF,  phenylmethanesulfonylfluoride or phenylmethylsulfonyl fluoride;  PBS, phosphate buffered saline.",Non-OADS,/arxiv_data1/oa_pdf/e7/87/kjpp-16-153.PMC3394916.pdf
"159Korean J Physiol Pharmacol Vol 16: 159 －165, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.159 ABBREVIATIONS: SCC, squamous cell carcinoma; AC, adenocarci- noma; NSCLC, non small cell lung carcinoma; Pak, p21-associated  kinase; LIMK, p-Lin-11/Isl-1/Mec-3 kinase.",Non-OADS,/arxiv_data1/oa_pdf/6b/76/kjpp-16-159.PMC3394917.pdf
"167Korean J Physiol Pharmacol Vol 16: 167 －174, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.167 ABBREVIATIONS: GVHD, graft-versus-host disease; BM, bone  marrow; HSCs, hematopoietic stem cells; NK, natural killer; SCF, stem cell factor; IL, interleukin; FLT3L, fms-like tyrosine kinase-3  ligand; HDC, hydrocortisone; FCS, fetal calf serum; DMEM,  Dulbecco’s modified eagles medium; FITC, fluorescein isothiocyanate;PE, phycoerythrin; HUVECs, human umbilical vein endothelial cells;  SPF, specific pathogen-free.",Non-OADS,/arxiv_data1/oa_pdf/3e/85/kjpp-16-167.PMC3394918.pdf
"175Korean J Physiol Pharmacol Vol 16: 175 －180, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.175 ABBREVIATIONS: IR, insulin resistance; BMI, body mass index;  HRR, heart rate reserve; HOMA-IR, homeostasis model assessment of insulin resistance; FM, fat mass; FFM, fat free mass; BF %, body  fat %; TC, total cholesterol; TG, triglyceride; ACSM, American  college of sports medicine; CDC, centers for disease control; RPE, rate of perceived exertion; THR, targeted heart rate; BMR, basal  metabolic rate.",Non-OADS,/arxiv_data1/oa_pdf/f4/cf/kjpp-16-175.PMC3394919.pdf
"181Korean J Physiol Pharmacol Vol 16: 181 －186, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.181 ABBREVIATIONS: PPARα, peroxisome proliferator-activated receptor α; CCK, cholecystokinin; LETO, Long-Evans Tokushima; OLETF, Otsuka Long-Evans Tokushima Fatty.",Non-OADS,/arxiv_data1/oa_pdf/e3/c2/kjpp-16-181.PMC3394920.pdf
"187Korean J Physiol Pharmacol Vol 16: 187 －192, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.187 ABBREVIATIONS: i.p., intraperitoneal; i.t., intrathecal.",Non-OADS,/arxiv_data1/oa_pdf/e9/d7/kjpp-16-187.PMC3394921.pdf
"193Korean J Physiol Pharmacol Vol 16: 193 －198, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.193 ABBREVIATIONS: TC, tuberculous colitis; UC, ulcerative colitis;  2-DE, 2-dimentional elextrophoresis; IBD, inflammatory bowel disease; CD, crohn’s disease; MS, mass spectrometry; MALDI TOF/TOF, matrix-assisted laser desorption ionization time-of-flight/time-of-  flight spectrometry; EDTA, ethylenediaminetetraacetic acid; H&E,  hematoxylin & eosin; CHAPS, 3-[(3-cholamidopropyl)dimethylammo-nio]-1-propanesulfonate; IPG, immobilized pH gradient; IEF, isoelec- tric focusing; SDS, sodium dodecyl sulfate; ACN, acetonitrile; DDT,  dichloro-diphenyl-trichloro-ethane; TFA, trifluoroacetic acid; MS, massspectrometry, CID, channel iron deposits; PAGE, polyacrylamide gel  electrophoresis; CRTH2, chemoattractant receptor of T 2 cells.",Non-OADS,/arxiv_data1/oa_pdf/27/7d/kjpp-16-193.PMC3394922.pdf
The data  obtained were screened against rat  databases downloaded from both NCBI (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/27/7d/kjpp-16-193.PMC3394922.pdf
"199Korean J Physiol Pharmacol Vol 16: 199 －204, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.199 ABBREVIATIONS: NO, nitric oxide; ROS, reactive oxygen species;  eNOS, endothelial nitric oxide synthase; PTD, protein transduction domains; TNF, tumor necrosis factor; IPTG, Isopropyl-thiogalacto- side; DCF-DA, 2',7'-dichlorodihydrofluorescein diacetate.",Non-OADS,/arxiv_data1/oa_pdf/e7/b8/kjpp-16-199.PMC3394923.pdf
"205Korean J Physiol Pharmacol Vol 16: 205 －209, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.205 ABBREVIATIONS: UV, ultraviolet; ROS, reactive oxygen species;  HPLC, high performance liquid chromatography.",Non-OADS,/arxiv_data1/oa_pdf/8b/fb/kjpp-16-205.PMC3394924.pdf
"211Korean J Physiol Pharmacol Vol 16: 211 －217, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.211 ABBREVIATIONS: DRG, dorsal root ganglion (DRG); IC 50, concen- tration causing 50% of maximal inhibition; NO, nitric oxide; TRPV1,  transient receptor potential vanilloid subtype 1.",Non-OADS,/arxiv_data1/oa_pdf/ba/f0/kjpp-16-211.PMC3394925.pdf
"219Korean J Physiol Pharmacol Vol 16: 219 －224, June, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.3.219 ABBREVIATIONS: ERG, electroretinogram; NO, nitric oxide; NOS,  nitric oxide synthase; MFA, meclofenamic acid; SNP, sodium nitro- prusside; L-NAME, NG-nitro-L-arginine methyl ester; IPC, inter- plexiform cell; DA, dopamine; NADPH-d, nicotinamide dinucleotide  phosphate diaphorase.",Non-OADS,/arxiv_data1/oa_pdf/0f/af/kjpp-16-219.PMC3394926.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 11.7 10.1074/mcp.M111.013243–1,Non-OADS,/arxiv_data1/oa_pdf/82/e1/M111.013243.PMC3394938.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 11.7 10.1074/mcp.M111.014167–1,Non-OADS,/arxiv_data1/oa_pdf/65/83/M111.014167.PMC3394943.pdf
Implementation— BICEPS is implemented in C /H11001/H11001 and available from http://hci.iwr.uni-heidelberg.de/MIP/Software/ and http://software.steenlab.org.,OADS,/arxiv_data1/oa_pdf/65/83/M111.014167.PMC3394943.pdf
"There are a number of software packages available foridentifying proteins from PMF data by searching the peak listagainst a theoretical digest of a protein sequence databasesuch as: MS-Fit (part of ProteinProspector http://prospector.ucsf.edu/), ProFound (1) and Mascot (2).",OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 11.7 10.1074/mcp.M111.014381–1,Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
"The model was developed over several years in a proc - ess open to all interested parties and transparent at each stage,consisting of mailing list discussions, a code repository (http://code.google.com/p/psi-pi/), regular conference calls, and developmentworkshops at each PSI meeting ( 30–33).",Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
"In com-mon with other PSI CVs, the CV is in OBO format (http://www.geneontology.org/GO.format.shtml).",Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
Representing Specific Use Cases— Example mzIdentML documents have been made available to illustrate the wide range of proteomic analyses that are supported (http://code.google.com/p/psi-pi/source/ browse/trunk/examples/1_ 1examples): PMF ( supplemental file : mascot_pmf_example.,OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
Example encodings of NCBItranslation tables (http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi) within /H11021DatabaseTranslation /H11022are pro- vided ( supplemental file : Mascot_NA_example.mzid) in which every instance of /H11021PeptideEvidence /H11022contains a reference to the translation table used and the reading frame.,OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
"Controlled Vocabulary— The group has developed con- trolled vocabulary terms as part of the wider PSI-Mass Spec-trometry CV, which is used by mzML and other PSI formats, toensure unambiguous reporting of search engine methods,parameters and scores, available from the project homepage(http://www.psidev.info/controlled-vocabularies).",Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
"An example term that requires a unit is the fragment ion search tolerance ( e.g./H110060.5 Da) within the /H11021SpectrumIdenti- ficationProtocol /H11022, encoded as two CV terms: /H11021cvParam accession /H11005“MS:1001412” name /H11005“search tolerance plus value” value /H11005“0.5” cvRef /H11005“PSI-MS” unit Accession /H11005“UO:0000221” unitName /H11005“dalton” unitCv Ref/H11005“UO”/H11022 /H11021cvParam accession /H11005“MS:1001413” name /H11005“search tolerance minus value” value /H11005“0.5” cvRef /H11005“PSI-MS” unit Accession /H11005“UO:0000221” unitName /H11005“dalton” unitCvRef /H11005 “UO”/H11022 In this instance, the MS:1001412 CV entry specifies that a mass unit must be provided from the Unit Ontology (availablefrom the OBO foundry, http://www.obofoundry.org/).In addition to the CV, a mapping format has been devel- oped by the PSI which provides formal rules for associatingXML Schema elements with particular CV terms ( 45).",Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
The semantic validation software(http://psidev.info/validator) will be adapted to check whetherMIAPE compliance has been reached by particular files.,OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
"The developmentprocess of mzQuantML is ongoing, and we encourage furtherinput (please see the group webpage for details http://www.psidev.info/mzQuantML).",Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
Implementations— There is a growing list of implementa- tions available for mzIdentML (http://www.psidev.info/tools-implementing-mzidentml).,OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
"within ProCon: http://www.medizinisches-proteom-center.de/ProCon), OMSSA ( 4) and X!Tandem (5) (http://code.google.",Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
"An open-source Java API for reading and writing mzIdentML has alsobeen developed, available from http://code.google.com/p/jmzidentml/.",OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
EXAMPLE FILES All example files described in the text can be downloaded from: http://code.google.com/p/psi-pi/source/browse/trunk/examples/1_1examples/ ●55merge_mascot_full.mzid - ex- ample MS-MS search results including decoy matches fromMascot.,OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
We encourage further input on the standard by joining themailing list or attending a PSI meeting (see http://www.psidev.info/ for details).,Non-OADS,/arxiv_data1/oa_pdf/2c/cd/M111.014381.PMC3394945.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 11.7 10.1074/mcp.M111.015289–1,Non-OADS,/arxiv_data1/oa_pdf/df/60/M111.015289.PMC3394950.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 11.7 10.1074/mcp.M111.016162–1,Non-OADS,/arxiv_data1/oa_pdf/5c/44/M111.016162.PMC3394952.pdf
The protein in-teractions from this publication have been submitted to theIMEx (http://www.imexconsortium.org/) consortium throughIntAct (pmid: 17145710) and assigned the identifier IM-15696.,OADS,/arxiv_data1/oa_pdf/5c/44/M111.016162.PMC3394952.pdf
"To investigate these possibilities data from pub-lic databases was combined with an extended network anal-ysis in MetaCore™ (http://www.genego.com/metacore.php)prior to integration with novel E3-RING/E3-RING interactionsobserved in this study, in order to generate a final nonredun-dant human E3-RING centric network containing 4173 inter-actions involving 2047 different proteins (Fig.",OADS,/arxiv_data1/oa_pdf/5c/44/M111.016162.PMC3394952.pdf
The protein interactions from this publication have been submitted to the IMEx (http://www.imexconsortium.org/) consortium throughIntAct (pmid: 17145710) and assigned the identifier IM-15696.,OADS,/arxiv_data1/oa_pdf/5c/44/M111.016162.PMC3394952.pdf
"Primer sequences were designed (Supplementary Table 4; Figure 4A) using Primer 3 software (Whitehead Institutefor Biomedical Research, Cambridge, MA, USA; http://frodo.wi.mit.",OADS,/arxiv_data1/oa_pdf/b8/ba/bjc2012162a.PMC3394965.pdf
"Supplementary Information accompanies the paper on the British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Agell L, Hernandez S, de Muga S, Lorente JA, Juanpere N, Esqueva R, Serrano S, Gelabert A, Lloreta J (2008) KLF6 and TP53 mutations are arare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations.",Non-OADS,/arxiv_data1/oa_pdf/b8/ba/bjc2012162a.PMC3394965.pdf
"Regions of high incidence are areas of subSaharan Africa and South-east Asia (World Health Organization, http://www.who.int/whois), mainly linkedto the presence of risk factors such as chronic Hepatitis B and/or Hepatitis C infection (Lai et al, 2003).",Non-OADS,/arxiv_data1/oa_pdf/e6/f8/bjc2012230a.PMC3394972.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Boyault S, Rickman DS, de Reynies A (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.Hepatology 45: 42–52 Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, Smith R, Leeson B, Beard R, Lamb JR, Lim L, Mao M, Dai H, Luk JM (2010) MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.Mol Syst Biol 6: 402 Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF (2006) Long term outcome of resection of large hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/e6/f8/bjc2012230a.PMC3394972.pdf
"Available from URL http://www.who.int/whois Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW (2008) EpCAM and a- fetoprotein expression defines novel prognostic subtypes of hepatocel- lular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/e6/f8/bjc2012230a.PMC3394972.pdf
"Amplification and analysis were done according to the manu- facturer’s protocol in 96-well plates in an ABI PRISM 7000Sequence Detection System (Applied Biosystems, Life Technolo-gies Italia, Monza, Italy) and the pre-cast TaqMan Gene Expression Assays’ (Applera; https://products.appliedbiosystems.com/) for CACNA2D3 (Hs00218157_m1).",OADS,/arxiv_data1/oa_pdf/6c/fa/bjc2012231a.PMC3394973.pdf
"US Food and Drug Administration has published a warning regarding the use of the anti-angiogenicagent bevacizumab (Avastin) in combination with chest radio- therapy (http://www.fda.gov/medwaTCH/safety/2007/Avastin_DHCP_ TEF_Final8April2007.pdf) and sever al publications now report serious adverse events especially after treatment of thorax, gastrointestinaltract, head and neck and brain malignancies combining bevacizumab and radiotherapy (Willett et al, 2005; Crane et al, 2006; Carden et al, 2008; Seiwert et al, 2008; Gutin et al,2 0 0 9 ;S p i g e l et al, 2010; Lai et al, 2011).",Non-OADS,/arxiv_data1/oa_pdf/25/07/bjc2012236a.PMC3394974.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Amemiya H, Kono K, Itakura J, Tang RF, Takahashi A, An FQ, Kamei S, Iizuka H, Fujii H, Matsumoto Y (2002) c-Met expression in gastric cancer with liver metastasis.",Non-OADS,/arxiv_data1/oa_pdf/bf/f3/bjc2012237a.PMC3394975.pdf
"Statistical analyses Statistical analyses were performed by R (http://www.r-project.org/).The clinical parameters used for modelling were age, tumour size,histological subtype, myometrial depth of invasion, LVI, FIGO grade, lymph nodes positive, recurrence, status, recurrence time, and survival time.",OADS,/arxiv_data1/oa_pdf/2e/ac/bjc2012241a.PMC3394976.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES A b a j oA ,R o d r i g u e zJ ,B i t a r t eN ,Z a r a t eR ,B o n iV ,P o n zM ,C h o p i t e aA ,B a n d r e s E, Garcia-Foncillas J (2010) Dose-finding study and pharmacogenomicanalysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab inpretreated metastatic colorectal cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/37/e4/bjc2012242a.PMC3394977.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Annaheim B, Schmid H, Kuntsche E (2006) Sport und Bewegung von 11- bis 16 -ja ¨hrigen Schu ¨lerinnen und Schu ¨lern in der Schweiz .",Non-OADS,/arxiv_data1/oa_pdf/b1/25/bjc2012250a.PMC3394979.pdf
"http://www.sign.ac.uk/pdf/sign76.pdf (accessed 1 November 2010) Skrondal A, Rabe-Hesketh S (2008) Latent variable modelling.",OADS,/arxiv_data1/oa_pdf/b1/25/bjc2012250a.PMC3394979.pdf
"Eur Radiol 22: 1023–1032 Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, Jordan L, Baker L, Thompson A (2010) Quantitative shear waveultrasound elastography: initial experience in solid breast masses.Breast Cancer Res [serial on the Internet] 12(6): Available from http://breast-cancer-research.com/content/12/6/R104 Fleury E, Fleury JSV, Piato S, Roveda Jr D (2009) New elastographic classification of breast lesions during and after compression.",Non-OADS,/arxiv_data1/oa_pdf/c8/28/bjc2012253a.PMC3394981.pdf
Available from http://www.rcrbreastgroup.com This work is published under the standard license to publish agreement.,Non-OADS,/arxiv_data1/oa_pdf/c8/28/bjc2012253a.PMC3394981.pdf
"http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/ digitalasset/dh_123394.pdf (Accessed 12 July 2011) Fernandez ME, McCurdy SA, Arvey SR, Tyson SK, Morales-Campos D, Flores B, Useche B, Mitchell-Bennett L, Sanderson M (2009) HPVknowledge, attitudes, and cultural beliefs among Hispanic men andwomen living on the Texas-Mexico border.",Non-OADS,/arxiv_data1/oa_pdf/e5/34/bjc2012256a.PMC3394982.pdf
http://www.nice.org.uk/aboutnice/howwewo rk/developingnicecl inicalguidelines/ clinicalguidelinedevelopmentmethods/GuidelinesManual2009.jsp (Accessed 5January 2011) NHS Cancer Screening Programmes (2010) HPV Triage and Test of Cure Protocol for Women Aged 25 to 64 Years.,Non-OADS,/arxiv_data1/oa_pdf/e5/34/bjc2012256a.PMC3394982.pdf
"http://seer.cancer.gov/csr/1975_2008/ (based on November 2010 SEER data submission, posted to the SEER web site) Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics.",OADS,/arxiv_data1/oa_pdf/d7/6e/bjc2012257a.PMC3394983.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Allegra CJ, Jessup JM, Somerfield MR, Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF, Schilsky RL (2009) American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma topredict response to anti-epidermal growth factor receptor monoclonalantibody therapy.",Non-OADS,/arxiv_data1/oa_pdf/15/08/bjc2012259a.PMC3394984.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Bagri A, Berry L, Gunter B, Singh M, Kasman I, Damico LA, Xiang H, Schmidt M, Fuh G, Hollister B, Rosen O, Plowman GD (2010) Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy.",Non-OADS,/arxiv_data1/oa_pdf/a3/95/bjc2012261a.PMC3394985.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc)MLL4 in cell cycle and tumour growth KI Ansari et al 323 &2012 Cancer Research UK British Journal of Cancer (2012) 107(2), 315 – 324 Molecular Diagnostics",Non-OADS,/arxiv_data1/oa_pdf/0a/85/bjc2012263a.PMC3394987.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Agarwal R, Kaye SB (2003) Ovarian cancer: strategies for overcoming resistance to chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/58/c4/bjc2012265a.PMC3394988.pdf
"Available from http://globocan.iarc.fr Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P (2008) Diagnostic utility of alarm features for colorectalcancer: systematic review and meta-analysis.",OADS,/arxiv_data1/oa_pdf/65/fb/bjc2012266a.PMC3394989.pdf
"R Development Core Team: Vienna, Austria.ISBN 3-900051-07-0, http://www.R-project.org Richards MA (2009) The national awareness and early diagnosis initiative in England: assembling the evidence.",Non-OADS,/arxiv_data1/oa_pdf/65/fb/bjc2012266a.PMC3394989.pdf
"http://seer.cancer.gov/csr/1975_2008/, based on November2010 SEER data submission, posted to the SEER web siteKim JY, Kim NK, Sohn SK, Kim YW, Kim KJ, Hur H, Min BS, Cho CH (2009) Prognostic value of postoperative CEA clearance in rectal cancer patients withhigh preoperative CEA levels.",OADS,/arxiv_data1/oa_pdf/fb/de/bjc2012267a.PMC3394990.pdf
"http://www.nccn.org/index.asp (last accessed 12 March 2012) Park IJ, Choi GS, Lim KH, Kang BM, Jun SH (2009) Serum carcino- embryonic antigen monitoring after curative resection for colorectalcancer: clinical significance of the preoperative level.",Non-OADS,/arxiv_data1/oa_pdf/fb/de/bjc2012267a.PMC3394990.pdf
"http://www.sggssg.ch/Dokumente/Merkblaetter/NaSo_CRC_d.pdf, last accessed 7 May 2012 Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, Shih YL, Chang SJ, Wang JY (2009) Preoperative serum carcinoembryonic antigen, albuminand age are supplementary to UICC staging systems in predictingsurvival for colorectal cancer patients undergoing surgical treatment.BMC Cancer 9: 288 Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H (2008) Preoperative serum carcinoembryonicantigen level as a predictive factor of recurrence after curative resection of colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/fb/de/bjc2012267a.PMC3394990.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Faecal occult blood testing and colorectal cancer mortality G Libby et al 259 &2012 Cancer Research UK British Journal of Cancer (2012) 107(2), 255 – 259 Clinical Studies",Non-OADS,/arxiv_data1/oa_pdf/a5/be/bjc2012277a.PMC3394992.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2012 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Mucosal dehiscence coverage for dental implant  using sprit pouch technique: a two-stage approach Toyohiko Hidaka1, Daisuke Ueno2,* 1Second Department of Comprehensive Care, Tsurumi University School of Dental Medicine, Yokohama, Japan 2Unit of Oral and Maxillofacial Implantology, Tsurumi University School of Dental Medicine, Yokohama, Japan Purpose:  Soft tissue recessions frequently cause esthetic disharmony and dissatisfaction.",Non-OADS,/arxiv_data1/oa_pdf/46/08/jpis-42-105.PMC3394995.pdf
"Keywords:  Case report, Dental Esthetics, Mouth mucosa, Oral surgical procedures.J Periodontal Implant Sci 2012;42:105-109 • http://dx.doi.org/10.5051/jpis.2012.42.3.105Case Report INTRODUCTION Soft tissue recessions around dental implants have frequent - ly been observed.",Non-OADS,/arxiv_data1/oa_pdf/46/08/jpis-42-105.PMC3394995.pdf
"www.jpis.orgpISSN 2093-2278 eISSN 2093-2286Editorial Copyright © 2012 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).From so simple a beginningJ Periodontal Implant Sci 2012;42:65-66 • http://dx.doi.org/10.5051/jpis.2012.42.3.65 I am neither a Darwinian demagogue, nor an Intelligent  Design orator.",Non-OADS,/arxiv_data1/oa_pdf/8b/8a/jpis-42-65.PMC3394996.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2012 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Effect of rheumatoid arthritis on periodontitis:   a historical cohort study Parviz Torkzaban1, Tayebeh Hjiabadi1, Zahra Basiri2, Jalal Poorolajal3,* 1Department of Periodontology, Hamadan University of Medical Sciences School of Dentistry, Hamadan, Iran 2Department of Rheumatology, Hamadan University of Medical Sciences School of Medicine, Hamadan, Iran 3Department of Epidemiology & Biostatistics, Research Center for Health Sciences, Hamadan University of Medical Sciences School of  Public Health, Hamadan, Iran Purpose:  Rheumatoid arthritis (RA) is a chronic multi-systemic disease that causes damage to the bone and connective tissues.",Non-OADS,/arxiv_data1/oa_pdf/3f/f7/jpis-42-67.PMC3394997.pdf
"Keywords:  Rheumatoid arthritis, Periodontitis, Periodontal index, Iran.J Periodontal Implant Sci 2012;42:67-72 • http://dx.doi.org/10.5051/jpis.2012.42.3.67Research Article INTRODUCTION Periodontitis is an infectious disease and a leading cause of  chronic periodontal inflammation in which microbial plaque  causes damage to alveolar bone and surrounding connective  tissue; it is also a leading cause of tooth loss [1].",Non-OADS,/arxiv_data1/oa_pdf/3f/f7/jpis-42-67.PMC3394997.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2012 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Effects of immunosuppressants, FK506 and  cyclosporin A, on the osteogenic differentiation of  rat mesenchymal stem cells  Yu-Kyung Byun1, Kyoung-Hwa Kim1, Su-Hwan Kim2,3, Young-Sung Kim2,3, Ki-Tae Koo1, Tai-Il Kim1, Yang-Jo Seol1,  Young Ku1, In-Chul Rhyu1, Yong-Moo Lee1,* 1Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry, Seoul, Korea 2Department of Periodontics, Asan Medical Center, Seoul, Korea 3Department of Dentistry, University of Ulsan College of Medicine, Seoul, Korea Purpose:  The purpose of this study was to investigate the effects of the immunosuppressants FK506 and cyclosporin A (CsA)  on the osteogenic differentiation of rat mesenchymal stem cells (MSCs).",Non-OADS,/arxiv_data1/oa_pdf/50/c9/jpis-42-73.PMC3394998.pdf
"Keywords:  Cell differentiation, Cyclosporin A, FK506, Immunosuppressive agents, Mesenchymal stem cells.J Periodontal Implant Sci 2012;42:73-80 • http://dx.doi.org/10.5051/jpis.2012.42.3.73Research Article INTRODUCTION Mesenchymal stem cells (MSCs) are multipotent progeni - tor cells that reside in the bone marrow and other tissues [1].",Non-OADS,/arxiv_data1/oa_pdf/50/c9/jpis-42-73.PMC3394998.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2012 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Surface characteristics of thermally treated  titanium surfaces Yang-Jin Lee1, De-Zhe Cui2, Ha-Ra Jeon1, Hyun-Ju Chung1, Yeong-Joon Park3, Ok-Su Kim1, Young-Joon Kim1,* 1Department of Periodontology, Dental Science Research Institute, Chonnam National University School of Dentistry, Gwangju, Korea 2Dental Hospital, Yanbian Medical University, Yanji, People’s Republic of China 3Department of Dental Materials, Dental Science Research Institute, Chonnam National University School of Dentistry, Gwangju, Korea Purpose:  The characteristics of oxidized titanium (Ti) surfaces varied according to treatment conditions such as duration time  and temperature.",Non-OADS,/arxiv_data1/oa_pdf/b8/dd/jpis-42-81.PMC3394999.pdf
"Keywords:  Phase transition, Titanium, Transition temperature, Wettability.J Periodontal Implant Sci 2012;42:81-87 • http://dx.doi.org/10.5051/jpis.2012.42.3.81Research Article INTRODUCTION Titanium and titanium alloys have been widely used in den - tistry and orthopedics due to their excellent biocompatibility  and physical properties.",Non-OADS,/arxiv_data1/oa_pdf/b8/dd/jpis-42-81.PMC3394999.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2012 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Comparative evaluation of roughness of titanium  surfaces treated by different hygiene instruments Otgonbayar Unursaikhan†, Jung-Seok Lee†, Jae-Kook Cha, Jung-Chul Park, Ui-Won Jung, Chang-Sung Kim,  Kyoo-Sung Cho, Seong-Ho Choi* Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College of Dentistry, Seoul, Korea  Purpose:  The use of appropriate instruments to clean surfaces with minimal change, is critical for the successful maintenance  of a dental implant.",Non-OADS,/arxiv_data1/oa_pdf/84/3c/jpis-42-88.PMC3395000.pdf
"Keywords:  Dental implants, Dental instruments, Peri-implantitis, Periodontal debridement.J Periodontal Implant Sci 2012;42:88-94 • http://dx.doi.org/10.5051/jpis.2012.42.3.88Research Article INTRODUCTION Over the past few decades, dental implants have become  one of the most effective treatments following tooth loss.",Non-OADS,/arxiv_data1/oa_pdf/84/3c/jpis-42-88.PMC3395000.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2012 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Heat or radiofrequency plasma glow discharge  treatment of a titanium alloy stimulates osteoblast  gene expression in the MC3T3 osteoprogenitor  cell line Bruce E. Rapuano1, Kyle Hackshaw1, Daniel E. MacDonald1,2,3,* 1Hospital for Special Surgery affiliated with the Weill Medical College of Cornell University, New York, NY, USA 2General Medical Research, James J. Peters VA Medical Center, Bronx, NY, USA 3Langmuir Center for Colloids and Interfaces, Columbia University, New York, NY, USA Purpose:  The purpose of this study was to determine whether increasing the Ti6Al 4V surface oxide negative charge through  heat (600°C) or radiofrequency plasma glow discharge (RFGD) pretreatment, with or without a subsequent coating with fibro - nectin, stimulated osteoblast gene marker expression in the MC3T3 osteoprogenitor cell line.",Non-OADS,/arxiv_data1/oa_pdf/de/59/jpis-42-95.PMC3395001.pdf
"Keywords:  Cell differentiation, Dental implants, Fibronectins, Integrin alpha5beta1, Osteoblasts.J Periodontal Implant Sci 2012;42:95-104 • http://dx.doi.org/10.5051/jpis.2012.42.3.95Research Article INTRODUCTION Although the outcomes of dental and orthopedic implant  procedures are usually successful, in many instances the long- term stability and functionality of the implant cannot be achieved.",Non-OADS,/arxiv_data1/oa_pdf/de/59/jpis-42-95.PMC3395001.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/02/66/jgo-23-137.PMC3395006.pdf
3:137-138 http://dx.doi.org/10.3802/jgo.2012.23.3.137,OADS,/arxiv_data1/oa_pdf/02/66/jgo-23-137.PMC3395006.pdf
"Jong-Min Lee http://dx.doi.org/10.3802/jgo.2012.23.3.137 138  www.ejgo.org of viral markers in close to 100% of invasive cervical cancer,  and 75-90% of precancerous lesions [9,10].",OADS,/arxiv_data1/oa_pdf/02/66/jgo-23-137.PMC3395006.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/5b/4a/jgo-23-139.PMC3395007.pdf
"3:139-140 http://dx.doi.org/10.3802/jgo.2012.23.3.139 Received  Jun 19, 2012, Accepted  Jun 19, 2012 Correspondence to  Chulmin Lee Department of Obstetrics and Gynecology, Inje University Sanggye Paik  Hospital, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5b/4a/jgo-23-139.PMC3395007.pdf
"Chulmin Lee http://dx.doi.org/10.3802/jgo.2012.23.3.139 140  www.ejgo.org silencer, is a surrogate target for therapy because it is overex - pressed in a number of malignancies and the relevancy with  endometrial cancer has not been elucidated.",Non-OADS,/arxiv_data1/oa_pdf/5b/4a/jgo-23-139.PMC3395007.pdf
NOW AVAILABLE ONLINE  - http://www.ejgo.org,Non-OADS,/arxiv_data1/oa_pdf/5b/4a/jgo-23-139.PMC3395007.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To determine the baseline information about the knowledge of cervical cancer and explore attitude and practice of  Pap smear screening among staff nurses.",Non-OADS,/arxiv_data1/oa_pdf/7d/04/jgo-23-141.PMC3395008.pdf
3:141-146 http://dx.doi.org/10.3802/jgo.2012.23.3.141,Non-OADS,/arxiv_data1/oa_pdf/7d/04/jgo-23-141.PMC3395008.pdf
"http://dx.doi.org/10.3802/jgo.2012.23.3.141 142  www.ejgo.org and screen all the women coming / admitting to hospital for  any of their problems, along with motivating the peripheral  health workers to bring all the sexually active females to the  hospital for the cervical screening.",Non-OADS,/arxiv_data1/oa_pdf/7d/04/jgo-23-141.PMC3395008.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.141 144  www.ejgo.org half respondents (54%) knew that HPV infection is one of the  risk factors of cervical cancer.,Non-OADS,/arxiv_data1/oa_pdf/7d/04/jgo-23-141.PMC3395008.pdf
"http://dx.doi.org/10.3802/jgo.2012.23.3.141 146  www.ejgo.org Secondly, the method used for estimating the practice of Pap  smears-namely self-reported test history, which may be faulty  due to inaccurate recall or desirability bias [15].",Non-OADS,/arxiv_data1/oa_pdf/7d/04/jgo-23-141.PMC3395008.pdf
Available from: http://edition.cnn.,Non-OADS,/arxiv_data1/oa_pdf/7d/04/jgo-23-141.PMC3395008.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The purpose of this study was to describe the implementation of single visit approach or See -visual inspection of  the cervix with acetic acid (VIA) -and Treat -immediate cryotherapy in the VIA positive cases -model for the cervical cancer  prevention in Jakarta, Indonesia.",Non-OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
3:147-152 http://dx.doi.org/10.3802/jgo.2012.23.3.147,Non-OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.147 148  www.ejgo.org preventing cervical cancer is still focused on the screening  program.,Non-OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.147 150  www.ejgo.org The second pillar is the training management which had  been held for five days.,Non-OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
Available from: http://globocan.iarc.fr/factsheets/ populations/factsheet.asp?uno=900.,Non-OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
Available from:  http://iapindonesia.com.,Non-OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.147 152  www.ejgo.org Statistik Republik Indonesia; c2009 [cited 2012 Jun 11].,OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
Available from: http://dds.bps.go.id/eng/.,OADS,/arxiv_data1/oa_pdf/74/4d/jgo-23-147.PMC3395009.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The aim of this study was to investigate the risk and recurrence of early invasive adenocarcinoma of the cervix, and to  determine whether non-radical methods of management could be performed.",Non-OADS,/arxiv_data1/oa_pdf/85/ce/jgo-23-153.PMC3395010.pdf
3:153-158 http://dx.doi.org/10.3802/jgo.2012.23.3.153,Non-OADS,/arxiv_data1/oa_pdf/85/ce/jgo-23-153.PMC3395010.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.153 154  www.ejgo.org es IA1 and IA2 adenocarcinoma of the cervix and concluded  non-radical methods of management may be considered  suitable because of a good prognosis.,Non-OADS,/arxiv_data1/oa_pdf/85/ce/jgo-23-153.PMC3395010.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.153 156  www.ejgo.org spread ranged from 11 mm to 35 mm.,Non-OADS,/arxiv_data1/oa_pdf/85/ce/jgo-23-153.PMC3395010.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.153 158  www.ejgo.org of stage IA(1) cervical adenocarcinoma by conization  alone to preserve fertility: a preliminary report.,Non-OADS,/arxiv_data1/oa_pdf/85/ce/jgo-23-153.PMC3395010.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  We wanted to evaluate the outcomes of cervical cancer patients with supraclavicular lymph node (SCLN)  involvement and who received radiation therapy (RT) combined with chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/1d/ed/jgo-23-159.PMC3395011.pdf
3:159-167 http://dx.doi.org/10.3802/jgo.2012.23.3.159,Non-OADS,/arxiv_data1/oa_pdf/1d/ed/jgo-23-159.PMC3395011.pdf
"http://dx.doi.org/10.3802/jgo.2012.23.3.159 160  www.ejgo.org Recently published study [3] suggesting the role of CCRT in  cervical cancer patients with SCLN involvement report that  patients who had received RT to pelvis, PALN and SCLN with  simultaneous chemotherapy showed a long term survival.",Non-OADS,/arxiv_data1/oa_pdf/1d/ed/jgo-23-159.PMC3395011.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.159 162  www.ejgo.org to evaluate the response after CCRT.,OADS,/arxiv_data1/oa_pdf/1d/ed/jgo-23-159.PMC3395011.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.159 164  www.ejgo.org cancer with SCLN involvement.,Non-OADS,/arxiv_data1/oa_pdf/1d/ed/jgo-23-159.PMC3395011.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.159 166  www.ejgo.org tablished yet.,Non-OADS,/arxiv_data1/oa_pdf/1d/ed/jgo-23-159.PMC3395011.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/78/jgo-23-168.PMC3395012.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To determine the predictive accuracy of the combined panels of serum human tissue kallikreins (hKs) and CA-125 for  the detection of epithelial ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/5e/0a/jgo-23-175.PMC3395013.pdf
3:175-181 http://dx.doi.org/10.3802/jgo.2012.23.3.175,Non-OADS,/arxiv_data1/oa_pdf/5e/0a/jgo-23-175.PMC3395013.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.175 176  www.ejgo.org Singapore women showing mortality of advanced stage at  77.1% and 20% in the early stage disease over a 5-year pe - riod [3].,Non-OADS,/arxiv_data1/oa_pdf/5e/0a/jgo-23-175.PMC3395013.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.175 178  www.ejgo.org hK10 level and age.,Non-OADS,/arxiv_data1/oa_pdf/5e/0a/jgo-23-175.PMC3395013.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.175 180  www.ejgo.org [37].,OADS,/arxiv_data1/oa_pdf/5e/0a/jgo-23-175.PMC3395013.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To investigate the relationship between cisplatin resistance and histone deacetylase (HDAC) isoform overexpression  in ovarian cancer cell lines.",Non-OADS,/arxiv_data1/oa_pdf/77/e8/jgo-23-182.PMC3395014.pdf
3:182-189 http://dx.doi.org/10.3802/jgo.2012.23.3.182,Non-OADS,/arxiv_data1/oa_pdf/77/e8/jgo-23-182.PMC3395014.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.182 184  www.ejgo.org ing to manufacturer instructions.,Non-OADS,/arxiv_data1/oa_pdf/77/e8/jgo-23-182.PMC3395014.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.182 186  www.ejgo.org (Fig.,OADS,/arxiv_data1/oa_pdf/77/e8/jgo-23-182.PMC3395014.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.182 188  www.ejgo.org CONFLICT OF INTEREST No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/77/e8/jgo-23-182.PMC3395014.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Epidemiological studies suggest that selenium protects against the development of several cancers.",Non-OADS,/arxiv_data1/oa_pdf/cd/9f/jgo-23-190.PMC3395015.pdf
3:190-196 http://dx.doi.org/10.3802/jgo.2012.23.3.190,Non-OADS,/arxiv_data1/oa_pdf/cd/9f/jgo-23-190.PMC3395015.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.190 192  www.ejgo.org with a dose-dependent manner (Fig.,Non-OADS,/arxiv_data1/oa_pdf/cd/9f/jgo-23-190.PMC3395015.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.190 194  www.ejgo.org ing to selenium supplementation.,Non-OADS,/arxiv_data1/oa_pdf/cd/9f/jgo-23-190.PMC3395015.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.190 196  www.ejgo.org Cancer Inst 2009;101:1193-205.,Non-OADS,/arxiv_data1/oa_pdf/cd/9f/jgo-23-190.PMC3395015.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgExternal-beam radiation therapy with intracavitary high-dose-rate brachytherapy is the standard treatment modality for  advanced cervical cancer; however, late gastrointestinal complications are a major concern after radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/08/06/jgo-23-197.PMC3395016.pdf
3:197-200 http://dx.doi.org/10.3802/jgo.2012.23.3.197,Non-OADS,/arxiv_data1/oa_pdf/08/06/jgo-23-197.PMC3395016.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.197 198  www.ejgo.org patient returned to the hospital complaining of intermittent  rectal bleeding.,Non-OADS,/arxiv_data1/oa_pdf/08/06/jgo-23-197.PMC3395016.pdf
"http://dx.doi.org/10.3802/jgo.2012.23.3.197 200  www.ejgo.org a history of abdominal surgery, pelvic inflammatory disease,  or diverticulosis are at a greater risk of developing radiation- induced GI complications because such conditions may cre - ate adhesions to the uterus, which prevent the loops of the  bowel from moving during RT [9].",Non-OADS,/arxiv_data1/oa_pdf/08/06/jgo-23-197.PMC3395016.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgOvarian Sertoli-Leydig cell tumors are rare sex cord-stromal tumors, accounting for less than 1% of ovarian tumors.",Non-OADS,/arxiv_data1/oa_pdf/b7/32/jgo-23-201.PMC3395017.pdf
3:201-204 http://dx.doi.org/10.3802/jgo.2012.23.3.201,Non-OADS,/arxiv_data1/oa_pdf/b7/32/jgo-23-201.PMC3395017.pdf
"http://dx.doi.org/10.3802/jgo.2012.23.3.201 202  www.ejgo.org hormone, dehydroepiandrosterone sulphate [DHEAS]) were  normal.",Non-OADS,/arxiv_data1/oa_pdf/b7/32/jgo-23-201.PMC3395017.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.201 204  www.ejgo.org study of 54 cases.,Non-OADS,/arxiv_data1/oa_pdf/b7/32/jgo-23-201.PMC3395017.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/a8/a1/jgo-23-205.PMC3395018.pdf
3:205-206 http://dx.doi.org/10.3802/jgo.2012.23.3.205 Fig.,OADS,/arxiv_data1/oa_pdf/a8/a1/jgo-23-205.PMC3395018.pdf
http://dx.doi.org/10.3802/jgo.2012.23.3.205 206  www.ejgo.org CD 43 positive (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/a1/jgo-23-205.PMC3395018.pdf
"Karthik Udupa1, Prasanth Ganesan1, Urmila Majhi2,  Tenali Gnana Sagar1 Departments of 1Medical Oncology and 2Pathology, Cancer  Institute (WIA), Adyar, India  http://dx.doi.org/10.3802/jgo.2012.23.3.205Correspondence to  Prasanth Ganesan Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai  600036, India.",Non-OADS,/arxiv_data1/oa_pdf/a8/a1/jgo-23-205.PMC3395018.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
"2 (page number not for citation purpose)Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
"The coder pairs for each narrativeWhat do medical students learn when they follow patients from hospital to community Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
"4 (page number not for citation purpose)Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
"Our overall resultsWhat do medical students learn when they follow patients from hospital to community Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
"6 (page number not for citation purpose)Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
"Acad Med 2001; 76: 815/C120.What do medical students learn when they follow patients from hospital to community Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
"8 (page number not for citation purpose)Citation: Med Educ Online 2012, 17: 18899 - http://dx.doi.org/10.3402/meo.v17i0.18899",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/MEO-17-18899.PMC3395028.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The author declares no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/74/e2/srep00506.PMC3395029.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Ohshima, I.",Non-OADS,/arxiv_data1/oa_pdf/74/e2/srep00506.PMC3395029.pdf
"Fukushima Prefectural Government, http://www.pref.fukushima.jp/j/20- 50km40.pdf (accessed 3 April 2012).",Non-OADS,/arxiv_data1/oa_pdf/6e/38/srep00507.PMC3395030.pdf
"Nuclear Safety Commission of Japan, http://www.nsc.go.jp/mext_speedi/0312- 0406 _ex.pdf (accessed 3 April 2012).",OADS,/arxiv_data1/oa_pdf/6e/38/srep00507.PMC3395030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Tokonami, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/38/srep00507.PMC3395030.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e1/89/srep00505.PMC3395031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Russo, J.",Non-OADS,/arxiv_data1/oa_pdf/e1/89/srep00505.PMC3395031.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/af/09/emboj2012118a.PMC3395085.pdf
[http://creativecommons.org/licenses/by-nc-nd/3.0]Integration reactions in crystallo S Hare et al 3028 The EMBO Journal VOL 31 |NO 13 |2012 &2012 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/af/09/emboj2012118a.PMC3395085.pdf
"Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).Acknowledgements We thank Dr M Serrano (CNIO) for plasmids, cells and helpfuldiscussions.",Non-OADS,/arxiv_data1/oa_pdf/92/95/emboj2012122a.PMC3395087.pdf
[http://creativecommons.org/licenses/by-nc-sa/3.0/]p57 CDKi and p38 promote cell survival upon stress M Joaquin et al 2964 The EMBO Journal VOL 31 |NO 13 |2012 &2012 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/92/95/emboj2012122a.PMC3395087.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/11/71/emboj2012132a.PMC3395091.pdf
[http://creativecommons.org/ licenses/by-nc-sa/3.0/]Telomere dysfunction limits cancer progression in humans A Suram et al 2851 &2012 European Molecular Biology Organization The EMBO Journal VOL 31 |NO 13 |2012,Non-OADS,/arxiv_data1/oa_pdf/11/71/emboj2012132a.PMC3395091.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/95/bf/emboj2012142a.PMC3395096.pdf
"Yeast two-hybrid analysis Y east two-hybrid screening was performed by Hybrigenics, S.A., Paris,France (http://www.hybrigenics-services.com).",Non-OADS,/arxiv_data1/oa_pdf/86/eb/emboj2012151a.PMC3395097.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/86/eb/emboj2012151a.PMC3395097.pdf
[http://creativecommons.org/licenses/by-nc-sa/3.0/]Pex3 recruits Atg36 to peroxisomes AM Motley et al 2868 The EMBO Journal VOL 31 |NO 13 |2012 &2012 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/86/eb/emboj2012151a.PMC3395097.pdf
"The Database of Genomic Variants (http://projects.tcag.ca/variation/) reports three heterozygous deletions encom-passing the 3 9end of TNR (3/66741, frequency 4.5 310/C05), and there are no exonic deletions in TNR among 2026 control probands in the CNV CHOP database (http://www.cnv.chop.edu).",OADS,/arxiv_data1/oa_pdf/92/3d/jmedgenet-2012-100831.PMC3395313.pdf
"9Microarray expression experiments suggest that KIAA0040 has little to no expression in the central nervous system making its implication in our patient ’s pathology unlikely (data from HUGE (http://www.kazusa.or.jp/huge/),Gene Report BioGPS (http://www.biogps.org/), UCSC Genome Browser (http://www.genome.ucsc.edu/)).",OADS,/arxiv_data1/oa_pdf/92/3d/jmedgenet-2012-100831.PMC3395313.pdf
Retrieved from http://www.readingrecovery.org/rrcna/journals/ltl/index.asp .,Non-OADS,/arxiv_data1/oa_pdf/18/32/11145_2011_Article_9328.PMC3395353.pdf
Retrieved from http://www.reading.org/general/publications/journals/rrq.aspx .,Non-OADS,/arxiv_data1/oa_pdf/18/32/11145_2011_Article_9328.PMC3395353.pdf
Retrieved from http://www.jeremymiles.co.uk/ regressionbook/2006/04/huber-white-estimates-in-spss.html .,OADS,/arxiv_data1/oa_pdf/18/32/11145_2011_Article_9328.PMC3395353.pdf
Available at http://www.niﬂ.gov/early childhood/NELP/NELPreport.html .,Non-OADS,/arxiv_data1/oa_pdf/18/32/11145_2011_Article_9328.PMC3395353.pdf
Retrieved from http://work-learning.com/effect_sizes.htm .,OADS,/arxiv_data1/oa_pdf/18/32/11145_2011_Article_9328.PMC3395353.pdf
"“Primer3,” http://frodo.wi.mit.edu/primer3/input.htm .",Non-OADS,/arxiv_data1/oa_pdf/8d/ad/1534.PMC3395479.pdf
"“ImageJ,” http://rsbweb.nih.gov/ij/   37.",Non-OADS,/arxiv_data1/oa_pdf/8d/ad/1534.PMC3395479.pdf
"National Instruments Corporation , “LabView 8.2.1” ( 2007 ), http://www.ni.com/labview/ .",Non-OADS,/arxiv_data1/oa_pdf/f5/6c/1609.PMC3395485.pdf
"NVidia , “GeForce 8600” ( 2009 ), http://www.nvidia.com/object/geforce_8600.html .",Non-OADS,/arxiv_data1/oa_pdf/f5/6c/1609.PMC3395485.pdf
"Apple, “Working with Quartz Composer” ( 2009 ),  http://developer.apple.com/graphicsimaging/quartz/quartzcomposer.html .",Non-OADS,/arxiv_data1/oa_pdf/f5/6c/1609.PMC3395485.pdf
"NVidia , “FX Composer 2.5” ( 2009 ), http://developer.nvidia.com/object/fx_composer_ho me.html .",Non-OADS,/arxiv_data1/oa_pdf/f5/6c/1609.PMC3395485.pdf
"University of Glasgow School of Physics and Astronomy , “Optical tweezers software” ( 2010),  http://www.gla.ac.uk/schools/physics/research/groups/optics/research/opticaltweezers/software/ .",Non-OADS,/arxiv_data1/oa_pdf/f5/6c/1609.PMC3395485.pdf
"B. Fowle , “Setting up OpenGL in an MFC control” ( 2006 ), http://www.codeguru.com .",Non-OADS,/arxiv_data1/oa_pdf/f5/6c/1609.PMC3395485.pdf
"“WHO Disease and injury country estimates,” World Health Organization, 2009 ,  http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html   4.",Non-OADS,/arxiv_data1/oa_pdf/e7/8b/1632.PMC3395487.pdf
"Our source CDF code can be accessed via Mathematica, the computational software developed by Wolfram Research (Oct. 2011), http://optics.nuigalway.ie/people/mehdiB/CDF .html.",OADS,/arxiv_data1/oa_pdf/3a/c5/1684.PMC3395491.pdf
"Mardal, G. N. Wells et al.,Automated Solution of Differential Equations by the Finite Element Method(Springer,2012);software available from http://fenicsproject.org.",OADS,/arxiv_data1/oa_pdf/6a/2f/1732.PMC3395495.pdf
Two months after publication it is available to the  public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/72/bd/2621.PMC3395650.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/91/c2/2622.PMC3395651.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/37/ac/2623.PMC3395652.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/95/a7/2635.PMC3395653.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e6/ba/2645.PMC3395654.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8a/0e/2658.PMC3395655.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/09/ef/2671.PMC3395656.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/65/63/2680.PMC3395657.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a9/20/2692.PMC3395658.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/55/7c/2702.PMC3395659.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1b/52/2712.PMC3395660.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/92/e6/2723.PMC3395661.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/55/06/2741.PMC3395662.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/96/32/2755.PMC3395663.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/60/7e/2770.PMC3395664.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cc/fc/2782.PMC3395665.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/31/ac/2793.PMC3395666.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1e/3a/2805.PMC3395667.pdf
Analysis of the  complete gene data set using the Web-based tools GeneCodis  (http://genecodis.dacya.ucm.es) and FunSpec (http://funspec.med   .utoronto.ca) allowed us to establish transcription (GO:0006350) as  the biological process with the highest statistical significance.,OADS,/arxiv_data1/oa_pdf/1e/3a/2805.PMC3395667.pdf
Gene functional categories were assigned according to the information  from the Biobase BioKnowledge Library (BKL; http://rous.mit.edu/index.php/Biobase_BioKnowledge_Library).,OADS,/arxiv_data1/oa_pdf/1e/3a/2805.PMC3395667.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer, as the most common malignancy, is the major  cause of cancer-related deaths of women worldwide [1-3].",Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
"Therefore, significant improvement in therapeutic efficacy can be achieved only by developing effective approaches based on a comprehensive understanding of the radiobiology of the tumor and normal tissues, to selectively enhance the radiation Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by  2-Deoxy-D-Glucose in Combination Therapy  Fahimeh Aghaee, Jalil Pirayesh Islamian, Behzaad Baradaran1 Departments of Medical Physics and  1Immunology, Tabriz University of Medical Sciences School of Medicine, Tabriz, Iran REVIEW ARTICLEJ Breast Cancer 2012 June; 15(2): 141-147  http://dx.doi.org/10.4048/jbc.2012.15.2.141 Breast cancer is the most common malignancy, and it is also the  major cause of cancer-related deaths of women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.141damage in tumors while reducing the damage to normal tissues  [10,11,15].",Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
"Radiosensitivity andChemosensitivity ofBreast Cancer Cells  143 http://dx.doi.org/10.4048/jbc.2012.15.2.141  http://ejbc.kr2-DEOXY-D-GLUCOSE FUNCTION Cellular processes leading to the error-free repair and fixation  of DNA lesions require a continuous flow of metabolic energy,  which is frequently supplied by enhanced glycolysis in cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.1412-DEOXY-D-GLUCOSE AS RADIOSENSITATOR Analyzing the radiomodifying effects of 2-DG observed in  several tumor cell lines reveal that the time of administration  of 2-DG with respect to irradiation plays a critical role in   determining the effects.,Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
"Radiosensitivity andChemosensitivity ofBreast Cancer Cells  145 http://dx.doi.org/10.4048/jbc.2012.15.2.141  http://ejbc.krattributed to one of several mechanisms; translocation of   transporter from an intracellular compartment to the plasma  membrane, changes in the glycosylation pattern of the Glut1 transporter with decreased turnover of the protein, or by   increased synthesis of mRNA and protein [17].",Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.141metabolism (i.e., 2-DG), tumor cells with high glucose   utilization will be more sensitive to cell death resulting from  respiratory dependent metabolic oxidative stress than tumor cells with low glucose utilization and normal cells.",Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
http://www.bhj.org/journal/2001_4304_oct/review_537.htm.,Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
Radiosensitivity andChemosensitivity ofBreast Cancer Cells  147 http://dx.doi.org/10.4048/jbc.2012.15.2.141  http://ejbc.krceptors 	induce 	apoptosis 	in	bcl-2-positive 	human 	breast 	cancer 	cells.,Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
http://www.webmd.com/breast-cancer/breast-cancer-types- er-positive-her2-positive.,Non-OADS,/arxiv_data1/oa_pdf/be/0c/jbc-15-141.PMC3395736.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Malignancy induces a prothrombotic state, and cancer treat - ment is often complicated by either venous or arterial throm - botic events.",Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
"Con-   versely, patients with histories of hospitalization for VTE have Breast Cancer as an Acquired Thrombophilic State V asiliki Kyriazi Hematological Department, Central Polyclinic, Institution of Social Insurance, Thessaloniki, GreeceREVIEW ARTICLEJ Breast Cancer 2012 June; 15(2): 148-156  http://dx.doi.org/10.4048/jbc.2012.15.2.148 Cancer is an acquired thrombophilic condition manifested by   increased incidence of venous and arterial thromboembolic   complications.",Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
"Breast Cancer and Thrombosis 149 http://dx.doi.org/10.4048/jbc.2012.15.2.148  http://ejbc.kra 1.5 times higher risk of a breast cancer diagnosis within 24  months following the thrombotic episode (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.05-3.20) [4].",Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
150  Vasiliki Kyriazi http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.148thrombin.,Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
Breast Cancer and Thrombosis 151 http://dx.doi.org/10.4048/jbc.2012.15.2.148  http://ejbc.krby chemotherapy and radiotherapy causes the release of pro - cagulant agents and direct damage to vascular endothelium.,Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
"152  Vasiliki Kyriazi http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.148characteristics (i.e., age, gender, race, comorbidities), cancer  properties (i.e., stage, primary site), treatment modalities (i.e., surgery, hospitalization, chemotherapy, supportive care), while several biomarkers, such as platelet count, leukocyte count, TF expression, soluble p-selectin, D-dimers, and C-reactive protein may be predictive of cancer-related thrombosis [1].",Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
Breast Cancer and Thrombosis 153 http://dx.doi.org/10.4048/jbc.2012.15.2.148  http://ejbc.kr[28].,Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
154  Vasiliki Kyriazi http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.148tial antineoplastic properties of heparins.,Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
Breast Cancer and Thrombosis 155 http://dx.doi.org/10.4048/jbc.2012.15.2.148  http://ejbc.kr11.,Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
156  Vasiliki Kyriazi http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.148with	malignancy 	and	venous 	thromboembolism 	by	tumour 	subtype 	 and	thrombus 	location.,Non-OADS,/arxiv_data1/oa_pdf/a2/a4/jbc-15-148.PMC3395737.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Manganese superoxide dismutase (MnSOD) is a metallo - enzyme that converts superoxide to hydrogen peroxide and  quenches the free radicals generated by the electron transport chain [1].",Non-OADS,/arxiv_data1/oa_pdf/0f/44/jbc-15-157.PMC3395738.pdf
"This alteration may affect the cellular allocation of MnSOD within the mitochondria; therefore, MnSOD leaves Association of Alanine-Valine Manganese Superoxide Dismutase Gene  Polymorphism and Microheterogeneity Manganese Superoxide Dismutase  Activity in Breast Cancer and Benign Breast Tissue Manar Atoum, Malak Abdel-Fattah1, Nisreen Nimer, Saleem Abdel-Rahman1, Sawsan A. Abdeldayem2   Department of Medical Laboratories, Faculty of Allied Health Sciences, Hashemite University,  1Department of Biology and Biotechnology, Faculty of  Sciences, Hashemite University, Zarqa,  2Medical Laboratory Sciences, King Hussein Medical Center, Amman, JordanORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 157-161  http://dx.doi.org/10.4048/jbc.2012.15.2.157 Purpose:  Although the etiology of breast cancer is multifactorial,  oxidative stress plays an important role in carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/0f/44/jbc-15-157.PMC3395738.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.157the mitochondria without defense against superoxide radicals  [16].,Non-OADS,/arxiv_data1/oa_pdf/0f/44/jbc-15-157.PMC3395738.pdf
"Manganese Superoxide Dismutase Activity, Benign andBreast Cancer 159 http://dx.doi.org/10.4048/jbc.2012.15.2.157  http://ejbc.krgroups using analysis of variance.",Non-OADS,/arxiv_data1/oa_pdf/0f/44/jbc-15-157.PMC3395738.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.157the Ala-variant of the MnSOD successfully targets the mito - chondria.,Non-OADS,/arxiv_data1/oa_pdf/0f/44/jbc-15-157.PMC3395738.pdf
"Manganese Superoxide Dismutase Activity, Benign andBreast Cancer 161 http://dx.doi.org/10.4048/jbc.2012.15.2.157  http://ejbc.krpolymorphism 	in	the	manganese 	superoxide 	dismutase 	gene	and	breast 	 cancer.",Non-OADS,/arxiv_data1/oa_pdf/0f/44/jbc-15-157.PMC3395738.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer represents a heterogeneous group of tumors  with differences in morphology, in biology and in treatment.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
"Moreover, an association has been demonstrated between the CD44+/CD24- stem-like phenotype to basal-like and BRCA1 hereditary breast cancer [8], and an increased expression of other putative stem cell markers, BMI-1, EZH2, and Oct-4 Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated  with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer Maurizio Di Bonito *, Monica Cantile *, Francesca Collina, Giosuè Scognamiglio, Margherita Cerrone, Elvira La Mantia,  Antonio Barbato, Giuseppina Liguori, Gerardo Botti INT Fondazione Pascale, Naples, ItalyORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 162-171  http://dx.doi.org/10.4048/jbc.2012.15.2.162 Purpose:  Triple-negative breast cancer, has a significant clinical  relevance being associated with a shorter median time to relapse  and death and does not respond to endocrine therapy or other available targeted agents.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
Geminin and Cancer Stem Cells in Triple-Negative Breast Cancers 163 http://dx.doi.org/10.4048/jbc.2012.15.2.162  http://ejbc.kronly in basal-like breast cancers [9].,Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.162DAKO), c-erbB-2 (Polyclonal Rabbit Anti-Human Oncopro - tein, dilution 1:300; DAKO), Ki-67 (Monoclonal Mouse Anti- Human Ki-67 Ag Clone MIB-1, dilution 1:75; DAKO), and Geminin (Rabbit polyclonal ab12147-50, dilution 1:400; Ab - cam, Cambridge, UK) over night.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
"Geminin and Cancer Stem Cells in Triple-Negative Breast Cancers 165 http://dx.doi.org/10.4048/jbc.2012.15.2.162  http://ejbc.krBiochemicals), and Geminin  (RealTime Designer Assay cod.",OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.162and in triple-negative metastases CD133 was absent.,OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
Geminin and Cancer Stem Cells in Triple-Negative Breast Cancers 167 http://dx.doi.org/10.4048/jbc.2012.15.2.162  http://ejbc.kr High Geminin expression relates with CD133 expression in  triple-negative breast cancers Based on statistical elaboration of CD133 and Geminin  protein expression analysis with the other clinicopathological  A  C  B D  F  E Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.162parameters in triple-negative breast cancers it was shown that  CD133 expression was significantly associated with high Geminin expression ( p= 0.017) (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
Geminin and Cancer Stem Cells in Triple-Negative Breast Cancers 169 http://dx.doi.org/10.4048/jbc.2012.15.2.162  http://ejbc.krexpression of CD133 and Geminin showed a strong overlap  between the 2 methods.,Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.162between Geminin and CD133 expression in triple-negative  samples suggesting the possibility that the cell cycle pathway linked to Geminin activity can be associated to preservation and propagation of cancer stem cells.,Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
Geminin and Cancer Stem Cells in Triple-Negative Breast Cancers 171 http://dx.doi.org/10.4048/jbc.2012.15.2.162  http://ejbc.krmammary 	epithelial 	cells	and	is	a	frequent 	event 	in	human 	tumors.,Non-OADS,/arxiv_data1/oa_pdf/44/ca/jbc-15-162.PMC3395739.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common cancer of women in  Western Europe and North America, and the leading cause   of cancer deaths [1].",Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
"Increases in glucose consump -The Glycolytic Phenotype is Correlated with Aggressiveness and Poor  Prognosis in Invasive Ductal Carcinomas Se Min Jang *, Hulin Han, Ki-Seok Jang, Y oung Jin Jun, Si-Hyong Jang, Kyueng-Whan Min, Min Sung Chung1,*,  Seung Sam Paik Departments of Pathology and 1Surgery, Hanyang University College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 172-180  http://dx.doi.org/10.4048/jbc.2012.15.2.172 Purpose:  Glucose uptake and glycolytic metabolism are enhanced  in cancer cells, and increased expression of glucose transporter  1 (GLUT1) has also been reported.",Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
GLUT1 Expression in Invasive Ductal Carcinomas 173 http://dx.doi.org/10.4048/jbc.2012.15.2.172  http://ejbc.krtion help supply the energy that is necessary for tumor cell  proliferation and reflect adaptation to the adverse conditions of the tumor environment.,Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.172classified as GLUT1 negative, and if it was >10%, it was clas - sified as GLUT1 positive.",OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
GLUT1 Expression in Invasive Ductal Carcinomas 175 http://dx.doi.org/10.4048/jbc.2012.15.2.172  http://ejbc.krsurvival.,Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.172or hypoxia [17,18].",Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
GLUT1 Expression in Invasive Ductal Carcinomas 177 http://dx.doi.org/10.4048/jbc.2012.15.2.172  http://ejbc.krFigure 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.172Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
GLUT1 Expression in Invasive Ductal Carcinomas 179 http://dx.doi.org/10.4048/jbc.2012.15.2.172  http://ejbc.kr39 cases of breast malignancies.,Non-OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.172Baselga 	J,	et	al.",OADS,/arxiv_data1/oa_pdf/d6/fd/jbc-15-172.PMC3395740.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The most frequently encountered malignancy of breast   cancer tissue in women represents a classical model of estro - gen dependent condition [1].",Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
"The Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via  Nitric Oxide Production in Human Breast Cancer Karabi Ganguly Bhattacharjee, Mau Bhattacharyya, Umesh Chandra Halder1, Pradipta Jana, Asru K. Sinha Sinha Institute of Medical Science & Technology, Garia;  1Department of Chemistry, Jadavpur University, Kolkata, IndiaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 181-188  http://dx.doi.org/10.4048/jbc.2012.15.2.181 Purpose:  Estrogen, through its binding to nuclear estrogen re - ceptor (ER), has been implicated in the development of human  breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.181Appropriate permission was also obtained from the IRB   (approval no.,Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
Estrogen Receptor Status inMaspin Synthesis inHuman Breast Cancer  183 http://dx.doi.org/10.4048/jbc.2012.15.2.181  http://ejbc.krserved and photographed under fluorescence microscopy.,Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.181ing a homogeneous ER population within the neutrophils  (Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
"Estrogen Receptor Status inMaspin Synthesis inHuman Breast Cancer  185 http://dx.doi.org/10.4048/jbc.2012.15.2.181  http://ejbc.krdemonstrate estrogen binding, it was not possible to determine  the ER number or the dissociation constant under the experi - mental conditions described in the Methods section.",Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.181In contrast to normal and ER+ neutrophils, treatment of  ER- neutrophils with similar amounts of estrogen failed to pro - duce NO, or maspin (Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
Estrogen Receptor Status inMaspin Synthesis inHuman Breast Cancer  187 http://dx.doi.org/10.4048/jbc.2012.15.2.181  http://ejbc.krtrophils (Figures 4 and 5).,Non-OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.181maspin production due to the activation of ER that stimulated  NO synthesis, the NO was acting like a “messenger” for maspin synthesis in neutrophils.",OADS,/arxiv_data1/oa_pdf/7a/70/jbc-15-181.PMC3395741.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The proto-oncogene in human breast cancer, c-erbB-2, is  also known as HER2/ neu.",Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
"Two smaller published reports investigated  the correlation between pretreatment serum HER2/ neu and  pathologic complete response during neoadjuvant chemo -The Predictive Value of Serum HER2/ neu for Response to Anthracycline- Based and Trastuzumab-Based Neoadjuvant Chemotherapy Jung Sun Lee, Byung-Ho Son1, Sei Hyun Ahn1 Department of Surgery, Haeundae Paik Hospital, Inje University College of Medicine, Busan;  1Division of Breast-Endocrine Surgery, Department of  Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 189-196  http://dx.doi.org/10.4048/jbc.2012.15.2.189 Purpose:  Little information exists about the possible influence  of serum HER2/ neu on response to chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.189therapy plus trastuzumab.,Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
"Serum HER2/ neuandNeoadjuvant Chemotherapy  191 http://dx.doi.org/10.4048/jbc.2012.15.2.189  http://ejbc.krSerum HER2/ neu ECD assay Blood was drawn into serum separator tubes and was cen - trifuged at 2,000 g for 10 minutes at room temperature.",Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.189and tissue HER2/ neu status categories with score 0, 1+, and  2+, without gene amplification, and with scores 3+ and 2+,  with gene amplification and estrogen and progesterone recep - tor status and ycT stage, ypT stage, ycN stage, and ypN stage (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
"Serum HER2/ neuandNeoadjuvant Chemotherapy  193 http://dx.doi.org/10.4048/jbc.2012.15.2.189  http://ejbc.krsignificantly higher than that in patients with CR (pCR, 13.2±  14.1; PR, 2.06±1.3; p=0.02) (Table 2, Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.189an independent prognostic factor enabling the identification of  patients likely to benefit from aggressive adjuvant treatments.,Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
"Serum HER2/ neuandNeoadjuvant Chemotherapy  195 http://dx.doi.org/10.4048/jbc.2012.15.2.189  http://ejbc.krIn contrast to our findings, in the series reported by Mazouni  et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.18924.,Non-OADS,/arxiv_data1/oa_pdf/0f/90/jbc-15-189.PMC3395742.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Screening mammography have increased detection of early  breast cancers, and aggressive multimodal treatment has   successfully reduced the mortality rate of breast cancer [1].",Non-OADS,/arxiv_data1/oa_pdf/3a/b8/jbc-15-197.PMC3395743.pdf
"Also, Impact of Triple-Negative Breast Cancer Phenotype on Prognosis in Patients  with Stage I Breast Cancer Jeong Eun Kim, Heui June Ahn, Jin-Hee Ahn, Dok Hyun Y oon, Sung-Bae Kim, Kyung Hae Jung, Gyung-Yub Gong1,  Mi-Jung Kim1, Byung Ho Son2, Sei Hyun Ahn2 Departments of Oncology,  1Pathology, and  2Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 197-202  http://dx.doi.org/10.4048/jbc.2012.15.2.197 Purpose:  Although most patients with stage I breast cancer have  a good prognosis, their clinical outcomes may vary significantly.",Non-OADS,/arxiv_data1/oa_pdf/3a/b8/jbc-15-197.PMC3395743.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.197we compared the clinicopathologic characteristics and prog - nosis of TNBC with those of non-TNBC in a cohort of stage I  breast carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/3a/b8/jbc-15-197.PMC3395743.pdf
TNBC Phenotype onPrognosis inStage IBreast Cancer 199 http://dx.doi.org/10.4048/jbc.2012.15.2.197  http://ejbc.krthe median age of each was 46 years ( p=0.799).,Non-OADS,/arxiv_data1/oa_pdf/3a/b8/jbc-15-197.PMC3395743.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.197Survival and prognostic factors The 10-year OS and RFS rates of all patients were 90.2% and  85.7%.,Non-OADS,/arxiv_data1/oa_pdf/3a/b8/jbc-15-197.PMC3395743.pdf
"TNBC Phenotype onPrognosis inStage IBreast Cancer 201 http://dx.doi.org/10.4048/jbc.2012.15.2.197  http://ejbc.krto TNBC, histologic grade 3 and an absence of adjuvant che - motherapy as well as age <40 were significantly associated with  poorer OS and RFS.",Non-OADS,/arxiv_data1/oa_pdf/3a/b8/jbc-15-197.PMC3395743.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.197Brunet 	M.	Prognostic 	value 	of	histologic 	grade 	nuclear 	components 	of	 Scarff-Bloom-Richardson 	(SBR).,OADS,/arxiv_data1/oa_pdf/3a/b8/jbc-15-197.PMC3395743.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Neoadjuvant chemotherapy (NACT) was initially used for  inoperable locally advanced and inflammatory breast cancer  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
"Recent studies have used gene expression profiling to classify Impact of Immunohistochemistry-Based Molecular Subtype on  Chemosensitivity and Survival in Patients with Breast Cancer Following  Neoadjuvant Chemotherapy Changhoon Y oo, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Hak-Hee Kim1, Hee Jung Shin1, Sei Hyun Ahn2,  Byung Ho Son2, Gyungyub Gong3 Departments of Oncology,  1Radiology,  2Surgery, and 3Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 203-210  http://dx.doi.org/10.4048/jbc.2012.15.2.203 Purpose:  Pathologic complete response (pCR) has been sug - gested as a surrogate prognostic indicator in breast cancer   patients treated with neoadjuvant chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.203breast cancers into molecularly distinct subgroups, and have  suggested that this categorization could be used for the predic - tion of prognosis [7,8].",Non-OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
"Impact ofIHC-Based Molecular Subtype onpCR 205 http://dx.doi.org/10.4048/jbc.2012.15.2.203  http://ejbc.kr48 (17.4%) were luminal B, 51 (18.5%) were ERBB-2, and 69  (25.0%) were triple negative subtype.",OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.203patients (41.4%) were given trastuzumab as a part of NACT.,Non-OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
Impact ofIHC-Based Molecular Subtype onpCR 207 http://dx.doi.org/10.4048/jbc.2012.15.2.203  http://ejbc.krTable 3.,OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.203(p=0.315) (Figure 3).,OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
"Impact ofIHC-Based Molecular Subtype onpCR 209 http://dx.doi.org/10.4048/jbc.2012.15.2.203  http://ejbc.krshown that patients with hormone receptor-positive breast  cancer are less likely to achieve pCR [6,18].",Non-OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.20314.,Non-OADS,/arxiv_data1/oa_pdf/ab/30/jbc-15-203.PMC3395744.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common malignant tumor among  women, representing 31% of all cancers [1,2].",Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
"Today, there are two different methods used for SLN determi -Efficiency of Ultrasound and Ultrasound-Guided Fine Needle Aspiration  Cytology in Preoperative Assessment of Axillary Lymph Node Metastases in  Breast Cancer Aysegul Oz, Figen Basaran Demirkazik, Meltem Gulsun Akpinar, Isıl Soygur, Atac Baykal1, Sevgen Celik Onder2,  Aysegul Uner2 Departments of Radiology,  1General Surgery, and  2Pathology, Hacettepe University, Ankara, TurkeyORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 211-217  http://dx.doi.org/10.4048/jbc.2012.15.2.211 Purpose:  We performed this study to detect preoperative axillary  metastases with ultrasound (US)-guided fine needle aspiration  biopsy (FNAB), to eliminate the need for time-consuming and costly sentinel lymph node (SLN) scintigraphy and biopsy steps in the treatment of breast cancer patients, and in that of with suspicious US findings, and to evaluate the accuracy of preop - erative US-guided FNAB for patients with suspicious lymph node metastases on US.",Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.211nation, including the use of a surgical gamma probe by preop - erative lymphoscintigraphy and lymphatic mapping using  methylene blue.",Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
"Detection ofAxillary Metastases inBreast Cancer withUS-Guided FNAB  213 http://dx.doi.org/10.4048/jbc.2012.15.2.211  http://ejbc.krRESULTS FNAB was performed in 38 lymph nodes of a total of 36   females with an age range of 25 to 68 years (mean, 48.52 years).",Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.211While an increase was detected in the sphericity index of all  the lymph nodes in 30 patients with metastases detected on  pathology (sphericity index, 0.5-0.91; mean, 0.57), five of the eight lymph nodes without metastases exhibited an increase in the sphericity index (sphericity index, 0.22-0.71; mean, 0.52).",Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
"Detection ofAxillary Metastases inBreast Cancer withUS-Guided FNAB  215 http://dx.doi.org/10.4048/jbc.2012.15.2.211  http://ejbc.krmarkedly [19], leading to a reduction in healthcare expenses  by nearly 20% [9,18,19,21,22].",Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.211in any of the fine-needle aspiration cases.,Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
Detection ofAxillary Metastases inBreast Cancer withUS-Guided FNAB  217 http://dx.doi.org/10.4048/jbc.2012.15.2.211  http://ejbc.kr5.,Non-OADS,/arxiv_data1/oa_pdf/23/ec/jbc-15-211.PMC3395745.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION According to the Annual Report of Korea Central Cancer  Registry in 2009 the number of breast cancer occurrences for  women’s in Korea in 2007 is 15.1%, the second highest one next to thyroid cancer [1].",Non-OADS,/arxiv_data1/oa_pdf/d3/e7/jbc-15-218.PMC3395746.pdf
"METHODS Subject The 95 cases of metastatic breast cancer patients who had The Risk Factors Influencing between the Early and Late Recurrence in  Systemic Recurrent Breast Cancer Won Jong Song, Kwan Il Kim, Sang Hyun Park, Mi Seon Kwon, Tae Hoon Lee, Heung Kyu Park, Jung Suk An1 Departments of Breast Surgery and  1Pathology, Gachon University Gil Hospital, Incheon, KoreaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 218-223  http://dx.doi.org/10.4048/jbc.2012.15.2.218 Purpose:  Patients with recurrent breast cancer usually die of their  disease, even after radical surgery and adjuvant therapies which  could reduce the odds of dying.",Non-OADS,/arxiv_data1/oa_pdf/d3/e7/jbc-15-218.PMC3395746.pdf
The Factors Associated with the Timing of Recurrence  219 http://dx.doi.org/10.4048/jbc.2012.15.2.218  http://ejbc.krsystemic recurrences had curative surgeries at the Breast Cancer  Clinic of Gachon University Gill Hospital between January 2002 to December 2008.,Non-OADS,/arxiv_data1/oa_pdf/d3/e7/jbc-15-218.PMC3395746.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.218netic resonance imaging (MRI).,OADS,/arxiv_data1/oa_pdf/d3/e7/jbc-15-218.PMC3395746.pdf
The Factors Associated with the Timing of Recurrence  221 http://dx.doi.org/10.4048/jbc.2012.15.2.218  http://ejbc.krcant difference ( p=0.005) between early recurrence and late  recurrence.,OADS,/arxiv_data1/oa_pdf/d3/e7/jbc-15-218.PMC3395746.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.218Breast cancers are diagnosed mostly for women in their 40’s  in Korea.,Non-OADS,/arxiv_data1/oa_pdf/d3/e7/jbc-15-218.PMC3395746.pdf
"The Factors Associated with the Timing of Recurrence  223 http://dx.doi.org/10.4048/jbc.2012.15.2.218  http://ejbc.krlogical factors, which are currently under investigation, are re - quired.",Non-OADS,/arxiv_data1/oa_pdf/d3/e7/jbc-15-218.PMC3395746.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION In Western societies, one woman in eight develops breast  cancer during her lifetime; it has been reported that approxi - mately 60% of women have benign breast diseases [1].",Non-OADS,/arxiv_data1/oa_pdf/d5/f6/jbc-15-224.PMC3395747.pdf
"With the development of vacuum-assisted breast biopsy  (V ABB) (Mammotome ®; Devicore Medical, Cincinnati, USA),  benign breast tumors can be excised, including surrounding normal tissue in a minimally invasive way; complete excision, Long-Term Follow-Up Result of Benign Phyllodes Tumor of the Breast  Diagnosed and Excised by Ultrasound-Guided Vacuum-Assisted Breast  Biopsy Hai-Lin Park, Sea-Hyun Kwon, So Y ong Chang1, Jung Yin Huh1, Ji-Y oung Kim2, Jeong Yun Shim2, Y oon Hee Lee2 Departments of Surgery,  1Diagnostic Radiology, and  2Diagnostic Pathology, Kangnam CHA Hospital, CHA University College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 224-229  http://dx.doi.org/10.4048/jbc.2012.15.2.224 Purpose:  Percutaneous removal of benign breast tumors using  ultrasound-guided vacuum-assisted breast biopsy (VABB) has  been recently regarded as a feasible and safe method without serious complications.",Non-OADS,/arxiv_data1/oa_pdf/d5/f6/jbc-15-224.PMC3395747.pdf
"Long-Term Result of Benign Phyllodes Tumor Treatment with Mammotome Excision  225 http://dx.doi.org/10.4048/jbc.2012.15.2.224  http://ejbc.krwithout residual tissues is possible in most cases [9,10].",Non-OADS,/arxiv_data1/oa_pdf/d5/f6/jbc-15-224.PMC3395747.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.224more on the right breast than the left (16 vs. 15).,Non-OADS,/arxiv_data1/oa_pdf/d5/f6/jbc-15-224.PMC3395747.pdf
Long-Term Result of Benign Phyllodes Tumor Treatment with Mammotome Excision  227 http://dx.doi.org/10.4048/jbc.2012.15.2.224  http://ejbc.krand phyllodes tumors.,Non-OADS,/arxiv_data1/oa_pdf/d5/f6/jbc-15-224.PMC3395747.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.224upon active follow-up.,Non-OADS,/arxiv_data1/oa_pdf/d5/f6/jbc-15-224.PMC3395747.pdf
Long-Term Result of Benign Phyllodes Tumor Treatment with Mammotome Excision  229 http://dx.doi.org/10.4048/jbc.2012.15.2.224  http://ejbc.krSurg	Oncol 	2003;12:27-37.,Non-OADS,/arxiv_data1/oa_pdf/d5/f6/jbc-15-224.PMC3395747.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Although 5-year survival rate of breast cancer is relatively  high, the recurrence rate of it is also high (about 20% to 30%,  depending on stage) [1].",Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
"[5] demonstrated that Development of Novel Breast Cancer Recurrence Prediction Model Using  Support Vector Machine Woojae Kim1,*, Ku Sang Kim1,2,*, Jeong Eon Lee3, Dong-Y oung Noh4, Sung-Won Kim4, Y ong Sik Jung2, Man Y oung Park1,  Rae Woong Park1 Departments of  1Biomedical Informatics and  2Surgery, Ajou University School of Medicine, Suwon;  3Department of Surgery, Samsung Medical Center,  Seoul;  4Department of Surgery, Seoul National University College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2012 June; 15(2): 230-238  http://dx.doi.org/10.4048/jbc.2012.15.2.230 Purpose:  The prediction of breast cancer recurrence is a crucial  factor for successful treatment and follow-up planning.",OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
The prediction model is freely available in the web - site (http://ami.ajou.ac.kr/bcr/).,Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
Recurrence Prediction Model for Breast Cancer 231 http://dx.doi.org/10.4048/jbc.2012.15.2.230  http://ejbc.krthe prognoses of patients with lymph node-negative breast  cancer in Japan tended to be more positive than those of their Western counterparts.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.230surgeon, 14 variables were selected.",OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
Recurrence Prediction Model for Breast Cancer 233 http://dx.doi.org/10.4048/jbc.2012.15.2.230  http://ejbc.krand comparison.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.230cases (28.6%) recurred during the study period.,OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
Recurrence Prediction Model for Breast Cancer 235 http://dx.doi.org/10.4048/jbc.2012.15.2.230  http://ejbc.krpathologic features differed significantly between the recurrent  and the non-recurrent groups (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.230algorithms, the SVM proved superior to that of the other   algorithms utilized herein.",Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
"For the convenience of clinicians interested in the BCRSVM, we developed a tool realizing the BCRSVM and embedded it in the webpage (http://ami.ajou.ac.kr/bcr/), as shown in Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
"Recurrence Prediction Model for Breast Cancer 237 http://dx.doi.org/10.4048/jbc.2012.15.2.230  http://ejbc.krprognostic factor for the prediction of recurrence, because it  accounts for 55.3% and 21.5% of importance in the SVM and ANN models, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
"The BCRSVM could be easily employed to assist clinicians and patients in making decisions, regarding breast cancer treatment through internet connection to the webpage (http://ami.ajou.ac.kr/bcr).",Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.230invasive 	breast 	cancer 	in	Japanese 	patients.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbc-15-230.PMC3395748.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The aim of clinical practice guidelines is to reduce inappro - priate variations in physician-ordered treatment and to opti - mize the care given to every patient [1].",Non-OADS,/arxiv_data1/oa_pdf/2c/47/jbc-15-239.PMC3395749.pdf
"The first edition of the KBCCPG was formatted in an Survey of the Application of the Korean Clinical Practice Recommendations  on Breast Cancer Treatment: The Utility of the Korean Breast Cancer Society  Guidelines Geumhee Gwak, Hae Kyung Lee1, Hee Jung Kim2, Si Y oun Lee3, Y ong Lai Park4, Jong Won Lee2, Seung Gi Kim5, Ho Huh6,  Hyukjai Shin7, Je Ryong Kim8, Jin-Seok Ahn9, Ju Hyuk Son10, Il Gyun Lee11, Woo Chan Park12, Sung Y ong Kim13,  Sehwan Han, Eun Sook Lee14; Korean Breast Cancer Society; Korea Breast Cancer Foundation Department of Surgery, Inje University Sanggye Paik Hospital, Seoul;  1Department of Surgery, Cheil General Hospital & Women’s Healthcare Center, Seoul;  2Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul;  3Center of Breast Cancer, National Cancer Center, Goyang;  4Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul;  5Department of Surgery, Kangnam CHA Hospital,  Seoul;  6Department of Surgery, Ilsan Hospital, Goyang;  7Department of Surgery, Myongji Hospital, Kwandong University College of Medicine, Goyang;  8Department of Surgery, Chungnam National University Hospital, Daejeon;  9Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul;  10Division of Hematology-Oncology, Severance Hospital, Y onsei University College of Medicine, Seoul;  11Department  of Surgery, Kangnam MizMedi Hospital, Seoul;  12Department of Surgery, Y eouido St. Mary’s Hospital, The Catholic University of Korea College of Medicine,  Seoul;  13Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan;  14Research Institute and Hospital, National Cancer Center,  Goyang, KoreaSPECIAL REPORTJ Breast Cancer 2012 June; 15(2): 239-243  http://dx.doi.org/10.4048/jbc.2012.15.2.239 This survey was performed to analyze the usability of the third  edition of the Korean breast cancer clinical practice guidelines (KBCCPG) in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/2c/47/jbc-15-239.PMC3395749.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.239abridged version.,Non-OADS,/arxiv_data1/oa_pdf/2c/47/jbc-15-239.PMC3395749.pdf
"TheUtility oftheKBCS Guidelines 241 http://dx.doi.org/10.4048/jbc.2012.15.2.239  http://ejbc.krtions but the margins were positive when permanent sections  were examined, about 50% of physicians perform secondary operations to guarantee negative margins.",Non-OADS,/arxiv_data1/oa_pdf/2c/47/jbc-15-239.PMC3395749.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.239RECONSTRUCTION In the present survey, after mastectomy, we found that about  two-thirds of physicians perform reconstruction in patients  with EBC but only one-third do so in those with local breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/2c/47/jbc-15-239.PMC3395749.pdf
TheUtility oftheKBCS Guidelines 243 http://dx.doi.org/10.4048/jbc.2012.15.2.239  http://ejbc.krfor realistic and useful guidelines.,Non-OADS,/arxiv_data1/oa_pdf/2c/47/jbc-15-239.PMC3395749.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION  Renal cell carcinoma is one of the most aggressive urolo-   gical tumors and account for 3% of all neoplasms in adults.",Non-OADS,/arxiv_data1/oa_pdf/2a/06/jbc-15-244.PMC3395750.pdf
"She was disease free clinically and radiologically Breast Metastasis from Renal Cell Carcinoma: Rare Initial Presentation of  Disease Recurrence after 5 Y ears Mervat Mahrous, Walid Al Morsy, Ahmed Al-Hujaily1, Sameerah AL-Sulimani2 Departments of Oncology,  1Pathology, and  2Radiology, King Fahad Hospital, Madina, Saudi ArabiaCASE REPORTJ Breast Cancer 2012 June; 15(2): 244-247  http://dx.doi.org/10.4048/jbc.2012.15.2.244 Metastasis to the breast from extra-mammary tumors is rare  with only a few sporadic cases reported.",Non-OADS,/arxiv_data1/oa_pdf/2a/06/jbc-15-244.PMC3395750.pdf
"Breast Metastasis from Renal Cell Carcinoma, Unusual Initial Presentation 245 http://dx.doi.org/10.4048/jbc.2012.15.2.244  http://ejbc.kruntil March 2009, when the patient presented to the breast  clinic with a painless, palpable, and rapidly growing left breast mass discovered during breast self examination 2 months pre - viously.",Non-OADS,/arxiv_data1/oa_pdf/2a/06/jbc-15-244.PMC3395750.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.244hypodensity and surrounded by fat stranding and skin density  (Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/2a/06/jbc-15-244.PMC3395750.pdf
"Breast Metastasis from Renal Cell Carcinoma, Unusual Initial Presentation 247 http://dx.doi.org/10.4048/jbc.2012.15.2.244  http://ejbc.krliterature regarding the prognosis of patients with metastatic  disease to the breast; most information of this topic consists of case reports and small series [11].",Non-OADS,/arxiv_data1/oa_pdf/2a/06/jbc-15-244.PMC3395750.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Male breast cancer is a rare condition, accounting for <1%  of all breast cancers [1,2].",Non-OADS,/arxiv_data1/oa_pdf/c7/9c/jbc-15-248.PMC3395751.pdf
"However, levels of estradiol 58.9 pg/mL (normal range [NR], 15-47), luteiniz - ing hormone (LH) 6.3 m/U/mL (NR, 1.0-5.3), and follicular stimulating hormone (FSH) 10.9 m/U/mL (NR, 1.0-5.3) were Synchronous Bilateral Male Breast Cancer: A Case Report Woo-Y oung Sun, Ki-Hyeong Lee1, Ho-Chang Lee2, Dong-Hee Ryu, Jin-Woo Park, Hyo-Y oung Yun, Y oung-Jin Song Departments of Surgery,  1Internal Medicine, and  2Pathology, Chungbuk National University College of Medicine and Medical Research Institute, Cheongju,  KoreaCASE REPORTJ Breast Cancer 2012 June; 15(2): 248-251  http://dx.doi.org/10.4048/jbc.2012.15.2.248 Synchronous bilateral breast cancer is extremely rare in men and  has not, up to date, been reported in Korea.",Non-OADS,/arxiv_data1/oa_pdf/c7/9c/jbc-15-248.PMC3395751.pdf
Synchronous Bilateral Male Breast Cancer 249 http://dx.doi.org/10.4048/jbc.2012.15.2.248  http://ejbc.krslightly increased.,Non-OADS,/arxiv_data1/oa_pdf/c7/9c/jbc-15-248.PMC3395751.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.248papillary carcinoma in the left breast showed solid tumor cell  nests with focal necrosis (Figure 5).,Non-OADS,/arxiv_data1/oa_pdf/c7/9c/jbc-15-248.PMC3395751.pdf
"Synchronous Bilateral Male Breast Cancer 251 http://dx.doi.org/10.4048/jbc.2012.15.2.248  http://ejbc.krsory breasts in the axilla, with nipples, in a male patient with  bilateral synchronous breast cancer has not been described before.",Non-OADS,/arxiv_data1/oa_pdf/c7/9c/jbc-15-248.PMC3395751.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Tc-99m methoxyisobutylisonitrile (MIBI) scintigraphy is a  functional imaging test that was introduced in early 90s, and is  now widely used for cardiac imaging.",Non-OADS,/arxiv_data1/oa_pdf/5f/d7/jbc-15-252.PMC3395752.pdf
"First, the lesion was An Incidentally Detected Breast Cancer on Tc-99m MIBI Cardiac Scintigraphy Duray Seker, Gaye Seker, Emine Ozturk1, Bahattin Bayar, Hakan Kulacoglu Departments of Surgery and 1Radiology, Diskapi Yildirim Beyazit Teaching and Research Hospital, Ankara, T urkeyCASE REPORTJ Breast Cancer 2012 June; 15(2): 252-254  http://dx.doi.org/10.4048/jbc.2012.15.2.252 T c-99m methoxyisobutylisonitrile (MIBI) scintigraphy is generally  used as a second-line diagnostic tool for obscured breast lesions.",Non-OADS,/arxiv_data1/oa_pdf/5f/d7/jbc-15-252.PMC3395752.pdf
Incidentally Breast Cancer Detection 253 http://dx.doi.org/10.4048/jbc.2012.15.2.252  http://ejbc.krexcised totally and sent to histopathology department for frozen  section examination.,Non-OADS,/arxiv_data1/oa_pdf/5f/d7/jbc-15-252.PMC3395752.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.252breast 	carcinomas: 	comparison 	with	T c-99m 	antimony 	sulphide 	col- loid.,Non-OADS,/arxiv_data1/oa_pdf/5f/d7/jbc-15-252.PMC3395752.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION  Angiosarcoma of the breast is a rare tumor with a poor prog - nosis [1].",Non-OADS,/arxiv_data1/oa_pdf/08/f6/jbc-15-255.PMC3395753.pdf
"In MRI Findings of Large Low-Grade Angiosarcoma of the Breast with  Subsequent Bone Metastases: A Case Report Eleonora Cucci, Matteo Ciuffreda, Rosa Tambaro1, Lorena Aquilani, Michele Barrassi2, Giuseppina Sallustio Departments of Radiology and  1Oncology, Catholic University of the Sacred Heart-Foundation for Research and Treatment “John Paul II” , Campobasso;  2Department of Radiology, Hospital “ A. Cardarelli” , Campobasso, ItalyCASE REPORTJ Breast Cancer 2012 June; 15(2): 255-257  http://dx.doi.org/10.4048/jbc.2012.15.2.255 We describe the magnetic resonance imaging (MRI) findings   of 13 cm-sized low-grade angiosarcoma of the breast that   occurred in a 23-year-old woman.",Non-OADS,/arxiv_data1/oa_pdf/08/f6/jbc-15-255.PMC3395753.pdf
"http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.255consideration of the low-grade tumor and positive margins,  radiotherapy without chemotherapy was recommended.",Non-OADS,/arxiv_data1/oa_pdf/08/f6/jbc-15-255.PMC3395753.pdf
"Breast Angiosarcoma: MRIFindings  257 http://dx.doi.org/10.4048/jbc.2012.15.2.255  http://ejbc.krtients with primary angiosarcoma after a median follow-up of  only 40 months and the most common site of recurrence was locoregional location (52.6%) followed by liver (13.2%), bone (10.5%), and lung (10.5%).",Non-OADS,/arxiv_data1/oa_pdf/08/f6/jbc-15-255.PMC3395753.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Metastasis of extramammarian malignancies to the breast  are very unusual.",Non-OADS,/arxiv_data1/oa_pdf/ec/98/jbc-15-258.PMC3395754.pdf
"The giant right breast mass was   hyperintense-isointense on precontrast fat saturated T1W   images (Figure 1A) and heterogeneously hypointense-hyper -Giant Breast Involvement in Acute Lymphoblastic Leukemia: MRI Findings Isil Basara, Sebnem Orguc Department of Radiology, Celal Bayar University of Medicine, Manisa, TurkeyCASE REPORTJ Breast Cancer 2012 June; 15(2): 258-260  http://dx.doi.org/10.4048/jbc.2012.15.2.258 Breast metastases in cases of leukemia are rare.",Non-OADS,/arxiv_data1/oa_pdf/ec/98/jbc-15-258.PMC3395754.pdf
Giant Breast Metastasis of Acute Lymphoblastic Leukemia 259 http://dx.doi.org/10.4048/jbc.2012.15.2.258  http://ejbc.krintense on STIR and fat saturated T2W images (Figure 1B   and 1C).,Non-OADS,/arxiv_data1/oa_pdf/ec/98/jbc-15-258.PMC3395754.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.258DISCUSSION Metastases to the breast from extramammary malignant  neoplasms are unusual and were described first in 1903.,Non-OADS,/arxiv_data1/oa_pdf/ec/98/jbc-15-258.PMC3395754.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Bone metastases from breast cancer can cause skeletal com - plications, including bone pain, pathologic fractures, spinal  cord compression, and hypercalcemia of malignancy [1].",Non-OADS,/arxiv_data1/oa_pdf/d5/87/jbc-15-261.PMC3395755.pdf
"The tumor was positive for estrogen and pro - gesterone receptors on immunohistochemical staining, and Atypical Subtrochanteric Femur Fracture in Patient with Metastatic Breast  Cancer Treated with Zoledronic Acid Y ong-Seok Kim, Woo-Chan Park Department of Surgery, The Catholic University of Korea College of Medicine, Seoul, KoreaCASE REPORTJ Breast Cancer 2012 June; 15(2): 261-264  http://dx.doi.org/10.4048/jbc.2012.15.2.261 Several case series have suggested an association exists   between atypical femoral subtrochanteric fractures and long-   term use of bisphosphonates.",Non-OADS,/arxiv_data1/oa_pdf/d5/87/jbc-15-261.PMC3395755.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.261negative for HER2 overexpression by fluorescence in situ  hy- bridization.,OADS,/arxiv_data1/oa_pdf/d5/87/jbc-15-261.PMC3395755.pdf
Atypical Subtrochanteric Femur Fracture inPatient Treated withZoledronic Acid 263 http://dx.doi.org/10.4048/jbc.2012.15.2.261  http://ejbc.krsubtrochanteric fracture remained.,Non-OADS,/arxiv_data1/oa_pdf/d5/87/jbc-15-261.PMC3395755.pdf
http://ejbc.kr http://dx.doi.org/10.4048/jbc.2012.15.2.261fractures were in patients being treated with alendronate.,Non-OADS,/arxiv_data1/oa_pdf/d5/87/jbc-15-261.PMC3395755.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):187-194 http://dx.doi.org/10.4162/nrp.2012.6.3.187 pISSN 1976-1457 eISSN 2005-6168 Antibacterial effect of citrus press-cakes dried by high speed and far-infrared radiatio n drying methods Kalpa Samarakoon1, Mahinda Senevirathne2, Won-Woo Lee1, Young-Tae Kim3, Jae-Il Kim4, Myung-Cheol Oh5 and You-Jin Jeon1§ 1School of Marine Biomedical Sciences, Jeju National University, 1 Ara-dong, Jeju-si, Jeju 690-756, Korea 2Marine Bioprocess Research Centre, Pukyoung National University, Busan 608-737, Korea 3Food Biotechnology Major, Kunsan National University, Jeonbuk 573-701, Korea 4Department of Food Science and Nutrition, Pukyoung National University, Busan 608-737, Korea 5Department of Tourism Hotel Culinary Art, Jeju College of Technology, Jeju 690-140, Korea Abstract In this study, the antibacterial effect was evaluated to determine the benefits of high speed drying (HSD) and far-infrared rad iation drying (FIR) compared to the freeze drying (FD) method.",Non-OADS,/arxiv_data1/oa_pdf/1f/5e/nrp-6-187.PMC3395782.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):195-200 http://dx.doi.org/10.4162/nrp.2012.6.3.195 pISSN 1976-1457 eISSN 2005-6168 α-Lipoic acid reduced weight gain and improved the lipid profile in rats fed with hig h fat diet Eun Young Seo, Ae Wha Ha and Woo Kyoung Kim§ Department of Food Science and Nutrition, Dankook University , 152, Jukjeon-ro, Suji-gu, Yongin-si, Gyeonggi 448-701, Korea Abstract The purpose of this study was to investigate the effects of α-lipoic acid on body weight and lipid profiles in Sprague-Dawley rats fed a hig h fat diet (HFD).",Non-OADS,/arxiv_data1/oa_pdf/77/c7/nrp-6-195.PMC3395783.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):201-207 http://dx.doi.org/10.4162/nrp.2012.6.3.201 pISSN 1976-1457 eISSN 2005-6168 Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice Soo-Mi Jeong, Min-Jung Kang, Ha-Neul Choi, Ji-Hye Kim, and Jung-In Kim§ Department of Smart Foods and Drugs, School of Food and Life Science, Inje University, 607 Obang-dong, Gimhae, Gyungnam  621-749, Korea Abstract This study investigated the hypoglycemic, hypolipidemic, and antioxi dant effects of dietary quercetin in an animal model of typ e 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/25/89/nrp-6-201.PMC3395784.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):208-212 http://dx.doi.org/10.4162/nrp.2012.6.3.208 pISSN 1976-1457 eISSN 2005-6168 Effects of adlay, buckwheat, and barley on transit time and the antioxidative syste m  in obesity induced rats Jung Yun Kim1, Bo Kyung Son2 and Sang Sun Lee2§ 1Department of Food and Nutrition, Bucheon University, Bucheon 420-735, Korea 2Department of Food and Nutrition, Hanyang University, 17 Haengdang-dong, Seongdong-gu, Seoul 133-791, Korea Abstract In the present study, we examined whether four grains including adlay (AD), buckwheat (BW), glutinous barley (GB), and white ri ce (WR) affec t the duration of food residence in the gastrointestinal tract and hepatic enzyme activities in rats fed different combinations o f the grains.",Non-OADS,/arxiv_data1/oa_pdf/de/63/nrp-6-208.PMC3395785.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):213-220 http://dx.doi.org/10.4162/nrp.2012.6.3.213 pISSN 1976-1457 eISSN 2005-6168 Evaluation of nutrient intake and diet quality of gastric cancer patients in Korea Heesook Lim1, Gyuseok Cho2 and Soonkyung Kim3§ 1Department of Nutrition, Soonchunhyang University Bucheon Hospital, Gyeonggi 420-767, Korea 2Department of Surgery, Soonchunhyang University College of Medicine, Gyeonggi 420-767, Korea 3Department of Food Sciences & Nutrition, Soonchunhyang Uni versity, 646, Eupnae-ri, Shinchang-myeon, Asan-si, Chungnam  336-745, Korea Abstract This study was conducted to identify dietary factors that may affect the occurrence of gastric cancer in Koreans.",Non-OADS,/arxiv_data1/oa_pdf/7e/1a/nrp-6-213.PMC3395786.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):221-225 http://dx.doi.org/10.4162/nrp.2012.6.3.221 pISSN 1976-1457 eISSN 2005-6168 Effect of zinc supplementation on insulin resistance and metabolic risk factors in obes e Korean women Jihye Kim§ and Sunju Lee Department of Food and Nutrition, Daegu Univers ity, Jillyang, Gyeongsan, Gyeongbuk 712-714, Korea Abstract Zinc deficiency is known to be associated with insulin resistance in obese individuals.",Non-OADS,/arxiv_data1/oa_pdf/1d/77/nrp-6-221.PMC3395787.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):226-231 http://dx.doi.org/10.4162/nrp.2012.6.3.226 pISSN 1976-1457 eISSN 2005-6168 Independent beneficial effects of aged garlic extract intake with regular exercise o n  cardiovascular risk in postmenopausal women Dae Yun Seo1, Sung Ryul Lee1, Hyoung Kyu Kim1, Yeong Ho Baek2, Yi Sub Kwak3, Tae Hee Ko1, Nari Kim1, Byoung Doo Rhee1, Kyoung Soo Ko1, Byung Joo Park4 and Jin Han1§ 1National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular  and Metabolic Disease Center, Inje University, 633- 165, Gaegeum-dong, Busanjin-gu, Busan 614-735, Korea 2Department of Physical Education, Pus an National University, Busan 609-735, Korea 3Department of Physical Education, Dong-Eui University, Busan 614-714, Korea  4Division of Leisure & Sports Science, Dong Seo University, Busan 617-716, Korea Abstract The purpose of the study was to assess the effects of a 12 weeks aged garlic extract (AGE) regimen with regular exercise on car diovascula r disease (CVD) risk in postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/97/be/nrp-6-226.PMC3395788.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):232-237 http://dx.doi.org/10.4162/nrp.2012.6.3.232 pISSN 1976-1457 eISSN 2005-6168 The effect of salt usage behavior on sodium intake and excretion among Korean wome n Jeung Yun Lee1, Dong Sook Cho2 and Hyun Ju Kim3§ 1Department of Food and Nutrition, Eulji University, Seongnam 461-713, Korea 2College of Nursing, Eulji University, Seongnam 461-713, Korea 3Department of Food and Nutrition, Daejeon Health Sciences  College, 21 Chungjeong-ro, Dong-gu, Daejeon 300-711, Korea Abstract This study was done to explore the effect of Korean women’s salt usage behavior on their sodium intake and excretion according to aging.",Non-OADS,/arxiv_data1/oa_pdf/54/e6/nrp-6-232.PMC3395789.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):238-245 http://dx.doi.org/10.4162/nrp.2012.6.3.238 pISSN 1976-1457 eISSN 2005-6168 Preference and intake frequency of high so dium foods and dishes and their correlation s with anthropometric measurements among Malaysian subjects Stella Sinn-Yee Choong, Sumitha Nair Balan, Leong-Siong Chua and Yee-How Say§ Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman (UTAR) Perak Campus, Jalan Universiti,  Bandar Barat, 31900 Kampar, Perak, Malaysia Abstract This study investigated the preference and intake frequency of a list of 15 commonly available high sodium Malaysian foods/dish es, discretionar y salt use, and their possible association with demographics, blood pressures and anthropometric measurements among 300 Malaysian  university students  (114 males, 186 females; 259 ethnic Chinese, 41 Indians; 220 lean, 80 overweight).",Non-OADS,/arxiv_data1/oa_pdf/04/12/nrp-6-238.PMC3395790.pdf
Available from: http://www.nutrition.com.sg/do/hnoodle.asp.16.,Non-OADS,/arxiv_data1/oa_pdf/04/12/nrp-6-238.PMC3395790.pdf
Available from: http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/SR23/nutrlist/sr23a307.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/12/nrp-6-238.PMC3395790.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):246-253 http://dx.doi.org/10.4162/nrp.2012.6.3.246 pISSN 1976-1457 eISSN 2005-6168 The framingham risk score, diet, and inflammatory markers in Korean men wit h  metabolic syndrome Cheongmin Sohn1§, Juyong Kim2 and Wookyung Bae2 1Major in Food and Nutrition, Wonkwang University , 344-2 Sinyong-Dong, Iksan, Jeonbuk 570-749, Korea 2Health Promotion Center, Seoul National University of Bundang Hospital, Seongnam 463-707, Korea Abstract The Framingham risk score (FRS) has been used to assess the risk of a cardiovascular event and to identify patients for risk fa ctor modifications .",Non-OADS,/arxiv_data1/oa_pdf/6e/6a/nrp-6-246.PMC3395791.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):254-262 http://dx.doi.org/10.4162/nrp.2012.6.3.254 pISSN 1976-1457 eISSN 2005-6168 A study on the trend analysis regarding the rice consumption of Korean adults using Korean National Health and Nutrition Examination Survey data from 1998, 2001 an d 2005 Ho-Myoung Cha1, Gyusang Han2 and Hea-Jung Chung1§ 1Creative Culinary Institute of Korea, 303 Cheonjam-ro, Wansan-gu, Jeonju 560-759, Korea 2Department of Global Korean Culinary Arts, Woosong University, Daejeon 300-718, Korea Abstract The objective of this study was to provide information regarding trends of rice consumption of Korean adults based on different  meal types.",Non-OADS,/arxiv_data1/oa_pdf/5f/91/nrp-6-254.PMC3395792.pdf
Available from: http://knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/5f/91/nrp-6-254.PMC3395792.pdf
Available from: http://knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/5f/91/nrp-6-254.PMC3395792.pdf
Available from: http://knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/5f/91/nrp-6-254.PMC3395792.pdf
Available from: http://kostat.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/5f/91/nrp-6-254.PMC3395792.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):263-269 http://dx.doi.org/10.4162/nrp.2012.6.3.263 pISSN 1976-1457 eISSN 2005-6168 Educational attainment and differences in  fruit and vegetable consumption among  middle-aged adults in the Korean National Health and Nutrition Examination Survey I V Seo Ah Hong1,2, Kirang Kim1,2 and Mi Kyung Kim1,2§ 1Department of Preventive Medicine, College of Medicine, Hanyang University, Seoul 137-791, Korea 2Institute for Community Health, Hanyang Unive rsity, Haengdang 1-dong, Seongdong-gu, Seoul 137-791, Korea Abstract We investigated whether socioeconomic differences affect fruit and vegetable (FV) consumption with respect to total intake and intake of various  FV subgroups.",Non-OADS,/arxiv_data1/oa_pdf/bd/f2/nrp-6-263.PMC3395793.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2012;6(3):270 http://dx.doi.org/10.4162/nrp.2012.6.3.270 pISSN 1976-1457 eISSN 2005-6168 Erratum: Funding Acknowledgment Mi Ja Chung, Jeong-Mi Kim, Sangchul Lee, Taewoo  Kim, Daejung Kim, Jong mi Baek, Taehyuk Kim,  Jaesung Lee, Kyoungkon Kim, Jin A Yoon, Myeon Choe To the Editor: We found an error in our published article:Mi Ja Chung, Jeong-Mi Kim, Sangchul Lee, Taewoo Kim, Daejung Kim, Jongmi Baek, Taehyuk Kim, Jaesung Lee, Kyoungkon Kim, Jin A Yoon, Myeon Choe.",Non-OADS,/arxiv_data1/oa_pdf/40/32/nrp-6-270.PMC3395794.pdf
Nutr Res Pract 2012;6:97-105. http://dx.doi.org/10.4162/ nrp.2012.6.2.97 The funding acknowledgment in this article was omitted as published.Additional acknowledgment is as follow: The work was supported by the Corporate-affiliated Research Institute of Academic-Industrial-Institutional Cooperation Establis hment  Business and Well-being Bioproducts Regional Innovation Center.,Non-OADS,/arxiv_data1/oa_pdf/40/32/nrp-6-270.PMC3395794.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/49/inj-16-100.PMC3395798.pdf
"Jang Hwan Kim Department of Urology, Y onsei University College of Medicine E-mail: jkim@yuhs.acBook Review http://dx.doi.org/10.5213/inj.2012.16.2.100 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/23/49/inj-16-100.PMC3395798.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/31/inj-16-55.PMC3395799.pdf
Editorial http://dx.doi.org/10.5213/inj.2012.16.2.55 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/b3/31/inj-16-55.PMC3395799.pdf
"56    www.einj.orgKim  •  Adult Neurological Handicap: New Insight from Neurogenesis http://dx.doi.org/10.5213/inj.2012.16.2.55INJ Clearly, by acquiring a deeper understanding of neuronal cell  proliferation and/or adult neurogenesis, we hope to develop  better tools for the assessment of neurourology and relevant el - derly-patient-related outcomes.",Non-OADS,/arxiv_data1/oa_pdf/b3/31/inj-16-55.PMC3395799.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/a2/inj-16-57.PMC3395800.pdf
"The formation of DG  occurs mainly during postnatal development, and NSCs in the  secondary germinal zone appear to remain in the SGZ, supply - ing neurons to the existing hippocampal network throughout  adulthood [4,9].Review Article http://dx.doi.org/10.5213/inj.2012.16.2.57 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/33/a2/inj-16-57.PMC3395800.pdf
"58    www.einj.orgKim and Sun  •  Adult Neurogenesis in the CNS and PNS http://dx.doi.org/10.5213/inj.2012.16.2.57INJ  Similar to the SVZ, different types of NSCs exist along the  ventricular system, including the 3rd and 4th ventricles of the  brain, and the central canal of the spinal cord [10-12].",Non-OADS,/arxiv_data1/oa_pdf/33/a2/inj-16-57.PMC3395800.pdf
"www.einj.org     59 Kim and Sun  •  Adult Neurogenesis in the CNS and PNS http://dx.doi.org/10.5213/inj.2012.16.2.57INJ ing that SVZ and DG neurogenesis is evident although reduced  in aged (1 to 2 years old) mice, such rapid depletion may be re - lated to the termination of white matter development.",Non-OADS,/arxiv_data1/oa_pdf/33/a2/inj-16-57.PMC3395800.pdf
"60    www.einj.orgKim and Sun  •  Adult Neurogenesis in the CNS and PNS http://dx.doi.org/10.5213/inj.2012.16.2.57INJ ed with caution, however, and examination under more natural  settings is required.",Non-OADS,/arxiv_data1/oa_pdf/33/a2/inj-16-57.PMC3395800.pdf
www.einj.org     61 Kim and Sun  •  Adult Neurogenesis in the CNS and PNS http://dx.doi.org/10.5213/inj.2012.16.2.57INJ 25.,OADS,/arxiv_data1/oa_pdf/33/a2/inj-16-57.PMC3395800.pdf
http://dx.doi.org/10.1016/j.neuint.2012.02.027.,OADS,/arxiv_data1/oa_pdf/33/a2/inj-16-57.PMC3395800.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
"Because the α1a AR subtype predominates  in the smooth muscle of the prostate and the proximal urethra, Original Article http://dx.doi.org/10.5213/inj.2012.16.2.62 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
•  Bladder Adrenergic Receptors in Spinal Cord Injury http://dx.doi.org/10.5213/inj.2012.16.2.62INJ this subtype has been assumed to be responsible for the dynam - ic component of obstruction and the related voiding symptoms  [8-12].,Non-OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
"•  Bladder Adrenergic Receptors in Spinal Cord Injury  http://dx.doi.org/10.5213/inj.2012.16.2.62INJ the mRNA of the AR subtypes and GAPDH, partial cDNAs  were amplified from a rat urinary bladder sample by using each  AR subtype and GAPDH primers (Table 1).",OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
•  Bladder Adrenergic Receptors in Spinal Cord Injury http://dx.doi.org/10.5213/inj.2012.16.2.62INJ  The AR subtype expression of the SCI group differed from  that of the controls.,Non-OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
"•  Bladder Adrenergic Receptors in Spinal Cord Injury  http://dx.doi.org/10.5213/inj.2012.16.2.62INJ urinary bladder after SCI, we can extrapolate the significance of  the GAPDH change in the urinary bladder after SCI from the  findings of the partial bladder neck obstruction model.",Non-OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
•  Bladder Adrenergic Receptors in Spinal Cord Injury http://dx.doi.org/10.5213/inj.2012.16.2.62INJ prostatic smooth muscle contraction [11].,Non-OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
•  Bladder Adrenergic Receptors in Spinal Cord Injury  http://dx.doi.org/10.5213/inj.2012.16.2.62INJ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b9/5c/inj-16-62.PMC3395801.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
[10] reported  the role of transient receptor potential cation channel subfamily Original Article http://dx.doi.org/10.5213/inj.2012.16.2.69 pISSN 2093-4777 · eISSN 2093-6931,OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
•  The Function of TRPM8 in BOO http://dx.doi.org/10.5213/inj.2012.16.2.69INJ M member 8 (TRPM8) in OAB and suggested that increased  TRPM8 channels may provide a new therapeutic opportunity  for DO/OAB.,OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
•  The Function of TRPM8 in BOO http://dx.doi.org/10.5213/inj.2012.16.2.69INJ water.,OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
•  The Function of TRPM8 in BOO http://dx.doi.org/10.5213/inj.2012.16.2.69INJ bladder.,OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
•  The Function of TRPM8 in BOO http://dx.doi.org/10.5213/inj.2012.16.2.69INJ pressure in normal urethane-anesthetized guinea pig bladder  slowly rises as saline is infused and then the full bladder elimi - nates the saline.,Non-OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
•  The Function of TRPM8 in BOO http://dx.doi.org/10.5213/inj.2012.16.2.69INJ  Andersson et al.,OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
"•  The Function of TRPM8 in BOO http://dx.doi.org/10.5213/inj.2012.16.2.69INJ is associated with OAB and pain symptoms [15,19].",Non-OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
"•  The Function of TRPM8 in BOO http://dx.doi.org/10.5213/inj.2012.16.2.69INJ ny C, et al.",OADS,/arxiv_data1/oa_pdf/cf/56/inj-16-69.PMC3395802.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
"It consists of 33 self-administered  questions, eight which involve a symptom-bother scale and 25  involving HRQoL scores that constitute four subscales measur -Original Article http://dx.doi.org/10.5213/inj.2012.16.2.77 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
"•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ ing coping, concern, sleep, and social interaction.",Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
"•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ our previous study that validated the Korean version of the KHQ  [17,18].",Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
"•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ OAB-q HRQoL total, 0.010 with SF-36 mental health, 0.065  with SF-36 pain).",Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ pha coefficient (0.90).,OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
"•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ has may be widely used by both Korean patients and physicians,  we felt that a revision was necessary.",Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ Table 6.,Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ ported.,Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
"•  Psychometric Validity of Korean Version OAB-q http://dx.doi.org/10.5213/inj.2012.16.2.77INJ equivalence of the OAB-q in Danish, German, Polish, Swedish, and  Turkish.",Non-OADS,/arxiv_data1/oa_pdf/ed/27/inj-16-77.PMC3395803.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/2c/inj-16-86.PMC3395804.pdf
Anecdotal reports Original Article http://dx.doi.org/10.5213/inj.2012.16.2.86 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/f1/2c/inj-16-86.PMC3395804.pdf
•  Prevalence of SUI in Women with MS http://dx.doi.org/10.5213/inj.2012.16.2.86INJ suggest that few women with MS present to a urologist with a  complaint of SUI.,Non-OADS,/arxiv_data1/oa_pdf/f1/2c/inj-16-86.PMC3395804.pdf
•  Prevalence of SUI in Women with MS http://dx.doi.org/10.5213/inj.2012.16.2.86INJ ty.,Non-OADS,/arxiv_data1/oa_pdf/f1/2c/inj-16-86.PMC3395804.pdf
"•  Prevalence of SUI in Women with MS http://dx.doi.org/10.5213/inj.2012.16.2.86INJ the women (54%) were only slightly bothered by their SUI, an - swers to the IIQ-7 questionnaire demonstrated that SUI has a  significant negative impact on their lives.",Non-OADS,/arxiv_data1/oa_pdf/f1/2c/inj-16-86.PMC3395804.pdf
•  Prevalence of SUI in Women with MS http://dx.doi.org/10.5213/inj.2012.16.2.86INJ women: variation in prevalence estimates and risk factors.,Non-OADS,/arxiv_data1/oa_pdf/f1/2c/inj-16-86.PMC3395804.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/47/inj-16-91.PMC3395805.pdf
Chuang and Kuo [5] demonstrated that pa -Original Article http://dx.doi.org/10.5213/inj.2012.16.2.91 pISSN 2093-4777 · eISSN 2093-6931,OADS,/arxiv_data1/oa_pdf/8e/47/inj-16-91.PMC3395805.pdf
•  Short-term Effect of Adjuvant Radiation Therapy on Bladder http://dx.doi.org/10.5213/inj.2012.16.2.91INJ tients who were treated by RH with RT had worse bladder con - ditions than did patients treated by RH only.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/inj-16-91.PMC3395805.pdf
•  Short-term Effect of Adjuvant Radiation Therapy on Bladder http://dx.doi.org/10.5213/inj.2012.16.2.91INJ Table 2.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/inj-16-91.PMC3395805.pdf
"•  Short-term Effect of Adjuvant Radiation Therapy on Bladder http://dx.doi.org/10.5213/inj.2012.16.2.91INJ surgery for uterine cervical cancer is known to be between 70%  and 85% [13,14].",Non-OADS,/arxiv_data1/oa_pdf/8e/47/inj-16-91.PMC3395805.pdf
•  Short-term Effect of Adjuvant Radiation Therapy on Bladder http://dx.doi.org/10.5213/inj.2012.16.2.91INJ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/inj-16-91.PMC3395805.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/04/inj-16-96.PMC3395806.pdf
"First, a rectangular 3 cm  sized flap was drawn on the stretched skin of the posterior scro - tal face, centered over the mid raphe, for tubular urethroplasty Case Report http://dx.doi.org/10.5213/inj.2012.16.2.96 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/c9/04/inj-16-96.PMC3395806.pdf
www.einj.org     97 Jeong  •  Scrotal Flap in Urethral Stricture http://dx.doi.org/10.5213/inj.2012.16.2.96INJ (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c9/04/inj-16-96.PMC3395806.pdf
"98    www.einj.orgJeong  •  Scrotal Flap in Urethral Stricture http://dx.doi.org/10.5213/inj.2012.16.2.96INJ  In the second case, a 45-year-old man visited our hospital  with a penile urethral avulsion injury.",Non-OADS,/arxiv_data1/oa_pdf/c9/04/inj-16-96.PMC3395806.pdf
www.einj.org     99 Jeong  •  Scrotal Flap in Urethral Stricture http://dx.doi.org/10.5213/inj.2012.16.2.96INJ CONFLICT OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/c9/04/inj-16-96.PMC3395806.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Germline copy number variation associated with Mendelian inheritance of CLL in two families Leukemia (2012) 26, 1710- -1713; doi:10.1038/leu.2012.33 Chronic lymphocytic leukemia (CLL) shows signiﬁcant familial predisposition, yet few genes have been associated with diseaserisk.",Non-OADS,/arxiv_data1/oa_pdf/09/72/leu201227a.PMC3395971.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)Letters to the Editor 1692 Leukemia (2012) 1681 - - 1729 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/leu20126a.PMC3395972.pdf
Raw AFM images are processed using Gwyddion software (http://gwyddion.net).,OADS,/arxiv_data1/oa_pdf/c3/f7/srep00509.PMC3396134.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c3/f7/srep00509.PMC3396134.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Lim, C.J., Lee, S.Y., Kenney, L.J.",Non-OADS,/arxiv_data1/oa_pdf/c3/f7/srep00509.PMC3396134.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interest.,Non-OADS,/arxiv_data1/oa_pdf/8b/09/srep00510.PMC3396136.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Singhal, R., Mochalin, V., Lukatskaya, M., Friedman, G. & Gogotsi, Y.",Non-OADS,/arxiv_data1/oa_pdf/8b/09/srep00510.PMC3396136.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b3/51/srep00508.PMC3396152.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Morimae, T. & Fujii, K. Not all physical errors can be linear CPTP maps in a correlation space.",Non-OADS,/arxiv_data1/oa_pdf/b3/51/srep00508.PMC3396152.pdf
"To date,  1426 miRNA encoding sequences have been identified in the human genome and more than half of them have been experimentally validated (ftp://mirbase.org/pub/mirbase/CU RRENT/genomes/hsa.gff) [23].",Non-OADS,/arxiv_data1/oa_pdf/11/cd/TORJ-6-130.PMC3396185.pdf
"Comprehensive in silico analysis of miRNA targets is provided at the miRGen  database (http://www.diana.pcbi.upenn.edu/miRGen.html),  which merges the results of multiple miRNA prediction databases, such as DIANA microT, miRanda (microrna.org), miRanda (miRBase), PicTar (4-way and 5-way), and TargetScanS [29].",OADS,/arxiv_data1/oa_pdf/11/cd/TORJ-6-130.PMC3396185.pdf
"2008; Free Software Foundation, Available at: http://www.hypergraph.dk/  [13] Volcheck GW.",Non-OADS,/arxiv_data1/oa_pdf/2b/00/TORJ-6-170.PMC3396280.pdf
"(C)Drgal 1-L2 (green )was modeled at the SWISS-MODEL Protein Modeling Server (http://swissmodel.expasy.org) based on the bovinegalectin-1 structure (yellow, PDB 1slt).",OADS,/arxiv_data1/oa_pdf/b0/b6/fimmu-03-00199.PMC3396283.pdf
"(D)C. elegans 16-kDa galectin (Lec-6; shown in green) was modeled at the SWISS-MODEL Protein Modeling Server (http://swissmodel.expasy.org)based on the bovine galectin-1 structure (shown in yellow, PDB 1slt).",OADS,/arxiv_data1/oa_pdf/b0/b6/fimmu-03-00199.PMC3396283.pdf
"Keywords Smoking, growth, obesity, pregnancy, child, ALSPACThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ff/fa/dys025.PMC3396309.pdf
"In an example ofmeta-analysis of six studies, incorporating external evidence led toa smaller heterogeneity estimate and a narrower confidence intervalfor the combined intervention effect.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/5a/74/dys041.PMC3396310.pdf
"Health Outcomes Research: A Primer .http://www.academyhealth.org/files/ publications/healthoutcomes.pdf (1 March 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/5a/74/dys041.PMC3396310.pdf
"Health Research Classification System .http://www.hrcsonline.net/pages/hrcs _download (1 March 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/5a/74/dys041.PMC3396310.pdf
"Its benefits in terms of child nutri- tional status, cognitive and physical development, and in reducing morbidity and mortality—particularly dueto diarrhoea, ear infections, respiratory tract infections and meningitis—are well known.1–4Recent evidence from long-term cohorts suggests that breastfeeding may also help reduce the incidence of some chronic dis- eases and related conditions in adults.5,6This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c5/c4/dys002.PMC3396312.pdf
"2TB epidemiolo- gical studies continue district wide today.3In 1987, studies were conducted that established the presence of HIV, which has since then become a major theme of our research.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4c/7c/dys088.PMC3396313.pdf
"4The Karonga HDSS became a member of the INDEPTHinternational network of field sites with continuous demographic evaluation of populations and their health in developing countries ( http://www.indepth- network.org ) in 2004, and was one of the founder sites of the ALPHA network for analysis of longitu-dinal, population-based HIV/AIDS data in Africa(http://www.lshtm.ac.uk/eph/psd/alpha ) in 2005.",Non-OADS,/arxiv_data1/oa_pdf/4c/7c/dys088.PMC3396313.pdf
"Vaccination coverage in children was high eventu- ally, but frequently delayed, particularly in those frompoorer families and living at a distance from health facilities.24 For full KPS publications, visit http://www.lshtm.ac.",Non-OADS,/arxiv_data1/oa_pdf/4c/7c/dys088.PMC3396313.pdf
"In a combined INDEPTH and ALPHA networks ini- tiative, we are using our detailed verbal autopsy ques- tionnaire data to validate Inter-VA ( http://www.interva.net )—a computer model that facilitates inter- pretation of verbal autopsies and their application to populations by assigning probabilities of multiple causes to each death.",Non-OADS,/arxiv_data1/oa_pdf/4c/7c/dys088.PMC3396313.pdf
Applications to access HDSS data for collaborative analysis are encouraged and can bemade by proposal submission to the Deputy Director/ Scientific Programme Manager: mia.cram- pin@lshtm.ac.uk ( http://www.lshtm.ac.uk/eph/ide/re- search/kps/index.html ).,Non-OADS,/arxiv_data1/oa_pdf/4c/7c/dys088.PMC3396313.pdf
"Conclusions Cultural integration was associated with better mental health, in- dependent of the mental health advantage found among specificethnic groups: Black Caribbean and some Black African male stu-dents and female Indian students.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/26/a6/dys007.PMC3396315.pdf
Deprivation at the area of residence level was measured using the income dimension of the Index of MultipleDeprivation for the periods 2001–02 and 2004–06(http://www.neighbourhood.statistics.gov.uk ).,OADS,/arxiv_data1/oa_pdf/26/a6/dys007.PMC3396315.pdf
"26A cut-off of TDS 417 was used to identify potentially clinical cases ( http://www.sdqinfo.org/py/ doc/c0.py ) based on normative score distributions that show that /C2410% of adolescent populations, those with clinically significant psychological distress,score over 17.",Non-OADS,/arxiv_data1/oa_pdf/26/a6/dys007.PMC3396315.pdf
The SDQ has been validated in multiple cultures and languages (see http://www.sdqinfo.org/ py/doc/c0.py ).,Non-OADS,/arxiv_data1/oa_pdf/26/a6/dys007.PMC3396315.pdf
"Copenhagen: WHO Regional Office for Europe, 2008. http://www.euro.who.int/__data/ assets/pdf_file/0005/84623/E91921.pdf .",OADS,/arxiv_data1/oa_pdf/26/a6/dys007.PMC3396315.pdf
"Although the locations of these sites are somewhat serendipitous, rather than being strategically planned,it is evident that there is considerable coverage across the areas of the world that lack substantialThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/5b/8e/dys081.PMC3396316.pdf
"NCRM Working Paper Series 7/06, ESRC National Centre for Research Methods, Leeds, 2006. http://eprints.ncrm.ac.uk/480/1/ 0706_anonymising_research_data.pdf (10 April 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/5b/8e/dys081.PMC3396316.pdf
"Maryland: ORC Macro, 2006. http://www.measuredhs.com/pubs/ pdf/DHSG1/Guide_DHS_Statistics.pdf (10 April 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/5b/8e/dys081.PMC3396316.pdf
"1,2This involved establishing temporary demographic surveillance for a population of 56 000This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ff/be/dys062.PMC3396317.pdf
"The household questionnaires (available athttp://www.kemri-wellcome.org/khdss ) determine the vital status of each resident and, since March 2003, the pregnancy status of each female resident aged 13–55 years.",Non-OADS,/arxiv_data1/oa_pdf/ff/be/dys062.PMC3396317.pdf
"Although subject toconfounding and reverse causality bias, these findings meritevaluation in additional cohorts.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ce/da/dys003.PMC3396318.pdf
"http://www.cdc.gov/nchs/nhanes/ (9 January 2011, date last accessed).",OADS,/arxiv_data1/oa_pdf/ce/da/dys003.PMC3396318.pdf
"Keywords Socio-economic factors, social class, poverty, measurement, meth- ods, developing countriesThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4c/79/dys037.PMC3396323.pdf
"http://go.world bank.org/IPLXWMCNJ0 (23 April 2008, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/4c/79/dys037.PMC3396323.pdf
European Commission: 28-6-2011 .http://epp.eurostat.ec.,Non-OADS,/arxiv_data1/oa_pdf/4c/79/dys037.PMC3396323.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.132662.111.",OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
We then used the NextBio database (http://www.nextbio.com) (Kupershmidtet al.,OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
"bGene function from GeneCards website, http://www.genecards.org/.",Non-OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
"bGene function from GeneCards website, http://www.genecards.org/.",Non-OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
"For example, the compari- son of lung adenocarcinoma DNA methylation profiles with those of white blood cells and other types of cancers (e.g., through The Cancer Genome Atlas; http://cancergenome.nih.gov/), could lead to the development of improved DNA methylation-based bloodbiomarkers specific for lung adenocar- cinoma (Esteller et al.",Non-OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
Probes with detection P-values of >0.05 were deemed not significantly different from background noise and were labeled ‘‘NA.’’ Data for all samples are publicly available at the EDRN Public Portal (http://www.cancer.gov/edrn).,Non-OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
Genes for which expression levels change in concordance with DNA methylationchanges were analyzed for gene network and biological processesenrichment using IPA (Ingenuity Systems; http://www.ingenuity.,OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
"Meta-analyses to identify correlated biosets and overlapping genes in publicly available data sets were performed using theNextBio online database (NextBio, Cupertino, CA; http://www.nextbio.com).",OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
Data access The DNA methylation and expression data generated for the studyhave been submitted to the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/ g e o / )u n d e ra c c e s s i o nn u m b e r GSE32867.,OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
All genome-scale data generated in the study are alsopublicly available at the EDRN Public Portal (http://edrn.nci.nih.gov/).,OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/db/be/1197.PMC3396362.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.132308.111.",OADS,/arxiv_data1/oa_pdf/82/8f/1212.PMC3396363.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.128819.111.",OADS,/arxiv_data1/oa_pdf/7b/ba/1222.PMC3396364.pdf
"Art icle, supplemental material, and publica- tion date are at http://www.genome.or g/cgi/doi/10.1101/gr.130062.111.",OADS,/arxiv_data1/oa_pdf/51/44/1231.PMC3396365.pdf
"2010), we found that 333 (4.5%) had at least two matching reads from the Human Body Map data set, 212 (3%) had matching reads in two tissues, and 156 (2.2%) matched at least two nonidentical chimeric reads, i.e., mapped to distinct nucleotide positions in the chimera junction site (Table 1; http://chimera.bioinfo.cnio.es/).",OADS,/arxiv_data1/oa_pdf/51/44/1231.PMC3396365.pdf
"The peptides weresynthesized (JPT Peptide Technologies, http://www.jpt.com/) withheavy isotopic labels: C terminus R (15N6, 13C4) or C terminus K (15N6, 13C2) and added to the cell lysates prior to the analysis.",Non-OADS,/arxiv_data1/oa_pdf/51/44/1231.PMC3396365.pdf
The summary outputsof SignalP 3.0 and TMHMM 2.0 are available in the Supplemental Material (Supplemental Data and http://chimera.bioinfo.cnio.es/).,OADS,/arxiv_data1/oa_pdf/51/44/1231.PMC3396365.pdf
All the sequences of the chimeric RNAs presented inthis study are ESTs or mRNAs from GenBank (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/51/44/1231.PMC3396365.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.132514.111.",OADS,/arxiv_data1/oa_pdf/16/75/1243.PMC3396366.pdf
The February 2012 release of the 1000 Human Genome Project was downloaded from ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/release/20110521.,OADS,/arxiv_data1/oa_pdf/16/75/1243.PMC3396366.pdf
Association tests We used a compressed mixed linear model implemented in theGAPIT (http://www.maizegenetics.net/gapit) package (Zhang et al.,OADS,/arxiv_data1/oa_pdf/16/75/1243.PMC3396366.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.132100.111.",OADS,/arxiv_data1/oa_pdf/1a/eb/1255.PMC3396367.pdf
"Data access All microarray and RNA-seq data presented in this manuscripthave been submitted to the NCBI Gene Expression Omnibus(GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accession num-bers GSE23 309, GSE31722, and GSE31723.",OADS,/arxiv_data1/oa_pdf/1a/eb/1255.PMC3396367.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.128876.111.",OADS,/arxiv_data1/oa_pdf/a9/f0/1266.PMC3396368.pdf
"Data access All raw data have been submitted to the NCBI Gene ExpressionOmnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under acces-sion numbers GSE29972 and GSE36108, and are freely available.",OADS,/arxiv_data1/oa_pdf/a9/f0/1266.PMC3396368.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.131920.111.",Non-OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
"To facilitate further discovery, we have placed the quantitative expression data for all cells and raw images at our Expression Patterns in C. elegans (EPIC) database (http://epic.gs.washington.edu) where they are freely available for viewing and download.",OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
"To store and organize the data, we developed a custom XML-based embryodatabase (source code and java executable available at http://waterston.gs.washington.edu/tools.html).",OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
Expression and posi- tion data for each cell at each time point in each embryo are available as comma-separated value files at http://waterston.gs.washington.edu/epic/.,OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
The full lineages of all pop-1 RNAi embryos are available in the EPIC database at http://waterston.gs.washington.edu/epic/.,OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
Data access The quantitative data are freely available for download at our Expression Patterns in C. elegans (EPIC) database (http://epic.gs.,OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
"All software pro- grams (Embryo Database, AceTree, Starrynite) are freely availablefrom our website at http://waterston.gs.washington.edu/tools.html.",OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
http://www.wormbook.org.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/1282.PMC3396369.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.129437.111.",Non-OADS,/arxiv_data1/oa_pdf/da/67/1295.PMC3396370.pdf
Optimization The optimization is performed usinga combination of simulated annealing molecular dynamics and the conjugate gradient methods implemented in the Integrated ModelingPlatform (IMP; http://www.integrativemodeling.org) (Alber et al.,OADS,/arxiv_data1/oa_pdf/da/67/1295.PMC3396370.pdf
"Article, supplemental material, and publication date are at http://www.ge nome.org/cgi/doi/10.1101/gr.131474.111.",Non-OADS,/arxiv_data1/oa_pdf/94/b6/1306.PMC3396371.pdf
"soybase.org), and rice (http://www.ars.",Non-OADS,/arxiv_data1/oa_pdf/94/b6/1306.PMC3396371.pdf
We developed a software package called Iterative Read-Mapping and Realignment (IMR) v0.3.0 (http://mus.well.,OADS,/arxiv_data1/oa_pdf/94/b6/1306.PMC3396371.pdf
Data access The Illumina DNA sequencing data files analyzed in this manu-script have been submitted to the NCBI Sequence Read Archive (SRA) (http://www.ncbi.nlm.nih.gov/sra) under accession numberSRA051285.,OADS,/arxiv_data1/oa_pdf/94/b6/1306.PMC3396371.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.122879.111.",OADS,/arxiv_data1/oa_pdf/b6/ab/1316.PMC3396372.pdf
Data access All Illumina deep sequencing data have been submitted to the NCBISequence Read Archive (SRA) (http://trace.ncbi.nlm.nih.gov/Traces/ sra/sra.cgi) under acce ssion number SRA050213.,OADS,/arxiv_data1/oa_pdf/b6/ab/1316.PMC3396372.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.138792.112.",OADS,/arxiv_data1/oa_pdf/65/47/1327.PMC3396373.pdf
Data access The deep sequencing data are available at the NCBI Sequence Read Archive (SRA) (http://www.ncbi.nlm.nih.gov/sra) under accession number SRA051467.,OADS,/arxiv_data1/oa_pdf/65/47/1327.PMC3396373.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.127191.111.",OADS,/arxiv_data1/oa_pdf/eb/53/1334.PMC3396374.pdf
"Network and source code availability The integrative networks, input and validation data sets, and thesource code used for network inference and validation are providedin the online Supplemental Material and on the companion website of this article (http://compbio.mit.edu/flynet).",OADS,/arxiv_data1/oa_pdf/eb/53/1334.PMC3396374.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.130161.111.",OADS,/arxiv_data1/oa_pdf/ec/26/1350.PMC3396375.pdf
"Primers were designed with the ProbeFinderonline tool (http://qpcr.probefinder.com/organism.jsp, Roche Ap- plied Science).",OADS,/arxiv_data1/oa_pdf/ec/26/1350.PMC3396375.pdf
Data access Microarray data were deposited in ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) under accession number E-MTAB-760.Acknowledgments We thank the members of the Tresch and Cramer laboratories.,OADS,/arxiv_data1/oa_pdf/ec/26/1350.PMC3396375.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.133330.111.",OADS,/arxiv_data1/oa_pdf/e4/3c/1360.PMC3396376.pdf
"150 ng of TAP::ALG-1 associated RNA isolated from synchronized lateL4 animals were sent to the GeneCore facilty in Heidelberg, Ger-many (http://www.genecore.embl.de/index.cfm), and the micro- array data were generated according to their standard protocol (Weinmann et al.",OADS,/arxiv_data1/oa_pdf/e4/3c/1360.PMC3396376.pdf
GO term assignment analysis The Gene Ontology website (http://www.geneontology.org/) wasused for GO term assignments for all up-regulated RIP-chip-SRMtargets as well as for background distributions (the whole C. elegans genome).,OADS,/arxiv_data1/oa_pdf/e4/3c/1360.PMC3396376.pdf
Data access Array data have been submitted to the NCBI Gene ExpressionOmnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under acces- sion number GSE32944.,OADS,/arxiv_data1/oa_pdf/e4/3c/1360.PMC3396376.pdf
Triplexator is available at http://bioinformatics.org.au/ triplexator.,OADS,/arxiv_data1/oa_pdf/d5/6d/1372.PMC3396377.pdf
Circular dichroism HPLC-purified oligonucleotides were ordered from IDT (http://www.idtdna.com) with sequences and predicted triplex formation as shown as in Figure 4.,OADS,/arxiv_data1/oa_pdf/d5/6d/1372.PMC3396377.pdf
Available from: http://www.samhsa.gov/data/  NSDUH/2k9NSDUH/2k9Results.htm  3.,OADS,/arxiv_data1/oa_pdf/ac/3b/jphr-2012-1-e6.PMC3396434.pdf
Available  from: http://2010.census.gov/2010census/data/  16.,OADS,/arxiv_data1/oa_pdf/ac/3b/jphr-2012-1-e6.PMC3396434.pdf
Available from: http://www.deadi - version.usdoj.gov/nflis/2010midyear.pdf  17.,Non-OADS,/arxiv_data1/oa_pdf/ac/3b/jphr-2012-1-e6.PMC3396434.pdf
Available from: http://www.justice.gov/ndic/pubs31/  31379/heroin.htm  18.,Non-OADS,/arxiv_data1/oa_pdf/ac/3b/jphr-2012-1-e6.PMC3396434.pdf
Available from: http://www.justice.gov/ndic/  pubs0/668/heroin.htm  27.,OADS,/arxiv_data1/oa_pdf/ac/3b/jphr-2012-1-e6.PMC3396434.pdf
"In conclusion, this study shows that PGB applied for 40–48 h, but not acute application inhibits excitatory synaptic transmission at DRG-DH synapses, in response to nociceptive stimulation, most likely by a presynaptic effect on neurotransmitter release from DRG presynaptic terminals.Chronic pregabalin inhibits synaptic transmission  between rat dorsal root ganglion and dorsal horn  neurons in culture Janek Hendrich,† Claudia S. Bauer and Annette C. Dolphin* Department of Neuroscience, Physiology and Pharmacology; University College London; London, UK †Current affiliation: Department of Oral and Maxillofacial Surgery; University of California, San Francisco; San Francisco, CA USA Keywords:  synaptic transmission, dorsal root ganglion, dorsal horn, pregabalin, spinal cord, calcium channel, α2δ subunit *Correspondence to: Annette C. Dolphin; Email: a.dolphin@ucl.ac.uk Submitted: 12/02/11; Revised: 02/20/12; Accepted: 02/23/12http://dx.doi.org/10.4161/chan.19805α2δ-1 in DRG terminals.12 Prolonged treatment with PGB (8  d) reduced the nerve injury-associated pain behavior as well  as the increased α2δ-1 level in superficial DH but not in the  DRG cell bodies.12 This reduction of α2δ-1 is likely to repre - sent an effect of PGB on trafficking of α2δ-1 to presynaptic  terminals under neuropathic conditions.12 The PGB analog,  GBP, affects trafficking of the α2δ-1 and α2δ-2 subunits in  cell lines,14,15 and has been shown to inhibit the post-Golgi  forward trafficking of α2δ-2 by the interruption of a Rab-11- dependent recycling pathway.4 Previous work has identified actions at the cellular level for  PGB and GBP, as well as widespread behavioral effects.1,7,12,16  However, the mechanism of action of gabapentinoid drugs on the sensory networks involved in peripheral nociception, including those of the afferent DRG fibers and the initial processing in the DH, remains poorly defined.",Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Proc Natl Acad Sci USA 2006; 103:17537- 42; PMID:17088553; http://dx.doi.org/10.1073/ pnas.0409066103.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Proc Natl Acad Sci USA  2005; 102:11230-5; PMID:16061813; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Neurosci  2010; 30:12856-67; PMID:20861389; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Nat Neurosci  2009; 12:1415-23; PMID:19820706; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Nature  1997; 389:816-24; PMID:9349813; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Ther Drug Monit 2005; 27:451- 6; PMID:16044101; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Neurophysiol 2007; 98:1057- 63; PMID:17567772; http://dx.doi.org/10.1152/ jn.00581.2007.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Physiol 2002; 540:189-207;  PMID:11927679; http://dx.doi.org/10.1113/jphysi - ol.2001.012890.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Neuroscience 2007; 144:714-20;  PMID:17084535; http://dx.doi.org/10.1016/j.neuro - science.2006.09.044.17.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Neuropharmacology 2004; 46:743-9;  PMID:14996552; http://dx.doi.org/10.1016/j.neuro - pharm.2003.11.010.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Neurosci 2008; 28:5295-311;  PMID:18480286; http://dx.doi.org/10.1523/ JNEUROSCI.4810-07.2008.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Neurosci Methods 2001; 105:175-84; PMID:11275274; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Proc Natl Acad Sci USA 2010; 107:1654- 9; PMID:20080692; http://dx.doi.org/10.1073/ pnas.0908735107.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Neurophysiol 2007; 97:15- 25; PMID:17021029; http://dx.doi.org/10.1152/ jn.00559.2006.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Brain Res 2006; 1075:68- 80; PMID:16460711; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Neuroscience 2008; 155:510-21;  PMID:18616987; http://dx.doi.org/10.1016/j.neuro - science.2008.05.053.7.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Cell 2009; 139:380- 92; PMID:19818485; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Bioenerg Biomembr 2003; 35:639- 47; PMID:15000524; http://dx.doi.org/10.1023/ B:JOBB.0000008028.41056.58.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Mol Pharmacol 2002; 62:485-96; PMID:12181424;  http://dx.doi.org/10.1124/mol.62.3.485.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Neurosci 2009; 29:4076- 88; PMID:19339603; http://dx.doi.org/10.1523/JNEUROSCI.0356-09.2009.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
Channels (Austin) 2008; 2:4-9; PMID:18690052; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
J Pharmacol Sci 2009; 110:223-6; PMID:19498268; http://dx.doi.org/10.1254/ jphs.09091SC.,Non-OADS,/arxiv_data1/oa_pdf/be/79/chan-6-124.PMC3396689.pdf
"The first is Gpa2, which is a homolog of the G- a ssubunits of mammalian heterotrimeric G-proteins.3,4In this pathway, glucose itself appears to be a ligand for the seven-transmembrane receptor, Gpr1p.5Upon glucose*Correspondence to: Kevin K. Fuller; Email: kevin.fuller@dartmouth.edu Submitted: 12/02/11; Revised: 01/16/12; Accepted: 01/17/12 http://dx.doi.org/10.4161/viru.19396REVIEW Virulence 3:2, 109 –121; March/April 2012; G2012 Landes Bioscience www.landesbioscience.com Virulence 109",Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Annu Rev Biochem 1990; 59:971-1005; PMID:2165385; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
FEMS Microbiol Rev 2001; 25:349-64; PMID: 11348689; http://dx.doi.org/10.1111/j.1574-6976.2001.tb00582.x 3.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Novel sensing mecha- nisms and targets for the cAMP-protein kinase Apathway in the yeast Saccharomyces cerevisiae .M o l Microbiol 1999; 33:904-18; PMID:10476026; http://dx.doi.org/10.1046/j.1365-2958.1999.01538.x 4.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Saccharomyces cerevisiae plasma mem- brane nutrient sensors and their role in PKA signaling.FEMS Yeast Res 2010; 10:134-49; PMID:19849717;http://dx.doi.org/10.1111/j.1567-1364.2009.00587.x 5.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Cell 2004; 16:293-9; PMID:15494315; http://dx.doi.org/10.1016/j.molcel.2004.10.004 6.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Biol Cell 2005; 16:4557-71; PMID:16030250; http://dx.doi.org/10.1091/mbc.E05-05-0403 7.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Proc Natl Acad Sci U S A 2006; 103: 13034-9; PMID:16924114; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Microbiol 1991; 5:1301-7; PMID:1664904; http://dx.doi.org/ 10.1111/j.1365-2958.1991.tb00776.x 10.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
J Biol Chem 2004; 279:46715-22; PMID:15339905; http://dx.doi.org/10.1074/jbc.M405136200 11.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
EMBO J 1998; 17: 3326-41; PMID:9628870; http://dx.doi.org/10.1093/emboj/17.12.3326 12.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Biochem Soc Trans 2005; 33:253-6; PMID: 15667319; http://dx.doi.org/10.1042/BST0330253 13.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Cell 1987; 50:277-87; PMID:3036373; http://dx.doi.org/10.1016/0092-8674(87)90223-6 14.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Proc Natl Acad Sci U S A 2000;97:5984-8; PMID:10811893; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
The control of the yeastH2O2 response by the Msn2/4 transcription factors.Mol Microbiol 2002; 45:233-41; PMID:12100562; http://dx.doi.org/10.1046/j.1365-2958.2002.03011.x 19.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Genes Dev 1998; 12:586-97; PMID:9472026; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Genes Dev 1998; 12:2943-55; PMID:9744870; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Microbiol Mol Biol Rev 2000; 64:746-85; PMID:11104818; http://dx.doi.org/10.1128/MMBR.64.4.746-785.2000 27.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Int J Antimicrob Agents 1996; 6:141-4; PMID:18611700; http://dx.doi.org/10.1016/0924-8579(95) 00049-6 28.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Annu Rev Microbiol 2005; 59:113-33; PMID:16153165; http://dx.doi.org/10.1146/annurev.micro.59.030804.121034 30.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Cell Microbiol 2005; 7:1546-54; PMID:16207242; http://dx.doi.org/10.1111/j.1462-5822.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Cell 1997; 90:939-49; PMID: 9298905; http://dx.doi.org/10.1016/S0092-8674(00) 80358-X 32.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
EMBO J 2004; 23: 1845-56; PMID:15071502; http://dx.doi.org/10.1038/ sj.emboj.7600195 33.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Science 1997; 277:105-9; PMID:9204892;http://dx.doi.org/10.1126/science.277.5322.105 34.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2010; 6:e1000889; PMID:20485517; http://dx.doi.org/10.1371/journal.ppat.1000889 35.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Eukaryot Cell 2003; 2:1053-60; PMID:14555488; http://dx.doi.org/ 10.1128/EC.2.5.1053-1060.2003 36.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Biol Cell 2006; 17:295-307; PMID:16267276; http://dx.doi.org/10.1091/mbc.E05-06-0502 39.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
J Bacteriol 2001; 183:3211-23; PMID:11325951; http://dx.doi.org/10.1128/JB.183.10.3211-3223.2001 41.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Microbiol 2001; 42:673-87; PMID:11722734; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Biol Cell 2005; 16:1971-86; PMID:15673611; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Cell Microbiol2005; 7:499-510; PMID:15760450; http://dx.doi.org/ 10.1111/j.1462-5822.2004.00476.x 46.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
FEMS Microbiol Lett 2009; 295:1-9; PMID:19473245;http://dx.doi.org/10.1111/j.1574-6968.2009.01564.x 48.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Biol Cell 2005; 16:1971-86; PMID:15673611; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Cell Host Microbe 2008; 4: 28-39; PMID:18621008; http://dx.doi.org/10.1016/j.chom.2008.05.014 50.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Int J Antimicrob Agents 2008; 32(Suppl 2):S87-91; PMID:19013346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Curr Biol 2005; 15:2021-6; PMID:16303561; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Curr Biol 2009; 19:621-9; PMID: 19327993; http://dx.doi.org/10.1016/j.cub.2009.03.017 53.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Virulence 2010; 1:45-8; PMID:21178413; http://dx.doi.org/10.4161/viru.1.1.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Future Microbiol 2009; 4:1263-70; PMID:19995187;http://dx.doi.org/10.2217/fmb.09.106 55.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Annu Rev Phytopathol 2003; 41:399-427; PMID:12651963; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Plant Microbe Interact 1997; 10:1075-86; PMID:9390422; http://dx.doi.org/10.1094/MPMI.1997.10.9.1075 58.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Plant Microbe Interact 1996; 9:450-6; PMID:8755621; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Exp Mycol 1988; 12:1-7; http://dx.doi.org/10.1016/0147-5975(88)90011-4 62. d'Enfert C. Fungal spore germination: Insights from the molecular genetics of Aspergillus nidulans and Neurospora crassa .,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Fungal Genet Biol 1997; 21:163-72; http://dx.doi.org/10.1006/fgbi.1997.0975 63.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Microbiology 1994; 140:1467-72; PMID:8081506; http://dx.doi.org/10.1099/00221287-140-6-1467 64.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Plant Microbe Interact 1999; 12:430-9; PMID:10226376; http://dx.doi.org/10.1094/MPMI.1999.12.5.430 66.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Plant Microbe Interact 2001; 14: 1149-57; PMID:11605954; http://dx.doi.org/10.1094/ MPMI.2001.14.10.1149 67.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Fungal Genet Biol 2009; 46:277-85; PMID: 19124083; http://dx.doi.org/10.1016/j.fgb.2008.12.001 68.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Physiol Mol Plant Pathol 2000; 56: 51-61; http://dx.doi.org/10.1006/pmpp.1999.0247 69.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
N Engl J Med 2009; 360: 1870-84; PMID:19403905; http://dx.doi.org/10.1056/ NEJMra0808853 70.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Clin Infect Dis 2007; 44:531-40; PMID: 17243056; http://dx.doi.org/10.1086/510592 71.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Eukaryot Cell 2009; 8:271-7; PMID:19124579; http://dx.doi.org/ 10.1128/EC.00391-08 72.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
"Fuller KK, Richie DL, Feng X, Krishnan K, Stephens TJ, Wikenheiser-Brokamp KA, et al.Divergent Protein Kinase A isoforms co-ordinatelyregulate conidial germination, carbohydrate metabo- lism and virulence in Aspergillus fumigatus .M o l Microbiol 2011; 79:1045-62; PMID:21210869; http://dx.doi.org/10.1111/j.1365-2958.2010.07509.x 73.",OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Eukaryot Cell 2011; 10:1306-16; PMID:21821718; http://dx.doi.org/10.1128/EC.05179-11 77.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
FEMS Yeast Res 2004; 4:765-71;PMID:15450183; http://dx.doi.org/10.1016/j.femsyr.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Cell Biol 2001; 21:3179- 91; PMID:11287622; http://dx.doi.org/10.1128/MCB.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2007; 3:e42; PMID:17367210; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Eukaryot Cell 2005; 4:1420-33; PMID:16087747; http://dx.doi.org/10.1128/EC.4.8.1420- 1433.2005 81.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Curr Opin Microbiol 2009; 12:365-70; PMID:19632143; http://dx.doi.org/10.1016/j.mib.2009.05.006 82.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2010; 6:e1000776; PMID: 20174553; http://dx.doi.org/10.1371/journal.ppat.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Curr Biol 2005; 15:2013-20; PMID:16303560;http://dx.doi.org/10.1016/j.cub.2005.09.047 84.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Trends Microbiol 2009; 17:406-13; PMID:19726196; http://dx.doi.org/10.1016/j.tim.2009.06.006 85.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Genes Dev1997; 11:3206-17; PMID:9389652; http://dx.doi.org/ 10.1101/gad.11.23.3206 87.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Biol Cell 2006; 17:667-79; PMID:16291861;http://dx.doi.org/10.1091/mbc.E05-07-0699 www.landesbioscience.com Virulence 119,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Eukaryot Cell 2010; 9:360-78; PMID:20097740; http://dx.doi.org/10.1128/EC.00309-09 89.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
J Biol Chem 2006; 281: 32596-605; PMID:16950773; http://dx.doi.org/10.1074/jbc.M602768200 90.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Microbiology 2008; 154:392-401; PMID:18227243; http://dx.doi.org/10.1099/mic.0.2007/012260-0 91.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Genetics 2005; 171:81-9; PMID:15944346; http://dx.doi.org/10.1534/genetics.105.042796 92.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Eukaryot Cell 2002; 1:378-90; PMID:12455986; http://dx.doi.org/10.1128/EC.1.3.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Fungal Genet Biol 2003; 38:143-58; PMID:12620252; http://dx.doi.org/ 10.1016/S1087-1845(02)00526-1 94.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Fungal GenetBiol 1998; 25:63-74; PMID:9806807; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Med MicrobiolImmunol 1998; 187:79-89; PMID:9832321; http://dx.doi.org/10.1007/s004300050077 96.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Cell Microbiol 2002; 4:793-803; PMID:12464010; http://dx.doi.org/10.1046/j.1462-5822.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Genet Genomics 2003; 269:420-35; PMID:12734751; http://dx.doi.org/10.1007/s00438-003-0852-0 98.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Infect Immun 2004; 72:5193-203; PMID: 15322014; http://dx.doi.org/10.1128/IAI.72.9.5193-5203.2004 99.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Infect Immun 2006; 74:4865-74; PMID: 16861675; http://dx.doi.org/10.1128/IAI.00565-06 100.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Yeast 2009; 26:273-85; PMID:19391100; http://dx.doi.org/10.1002/yea.1665101.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Fungal GenetBiol 2009; 46:210-9; PMID:19032986; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Appl Environ Microbiol 2008; 74:4923- 33; PMID:18539819; http://dx.doi.org/10.1128/AEM.00470-08 104.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2008; 4:e1000154; PMID:18787699; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Respir PhysiolNeurobiol 2007; 159:331-7; PMID:17369109; http://dx.doi.org/10.1016/j.resp.2007.02.014 106.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Microbiol2008; 69:1456-75; PMID:18673460; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
In vivo and ex vivo comparative transcriptional profiling of invasive and non-invasive Candida albicans isolates identifies genes associated with tissue invasion.Mol Microbiol 2007; 63:1606-28; PMID:17367383; http://dx.doi.org/10.1111/j.1365-2958.2007.05614.x 108.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2009; 5:e1000612; PMID: 19816560; http://dx.doi.org/10.1371/journal.ppat.1000612 110.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Nature 2001; 412:83-6; PMID: 11452311; http://dx.doi.org/10.1038/35083594 111.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
MBio 2011; 2:e00103-11; PMID:21652778; http://dx.doi.org/10.1128/mBio.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Med Mycol 2010; 48:1-15; PMID:19462332;http://dx.doi.org/10.3109/13693780902947342 113.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2008; 4:e1000200; PMID:18989462; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2007; 3:e22; PMID:17319742; http://dx.doi.org/10.1371/journal.ppat.0030022115.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Genet 2011; 7:e1002374; PMID:22144905; http://dx.doi.org/10.1371/journal.pgen.1002374 116.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Nat Rev Microbiol 2004; 2:946-53; PMID: 15550940; http://dx.doi.org/10.1038/nrmicro1046 118.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Microbiol 2003; 47:1185-97; PMID: 12603727; http://dx.doi.org/10.1046/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Microbiol 2007; 66:279-90; PMID:17854405; http://dx.doi.org/10.1111/j.1365-2958.2007.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Cell Mol Life Sci 2006; 63:3018-29; PMID:17075695; http://dx.doi.org/10.1007/s00018-006-6269-2 121.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2008; 4:e1000040; PMID:18389063;http://dx.doi.org/10.1371/journal.ppat.1000040 122.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Antimicrob Agents Chemother 2012; 56:208-17; PMID:21986821; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Microbiol Mol Biol Rev 2005; 69:262-91; PMID:15944456; http://dx.doi.org/10.1128/MMBR.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Plant Microbe Interact 2008; 21:525-34; PMID:18393612; http://dx.doi.org/10.1094/MPMI-21-5-0525 126.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Physiol Genomics 2003; 16:107-18; PMID:14570984; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Mol Microbiol 2007; 65:841-56; PMID:17614954;http://dx.doi.org/10.1111/j.1365-2958.2007.05788.x 120 Virulence Volume 3 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
PLoS Pathog 2010; 6:e1000752; PMID:20140194; http://dx.doi.org/10.1371/journal.ppat.1000752 130.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Eukaryot Cell 2010; 9:1120-35; PMID:20453072; http://dx.doi.org/10.1128/EC.00362-09 131.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Nat Rev Microbiol 2007; 5:418-30; PMID:17505522;http://dx.doi.org/10.1038/nrmicro1680 132.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
J Infect Dis 2007; 195:756-64; PMID:17262720; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Clin Infect Dis 2003; 36: 46-52; PMID:12491201; http://dx.doi.org/10.1086/ 345441 134.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Antimicrob Agents Chemother 2007; 51:2979-81; PMID:17502415; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Antimicrob Agents Chemother 2010; 54:1555-63; PMID:20124000; http://dx.doi.org/10.1128/ AAC.00854-09136.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Fungal Genet Biol 2003; 38:133-41; PMID:12553943; http://dx.doi.org/10.1016/S1087-1845(02)00520-0 137.,OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
Ann N YAcad Sci 2002; 968:139-47; PMID:12119273; http://dx.doi.org/10.1111/j.1749-6632.2002.tb04332.x www.landesbioscience.com Virulence 121,Non-OADS,/arxiv_data1/oa_pdf/3c/57/viru-3-109.PMC3396691.pdf
"10-12Furthermore, Salmonella uses acidic pH (~pH 4.5) for transcriptional regulation of a subset of PhoPregulated genes 13and assembly of the Salmonella pathogenicity *Correspondence to: Dipshikha Chakravortty; Email: dipa@mcbl.iisc.ernet.in Submitted: 07/25/11; Revised: 12/13/11; Accepted: 12/13/11 http://dx.doi.org/10.4161/viru.19029Virulence 3:2, 122 –135; March/April 2012; G2012 Landes Bioscience 122 Virulence Volume 3 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
FEMS Microbiol Lett 2010; 305:1-13; PMID:20146749; http://dx.doi.org/10.1111/ j.1574-6968.2010.01904.x 2.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Infect Immun 2010; 78:2356-69; PMID:20385760; http://dx.doi.org/10.1128/IAI.00096-10 3.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
FEMS Microbiol Rev 2005; 29:1021-40;PMID:16023758; http://dx.doi.org/10.1016/j.femsre.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Crit Rev Microbiol 1995; 21:215-37; PMID:8688153; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Infect Immun 2000; 68:7039-48; PMID:11083829; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
J Exp Med 2002; 195:1155-66; PMID: 11994420; http://dx.doi.org/10.1084/jem.20011547 11.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Curr Opin Microbiol 2004; 7:78-84; PMID:15036145; http://dx.doi.org/10.1016/j.mib.2003.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
J Bacteriol 2001; 183:1835-42; PMID:11222580; http://dx.doi.org/10.1128/JB.183.6.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
"Rappl C, Deiwick J, Hensel M. Acidic pH is required for the functional assembly of the type III secretionsystem encoded by Salmonella pathogenicity island 2.FEMS Microbiol Lett 2003; 226:363-72; PMID: 14553934; http://dx.doi.org/10.1016/S0378-1097(03) 00638-4 15.",OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
EMBO J 2005;24:2043-52; PMID:15889142; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Science 2010; 328:1040-3; PMID: 20395475; http://dx.doi.org/10.1126/science.1189000 17.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Mol Microbiol 2003; 47:103-18; PMID: 12492857; http://dx.doi.org/10.1046/j.1365-2958.2003.03313.x 18.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
J Bacteriol 2001; 183:6036-45; PMID:11567004; http://dx.doi.org/10.1128/JB.183.20.6036-6045.2001 19.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Proc Natl Acad Sci USA 2006; 103:1906-11; PMID:16443683; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Z Gerontol Geriatr 2001; 34: 196-206; PMID:11487962; http://dx.doi.org/10.1007/ s003910170064 21.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
J Bacteriol 2003;185:2475-84; PMID:12670971; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Mol Microbiol 1998;30:175-88; PMID:9786194; http://dx.doi.org/10.1046/ j.1365-2958.1998.01048.x 27.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Microbes Infect 2001; 3: 1305-11; PMID:11755419; http://dx.doi.org/10.1016/ S1286-4579(01)01491-5 28.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Antimicrob Agents Chemother 2009; 53:2402-9; PMID:19307359; http://dx.doi.org/10.1128/AAC.01483-08 29.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
PLoS Pathog 2009; 5: e1000306; PMID:19229334; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Mol Microbiol 1999; 33:806-16; PMID:10447889; http://dx.doi.org/10.1046/j.1365-2958.1999.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
J Exp Med 2005; 202:625-35; PMID:16129704; http://dx.doi.org/10.1084/jem.20050246 33.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
EMBO J 1999; 18:3924-33; PMID:10406797; http://dx.doi.org/10.1093/emboj/ 18.14.3924 34.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Cell Microbiol 2001; 3:731-44; PMID: 11696033; http://dx.doi.org/10.1046/j.1462-5822.2001.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Int J Med Microbiol 2001; 291:97-106; PMID:11437344; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
FEMS Microbiol Lett 1997; 147: 173-80; PMID:9119190; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
J Biol Chem 2004; 279:34631-42; PMID:15169785; http://dx.doi.org/10.1074/jbc.M402760200 38.,OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Microbiology 2009; 155:1613-22; PMID:19372159; http://dx.doi.org/10.1099/mic.0.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Schmerz 2001; 15: 164-71; PMID:11810351; http://dx.doi.org/10.1007/ s004820170018 40.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Methods Mol Biol 2008; 431:201- 11; PMID:18287758; http://dx.doi.org/10.1007/978- 1-60327-032-8_16 41.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Microbiology 2008; 154:666-78; PMID: 18227269; http://dx.doi.org/10.1099/mic.0.2007/011114-0 42.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
J Bacteriol 2002; 184:4971-80; PMID:12193612; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Microbes Infect 2001; 3:1345-52;PMID:11755424; http://dx.doi.org/10.1016/S1286- 4579(01)01496-4 45.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Mol Microbiol 1996; 22:367-78; PMID: 8930920; http://dx.doi.org/10.1046/j.1365-2958.1996.00120.x 46.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
Microbiology 2009; 155:2476-89; PMID:19520723; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7f/42/viru-3-122.PMC3396692.pdf
"*Correspondence to: Naveed Ahmed Khan; Email: Naveed5438@gmail.com Submitted: 06/30/11; Revised: 08/03/11; Accepted: 08/04/11http://dx.doi.org/10.4161/viru.17631Transmigration of neuropathogens across the blood- brain barrier is a key step in the development of central nervous system infections, making it a prime target for drug development.",Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
Microb Pathog 2003; 35:235-41; PMID:14580387; http://dx.doi.org/10.1016/j.micpath.2003.07.001.,OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
Annu Rev Immunol 2004; 22:457-83; PMID:15032585; http://dx.doi.org/10.1146/annurev.immu-nol.22.012703.104626.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
Infect Immun 2004; 72:4985-95; PMID:15321990; http://dx.doi.org/10.1128/IAI.72.9.4985-4995.2004.4.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
J Parasitol 2004; 90:970-9; PMID:15562595; http://dx.doi.org/10.1645/GE-287R.,OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
Infect Immun 2001; 69:4536-44; PMID:11401997; http://dx.doi.org/10.1128/IAI.69.7.4536-4544.2001.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
J Biol Chem 2002; 277:15607-12; PMID:11877402; http://dx.doi.org/10.1074/jbc.M112224200.8.,OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
Infect Immun 2007; 75:5735-9; PMID:17875634; http://dx.doi.org/10.1128/IAI.00740-07.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
Int J Parasitol 2009; 39:1611-6; PMID:19580812; http://dx.doi.org/10.1016/j.ijpara.2009.06.004.,OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
J Neurovirol 1999; 5:570-8; PMID:10602398; http://dx.doi.org/10.3109/13550289909021286.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
J Med Microbiol 2008; 57:106-10; PMID:18065675; http://dx.doi.org/10.1099/jmm.0.47568-0.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
J Clin Invest 1998; 102:347-60; PMID:9664076; http://dx.doi.org/10.1172/JCI2406.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
J Neuroimmunol 1997; 76:81-90; PMID:9184636; http://dx.doi.org/10.1016/S0165-5728(97)00036-2.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
Microb Pathog 2001; 30:19-28; PMID:11162182; http://dx.doi.org/10.1006/mpat.2000.0406.12.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
J Med Microbiol 2009; 58:503-8; PMID:19273647; http://dx.doi.org/10.1099/jmm.0.005462-0.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
BMC Microbiol 2010; 10:186; PMID:20615207; http://dx.doi.org/10.1186/1471-2180-10-186.,Non-OADS,/arxiv_data1/oa_pdf/6e/a2/viru-3-159.PMC3396694.pdf
"17*Correspondence to: Xavier Nassif; Email: xavier.nassif@inserm.fr Submitted: 09/14/11; Revised: 11/02/11; Accepted: 11/03/11 http://dx.doi.org/10.4161/viru.18639Virulence 3:2, 164 –172; March/April 2012; G2012 Landes Bioscience 164 Virulence Volume 3 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Infect Dis Clin North Am 1999; 13: 711-33; PMID:10470563; http://dx.doi.org/10.1016/ S0891-5520(05)70102-1 2.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
"Microbes Infect 2000; 2:1237-44; PMID:11008113; http://dx.doi.org/10.1016/S1286- 4579(00)01277-6 3. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF.",OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
N Engl J Med 2006; 354:44-53; PMID:16394301; http://dx.doi.org/10.1056/NEJMra052116 4.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Trends Microbiol 2002; 10:227-32; PMID:11973156; http://dx.doi.org/10.1016/S0966-842X(02)02349-1 5.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Role of intra- vascular replication in the pathogenesis of experimental bacteremia due to Haemophilus influenzae type b. J Infect Dis 1985; 152:307-14; PMID:3875663;http://dx.doi.org/10.1093/infdis/152.2.307 6.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Infect Dis 1981; 143:517-24; PMID: 6972419; http://dx.doi.org/10.1093/infdis/143.4.517 8.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Infect Dis 1992; 165(Suppl 1):S62-5; PMID:1588179;http://dx.doi.org/10.1093/infdis/165-Supplement_1-S62 9.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Rev Infect Dis 1981; 3(Suppl 1):S1-17; PMID:7025155; http://dx.doi.org/10.1093/clinids/3.Supplement_1.S1 10.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Infect Dis 1980; 142:556-68; PMID:6108344; http://dx.doi.org/10.1093/infdis/142.4.556 11.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Infect Immun 2002; 70:5193-201; PMID:12183570; http://dx.doi.org/10.1128/IAI.70.9.5193-5201.200212.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Lancet Infect Dis 2009; 9:31-44; PMID:19036641;http://dx.doi.org/10.1016/S1473-3099(08)70261-5 16.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Lancet Infect Dis 2010; 10: 262-74; PMID:20334849; http://dx.doi.org/10.1016/ S1473-3099(10)70045-1 17.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Exp Med 2005; 201:1905- 13; PMID:15967821; http://dx.doi.org/10.1084/jem.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
PLoS ONE 2008; 3:e3885; PMID:19065260; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Infect Dis 1997; 176:1285-92; PMID:9359730;http://dx.doi.org/10.1086/51412422.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 2000; 36:817-29;PMID:10844670; http://dx.doi.org/10.1046/j.1365-2958.2000.01923.x 23.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Neuron 2008;57:178-201; PMID:18215617; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Gen Physiol 1981; 77:349-71; PMID:7241087; http://dx.doi.org/10.1085/jgp.77.4.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Curr Opin Neurobiol 1996; 6:622-7; PMID:8937826; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Cell Biol 2008; 183:409-17; PMID: 18955553; http://dx.doi.org/10.1083/jcb.200806024 28.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Nature 2010; 468:557-61; PMID: 20944627; http://dx.doi.org/10.1038/nature09522 30.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Nature 2010; 468:562-6; PMID: 20944625; http://dx.doi.org/10.1038/nature09513 31.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Neurosci Res 2005; 79:421-7; PMID:15635601; http://dx.doi.org/10.1002/jnr.20313 33.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Cell Biol1975; 67:863-85; PMID:1202025; http://dx.doi.org/ 10.1083/jcb.67.3.863 170 Virulence Volume 3 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Trends Immunol 2007; 28:5-11; PMID: 17140851; http://dx.doi.org/10.1016/j.it.2006.11.007 36.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Nat Rev Immunol 2003; 3:569-81; PMID: 12876559; http://dx.doi.org/10.1038/nri1130 37.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Exp Neurol 2001; 168:242-9; PMID: 11259112; http://dx.doi.org/10.1006/exnr.2000.7618 39.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Cell Microbiol 2001; 3:277-87; PMID:11298651; http://dx.doi.org/10.1046/j.1462- 5822.2001.00116.x 40.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Clin Invest 1998; 102:347-60; PMID:9664076; http://dx.doi.org/ 10.1172/JCI2406 41.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Microb Pathog 2001; 30:19-28; PMID:11162182; http://dx.doi.org/10.1006/mpat.2000.0406 43.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Infect Dis1992; 165(Suppl 1):S115-6; PMID:1588142; http://dx.doi.org/10.1093/infdis/165-Supplement_1-S115 46.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Microb Pathog1991; 10:231-45; PMID:1895925; http://dx.doi.org/ 10.1016/0882-4010(91)90057-H 47.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Int J Med Microbiol 2006; 296:553-8; PMID:17010667; http://dx.doi.org/10.1016/j.ijmm.2006.06.006 48.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Infect Immun 2009; 77:292-9; PMID: 18852235; http://dx.doi.org/10.1128/IAI.01071-08 49.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Clin Vaccine Immunol 2006;13:758-63; PMID:16829612; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 2011; 81:1330-42; PMID:21777301; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Vaccine 2009; 27(Suppl 2): B78-89; PMID:19481311; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Nat Rev Microbiol 2009; 7:274-86; PMID:19287450; http://dx.doi.org/ 10.1038/nrmicro2097 54.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
EMBO J 2000; 19:6408-18; PMID: 11101514; http://dx.doi.org/10.1093/emboj/19.23.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Nature 2000; 407:98-102; PMID:10993081; http://dx.doi.org/10.1038/35024105 56.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Proc Natl Acad Sci USA 2001; 98:6901-4; PMID:11381130; http://dx.doi.org/ 10.1073/pnas.121171698 57.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Gene 1997; 192:117-21; PMID:9224881;http://dx.doi.org/10.1016/S0378-1119(96)00830-X 60.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Nature 1995; 378:32-8; PMID:7477282; http://dx.doi.org/10.1038/378032a0 61.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Proc Natl Acad Sci USA 2004; 101:10798-803; PMID:15249686; http://dx.doi.org/ 10.1073/pnas.0402397101 62.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Gene 1997; 192:141-7; PMID:9224884; http://dx.doi.org/10.1016/S0378-1119(97)00082-664.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 2005; 55:65-77; PMID: 15612917; http://dx.doi.org/10.1111/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Curr Opin Struct Biol 2008; 18:267-77; PMID:18249533; http://dx.doi.org/10.1016/j.sbi.2007.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Proc Natl Acad Sci USA 2007; 104:15888-93; PMID:17893339; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 1999; 31:1345-57; PMID:10200956; http://dx.doi.org/10.1046/j.1365-2958.1999.01269.x 71.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Proc Natl Acad Sci USA 1994; 91: 3769-73; PMID:7909606; http://dx.doi.org/10.1073/ pnas.91.9.3769 73.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 2001; 40:846-56; PMID:11401692; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 1998; 29:321-30; PMID:9701824; http://dx.doi.org/10.1046/j.1365-2958.1998.00935.x 77.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 1995; 16:1087-97; PMID:8577245; http://dx.doi.org/10.1111/j.1365-2958.1995.tb02334.x 78.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Proc Natl Acad Sci USA 1999; 96:4017-22; PMID:10097155; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
PLoS Biol 2008; 6:e87; PMID:18416602; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Science 2011; 331:778-82; PMID: 21311024; http://dx.doi.org/10.1126/science.1200729 81.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Mol Microbiol 1999; 32:1316-32; PMID: 10383771; http://dx.doi.org/10.1046/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Science 2009; 325:83-7; PMID:19520910; http://dx.doi.org/10.1126/science.1173196 85.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Cell 2010; 143:1149-60;PMID:21183077; http://dx.doi.org/10.1016/j.cell.2010.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Infect Immun 2005; 73:3072-82; PMID:15845515; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Clin Invest 2009; 119:1638-46; PMID:19436113; http://dx.doi.org/10.1172/JCI36759 89.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Cell Microbiol2005; 7:1197-211; PMID:16008586; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Annu Rev Physiol 2007; 69:483-510; PMID:17305471; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Cell Biol 2006; 173: 627-37; PMID:16717131; http://dx.doi.org/10.1083/ jcb.200507128 92.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
PLoS Pathog 2009; 5:e1000314; PMID:19247442;http://dx.doi.org/10.1371/journal.ppat.1000314 93.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Blood 2005; 105:2852-61; PMID:15591117; http://dx.doi.org/10.1182/blood-2004-09-360697.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Cell Biol 2004; 167:377-88; PMID:15504916; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Exp Med 2004; 200:1571-80; PMID:15611287; http://dx.doi.org/10.1084/jem.20040965 99.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Cell Biol 2005; 170:895-901; PMID:16157700; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Cell Biol 2010; 191:585-98; PMID: 21041448; http://dx.doi.org/10.1083/jcb.201002151 101.,Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Proc Natl Acad Sci USA 2007;104:10882-7; PMID:17576929; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
Science 1999; 283:655-61;PMID:9924018; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
J Cell Biol 2001; 155:133-44; PMID: 11581290; http://dx.doi.org/10.1083/jcb.200106148 105.,OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
"Schubert-Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8.PLoS Pathog 2010; 6:e1000874; PMID:20442866; http://dx.doi.org/10.1371/journal.ppat.1000874 172 Virulence Volume 3 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/ab/43/viru-3-164.PMC3396695.pdf
"There are two principal Cryptococcus species that often cause human and animal infections, C. neo- formans (serotype A and D) and its sibling species C. gattii*Correspondence to: Chaoyang Xue; Email: xuech@umdnj.edu Submitted: 09/30/11; Revised: 11/04/11; Accepted: 11/07/11 http://dx.doi.org/10.4161/viru.18685SPECIAL FOCUS REVIEW: BLOOD-BRAIN BARRIER Virulence 3:2, 173 –181; March/April 2012; G2012 Landes Bioscience www.landesbioscience.com Virulence 173",Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
"Infect Dis Clin North Am 2009; 23:609-23; PMID:19665086;http://dx.doi.org/10.1016/j.idc.2009.04.009 2. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF.",OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Community-acquired bacterial meningitis in adults.N Engl J Med 2006; 354:44-53; PMID:16394301;http://dx.doi.org/10.1056/NEJMra052116 3.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
"Abbott NJ, Ronnback L, Hansson E. Astrocyte- endothelial interactions at the blood-brain barrier.Nat Rev Neurosci 2006; 7:41-53; PMID:16371949;http://dx.doi.org/10.1038/nrn1824 4.",OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Nat Rev Microbiol 2008; 6:625-34; PMID:18604221; http://dx.doi.org/10.1038/nrmicro1952 5.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Int J Parasitol 2006; 36:607-14; PMID:16542662; http://dx.doi.org/10.1016/j.ijpara.2006.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
FEMS Microbiol Rev 1996; 18:289- 99; PMID:8703507; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Curr Opin Microbiol 2007; 10:314-9; PMID: 17719267; http://dx.doi.org/10.1016/j.mib.2007.04.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Clin Chest Med 2009; 30:337-53; PMID:19375639; http://dx.doi.org/10.1016/j.ccm.2009.02.009 9.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Curr Opin Neurol 2008; 21:347-52; PMID:18451721; http://dx.doi.org/10.1097/WCO.0b013e3282fee95b 10.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Semin Neurol 2000; 20:307-22; PMID:11051295; http://dx.doi.org/10.1055/s-2000-9394 11.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Dis Clin North Am 2002; 16:837-74; PMID:12512184; http://dx.doi.org/10.1016/S0891-5520(02)00036-3 12.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
AIDS 2009; 23:525- 30; PMID:19182676; http://dx.doi.org/10.1097/ QAD.0b013e328322ffac 13.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Curr Infect Dis Rep 2000; 2:352- 7; PMID:11095877; http://dx.doi.org/10.1007/ s11908-000-0015-y 14.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eur J Epidemiol 1992; 8:321-5; PMID: 1397195; http://dx.doi.org/10.1007/BF00158562 17.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Med Vet Mycol 1992; 30: 407-8; PMID:1469544; http://dx.doi.org/10.1080/02681219280000541 18.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Cell Host Microbe 2007; 1:263-73; PMID:18005707; http://dx.doi.org/10.1016/j.chom.2007.05.005 20.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
"Nielsen K, De Obaldia AL, Heitman J. Cryptococcus neoformans mates on pigeon guano: implications for the realized ecological niche and globalization.Eukaryot Cell 2007; 6:949-59; PMID:17449657; http://dx.doi.org/10.1128/EC.00097-07 21.",OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
PLoS Pathog 2010; 6:e1000850; PMID: 20421942; http://dx.doi.org/10.1371/journal.ppat.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Nat Rev Microbiol 2011; 9:193-203; PMID:21326274;http://dx.doi.org/10.1038/nrmicro2522 24.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Nature 2005; 437:1360-4; PMID:16222245;http://dx.doi.org/10.1038/nature04220 25.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
PLoSONE 2009; 4:e5851; PMID:19516904; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2009; 77:4345- 55; PMID:19620339; http://dx.doi.org/10.1128/IAI.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2009; 77:3491-500; PMID:19451235; http://dx.doi.org/10.1128/IAI.00334-09 28.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Curr Infect Dis Rep 2007; 9:457-64; PMID:17999881; http://dx.doi.org/10.1007/s11908-007-0070-8 32.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2001; 69:2723-7; PMID:11254641; http://dx.doi.org/10.1128/IAI.69.4.2723-2727.2001 33.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Curr Biol 2006; 16:2161-5;PMID:17084702; http://dx.doi.org/10.1016/j.cub.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2004; 72:4985- 95; PMID:15321990; http://dx.doi.org/10.1128/IAI.72.9.4985-4995.2004 42.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eukaryot Cell 2005; 4:1079-87;PMID:15947200; http://dx.doi.org/10.1128/EC.4.6.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Mol Microbiol 2005; 58:393-408; PMID:16194228; http://dx.doi.org/10.1111/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eukaryot Cell 2008; 7:1685-98; PMID:18689526; http://dx.doi.org/10.1128/EC.00146-08 45.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Clin Invest 1985; 76: 508-16; PMID:3928681; http://dx.doi.org/10.1172/ JCI112000 46.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Curr Biol 2005; 15:2013-20; PMID:16303560; http://dx.doi.org/10.1016/j.cub.2005.09.047 47.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
PLoS Pathog 2011; 7:e1002047; PMID:21637814; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
PLoS Biol 2006; 4:e410; PMID:17121456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
PLoS Pathog 2006; 2:e120; PMID:17096589; http://dx.doi.org/10.1371/ journal.ppat.0020120 51.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Cell Microbiol 2006; 8:267-75; PMID: 16441437; http://dx.doi.org/10.1111/j.1462-5822.2005.00619.x 52.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Immunotherapy 2011; 3:997-1005; PMID:21843086; http://dx.doi.org/10.2217/imt.11.86 54.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Cell Microbiol 2003; 5:203-23; PMID:12675679; http://dx.doi.org/ 10.1046/j.1462-5814.2003.00268.x 57.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
FEMS Yeast Res 2004; 5:1-10; PMID:15381117; http://dx.doi.org/10.1016/j.femsyr.2004.04.004 58.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2004; 72:1693-9; PMID: 14977977; http://dx.doi.org/10.1128/IAI.72.3.1693- 1699.2004 59.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Nat Rev Microbiol 2007; 5:57-69; PMID: 17170747; http://dx.doi.org/10.1038/nrmicro1578 60.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Genes Dev 1997; 11:3206-17; PMID:9389652; http://dx.doi.org/ 10.1101/gad.11.23.3206 61.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Genes Dev 2001; 15:201-12; PMID:11157776; http://dx.doi.org/10.1101/gad.856001 62.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Curr Opin Microbiol 2006; 9:352-8; PMID: 16798065; http://dx.doi.org/10.1016/j.mib.2006.06.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Biol Chem 2004; 279:21144- 53; PMID:15014071; http://dx.doi.org/10.1074/jbc.M312995200 64.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Biol Chem 2005; 280: 36055-64; PMID:16129666; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Biol Chem 2005; 280:28547-55; PMID: 15946943; http://dx.doi.org/10.1074/jbc.M503404200 66.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2006; 74:5977-88; PMID:16988277; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Biochem J 2000; 347:431-9; PMID:10749672; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eukaryot Cell 2007; 6:37-47; PMID:17099081; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
PLoS Pathog 2010; 6:e1000953; PMID:20585559; http://dx.doi.org/10.1371/journal.ppat.1000953 73.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Clin Invest 2010; 120:1683-93;PMID:20424328; http://dx.doi.org/10.1172/JCI41963 76.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Infect Dis 2002; 186:522-30; PMID:12195380; http://dx.doi.org/10.1086/341564 77.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2009; 77:120-7; PMID: 18936186; http://dx.doi.org/10.1128/IAI.01065-08 78.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Am J Pathol 2004; 164:1761-71; PMID: 15111322; http://dx.doi.org/10.1016/S0002-9440 (10)63734-0 79.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Am J Pathol 2005; 166:421-32; PMID:15681826; http://dx.doi.org/10.1016/S0002- 9440(10)62265-1 80.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Med Microbiol 2003; 52:961-70; PMID:14532340; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eukaryot Cell 2009; 8:1803-7; PMID:19767445; http://dx.doi.org/ 10.1128/EC.00240-09 82.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Cell Microbiol 2008; 10:1313-26; PMID:18248627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
CellMicrobiol 2008; 10:1854-65; PMID:18489726; http://dx.doi.org/10.1111/j.1462-5822.2008.01172.x 85.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Trends Microbiol 2001; 9:273-8; PMID:11390242;http://dx.doi.org/10.1016/S0966-842X(01)02035-2 86.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eukaryot Cell 2010; 9:835- 46; PMID:20382758; http://dx.doi.org/10.1128/EC.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2000; 68:4225-37; PMID:10858240; http://dx.doi.org/10.1128/IAI.68.7.4225-4237.2000 88.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2007; 75:4792-8; PMID:17664261; http://dx.doi.org/10.1128/IAI.00587-07 89.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Micro- biology 2006; 152:3-9; PMID:16385110; http://dx.doi.org/10.1099/mic.0.28451-0 90.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
FEMS Yeast Res 2006; 6:480-8; PMID:16696644; http://dx.doi.org/10.1111/j.1567- 1364.2006.00039.x 91.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eukaryot Cell 2011; 10:618- 28; PMID:21398509; http://dx.doi.org/10.1128/EC.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Neurochem 2002; 82:736-54; PMID:12358779;http://dx.doi.org/10.1046/j.1471-4159.2002.01041.x94.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Neuroimage 2011; 54:2079-85; PMID:20951217; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Adv Carbohydr Chem Biochem 1976; 32:125-234; PMID:782183; http://dx.doi.org/10.1016/S0065-2318(08)60337-6 96.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Hum Pathol1996; 27:839-47; PMID:8760020; http://dx.doi.org/ 10.1016/S0046-8177(96)90459-1 98.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2010; 78:4213-25; PMID:20696827; http://dx.doi.org/10.1128/IAI.00551-10 100.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Mol Micro- biol 2011; 80:1088-101; PMID:21453402; http://dx.doi.org/10.1111/j.1365-2958.2011.07632.x 101.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Mol Microbiol 2001; 39:166-75; PMID:11123698; http://dx.doi.org/10.1046/j.1365- 2958.2001.02236.x 102.,OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2003; 71:1538- 47; PMID:12595473; http://dx.doi.org/10.1128/IAI.71.3.1538-1547.2003 103.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Mol Microbiol 2007; 64:614-29; PMID:17462012; http://dx.doi.org/10.1111/j.1365-2958.2007.05676.x 104.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
J Clin Invest 2007; 117:794-802; PMID:17290306; http://dx.doi.org/10.1172/JCI30006 105.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Mycopathologia 1983;82:179-84; PMID:6350885; http://dx.doi.org/10.1007/BF00439224107.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Antimicrob Agents Chemother 2007; 51:3011-3; PMID:17562797; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Neurol India 2007; 55:191-7; PMID:17921647; http://dx.doi.org/10.4103/0028-3886.35679 113.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Mycoses 2004; 47:4-13; PMID:14998393; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Infect Immun 2001; 69:4536-44; PMID:11401997; http://dx.doi.org/10.1128/IAI.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
PLoS Pathog 2011; 7:e1002305; PMID:21998592; http://dx.doi.org/10.1371/journal.ppat.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
Eukaryot Cell 2005; 4:685-93; PMID:15821128; http://dx.doi.org/10.1128/EC.4.4.685-693.2005 119.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
JNeuroinflammation 2008; 5:30; PMID:18606009; http://dx.doi.org/10.1186/1742-2094-5-30 120.,Non-OADS,/arxiv_data1/oa_pdf/5b/f2/viru-3-173.PMC3396696.pdf
"29-34ROP16 is a secreted protein kinase that leads to activation of the transcription factors STAT3*Correspondence to: Oliver Liesenfeld; Email: oliver.liesenfeld@charite.de Submitted: 09/24/11; Revised: 12/03/11; Accepted: 12/11/11 http://dx.doi.org/10.4161/viru.19004Virulence 3:2, 182 –192; March/April 2012; G2012 Landes Bioscience 182 Virulence Volume 3 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Mem Inst Oswaldo Cruz 2009;104:364-9; PMID:19430665; http://dx.doi.org/10.1590/S0074-02762009000200033 3.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Exp Parasitol 2010; 124:10-25; PMID:19324041; http://dx.doi.org/10.1016/j.exppara.2009.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Am Vet Med Assoc 2007; 231:1676-84; PMID:18052801; http://dx.doi.org/10.2460/javma.231.11.1676 5.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Trends Microbiol 2003; 11:426-30; PMID:13678858; http://dx.doi.org/ 10.1016/S0966-842X(03)00205-16.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Blood 2006; 107:309-16; PMID:16051744; http://dx.doi.org/10.1182/blood- 2005-02-0666 7.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Infect Dis 1994; 170:1057- 67; PMID:7963693; http://dx.doi.org/10.1093/infdis/ 170.5.1057 188 Virulence Volume 3 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Br J Ophthalmol 1996; 80:1099-107; PMID:9059278; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Clin InfectDis 2008; 47:554-66; PMID:18624630; http://dx.doi.org/10.1086/590149 10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Schizophr Bull 2007; 33:745-51; PMID:17322557; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Lancet 2004; 363:1965-76; PMID:15194258; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Microbes Infect 2007; 9:1291-8; PMID:17897859; http://dx.doi.org/10.1016/j.micinf.2007.06.003 14.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Schizophr Bull 2007; 33:757-60; PMID:17218612;http://dx.doi.org/10.1093/schbul/sbl074 16.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Forensic Sci Int 2009; 187:103-8; PMID:19356869; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
BMC Psychiatry 2004; 4:1; PMID:15018628; http://dx.doi.org/10.1186/1471- 244X-4-1 18.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Am J Med 2005; 118:212-6; PMID:15745715; http://dx.doi.org/10.1016/j.amjmed.2004.08.023 20.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
N Engl J Med 1993; 329:995-1000;PMID:8366923; http://dx.doi.org/10.1056/ NEJM199309303291403 22.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Proc Natl Acad Sci USA 2006;103:11423-8; PMID:16849431; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Infect Dis 1995; 172:1561-6; PMID:7594717; http://dx.doi.org/10.1093/infdis/172.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Microbiol 2008; 6:79-88; PMID:18059289; http://dx.doi.org/ 10.1038/nrmicro1800 30.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Curr Opin Microbiol 2007; 10:582- 7; PMID:17997128; http://dx.doi.org/10.1016/j.mib.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
PLoS Biol 2010; 8:e1000576; PMID:21203588; http://dx.doi.org/10.1371/journal.pbio.1000576 32.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Science 2006; 314:1780-3; PMID:17170306; http://dx.doi.org/10.1126/science.1133690 33.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Exp Med 2009; 206:2747-60; PMID:19901082; http://dx.doi.org/10.1084/jem.20091703 37.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
EMBO J 2008; 27:2495-509; PMID:18772884; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
PLoS Pathog 2005; 1:e24;PMID:16304607; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Exp Med 2011; 208:1533-46; PMID:21670204; http://dx.doi.org/10.1084/jem.20101660 42.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Neurosci 2006; 7:41-53; PMID:16371949; http://dx.doi.org/10.1038/nrn1824 43.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Neurobiol Dis 2010; 37:13-25; PMID:19664713; http://dx.doi.org/10.1016/j.nbd.2009.07.030 45.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Mol Neurobiol 2005; 25:59-127; PMID:15962509; http://dx.doi.org/10.1007/s10571-004-1377-8 47.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Mol Neurobiol 2005; 25:25-39; PMID: 15962507; http://dx.doi.org/10.1007/s10571-004-1375-x 48.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Acta Neurochir Suppl 2003; 86:565-8; PMID:14753507; http://dx.doi.org/10.1007/978-3-7091-0651-8_115 49.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Neurochem Int 2009; 54:253-63; PMID:19111869; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Biochem Biophys Res Commun 1998; 244:312-6; PMID:9514852; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Neuroimmunol 1996; 64:37-43; PMID:8598388; http://dx.doi.org/10.1016/0165- 5728(95)00148-4 53.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Mol Cell Biol 2004; 5:261-70; PMID:15071551; http://dx.doi.org/10.1038/nrm1357 54.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Histochem Cell Biol 2008;130:55-70; PMID:18415116; http://dx.doi.org/10.1007/s00418-008-0424-9 55.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Immunol 2007;7:678-89; PMID:17717539; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Lab Invest 2002; 82:521- 33; PMID:12003992; http://dx.doi.org/10.1038/ labinvest.3780446 59.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Antioxid Redox Signal 2009; 11:823-39; PMID: 18808323; http://dx.doi.org/10.1089/ars.2008.2204 60.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Leukoc Biol2009; 86:1119-24; PMID:19703898; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Immunol 2005; 5:546-59; PMID:15965491; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Immunity 2007; 26:784-97; PMID:17570692; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Trends Immunol 2007; 28:12-8; PMID:17129764; http://dx.doi.org/10.1016/j.it.2006.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cytometry A 2006; 69:147-51; PMID:16479603; http://dx.doi.org/10.1002/cyto.a.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Basic principles of immunological surveillance of the normal central nervous system.Glia 2001; 36:118-24; PMID:11596120; http://dx.doi.org/10.1002/glia.1101 67.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Central nervous system infections in individuals with HIV-1 infection.J Neurovirol 2002; 8:158-67; PMID:12053271; http://dx.doi.org/10.1080/1355028029004972368.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
AIDS 1990; 4:519-21; PMID:2386617; http://dx.doi.org/10.1097/00002030- 199006000-00004 69.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Ann Trop Med Parasitol2001; 95:587-93; PMID:11672464; http://dx.doi.org/ 10.1080/00034980120073931 70.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Immunol Rev 2011; 240:269-85; PMID:21349099; http://dx.doi.org/10.1111/j.1600-065X.2010.00992.x 75.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
JNeuroimmunol 1991; 31:185-98; PMID:1995650; http://dx.doi.org/10.1016/0165-5728(91)90040-E 77.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Infect Dis 2002; 185(Suppl 1): S58-65; PMID:11865441; http://dx.doi.org/10.1086/ 337999 79.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Immunity 2009; 30:300-11; PMID:19167248; http://dx.doi.org/ 10.1016/j.immuni.2008.12.013 80.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Neuropathol Exp Neurol 1994; 53:457-68; PMID:7521903; http://dx.doi.org/10.1097/00005072-199409000-00005 81.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Eur J Immunol 2003; 33:1418-28; PMID:12731069; http://dx.doi.org/10.1002/eji.20032282682.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Immunol 2005; 5:162-70; PMID:15662369; http://dx.doi.org/10.1038/nri1547 83.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Neuroimmunol2005; 165:63-74; PMID:16005735; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
PLoS Pathog 2011; 7: e1002246; PMID:21949652; http://dx.doi.org/10.1371/journal.ppat.1002246 86.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Neuropathol Exp Neurol 1996; 55:1150-6; PMID:8939198; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Infect Dis 1995; 171:516-8; PMID:7844409; http://dx.doi.org/10.1093/infdis/171.2.516 88.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2008; 76:4883-94; PMID:18765738; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
PLoS ONE 2011; 6:e20568; PMID:21698150; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Exp Med 1997; 185:1261-73; PMID:9104813; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Acta Neuropathol 2002; 103:458- 68; PMID:11935261; http://dx.doi.org/10.1007/ s00401-001-0491-7 190 Virulence Volume 3 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Acta Neuropathol 2006; 111:548-58;PMID:16718351; http://dx.doi.org/10.1007/s00401- 006-0062-z 98.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Int J Parasitol 2009; 39:23-39; PMID:18775432; http://dx.doi.org/10.1016/j.ijpara.2008.08.002 99.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Microbiol 2008; 6:625-34; PMID:18604221; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Rev Neurosci 2011; 12:345-57; PMID:21587289; http://dx.doi.org/10.1038/nrn3029 101.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Parasitol 2004; 90:970-9; PMID:15562595; http://dx.doi.org/10.1645/GE-287R 102.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2005; 73:1014-22; PMID:15664945; http://dx.doi.org/10.1128/IAI.73.2.1014-1022.2005 103.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2004; 72:4985- 95; PMID:15321990; http://dx.doi.org/10.1128/IAI.72.9.4985-4995.2004 104.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2001; 69:4536-44; PMID:11401997; http://dx.doi.org/10.1128/IAI.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Infect Dis 2002; 186(Suppl 2): S220-4; PMID:12424701; http://dx.doi.org/10.1086/ 344284 106.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Clin Invest 1998; 102:347-60; PMID:9664076; http://dx.doi.org/ 10.1172/JCI2406 107.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Virology 2009; 385:425-33; PMID:19135695;http://dx.doi.org/10.1016/j.virol.2008.11.047 108.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Int J Med Microbiol 2006; 296:553-8; PMID:17010667; http://dx.doi.org/10.1016/j.ijmm.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Microbiol 2003; 5:75-83; PMID:12580944;http://dx.doi.org/10.1046/j.1462-5822.2003.00258.x 112.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nat Immunol 2002; 3:1041-7;PMID:12407413; http://dx.doi.org/10.1038/ni1102-1041 113.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun2001; 69:1344-50; PMID:11179297; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2009; 77:970-6; PMID:19139191; http://dx.doi.org/10.1128/ IAI.00833-08 115.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
FEMS Immunol Med Microbiol 2008; 53:151-65; PMID:18462388; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Microbiol 2005; 7:167-80; PMID:15659061; http://dx.doi.org/10.1111/j.1462-5822.2004.00444.x 119.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Mol Neurobiol 2005; 25:181-99; PMID:15962513; http://dx.doi.org/10.1007/s10571-004-1383-x 121.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Microbiol 2010; 12:292-300; PMID:19995386; http://dx.doi.org/10.1111/j.1462-5822.2009.01417.x 122.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2005; 73:8060-8; PMID:16299300; http://dx.doi.org/10.1128/IAI.73.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Exp Med 2002; 195:1625-33; PMID: 12070289; http://dx.doi.org/10.1084/jem.20020258 125.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Curr Opin Cell Biol 2004; 16:32-40;PMID:15037302; http://dx.doi.org/10.1016/j.ceb.2003.11.013 126.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Mol Biol Cell 2003;14:396-406; PMID:12589042; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Microbiol 1999; 1:225-35;PMID:11207555; http://dx.doi.org/10.1046/j.1462- 5822.1999.00023.x 129.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Curr Opin Microbiol 2004; 7:388-96; PMID:15358257; http://dx.doi.org/10.1016/j.mib.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Microbiol 2005; 7:561-8; PMID:15760456; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Neuroimmunol 2011; 232:119-30; PMID:21106256; http://dx.doi.org/10.1016/j.jneuroim.2010.10.029 132.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Biochem Biophys Res Commun 2010; 391:477-80; PMID:19914206; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2000; 68:407-10; PMID:10603418; http://dx.doi.org/10.1128/IAI.68.1.407-410.2000 135.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Leukoc Biol 2003; 74:1015-25; PMID: 12972511; http://dx.doi.org/10.1189/jlb.0403164 137.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Microbiol 2006; 8:1611-23; PMID:16984416; http://dx.doi.org/10.1111/j.1462-5822.2006.00735.x 138.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Microbes Infect 2011; 13:96-102;PMID:20951223; http://dx.doi.org/10.1016/j.micinf.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Infect Immun 2009; 77:1679-88; PMID:19204091; http://dx.doi.org/10.1128/IAI.01289-08 140.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Microbiol 2005; 7:837-48; PMID:15888086; http://dx.doi.org/10.1111/ j.1462-5822.2005.00517.x 141.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Parasitol Int 2008; 57:515-8; PMID: 18652914; http://dx.doi.org/10.1016/j.parint.2008.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Science 2002; 298:837-40; PMID:12399593; http://dx.doi.org/10.1126/science.1074553 144.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Mol Biol Cell 2005; 16:4341-9; PMID:16000372; http://dx.doi.org/10.1091/mbc.E05-04-0281145.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
PLoS Pathog 2006; 2:e84; PMID:16933991; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Nature 2010; 465:359-62; PMID:20485436; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
PLoS Pathog2010; 6:e1001029; PMID:20686666; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Rab11A-controlled assembly of the inner membrane complex is required for completion of apicomplexan cytokinesis.PLoS Pathog 2009; 5:e1000270; PMID:19165333; http://dx.doi.org/10.1371/journal.ppat.1000270 150.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Curr Biol 2009; 19:277-86; PMID:19217293; http://dx.doi.org/10.1016/j.cub.2009.01.039151.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
Cell Host Microbe 2008; 3:77-87; PMID:18312842; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
PLoS Pathog 2009; 5:e1000505; PMID:19578440;http://dx.doi.org/10.1371/journal.ppat.1000505 153.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
J Immunol 2009; 182:6379-93; PMID:19414791; http://dx.doi.org/10.4049/jimmunol.0804307 154.,Non-OADS,/arxiv_data1/oa_pdf/f7/9b/viru-3-182.PMC3396697.pdf
"15Geographical differences in clinical patterns and prevalence of the syndrome are recognized and are likely due*Correspondence to: Laurent Rénia; Email: laurentrenia@gmail.com Submitted: 09/05/11; Revised: 12/09/11; Accepted: 12/12/11 http://dx.doi.org/10.4161/viru.19013SPECIAL FOCUS REVIEW: BLOOD-BRAIN BARRIER Virulence 3:2, 193 –201; March/April 2012; G2012 Landes Bioscience www.landesbioscience.com Virulence 193",Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Clin Invest 2008; 118: 1266-76; PMID:18382739; http://dx.doi.org/10.1172/JCI33996 2.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Curr Opin Microbiol 2005; 8:407-14; PMID:16019254; http://dx.doi.org/10.1016/j.mib.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Lancet 1990; 335:472; PMID:1968190; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Lancet Neurol 2005; 4:827-40; PMID:16297841; http://dx.doi.org/10.1016/S1474-4422(05)70247-7 www.landesbioscience.com Virulence 197,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
QJM 1999; 92:151-7; PMID:10326074; http://dx.doi.org/10.1093/ qjmed/92.3.151 11.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
N Engl J Med 1995; 332:1399-404; PMID:7723795; http://dx.doi.org/10.1056/NEJM199505253322102 12.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Microbes Infect 2008; 10:948-52; PMID:18672089; http://dx.doi.org/10.1016/j.micinf.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Lancet 1990; 336:950-1; PMID:1976969; http://dx.doi.org/10.1016/0140-6736(90) 92329-G 14.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Pharmacol Ther 1998; 79: 1-53; PMID:9719344; http://dx.doi.org/10.1016/S0163- 7258(98)00008-4 17.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Lancet 1990;336:1039-43; PMID:1977027; http://dx.doi.org/10.1016/0140-6736(90)92498-7 18.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Nat Med 2004; 10:143-5; PMID:14745442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Parasitol Today 1994; 10:412-4; PMID:15275553; http://dx.doi.org/ 10.1016/0169-4758(94)90238-0 30.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Infect Dis 2003; 187:461-6; PMID:12552430; http://dx.doi.org/10.1086/367960 31.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Am J Pathol 1999; 155:395-410;PMID:10433933; http://dx.doi.org/10.1016/S0002- 9440(10)65136-X 33.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
N Engl J Med 1989; 320:1586-91; PMID:2657427;http://dx.doi.org/10.1056/NEJM198906153202404 35.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Lancet 1990; 336: 1201-4; PMID:1978068; http://dx.doi.org/10.1016/ 0140-6736(90)92827-5 36.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Infect Immun 2004; 72:5630-7; PMID:15385460; http://dx.doi.org/10.1128/IAI.72.10.5630-5637.2004 37.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Semin Immunol 2006; 18:411-22;PMID:17023176; http://dx.doi.org/10.1016/j.smim.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Trends Parasitol 2010; 26: 271-2; PMID:20335068; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Malar J 2011; 10:23; PMID:21288352; http://dx.doi.org/10.1186/ 1475-2875-10-23 40.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Trends Parasitol 2010; 26:275-7; PMID:20363672; http://dx.doi.org/10.1016/j.pt.2010.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Trends Parasitol 2010; 26:277-8; PMID:20338809; http://dx.doi.org/10.1016/ j.pt.2010.03.002 42.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Trends Parasitol 2010; 26:274-5; PMID:20382077; http://dx.doi.org/10.1016/j.pt.2010.03.008 43.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Trends Parasitol 2010; 26:11-5; PMID:19932638; http://dx.doi.org/10.1016/j.pt.2009.10.007 44.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Science 2005; 307:82-6; PMID:15637271; http://dx.doi.org/10.1126/science.1103717 45.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Parasitol Today 1998; 14:245-9; PMID: 17040769; http://dx.doi.org/10.1016/S0169-4758 (98)01248-4 46.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
"Infect Immun 2011; 79:3633-41; PMID: 21708993; http://dx.doi.org/10.1128/IAI.05459-11 50. del Portillo HA, Fernandez-Becerra C, Bowman S, Oliver K, Preuss M, Sanchez CP, et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Nature 2001; 410:839-42; PMID: 11298455; http://dx.doi.org/10.1038/35071118 51.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Nature 1992; 357:689-92; PMID:1614515; http://dx.doi.org/10.1038/357689a0 52.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Infect Immun 2000; 68:5364-76; PMID:10948166; http://dx.doi.org/10.1128/IAI.68.9.5364-5376.2000 53.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Mol Biochem Parasitol 1996; 77:127-35; PMID:8813659; http://dx.doi.org/10.1016/ 0166-6851(96)02584-4 198 Virulence Volume 3 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Immunol 2010; 185:3632-42; PMID:20720206; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
PLoS ONE 2011; 6:e18720; PMID:21494565; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Infect Immun 2010; 78:4033-9; PMID:20605973; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Immunol2011; 186:6148-56; PMID:21525386; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Int J Parasitol 2011;41:155-63; PMID:20828575; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Blood 2003; 101:4253-9; PMID:12560237; http://dx.doi.org/10.1182/blood-2002-05-1493 62.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Infect Immun 2003; 71:3648-51; PMID: 12761155; http://dx.doi.org/10.1128/IAI.71.6.3648- 3651.2003 63.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Parasite Immunol 2008; 30:544-53; PMID:18665903; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Blood 2005; 105:1956-63; PMID:15494426; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Clin Exp Immunol 2000; 120:125-33; PMID:10759773; http://dx.doi.org/10.1046/j.1365- 2249.2000.01196.x 66.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Parasitol Int 2001;50:139-43; PMID:11438437; http://dx.doi.org/10.1016/S1383-5769(01)00063-0 67.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
"Boubou MI, Collette A, Voegtle D, Mazier D, Cazenave PA, Pied S. T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR Vbeta8 during experimental cerebral malaria.Int Immunol 1999; 11:1553-62; PMID:10464176; http://dx.doi.org/10.1093/intimm/11.9.1553 74.",OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Int J Parasitol 2006; 36:547-54; PMID: 16600241; http://dx.doi.org/10.1016/j.ijpara.2006.02.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
PLoS Pathog 2010; 6:e1001021; PMID:20686652; http://dx.doi.org/10.1371/journal.ppat.1001021 76.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Brain Res Rev 2010; 64:328-63; PMID:20685221; http://dx.doi.org/10.1016/ j.brainresrev.2010.05.003 77.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Endocrinology 2011; 152:2552-7; PMID: 21521751; http://dx.doi.org/10.1210/en.2011-0194 79.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Neurovirol 1999; 5:570-8; PMID:10602398; http://dx.doi.org/10.3109/13550289909021286 80.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Adv Parasitol 1972; 10:49-75; PMID: 4626184; http://dx.doi.org/10.1016/S0065-308X(08) 60172-4 81.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Trends Parasitol 2002; 18:360-6; PMID:12377286; http://dx.doi.org/10.1016/S1471-4922(02)02353-X 82.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Int J Parasitol 2006; 36:555-68; PMID:16616145; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Prog Neurobiol 2010; 91:140-51; PMID: 20117166; http://dx.doi.org/10.1016/j.pneurobio.2010.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
PLoS Pathog 2009; 5:e1000349; PMID:19300493; http://dx.doi.org/10.1371/journal.ppat.1000349 91.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Neuropathol Appl Neurobiol 1999; 25:331-40; PMID:10476050;http://dx.doi.org/10.1046/j.1365-2990.1999.00188.x 92.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Arch DisChild 1994; 70:281-7; PMID:8185359; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Radiology 2002; 224:811-6;PMID:12202719; http://dx.doi.org/10.1148/radiol.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Biochem Biophys Res Commun 1989; 162:1431-7; PMID:2788411; http://dx.doi.org/10.1016/0006-291X (89)90834-6 97.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Life Sci1999; 64:1941-53; PMID:10353592; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Biochem Biophys Res Commun 1997; 239:804-9; PMID:9367850; http://dx.doi.org/10.1006/bbrc.1997.7557 100.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Lancet 1993; 341:632-3; PMID:7679766; http://dx.doi.org/10.1016/0140-6736(93)90393-U 101.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Ann N Y Acad Sci 2003; 1010:582-6; PMID:15033796;http://dx.doi.org/10.1196/annals.1299.109 102.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Lancet 2003; 361:676-8; PMID:12606182; http://dx.doi.org/10.1016/ S0140-6736(03)12564-0 104.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Malar J 2003; 2:6; PMID:12716455; http://dx.doi.org/10.1186/1475-2875-2-6 106.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Histopathology 2000;37:269-77; PMID:10971704; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Biochem Biophys Res Commun 2005; 335:810-8; PMID:16105659; http://dx.doi.org/ 10.1016/j.bbrc.2005.07.151110.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Infect Dis 1999; 180:1742-6; PMID:10515846; http://dx.doi.org/10.1086/315078 111.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Infect Immun 2006; 74:3262- 70; PMID:16714553; http://dx.doi.org/10.1128/IAI.01625-05 112.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Blood 2009; 114: 4243-52; PMID:19713460; http://dx.doi.org/10.1182/ blood-2009-06-226415 113.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Cell 1995; 82:77-87; PMID:7541722; http://dx.doi.org/10.1016/0092-8674(95)90054-3 116.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Cell 1995; 82:89-100; PMID:7606788; http://dx.doi.org/10.1016/0092-8674(95)90055-1 117.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Cell 1995; 82:101-10; PMID:7606775; http://dx.doi.org/10.1016/0092-8674(95)90056-X 118.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Annu Rev Med 1994; 45:283-95; PMID:8198384; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Nat Rev Immunol 2005; 5:722-35; PMID:16138104; http://dx.doi.org/10.1038/nri1686 120.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
PLoS Pathog 2007; 3:1271-80; PMID:17907801; http://dx.doi.org/ 10.1371/journal.ppat.0030130 121.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Neurochem 2007; 103: 793-801; PMID:17662049; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Infect Dis 2003; 187:1283-90; PMID: 12696008; http://dx.doi.org/10.1086/373992 125.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Cell Microbiol 2011; 13:198-209; PMID:21029292; http://dx.doi.org/10.1111/j.1462-5822.2010.01528.x 127.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Infect Dis 2007; 196:1603-12; PMID:18008243; http://dx.doi.org/10.1086/522012 128.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
"Differential cellular accumulation of transforming growth factor-beta1, -beta2, and -beta3 in brains of patients who died with cerebral malaria.J Infect Dis 2000; 181:2111-5; PMID:10837206; http://dx.doi.org/10.1086/315493 131.",Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Microcirculation 2004; 11:559-76; PMID:15513866; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
"Glia 1997; 19:135-51; PMID: 9034830; http://dx.doi.org/10.1002/(SICI)1098-1136(199702)19:2 ,135::AID-GLIA5 .3.0.CO;2-# 135.",Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Parasitology 1988; 96:579-89; PMID:2457201;http://dx.doi.org/10.1017/S0031182000080203 200 Virulence Volume 3 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Infect Immun 2001; 69:3460-5; PMID:11292776; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Parasitology 1993; 107:477-87; PMID:8295787; http://dx.doi.org/10.1017/ S0031182000068050 138.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
"Glia 1997; 19:91-103; PMID: 9034826; http://dx.doi.org/10.1002/(SICI)1098- 1136(199702)19:2 ,91::AID-GLIA1 .3.0.CO;2-C 140.",Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Neurosci 2005; 25:7352-8; PMID: 16093385; http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Biol Chem 2007; 282:14505-14; PMID:17369263; http://dx.doi.org/ 10.1074/jbc.M608035200 142.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
J Infect Dis 2011; 203: 1454-63; PMID:21415018; http://dx.doi.org/10.1093/ infdis/jir058 148.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Nat Med 2006; 12:1417-22;PMID:17099710; http://dx.doi.org/10.1038/nm1499 149.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
Int J Parasitol 2006; 36:485-96; PMID: 16500656; http://dx.doi.org/10.1016/j.ijpara.2005.12.,OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
PLoS ONE 2008; 3:e3037;PMID:18725947; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7e/84/viru-3-193.PMC3396698.pdf
"The cerebral endothelial cells have low levels *Correspondence to: Krister Kristensson; Email: krister.kristensson@ki.se Submitted: 11/01/11; Revised: 12/23/11; Accepted: 12/23/11 http://dx.doi.org/10.4161/viru.19178Virulence 3:2, 202 –212; March/April 2012; G2012 Landes Bioscience 202 Virulence Volume 3 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Annu Rev Immunol 2009; 27:451-83; PMID:19105661; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
FEMS Immunol Med Microbiol 2011; 63:297-318;PMID:22092557; http://dx.doi.org/10.1111/j.1574- 695X.2011.00867.x 3.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Nat Rev Microbiol 2008; 6:625-34; PMID:18604221; http://dx.doi.org/10.1038/nrmicro1952 4.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Nat Rev Neurosci 2011; 12:345-57; PMID:21587289; http://dx.doi.org/10.1038/nrn3029 5.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Lancet 2004; 363:1965-76; PMID:15194258; http://dx.doi.org/10.1016/S0140-6736(04)16412-X 6.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging.Microbes Infect 2007; 9:1291-8; PMID:17897859; http://dx.doi.org/10.1016/j.micinf.2007.06.003 7.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Nat Rev Neurosci 2006; 7:41-53; PMID:16371949; http://dx.doi.org/10.1038/nrn18248.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Neurobiol Dis 2010; 37:13-25; PMID: 19664713; http://dx.doi.org/10.1016/j.nbd.2009.07.030 10.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Nature 2010; 468:557-61; PMID: 20944627; http://dx.doi.org/10.1038/nature09522 11.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Nat Rev Immunol 2010; 10:712-23; PMID:20865019; http://dx.doi.org/10.1038/nri2852 12.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Semin Immunopathol 2009; 31:497-511; PMID:19779720; http://dx.doi.org/10.1007/s00281- 009-0177-0 13.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J NeuropatholExp Neurol 2008; 67:1113-21; PMID:19018243;http://dx.doi.org/10.1097/NEN.0b013e31818f9ca815.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Exp Neurol 1993; 120: 245-63; PMID:8491281; http://dx.doi.org/10.1006/ exnr.1993.1059 16.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Subcell Biochem 2008; 47:121-39; PMID:18512347; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Biochimie 2008; 90:345-58; PMID:17936488; http://dx.doi.org/10.1016/j.biochi.2007.08.013 18.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Biol Chem 2010; 285: 18516-27; PMID:20378535; http://dx.doi.org/10.1074/ jbc.M109.086181 19.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Schistosome invasion of human skin and degradation ofdermal elastin are mediated by a single serine protease.J Biol Chem 2000; 275:38667-73; PMID:10993899; http://dx.doi.org/10.1074/jbc.M006997200 20.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Exp Med 2002; 195:1625-33; PMID: 12070289; http://dx.doi.org/10.1084/jem.20020258 www.landesbioscience.com Virulence 209,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Cell Microbiol 2005; 7:561-8; PMID:15760456; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Infect Immun 2001; 69:6527-31; PMID:11553600; http://dx.doi.org/10.1128/IAI.69.10.6527-6531.2001 24.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Neuroimmunol2011; 232:119-30; PMID:21106256; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Vet Immunol Immunopathol 2006; 112: 272-83; PMID:16730378; http://dx.doi.org/10.1016/ j.vetimm.2006.03.017 26.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Parasitol Int 2008; 57:515-8; PMID:18652914;http://dx.doi.org/10.1016/j.parint.2008.06.004 27.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Biol Chem 2000; 275:8863-71; PMID:10722732;http://dx.doi.org/10.1074/jbc.275.12.8863 28.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Trends Parasitol2002; 18:17-9; PMID:11850009; http://dx.doi.org/10.1016/S1471-4922(01)02120-1 29.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
"J Parasitol 2004; 90:970-9; PMID:15562595; http://dx.doi.org/10.1645/GE-287R 30. de Sousa KP, Atouguia J, Silva MS.",Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
PLoS Negl Trop Dis 2008; 2:e298; PMID:18820745; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Int J Parasitol 2006; 36:513-9; PMID:16620822; http://dx.doi.org/10.1016/j.ijpara.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
PLoS Negl Trop Dis 2009; 3:e479; PMID:19621073; http://dx.doi.org/10.1371/journal.pntd.000047935.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Cell Microbiol 2011; 13:1470-8; PMID: 21824246; http://dx.doi.org/10.1111/j.1462-5822.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Infect Immun 2009; 77:3686-95; PMID:19564392; http://dx.doi.org/10.1128/ IAI.00361-09 37.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Clin Vaccine Immunol 2010; 17:1322-9; PMID: 20660134; http://dx.doi.org/10.1128/CVI.00128-10 38.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Infect Immun 2011; 79: 3046-52; PMID:21628522; http://dx.doi.org/10.1128/ IAI.01042-10 39.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Cell Microbiol 2006; 8:1611-23; PMID:16984416; http://dx.doi.org/10.1111/j.1462-5822.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Microbes Infect 2011; 13:96-102; PMID:20951223; http://dx.doi.org/10.1016/j.micinf.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Blood 2006; 107:309-16; PMID:16051744; http://dx.doi.org/10.1182/blood- 2005-02-0666 42.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Eur J Immunol 2003; 33:1418-28; PMID:12731069;http://dx.doi.org/10.1002/eji.200322826 44.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Virol 2009; 83:20-8; PMID:18787010; http://dx.doi.org/10.1128/JVI.00682-08 45.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
"J Comp Neurol 1999; 414:114-30; PMID:10494082; http://dx.doi.org/10.1002/(SICI)1096-9861(19991108)414:1,114::AID-CNE9 .3.0.CO;2-G 46.",OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Neurosci Res 1988; 21:56-61; PMID:3216412; http://dx.doi.org/10.1002/jnr.490210109 47.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Acta Trop 2011; 119:14-8; PMID:21420376; http://dx.doi.org/10.1016/j.actatropica.2011.02.013 49.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Virulence 2012; 3:172-82; PMID:22460645; http://dx.doi.org/viru.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Acta Neuropathol 2002; 103:458-68; PMID:11935261; http://dx.doi.org/10.1007/ s00401-001-0491-7 54.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Exp Parasitol 2010; 126:167-77; PMID:20434443; http://dx.doi.org/10.1016/j.exppara.2010.04.019 55.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Interferon Cytokine Res 2007; 27:329-38; PMID:17477820; http://dx.doi.org/10.1089/jir.2006.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Scand J Immunol 2008; 68:484-91; PMID:18822108; http://dx.doi.org/10.1111/j.1365-3083.2008.02170.x 57.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Infect Dis 2012;205:320-32; PMID:22116836; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Cell1989; 59:1203-11; PMID:2688898; http://dx.doi.org/ 10.1016/0092-8674(89)90775-7 210 Virulence Volume 3 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Science 1989; 243:1160-5; PMID:2466335; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Am J Physiol Cell Physiol 2007; 293:C855-64; PMID:17507431; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Physiol Behav 2007; 92:110-4; PMID: 17582444; http://dx.doi.org/10.1016/j.physbeh.2007.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Infect Dis 2009;200:1556-65; PMID:19827943; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Prog Neurobiol 2010; 91:152-71; PMID: 19995590; http://dx.doi.org/10.1016/j.pneurobio.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Infect Dis 2007; 196:1620-8; PMID:18008245; http://dx.doi.org/10.1086/522011 66.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Identification ofstage biomarkers for human African trypanosomiasis.Am J Trop Med Hyg 2010; 82:983-90; PMID: 20519589; http://dx.doi.org/10.4269/ajtmh.2010.09- 0770 67.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
PLoS Negl Trop Dis 2009; 3:e459; PMID:19554086; http://dx.doi.org/10.1371/ journal.pntd.0000459 68.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
TropMed Int Health 2011; 16:119-26; PMID:20958893; http://dx.doi.org/10.1111/j.1365-3156.2010.02642.x 69.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Annu Rev Immunol 1989; 7:145-73; PMID:2523712; http://dx.doi.org/ 10.1146/annurev.iy.07.040189.001045 70.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Cell 1994; 76:241-51; PMID:7904900; http://dx.doi.org/10.1016/0092-8674(94)90332-8 71.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Nat Rev Immunol 2002; 2:499-511;PMID:12094224; http://dx.doi.org/10.1038/nri843 72.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Brain Res Bull 1997; 44:579-89; PMID: 9365801; http://dx.doi.org/10.1016/S0361-9230(97) 00309-273.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Microbes Infect 2002; 4:999-1006; PMID:12106794; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Res Immunol 1993; 144: 370-6; PMID:8278660; http://dx.doi.org/10.1016/S0923-2494(93)80082-A 76.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Brain Res 1995; 703:151-5; PMID:8719627; http://dx.doi.org/10.1016/0006-8993(95)01089-0 78.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Brain Res Mol Brain Res 1999; 69:135-43; PMID:10350645; http://dx.doi.org/10.1016/S0169-328X(99)00007-8 80.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Future Microbiol 2009; 4:1363-79; PMID:19995194; http://dx.doi.org/10.2217/fmb.09.89 81.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Int J Parasitol 2009; 39:895-901; PMID:19217908; http://dx.doi.org/10.1016/j.ijpara.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Expert Rev Mol Med 2011; 13:e31; PMID:22005272; http://dx.doi.org/10.1017/S1462399411002018 83.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Eur J Immunol 2010; 40:426-36; PMID: 19950183; http://dx.doi.org/10.1002/eji.200939705 86.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Trans R Soc Trop Med Hyg 2009; 103:973-8; PMID:19457529; http://dx.doi.org/10.1016/j.trstmh.2009.04.012 87.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Prog Neurobiol 2010; 91:140-51; PMID:20117166; http://dx.doi.org/10.1016/j.pneurobio.2010.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Int J Parasitol 2006; 36:569-82; PMID:16678181; http://dx.doi.org/10.1016/j.ijpara.2006.02.016 91.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Int J Parasitol 2006; 36:555- 68; PMID:16616145; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
"A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction.Trends Parasitol 2006; 22:503-8; PMID:16979941; http://dx.doi.org/10.1016/j.pt.2006.09.002 94.",Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Trends Parasitol 2011; 27:185-9; PMID: 21507718; http://dx.doi.org/10.1016/j.pt.2011.01.005 95.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Clin Microbiol Rev 2008; 21:435-48; PMID:18625680; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Med Microbiol 2004; 53:1007-12; PMID:15358823; http://dx.doi.org/10.1099/jmm.0.45721-0 97.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
FEMS Immunol Med Microbiol 2006; 47:83-91; PMID: 16706791; http://dx.doi.org/10.1111/j.1574-695X.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Microb Pathog 2008; 44:89-97; PMID:17913450; http://dx.doi.org/10.1016/j.micpath.2007.06.008 99.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Parasitology 2007; 134:51-8; PMID:17032481; http://dx.doi.org/10.1017/ S0031182006001272 101.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Parasite Immunol 2008; 30:525-34; PMID:18627507; http://dx.doi.org/ 10.1111/j.1365-3024.2008.01048.x www.landesbioscience.com Virulence 211,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Prog Neurobiol 2010; 91:172-84; PMID:20035822; http://dx.doi.org/10.1016/j.pneurobio.2009.12.008 103.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Neuroimmunol 2009; 206:118-20; PMID: 18947884; http://dx.doi.org/10.1016/j.jneuroim.2008.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Neuroimmunol 2006; 173:45-55; PMID: 16406118; http://dx.doi.org/10.1016/j.jneuroim.2005.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Vet Parasitol 2009; 160: 242-50; PMID:19117683; http://dx.doi.org/10.1016/j.vetpar.2008.11.015 106.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Microbes Infect 2010;12:881-8; PMID:20542135; http://dx.doi.org/10.1016/j.micinf.2010.06.001 107.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Lancet Neurol 2011;10:853-64; PMID:21849166; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Brain Pathol 1997; 7:649-62; PMID:9034571; http://dx.doi.org/10.1111/ j.1750-3639.1997.tb01080.x 110.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Travel Med Infect Dis2010; 8:201-6; PMID:20970721; http://dx.doi.org/ 10.1016/j.tmaid.2010.06.001 111.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Eukaryot Microbiol 2001; 48:713-7; PMID: 11831780; http://dx.doi.org/10.1111/j.1550-7408.2001.tb00211.x 112.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Brain Pathol 1997; 7:583- 98; PMID:9034567; http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Eukaryot Microbiol 2007; 54: 411-7; PMID:17910685; http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Pediatr Res 2010; 68:267-74; PMID:20606600; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Microbes Infect 2010;12:528-37; PMID:20348009; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Int J Parasitol 1979; 9:381-4; PMID:489242; http://dx.doi.org/10.1016/0020-7519(79)90089-4 120.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Trans R Soc Trop Med Hyg 1985; 79:527-31; PMID:4082265; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
PLoS One 2011; 6:e16414; PMID:21305024; http://dx.doi.org/10.1371/journal.pone.,OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Hum Vaccin 2010; 6:84-9; PMID: 19823032; http://dx.doi.org/10.4161/hv.6.1.9602 124.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Vaccine 2009; 27:2489- 98; PMID:19368791; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Hum Mol Genet 1997; 6:1357-60; PMID:9259284; http://dx.doi.org/10.1093/hmg/6.8.1357126.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Clin Invest 1997; 100:2521-9; PMID:9366566; http://dx.doi.org/10.1172/JCI119794 127.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Ann Trop Med Parasitol 1997; 91:551-7; PMID:9329992; http://dx.doi.org/10.1080/00034989760923 128.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
PLoS Pathog 2009; 5:e1000386; PMID:19381252; http://dx.doi.org/10.1371/journal.ppat.1000386 129.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Microb Pathog 2003; 35:235-41; PMID:14580387; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
J Med Microbiol 2007; 56:30-5; PMID:17172513;http://dx.doi.org/10.1099/jmm.0.46847-0 133.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
Lett Appl Microbiol 2008; 47:348-54; PMID: 18761612; http://dx.doi.org/10.1111/j.1472-765X.,Non-OADS,/arxiv_data1/oa_pdf/2f/53/viru-3-202.PMC3396699.pdf
"*Correspondence to: Marc Lecuit; Email: marc.lecuit@pasteur.fr Submitted: 12/15/11; Revised: 02/01/12; Accepted: 02/03/12 http://dx.doi.org/10.4161/viru.19586REVIEW Virulence 3:2, 213 –221; March/April 2012; G2012 Landes Bioscience www.landesbioscience.com Virulence 213",Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
"Lancet 2003; 361:2139-48; PMID: 12826449; http://dx.doi.org/10.1016/S0140-6736(03) 13693-8 2. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF.",OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
N Engl J Med 2006; 354:44-53; PMID:16394301; http://dx.doi.org/10.1056/NEJMra052116 3.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Pathol Bacteriol 1926; 29: 407-39; http://dx.doi.org/10.1002/path.17002904095.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
N Engl J Med 1983; 308:203-6; PMID:6401354; http://dx.doi.org/10.1056/ NEJM198301273080407 7.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Microbiol Rev 2001; 14:584-640; PMID:11432815; http://dx.doi.org/10.1128/CMR.14.3.584-640.2001 8.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Med Mal Infect 2011; 41:594-601; PMID:22036519; http://dx.doi.org/10.1016/j.medmal.2011.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Infect Dis 2009; 49:1838-47; PMID:19929384; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
JAMA 1995; 273:1118-22; PMID:7707600; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Infect Dis 2007; 44:513-20; PMID: 17243053; http://dx.doi.org/10.1086/511006 13.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Emerg Infect Dis 2008; 14:734-40; PMID:18439354; http://dx.doi.org/10.3201/eid1405.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Microbiol Infect 2010; 16:16-23; PMID:20002687; http://dx.doi.org/10.1111/j.1469- 0691.2009.03109.x 16.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Microbiol Immunol Infect 2010; 43:485-90; PMID:21195975; http://dx.doi.org/10.1016/ S1684-1182(10)60075-8 17.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Nat Rev Immunol 2004; 4:812-23; PMID: 15459672; http://dx.doi.org/10.1038/nri1461 18.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Nat Rev Microbiol 2006;4:423-34; PMID:16710323; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Microbiol Rev 2004; 17:323-47; PMID:15084504; http://dx.doi.org/10.1128/CMR.17.2.323-347.2004 20.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Interdiscip Perspect Infect Dis 2010; 2010:632513; PMID:20204066; http://dx.doi.org/10.1155/2010/632513 21.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Emerg InfectDis 2010; 16:136-8; PMID:20031061; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Vet Rec 1988; 122:274-6; PMID:3131946; http://dx.doi.org/ 10.1136/vr.122.12.274 23.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Vet Intern Med 2010; 24:983-5; PMID:20412434; http://dx.doi.org/10.1111/j.1939-1676.2010.0518.x 26.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Vet Pathol 2006; 43:381-3; PMID:16672590; http://dx.doi.org/10.1354/vp.43-3-38127.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Vet Med Sci 2000; 62:639- 41; PMID:10907692; http://dx.doi.org/10.1292/jvms.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Curr Infect Dis Rep 2008; 10:300-6; PMID:18765103; http://dx.doi.org/ 10.1007/s11908-008-0049-0 29.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Microbiol Rev 2011; 24:557-91; PMID:21734248; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
N Engl J Med 2001; 344:1378-88; PMID:11333996; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Med Microbiol 1984; 18:1-16; PMID:6146721; http://dx.doi.org/10.1099/00222615-18-1-1 32.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Int J Parasitol 2000;30:1217-58; PMID:11113252; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Neurol 2012; 259:720-8; PMID:21964751; http://dx.doi.org/10.1007/s00415-011-6252-1 35.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
"Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R. Enterovirus infections of the central nervous system.Virology 2011; 411:288-305; PMID:21251690; http://dx.doi.org/10.1016/j.virol.2010.12.014 36.",Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Infect Dis2006; 43:1233-8; PMID:17051485; http://dx.doi.org/ 10.1086/508462 37.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Medicine (Baltimore) 1998; 77:313-36; PMID:9772921; http://dx.doi.org/ 10.1097/00005792-199809000-00002 38.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
"N Engl J Med 1997; 337:970-6; PMID:9395430; http://dx.doi.org/10.1056/NEJM199710023371404 39. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis.",OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
N Engl J Med 2004; 351:1849-59; PMID:15509818;http://dx.doi.org/10.1056/NEJMoa040845 40.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Infect 1996; 33:79-85; PMID:8889993;http://dx.doi.org/10.1016/S0163-4453(96)92929-1 41.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Inflamm Bowel Dis 2008; 14:429-31; PMID:17973302; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Medicine (Baltimore) 2001; 80: 223-35; PMID:11470983; http://dx.doi.org/10.1097/ 00005792-200107000-0000143.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
"Clin Infect Dis 1997; 24:1-9, quiz 10-1; PMID:8994747; http://dx.doi.org/10.1093/clinids/ 24.1.1 44.",Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Infect Dis 2000; 31:770-5; PMID:11017828; http://dx.doi.org/10.1086/314008 45.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Brain stem encephalitis in listeriosis.Scand J Infect Dis 2005; 37:190-4; PMID:15849051;http://dx.doi.org/10.1080/00365540410020938 47.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Clin Infect Dis 1993; 16:689-702; PMID:8507761; http://dx.doi.org/10.1093/clind/ 16.5.689 48.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Brain Pathol 2005; 15:187-91; PMID:16196384; http://dx.doi.org/ 10.1111/j.1750-3639.2005.tb00519.x 49.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Vet J 1997; 153:9-29; PMID:9125353; http://dx.doi.org/10.1016/S1090-0233(97) 80005-6 52.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Vet Rec 2002; 150:38-42; PMID:11829065; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Vet Rec 2006; 158: 588-92; PMID:16648439; http://dx.doi.org/10.1136/ vr.158.17.588 54.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Brain Pathol 2010; 20:378-90; PMID:19476464; http://dx.doi.org/10.1111/ j.1750-3639.2009.00292.x 55.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Science 2001; 292:1722-5; PMID:11387478;http://dx.doi.org/10.1126/science.1059852 56.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Exp Med 2011; 208:2263-77; PMID:21967767; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Nature 2008; 455:1114-8; PMID:18806773; http://dx.doi.org/10.1038/nature07303 58.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
"Khelef N, Lecuit M, Bierne H, Cossart P. Species specificity of the Listeria monocytogenes InlB protein.Cell Microbiol 2006; 8:457-70; PMID:16469057; http://dx.doi.org/10.1111/j.1462-5822.2005.00634.x 59.",OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Infect Dis 2004; 189:2094-100; PMID: 15143478; http://dx.doi.org/10.1086/420853 61.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Nat Rev Microbiol 2008; 6: 625-34; PMID:18604221; http://dx.doi.org/10.1038/ nrmicro1952 62.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Neurobiol Dis 2010; 37:13-25; PMID:19664713; http://dx.doi.org/10.1016/j.nbd.2009.07.030 63.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Cell Biol 1991; 115:1725-35; PMID: 1661734; http://dx.doi.org/10.1083/jcb.115.6.1725 64.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Acta Neuropathol 2010; 119:75-88; PMID: 20033190; http://dx.doi.org/10.1007/s00401-009- 0627-8 66.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Mol Microbiol 1998; 28:81-93; PMID:9593298; http://dx.doi.org/10.1046/j.1365- 2958.1998.00776.x 67.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Infect Immun 2000; 68:3275-9; PMID:10816473; http://dx.doi.org/10.1128/IAI.68.6.3275-3279.2000 69.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
EMBO J 2005; 24:2827-38; PMID:16015374; http://dx.doi.org/10.1038/sj.emboj.7600750 70.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
PLoS Pathog 2011; 7:e1002305; PMID:21998592; http://dx.doi.org/10.1371/journal.ppat.1002305 71.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Infect Immun 2003; 71:1680-8; PMID:12654781; http://dx.doi.org/10.1128/ IAI.71.4.1680-1688.2003 72.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Mol Microbiol 2002; 44:1407-19; PMID:12028384; http://dx.doi.org/10.1046/j.1365-2958.2002.02973.x73.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J Infect Dis 1998; 178:1658-66; PMID:9815218; http://dx.doi.org/10.1086/314490 75.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Virology 1985; 147:231-6; PMID: 2998068; http://dx.doi.org/10.1016/0042-6822(85)90246-6 76.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Cell Microbiol 2007; 9:1397-411; PMID:17250592; http://dx.doi.org/10.1111/j.1462-5822.2006.00880.x 77.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Cell Microbiol 2001; 3:331-40; PMID:11298655; http://dx.doi.org/10.1046/j.1462-5822.2001.00120.x 78.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Cell Microbiol 2005; 7:167-80; PMID:15659061; http://dx.doi.org/10.1111/j.1462-5822.2004.00444.x 80.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Am J Pathol 1999; 155:1391-7; PMID:10514421; http://dx.doi.org/10.1016/S0002-9440(10)65241-8 82.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
J NeurolNeurosurg Psychiatry 1979; 42:931-3; PMID:512667; http://dx.doi.org/10.1136/jnnp.42.10.931 85.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Brain Pathol 2004; 14:225-6; PMID:15193037; http://dx.doi.org/10.1111/j.1750-3639.2004.tb00100.x 86.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Neuropathol Appl Neurobiol2011; 37:753-67; PMID:21486315; http://dx.doi.org/ 10.1111/j.1365-2990.2011.01183.x 87.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
EMBO J 1999; 18:3956-63; PMID:10406800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Infect Immun 2001; 69:2054-65; PMID:11254558; http://dx.doi.org/10.1128/IAI.69.4.2054- 2065.2001 91.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Infect Immun 2003; 71:4463-71; PMID:12874326; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Microbes Infect 2007; 9:1216-25; PMID:17720601; http://dx.doi.org/10.1016/j.micinf.2007.05.009 93.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Nat Protoc 2009; 4:799- 810; PMID:19444238; http://dx.doi.org/10.1038/nprot.,OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
Microb Pathog 1997; 23: 39-48; PMID:9250779; http://dx.doi.org/10.1006/ mpat.1997.0131 www.landesbioscience.com Virulence 221,Non-OADS,/arxiv_data1/oa_pdf/ba/6e/viru-3-213.PMC3396700.pdf
"With the exception of the circumventricular organs, which areregions of important exchanges between specialized neurons and*Correspondence to: Pierre-Emmanuel Ceccaldi; Email: pierre-emmanuel.ceccaldi@pasteur.fr Submitted: 01/30/12; Revised: 02/13/12; Accepted: 02/13/12 http://dx.doi.org/10.4161/viru.19697Virulence 3:2, 222 –229; March/April 2012; G2012 Landes Bioscience 222 Virulence Volume 3 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Semin Pediatr Infect Dis 2003; 14:72-82; PMID: 12881794; http://dx.doi.org/10.1053/spid.2003.127223 2.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neuropathol Exp Neurol 1989; 48: 620-30; PMID:2477505; http://dx.doi.org/10.1097/00005072-198911000-00004 3.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
FEMS MicrobiolLett 2004; 233:1-6; PMID:15098543; http://dx.doi.org/10.1016/j.femsle.2004.01.0354.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Trends Neurosci 2005; 28:202-8; PMID:15808355; http://dx.doi.org/ 10.1016/j.tins.2005.02.0017.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Brain ResBrain Res Rev 2004; 46:32-43; PMID:15297153;http://dx.doi.org/10.1016/j.brainresrev.2004.04.006 8.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Cell Biol 1967; 34:207-17; PMID:6033532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Fluids Barriers CNS 2011; 8:8; PMID: 21349156; http://dx.doi.org/10.1186/2045-8118-8-8 11.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Methods Mol Biol 2011; 686:69-100; PMID: 21082367; http://dx.doi.org/10.1007/978-1-60761- 938-3_3 12.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Biochim Biophys Acta 2009; 1788: 842-57; PMID:19061857; http://dx.doi.org/10.1016/ j.bbamem.2008.10.022 13.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Neurochem Res 2009; 34:2067-77; PMID:19856206; http://dx.doi.org/10.1007/s11064- 009-0081-y 14.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Cell Biol 1969; 40:648-77; PMID:5765759; http://dx.doi.org/10.1083/jcb.40.3.648 15.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Adv Drug Deliv Rev 2001; 46:247-79; PMID: 11259843; http://dx.doi.org/10.1016/S0169-409X (00)00139-3 16.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Nat Rev Neurosci 2005; 6:591-602; PMID:16025095; http://dx.doi.org/10.1038/nrn1728 17.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Eur J Immunol 2004; 34:2955-63; PMID:15376193; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Trends Microbiol 2002; 10:227-32; PMID: 11973156; http://dx.doi.org/10.1016/S0966-842X (02)02349-1 19.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Int Neuropsychol Soc 2002; 8:410- 24; PMID:11939699; http://dx.doi.org/10.1017/ S1355617702813212 21.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Ann Neurol 1986; 19:525-35; PMID:3014994; http://dx.doi.org/ 10.1002/ana.410190603 22.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Ann Neurol 1986; 19: 517-24; PMID:3729308; http://dx.doi.org/10.1002/ ana.410190602 23.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Cell Mol Neurobiol 2005; 25:181-99; PMID:15962513; http://dx.doi.org/10.1007/s10571-004-1383-x 25.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Curr Opin Neurol 1999; 12:377-81; PMID: 10555824; http://dx.doi.org/10.1097/00019052- 199908000-0000227.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Trends Neurosci 2002; 25: 468-73; PMID:12183208; http://dx.doi.org/10.1016/ S0166-2236(02)02234-8 29.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Am J Pathol 1999; 155:1915-27; PMID:10595922; http://dx.doi.org/10.1016/ S0002-9440(10)65511-3 30.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Neuropathol Appl Neurobiol 2000; 26:356-60; PMID:10931369; http://dx.doi.org/ 10.1046/j.1365-2990.2000.00255.x 31.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Ann Neurol 1987; 22:668; PMID: 3480698; http://dx.doi.org/10.1002/ana.410220526 34.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
AIDS 1998; 12:1327-32; PMID:9708412; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Infect Dis 1996; 174:1098-101; PMID:8896515; http://dx.doi.org/10.1093/infdis/174.5.1098 36.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Ann Neurol 1999;46:391-8; PMID:10482270; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Neurosci Lett 1998; 254:97-100; PMID: 9779929; http://dx.doi.org/10.1016/S0304-3940(98) 00674-0 38.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Infect Dis1998; 178:854-7; PMID:9728558; http://dx.doi.org/ 10.1086/515342 39.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurosci Res 1995; 42:34-40; PMID: 8531224; http://dx.doi.org/10.1002/jnr.49042010540.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurovirol 2000; 6:145-55; PMID:10822328; http://dx.doi.org/10.3109/13550280009013158 41.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
AIDS 2000; 14:475-82; PMID:10780709; http://dx.doi.org/10.1097/00002030-200003310-00002 43.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Mol Cell Neurosci 2003; 24:224-37; PMID: 14550782; http://dx.doi.org/10.1016/S1044-7431 (03)00171-4 44.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurosci Res 2003; 74:255-65; PMID:14515355; http://dx.doi.org/10.1002/jnr.10762 45.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurochem 2003; 84:169-79; PMID:12485413; http://dx.doi.org/10.1046/j.1471-4159.2003.01543.x 46.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Clin Invest 1996; 98:1979-90; PMID:8903316; http://dx.doi.org/ 10.1172/JCI119002 47.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Virol 2005; 79:4257-69; PMID:15767427; http://dx.doi.org/10.1128/JVI.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Brain Res 2005; 1045:57-63; PMID:15910762; http://dx.doi.org/10.1016/j.brainres.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurovirol 2008; 14:186-95; PMID:18569453; http://dx.doi.org/10.1080/13550280801993630 51.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Cereb Blood Flow Metab 2007; 27:123-34; PMID:16685256; http://dx.doi.org/ 10.1038/sj.jcbfm.9600330 www.landesbioscience.com Virulence 227,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
AIDS 1998; 12:1021-6; PMID:9662198; http://dx.doi.org/10.1097/00002030-199809000-00009 54.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Adv Neuroimmunol 1994; 4:239-47; PMID:7533040; http://dx.doi.org/10.1016/ S0960-5428(06)80262-7 56.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neuroimmunol2000; 102:125-30; PMID:10636480; http://dx.doi.org/ 10.1016/S0165-5728(99)00170-8 57.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
AIDS Res Hum Retroviruses 1987; 3:363-73; PMID:3447627; http://dx.doi.org/10.1089/aid.1987.3.363 58.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Ann Neurol 1996; 39:705-11; PMID:8651642; http://dx.doi.org/10.1002/ana.410390606 61.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Trends Immunol 2005; 26:485-95; PMID:16039904; http://dx.doi.org/10.1016/j.it.2005.07.004 63.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
"Gras G, Kaul M. Molecular mechanisms of neuroinva- sion by monocytes-macrophages in HIV-1 infection.Retrovirology 2010; 7:30; PMID:20374632; http://dx.doi.org/10.1186/1742-4690-7-30 64.",Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
"Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.AIDS 2000; 14:2709-13; PMID:11125889; http://dx.doi.org/10.1097/00002030-200012010-0001066.",OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Blood 2003; 102:2334-7; PMID:12805068; http://dx.doi.org/10.1182/blood-2002-10- 3275 67.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Proc Natl Acad Sci U S A 2002;99:13795-800; PMID:12374865; http://dx.doi.org/ 10.1073/pnas.202357499 68.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neuroimmune Pharmacol 2009; 4:430-47; PMID:19768553; http://dx.doi.org/10.1007/s11481-009-9174-2 69.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Exp Neurol1999; 156:165-71; PMID:10192787; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Eur J Neurosci 2005; 22:2805-16; PMID: 16324115; http://dx.doi.org/10.1111/j.1460-9568.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Virol 2008; 82:7591-600; PMID: 18508884; http://dx.doi.org/10.1128/JVI.00768-08 73.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Vet Pathol 1988; 25: 456-67; PMID:2850650; http://dx.doi.org/10.1177/ 030098588802500609 74.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Comparison of simian immunodeficiency virus and human immunodefi- ciency virus encephalitides in the immature host.Ann Neurol 1988; 23(Suppl):S108-12; PMID: 2831797; http://dx.doi.org/10.1002/ana.410230727 75.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Neuropathol Appl Neurobiol 2000; 26:454-62; PMID:11054186; http://dx.doi.org/10.1046/j.1365-2990.2000.00275.x78.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurovirol 2005; 11:337-45; PMID:16162477;http://dx.doi.org/10.1080/13550280500186445 79.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Gen Virol 1994; 75: 3647-53; PMID:7996160; http://dx.doi.org/10.1099/ 0022-1317-75-12-3647 80.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Vet J 2011; 188:260-9; PMID:20418131; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Ann N Y Acad Sci 1994; 724:50-67; PMID:8030977; http://dx.doi.org/10.1111/j.1749- 6632.1994.tb38895.x 82.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Lancet 1986; 2:104-5; PMID:2873363; http://dx.doi.org/10.1016/ S0140-6736(86)91636-3 84.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Lancet 1986; 1:1031-2; PMID: 2871307; http://dx.doi.org/10.1016/S0140-6736(86) 91298-5 85.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Lancet 1985; 2:407-10; PMID:2863442; http://dx.doi.org/10.1016/S0140-6736(85)92734-5 86.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Infect Dis 2000;182:1044-50; PMID:10979898; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neuroimmunol 1993; 45:133-6; PMID:8331158; http://dx.doi.org/10.1016/0165-5728(93)90173-V 91.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neuroimmunol 1993; 42:223-6; PMID:8429106; http://dx.doi.org/10.1016/0165-5728(93)90014-P 92.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
JNeuroimmunol 1993; 42:127-30; PMID:8429097; http://dx.doi.org/10.1016/0165-5728(93)90001-F 93.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neuroimmunol 1988; 18:87-94; PMID:3257971; http://dx.doi.org/10.1016/0165-5728(88)90137-3 94.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Ann Neurol 1995; 37:167-75; PMID:7847858;http://dx.doi.org/10.1002/ana.410370206 95.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Infect Dis 2002; 186(Suppl 2):S187-92; PMID:12424696; http://dx.doi.org/10.1086/344269 96.,OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Virol 2000; 74:6021-30; PMID:10846084; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurochem 2005; 94: 1580-93; PMID:16026393; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
PLoS Pathog 2008; 4:e1000205; PMID:19008946; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Blood 2007; 110:3722-8; PMID:17717136;http://dx.doi.org/10.1182/blood-2007-04-085076 102.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
"Neurol Clin 2008; 26:799-819, x;PMID:18657727; http://dx.doi.org/10.1016/j.ncl.",OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Int Rev Psychiatry 2008; 20:15- 24; PMID:18240059; http://dx.doi.org/10.1080/ 09540260701862037 104.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Clin Immunol2008; 28:528-41; PMID:18574677; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurovirol 1998; 4:619- 26; PMID:10065903; http://dx.doi.org/10.3109/ 13550289809114228 106.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
Adv ExpMed Biol 1998; 437:199-205; PMID:9666272;http://dx.doi.org/10.1007/978-1-4615-5347-2_22 107.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurovirol 2010; 16:294-305; PMID: 20624003; http://dx.doi.org/10.3109/13550284.2010.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurochem2010; 115:1495-507; PMID:20950334; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
J Neurochem 2010; 115:515-25; PMID:20722969; http://dx.doi.org/10.1111/j.1471-4159.2010.06948.x www.landesbioscience.com Virulence 229,Non-OADS,/arxiv_data1/oa_pdf/5c/d6/viru-3-222.PMC3396701.pdf
"This work was supported by an NIH, NIAMS (http://www.niams.nih.gov) career award grant AR48827 (CEP); a WellcomeTrust (http://www.wellcome.ac.uk) grant 85586 (CEP), an MRC (http://www.mrc.ac.uk) grant G0901844 (CEP), and a BSF (http://www.britishskin-foundation.org.uk) grant 929 s (CEP); an NIH grant AR44518 (RRI); and aShriners’ Hospitals grant 8550 (RRI).",Non-OADS,/arxiv_data1/oa_pdf/d3/a1/jid2012108a.PMC3396744.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 2084 Journal of Investigative Dermatology (2012), Volume 132CE Pullar et al.",Non-OADS,/arxiv_data1/oa_pdf/d3/a1/jid2012108a.PMC3396744.pdf
The new work seems to con- tradict that comforting idea ...’’ (http://www.nature.com/news/ fears-grow-over-lab-bred-ﬂu-1.9692 ).,Non-OADS,/arxiv_data1/oa_pdf/a2/48/FEB2-586-2199.PMC3396840.pdf
"At the 2010 Astrobiology Science Conference in League City (Texas), for example, the session Ori- gins of molecular asymmetry, homochirality and life detection dis- cussed the possibility of mechanisms for chiral symmetry breaking and ampliﬁcation ( http://www.lpi.usra.edu/meetings/ abscicon2010/pdf/sess503.pdf ).Speciﬁcally, Paul Davies specu- lated that Earth hosts, or has hosted, more than one form of life where amino acids and sugars may have had reversed the chiral signature that is familiar to standard life.",Non-OADS,/arxiv_data1/oa_pdf/a2/48/FEB2-586-2199.PMC3396840.pdf
"While not much hard data on this subject can be found in the scientiﬁc literature one can ﬁnd a good deal of activity in the ﬁeld in various Syn-thetic Biology laboratories ( http://arep.med.harvard.edu/SBP/ ), Fig.",Non-OADS,/arxiv_data1/oa_pdf/a2/48/FEB2-586-2199.PMC3396840.pdf
Mayo Clin Proc82:1341 –1349 [Erratum in: Mayo Clin Proc 2008; 83:255] ZOSTAVAX® SmPC (2006) Available at: http://www.ema.europa.eu/ docs/en_GB/document_library/E PAR_-_Product_Information/ human/000674/WC500053462.pdf .,Non-OADS,/arxiv_data1/oa_pdf/80/cd/10389_2011_Article_481.PMC3397124.pdf
"The processed AAindex1 database, supplementary material and the software are available at http://sysbio.icm.edu.pl/ aaindex/ .",OADS,/arxiv_data1/oa_pdf/ed/f0/726_2011_Article_1106.PMC3397137.pdf
Description of fuzzy clustering algorithms and validity measures Algorithms for known number of clusters Fuzzy c-means clusteringThe FCM algorithm (Bezdek 1981 ) is a widely used technique that uses the principles of fuzzy sets to evolve apartition matrix U(X) while minimizing the measure 1http://www.genome.jp/aaindex/ .584 I. Saha et al.,OADS,/arxiv_data1/oa_pdf/ed/f0/726_2011_Article_1106.PMC3397137.pdf
ClinicalTrials.gov Web Site (2011) BETH Study: Treatment of HER2 positive breast cancer with chemotherapy plus trastuzumab vs chemotherapy plus trastuzumab plus bevacizumab.http://www.clinicaltrials.gov/ct2/show/NCT00625898 .,Non-OADS,/arxiv_data1/oa_pdf/34/84/10549_2011_Article_1918.PMC3397213.pdf
http://www.clinicaltrials.gov/ct2/show/NCT00520975 .,Non-OADS,/arxiv_data1/oa_pdf/34/84/10549_2011_Article_1918.PMC3397213.pdf
"PC16: (year 2010: 16 cores) Operating system =Linux (64 bits) using WINE ( http://www.winehq.org ) (a Linux installation guide is given in the documentation folder of the download zip), processors=Dual octacore AMD op-teron 6128 2.0 GHz, memory=64 Gb 333 MHz DDR3, storage=3 9SATA II 1.5 TB/5400/32 Mb in Linux software raid5, 8 9120 Gb OCZ Vertex 2 SATA II 2.5 00 in raid0 (8 9SSD).",Non-OADS,/arxiv_data1/oa_pdf/d2/2a/11306_2011_Article_369.PMC3397215.pdf
http://www.destatis.de/ .,Non-OADS,/arxiv_data1/oa_pdf/9c/d7/11306_2011_Article_357.PMC3397217.pdf
http://cran.r-project.org/ web/packages/nortest/ .Metabolite alterations in colorectal cancer 651 123,Non-OADS,/arxiv_data1/oa_pdf/9c/d7/11306_2011_Article_357.PMC3397217.pdf
http://cran.r-project.org/web/packages/ltm/ .,Non-OADS,/arxiv_data1/oa_pdf/9c/d7/11306_2011_Article_357.PMC3397217.pdf
http://cran.r-project.org/web/ packages/pROC/ .,Non-OADS,/arxiv_data1/oa_pdf/9c/d7/11306_2011_Article_357.PMC3397217.pdf
http://www.r-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/9c/d7/11306_2011_Article_357.PMC3397217.pdf
http://arxiv.org/abs/1007.5516 .Metabolite alterations in colorectal cancer 653 123,Non-OADS,/arxiv_data1/oa_pdf/9c/d7/11306_2011_Article_357.PMC3397217.pdf
detected mass peaks) may reachAvailability and implementation MSClust is freely available for non-commercial users at http://www.metalign.nl .,Non-OADS,/arxiv_data1/oa_pdf/39/92/11306_2011_Article_368.PMC3397229.pdf
"The exact mass difference between mass signals enables the annotation of each ion detected, thereby facilitating the identiﬁcation of the molecular ion to be searched for in in-house mass-retention time databases or publicly available mass databases, forinstance MotoDB ( http://appliedbioinform atics.wur.nl/moto/ )and the Komics DB ( http://webs2.kazusa.or.jp/komics )i n the case of tomato fruit, or in the Human Metabolite DB (www.hmdb.ca ), MassBank ( www.massbank.jp ) and the Dictionary of Natural Products ( http://dnp.chemnetbase.",OADS,/arxiv_data1/oa_pdf/39/92/11306_2011_Article_368.PMC3397229.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Tian, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/9c/srep00511.PMC3397321.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Fordham, J.B. et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/6a/srep00512.PMC3397322.pdf
The ODE model and best parameter set are available from theBiomodels database under the ID: MODEL1012080000 (http://www.ebi.ac.uk/biomodels/).,OADS,/arxiv_data1/oa_pdf/5b/df/msb201222.PMC3397412.pdf
"Mass spectra have been deposited in the PRIDEdatabase (http://www.ebi.ac.uk/pride/, accession number19835–19854).",OADS,/arxiv_data1/oa_pdf/28/06/msb201220.PMC3397414.pdf
"Peptides from proteins belonging to a speciﬁed gene ontology term (e.g., Focal Adhesion GO:0005925) were annotated using AMIGO (http://amigo.geneontology.org), and wethen calculated a Kolmogorov-Smirnov statistic against the expecteddistribution.",OADS,/arxiv_data1/oa_pdf/28/06/msb201220.PMC3397414.pdf
Acquisition was performed with Metamorph software (Molecular Devices; http://www.photomet.com).,OADS,/arxiv_data1/oa_pdf/19/5f/msb201218.PMC3397415.pdf
Image processing and cell scoring were aided by use of ImageJsoftware (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/19/5f/msb201218.PMC3397415.pdf
(http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/19/5f/msb201218.PMC3397415.pdf
Gene regulatory information in terms of the number of regulatorymotifs per 1-kb region of a genes’ promoter was identiﬁed using theCISRED server (http://www.cisred.org).,OADS,/arxiv_data1/oa_pdf/20/35/msb201219.PMC3397417.pdf
"The SysBEP.org project website provides links to each of the disseminated materials with the transcriptomics data disseminated via GEO (Barrett et al, 2011) under the accession number GSE35237 and proteomics data via (http://omics.pnl.gov; Auberry et al, 2010).",OADS,/arxiv_data1/oa_pdf/ba/7c/msb201221.PMC3397418.pdf
"Available at http://www.genetests.org(accessed 6 June 2012) Watanabe H, Bannai S (1987) Induction of cystine transport activity in mouse peritoneal macrophages.",OADS,/arxiv_data1/oa_pdf/ba/7c/msb201221.PMC3397418.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.RHEUMATOLOGYRheumatology 2012;51:1368 /C1501377 doi:10.1093/rheumatology/kes001 Advance Access publication 17 February 2012CLINICAL SCIENCE",Non-OADS,/arxiv_data1/oa_pdf/c5/b2/kes001.PMC3397466.pdf
"http://www.pro- ject.org (23 January 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/c5/b2/kes001.PMC3397466.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.RHEUMATOLOGYRheumatology 2012;51:1416 /C1501425 doi:10.1093/rheumatology/kes032 Advance Access publication 24 March 2012CLINICAL SCIENCE",Non-OADS,/arxiv_data1/oa_pdf/20/b2/kes032.PMC3397467.pdf
"*8.8 (1.4) *Level of evidence: 5; grade of recommendation: D **Level of evidence: 3 (RA), 5 (other IA); grade of recommendation: C (RA), D (other IA) (11) In patients with IA and pre-existing hypertension,* CV* or renal disease,** paracetamol should be used first; NSAIDs including COX-2 selective inhibitors should be used with caution.8.8 (1.2) *Level of evidence: 2a (RA), 5 (other IA); grade of recommendation: C (RA), D (other IA) **Level of evidence: 5; grade of recommendation: D Level of evidence and grade of recommendation according to the Oxford Centre for Evidence-based Medicine Levels of Evidence (http://www.cebm.net/index.aspx?o=1025).",Non-OADS,/arxiv_data1/oa_pdf/20/b2/kes032.PMC3397467.pdf
"http://www.cebm.net/ index.aspx?o=1025 (28 September 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/20/b2/kes032.PMC3397467.pdf
"28 Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain, 2010. http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_a_v4_5.pdf (28 September 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/20/b2/kes032.PMC3397467.pdf
"Curr Biol 2011; 21:805–14; PMID:21549602; http://dx.doi.org/10.1016/j.cub.2011.04.016.Keywords:  spermatogenesis, mitochon - dria, cell elongation, microtubule, sperm  competition Submitted: 09/12/11Revised: 02/29/12Accepted: 02/29/12http://dx.doi.org/10.4161/f ly.19862 *Correspondence to: Shigeo Hayashi;   Email: shayashi@cdb.riken.jpSexual competition has selected a num - ber of extreme phenotypes like the tail  ornament of peacock male.",Non-OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Proc Natl Acad Sci USA 1995; 92:10614- 8; PMID:7479851; http://dx.doi.org/10.1073/ pnas.92.23.10614.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Science 2002; 298:1230-3; PMID:12424377; http://dx.doi.org/10.1126/sci - ence.1076968.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Curr Biol  2011; 21:805-14; PMID:21549602; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Science  2011; 333:1843-6; PMID:21960622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Genetics 2011; 188:773-82; PMID:21828278; http://dx.doi.org/10.1534/genet - ics.111.131433.16.,Non-OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Proc Biol Sci 2003; 270:1507-12; PMID:12965017;  http://dx.doi.org/10.1098/rspb.2003.2382.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Int J Insect  Morphol Embryol 1976; 5:107-15; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Tissue Cell 1982; 14:113-23; PMID:7089959; http://dx.doi.org/10.1016/0040- 8166(82)90011-8.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Development 2003;  130:1805-16; PMID:12642486; http://dx.doi.org/10.1242/dev.00406.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Cell  2006; 125:1375-86; PMID:16814722; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Cell 1997; 90:121-9;  PMID:9230308; http://dx.doi.org/10.1016/S0092- 8674(00)80319-0.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
Neuron 2002; 36:1063-77;  PMID:12495622; http://dx.doi.org/10.1016/S0896- 6273(02)01094-2.,OADS,/arxiv_data1/oa_pdf/c0/1d/fly-6-113.PMC3397921.pdf
"Do not distribute.www.landesbioscience.com  Fly 75Fly 6:2, 75-79; April/May/June 2012; © 2012 Landes Bioscience METHODS AND TECHNICAL ADVANCES METHODS AND TECHNICAL ADVANCES *Correspondence to: Pavel Hyrsl; Email: hyrsl@sci.muni.cz Submitted: 11/23/11; Revised: 01/10/12; Accepted: 01/31/12http://dx.doi.org/10.4161/fly.19553Introduction Entomopathogenic nematodes (EPNs) are soil-dwelling parasitic  worms that infect and kill insects.1 Like many other nematode  parasites, they exhibit non-feeding, free-living stages, also known as infective juveniles (IJs) that are tightly associated with their specific symbiotic bacteria.",Non-OADS,/arxiv_data1/oa_pdf/a2/d8/fly-6-75.PMC3397922.pdf
Parasitology 1994; 108:207-15; http://dx.doi.org/10.1017/ S003118200006830X.,Non-OADS,/arxiv_data1/oa_pdf/a2/d8/fly-6-75.PMC3397922.pdf
Biocontrol  Sci Technol 1996; 6:403-12; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a2/d8/fly-6-75.PMC3397922.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Nephrol Dial Transplant (2012) 27: 2673 –2685 doi: 10.1093/ndt/gfs279",Non-OADS,/arxiv_data1/oa_pdf/cd/cb/gfs279.PMC3398067.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 117New Hope for Wound Healing after Bowel Resection Ryung-Ah Lee Division of Coloproctology, Department of Surgery, Ewha Womans University School of Medicine, Seoul, KoreaEditorial  J Korean Soc Coloproctol 2012;28(3):117http://dx.doi.org/10.3393/jksc.2012.28.3.117 thelial differentiation during the cell manipulation stage.",Non-OADS,/arxiv_data1/oa_pdf/47/d8/jksc-28-117.PMC3398104.pdf
"How-ever, this feature does not confirm stem cell effects because vascular endothelial growth factor was used to induce endo - Correspondence to: Ryung-Ah Lee, M.D.Division of Coloproctology, Department of Surgery, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, KoreaTel: +82-2-2650-2659, Fax: +82-2-2644-7984E-mail: ralee@ewha.ac.kr  © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/d8/jksc-28-117.PMC3398104.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 118Good Post-operative Results Depend on Strict Patient  Selection and Strict Operative Procedure Yong Hee Hwang Department of Surgery, Sahmyook Medical Center, Seoul, KoreaEditorial  J Korean Soc Coloproctol 2012;28(3):118 http://dx.doi.org/10.3393/jksc.2012.28.3.118 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/dd/d5/jksc-28-118.PMC3398105.pdf
"Correspondence to: Yong Hee Hwang, M.D.Department of Sugery, Sahmyook Medical Center, 82 Mangu-ro, Dongdaemun-gu, Seoul 130-71 1, KoreaTel: +82-2-2210-3563, Fax: +82-2-2212-2673E-mail: hwangyon@hotmail.com © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/d5/jksc-28-118.PMC3398105.pdf
"Nam Kyu Kim Department of Surgery, Yonsei University College of Medicine, Seoul, KoreaEditorial  J Korean Soc Coloproctol 2012;28(3):119-120 http://dx.doi.org/10.3393/jksc.2012.28.3.119 lyzed and has been reported as a prognostic factor in rectal  cancer patients not colon cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/4e/jksc-28-119.PMC3398106.pdf
"Interestingly, pT3 subdivision has been ana - Correspondence to: Nam Kyu Kim, M.D.Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, KoreaTel: +82-2-2228-21 17, Fax: +82-2-313-8289E-mail: namkyuk@yuhs.ac © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/4e/jksc-28-119.PMC3398106.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 121A Comprehensive Review of Inflammatory Bowel Disease  Focusing on Surgical Management Seung Hyuk Baik, Won Ho Kim1 Departments of Surgery and 1Internal Medicine, Yonsei University College of Medicine, Seoul, KoreaReview J Korean Soc Coloproctol 2012;28(3):121-131 http://dx.doi.org/10.3393/jksc.2012.28.3.121 The two main diseases of inflammatory bowel disease are Crohn’s disease and ulcerative colitis.",Non-OADS,/arxiv_data1/oa_pdf/0e/06/jksc-28-121.PMC3398107.pdf
"Ulcerative colitis  Received: April 4, 2012   •   Accepted: June 10, 2012 Correspondence to: Won Ho Kim, M.D.Department of Internal Medicine, Yonsei University College of Medicine,   50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: +82-2-2228-1951, Fax: +82-2-393-6884E-mail: kimwonho@yuhs.ac © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/06/jksc-28-121.PMC3398107.pdf
http://dx.doi.org/10.1007/s00423-012-0919-7.,Non-OADS,/arxiv_data1/oa_pdf/0e/06/jksc-28-121.PMC3398107.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 132Adipose-tissue-derived Stem Cells Enhance the Healing of  Ischemic Colonic Anastomoses: An Experimental Study  in Rats Jong Han Yoo1, Jae Ho Shin1, Min Sung An1, Tae Kwun Ha1, Kwang Hee Kim1, Ki Beom Bae1,2,  Tae Hyeon Kim1, Chang Soo Choi1, Kwan Hee Hong1, Jeong Kim3, Soo Jin Jung3, Sun Hee Kim2,  Kuk Hwan Rho2, Jong Tae Kim2, Young Il Yang2,3 1Department of Surgery, Busan Paik Hospital, 2Paik Institute for Clinical Research, 3Department of Pathology, Busan Paik Hospital,  Inje University College of Medicine, Busan, Korea Original Article J Korean Soc Coloproctol 2012;28(3):132-139 http://dx.doi.org/10.3393/jksc.2012.28.3.132 Purpose:  This experimental study verified the effect of adipose-tissue-derived stem cells (ASCs) on the healing of ischemic  colonic anastomoses in rats.",Non-OADS,/arxiv_data1/oa_pdf/d7/b0/jksc-28-132.PMC3398108.pdf
"© 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/b0/jksc-28-132.PMC3398108.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 140Comparison of Long-term Clinical Outcomes according to  the Change in the Rectocele Depth between Transanal and Transvaginal Repairs for a Symptomatic Rectocele Choon Sik Chung, Sang Hwa Yu, Jeong Eun Lee, Dong Keun Lee Department of Surgery, Hansol Hospital, Seoul, KoreaOriginal Article J Korean Soc Coloproctol 2012;28(3):140-144 http://dx.doi.org/10.3393/jksc.2012.28.3.140 Purpose: This study was aimed to compare the results of a transanal repair with those of a transvaginal levatorplasty and  to determine the long-term clinical outcomes according to the change in the depth of the rectocele after the procedure.",Non-OADS,/arxiv_data1/oa_pdf/88/6b/jksc-28-140.PMC3398109.pdf
"© 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/6b/jksc-28-140.PMC3398109.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 145The Influence of Nutritional Assessment on the Outcome of  Ostomy Takedown Min Sang Kim, Ho Kun Kim, Dong Yi Kim, Jae Kyun Ju Department of Surgery, Chonnam National University Hospital, Gwangju, KoreaOriginal Article J Korean Soc Coloproctol 2012;28(3):145-151 http://dx.doi.org/10.3393/jksc.2012.28.3.145 Purpose: Ostomy takedown is often considered a simple procedure without intention; however, it is associated with signif - icant morbidity.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/jksc-28-145.PMC3398110.pdf
"Stoma takedown is often considered a “simple” procedure without intention; however,  Received: March 16, 2012   •   Accepted: June 20, 2012 Correspondence to: Jae Kyun Ju, M.D.Department of Surgery, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju   501-757, KoreaTel: +82-62-220-6456, Fax: +82-62-227-1635E-mail: jkju@jnu.ac.kr © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/jksc-28-145.PMC3398110.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 152Appendicitis during Pregnancy: The Clinical Experience of  a Secondary Hospital Soo Jung Jung, Do Kyung Lee, Jun Hyun Kim, Pil Sung Kong, Kyung Ha Kim, Sung Woo Bae1 Department of Surgery, Busan St. Mary’s Medical Center, Busan, 1Department of Surgery, Good Moonhwa Hospital, Busan, KoreaOriginal Article J Korean Soc Coloproctol 2012;28(3):152-159 http://dx.doi.org/10.3393/jksc.2012.28.3.152 Purpose: Appendicitis is the most common condition leading to an intra-abdominal operation for a non-obstetric prob- lem in pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/07/9e/jksc-28-152.PMC3398111.pdf
"In order to prevent these risks, early diagnosis and early treat - Received: November 17, 201 1   •   Accepted: February 14, 2012 Correspondence to: Do Kyung Lee, M.D.Department of Surgery, Busan St. Mary’s Medical Center, 25-14 Yongho-ro 232beon-gil, Nam-gu, Busan 608-838, KoreaTel: +82-51-933-7098, Fax: +82-51-933-8600 E-mail: mrdolee@hanmail.net © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/9e/jksc-28-152.PMC3398111.pdf
"Hong Yeol Yoo, Rumi Shin, Heon-Kyun Ha, Heung-Kwon Oh, Seung-Yong Jeong, Kyu Joo Park,  Gyeong Hoon Kang 1, Woo Ho Kim1, Jae-Gahb Park Departments of Surgery and 1Pathology, Seoul National University College of Medicine, Seoul, KoreaOriginal Article J Korean Soc Coloproctol 2012;28(3):160-164 http://dx.doi.org/10.3393/jksc.2012.28.3.160 Purpose: We analyzed the clinical data of T3 colorectal cancer patients to assess whether T3 subdivision correlates with  node (N) or metastasis (M) staging and stage-independent factors.Methods:  Five hundred fifty-five patients who underwent surgery for primary colorectal cancer from January 2003 to  December 2009 were analyzed for T3 subdivision.",Non-OADS,/arxiv_data1/oa_pdf/a8/61/jksc-28-160.PMC3398112.pdf
"Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 1 10-744, Korea Tel: +82-2-2072-0152, Fax: +82-2-766-3975 E-mail: syjeong@snu.ac.kr © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/61/jksc-28-160.PMC3398112.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 165Treatment of a Recurrent Rectourethral Fistula by Using  Transanal Rectal Flap Advancement and Fibrin Glue:  A Case Report Taek-Gu Lee, Sung-Su Park, Sang-Jeon Lee Department of Surgery, Chungbuk National University College of Medicine, Cheongju, KoreaCase Report J Korean Soc Coloproctol 2012;28(3):165-169 http://dx.doi.org/10.3393/jksc.2012.28.3.165 Rectourethral fistulas (RUFs) in adults are rare and could result from complicated trauma, and prostatic or rectal surgery.",Non-OADS,/arxiv_data1/oa_pdf/f2/a7/jksc-28-165.PMC3398113.pdf
"Department of Surgery, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 776 1 Sunhwan-ro, Heungdeok-gu, Cheongju 361-71 1, Korea Tel: +82-43-269-6360, Fax: +82-43-266-6037E-mail: colon@chungbuk.ac.kr  © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/a7/jksc-28-165.PMC3398113.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 170A Case of Rectal Cancer in a Patient with Neurofibromatosis  Type 1 Se Heon Oh, Jai Hyuen Lee1, Hwan Namgung Departments of Surgery and 1Nuclear Medicine, Dankook University College of Medicine, Cheonan, KoreaCase Report J Korean Soc Coloproctol 2012;28(3):170-173 http://dx.doi.org/10.3393/jksc.2012.28.3.170 A rectal cancer was found in a 67-year-old man with a history of neurofibromatosis type 1.",Non-OADS,/arxiv_data1/oa_pdf/3c/d9/jksc-28-170.PMC3398114.pdf
"An ulcerofungating mass was palpated   at 5 cm above the anal verge on the posterior side of the rectum   Received: June 13, 201 1   •   Accepted: August 4, 201 1 Correspondence to: Hwan Namgung, M.D.Department of Surgery, Dankook University College of Medicine,   San-29 Anseo-dong, Dongnam-gu, Cheonan 330-715, KoreaTel: +82-41-550-3929, Fax: +82-41-556-3878E-mail: gsnamgung@dankook.ac.kr © 2012 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/d9/jksc-28-170.PMC3398114.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  41 REVIEW http://dx.doi.org/10.5653/cerm.2012.39.2.41 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2012;39(2):41-45 Etv5, a transcription factor with versatile functions in  male reproduction Jinwon Eo1*, Haengseok Song2, Hyunjung Jade Lim1 1Department of Biomedical Science and Technology, Konkuk University; 2Department of Biomedical Science, CHA University, Seoul, Korea Transcription factors govern diverse aspects of cell growth and differentiation as major switches of gene expression.",Non-OADS,/arxiv_data1/oa_pdf/7f/a0/cerm-39-41.PMC3398115.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/a0/cerm-39-41.PMC3398115.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.41 Clin Exp Reprod Med 2012;39(2):41-45 42tially expressed in the mesenchyme and epithelium of the develop - ing lung, salivary gland, gut, olfactory, and optic organs [15].",Non-OADS,/arxiv_data1/oa_pdf/7f/a0/cerm-39-41.PMC3398115.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.41 Clin Exp Reprod Med 2012;39(2):41-45 44the GDNF-RET signaling pathway turns on multiple cytoplasmic ki - nases, and they contribute to the induction of Etv4 and Etv5 [31].",OADS,/arxiv_data1/oa_pdf/7f/a0/cerm-39-41.PMC3398115.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  46 REVIEW http://dx.doi.org/10.5653/cerm.2012.39.2.46 pISSN2233-8233 ·eISSN2233-8241 ClinExpReprodMed2012;39(2):46-51 Fertility preservation in women with cancer Sanghoon Lee1, Jae Yun Song1, Seung Yup Ku2, Sun Haeng Kim1, Tak Kim1 1Department of Obstetrics and Gynecology, Korea University College of Medicine; 2Department of Obstetrics and Gynecology, Seoul National  University College of Medicine, Seoul, Korea Fertility preservation (FP) is an effort to retain the fertility of cancer patients, and as an emerging discipline, it plays a central role in cancer care.",Non-OADS,/arxiv_data1/oa_pdf/02/bb/cerm-39-46.PMC3398116.pdf
"Candidates and determinants of access to  fertility preservation Candidates for FP include patients with childhood cancers, breast Received: Jun15,2012 ∙Accepted: Jun21,2012 Corresponding author: TakKim Department ofObstetrics andGynecology, Korea University College of Medicine, 73Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel:+82-2-920-6842 Fax:+82-2-921-5357 E-mail: tkim@kumc.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/bb/cerm-39-46.PMC3398116.pdf
"Embryo cryopreservation is a well established technique and the  current live-birth rate per transfer using frozen thawed embryos was  35.6% in US women under 35-year-old (http://www.sart.org, 2008).",Non-OADS,/arxiv_data1/oa_pdf/02/bb/cerm-39-46.PMC3398116.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.46 Clin Exp Reprod Med 2012;39(2):46-51 48Palliative radiotherapy for metastatic disease [17].,Non-OADS,/arxiv_data1/oa_pdf/02/bb/cerm-39-46.PMC3398116.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.46 Clin Exp Reprod Med 2012;39(2):46-51 50According to the development of early diagnosis and cancer treat - ments, techniques for FP including ART and freezing/thawing meth - ods are continuously being developed.",Non-OADS,/arxiv_data1/oa_pdf/02/bb/cerm-39-46.PMC3398116.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  52 ORIGINALARTICLE http://dx.doi.org/10.5653/cerm.2012.39.2.52 pISSN2233-8233 ·eISSN2233-8241 ClinExpReprodMed2012;39(2):52-57 Array comparative genomic hybridization screening  in IVF significantly reduces number of embryos  available for cryopreservation Jiaen Liu1, E Scott Sills2, Zhihong Yang2, Shala A Salem2, Tayyab Rahil2, Gary S Collins3, Xiaohong Liu1, Rifaat D Salem2 1IVF Division, Beijing Jia En De Yun Hospital, Beijing, China; 2Division of Reproductive Endocrinology, Pacific Reproductive Center, Torrance, USA;  3Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Oxford, UK Objective:  During IVF , non-transferred embryos are usually selected for cryopreservation on the basis of morphological criteria.",Non-OADS,/arxiv_data1/oa_pdf/a7/7a/cerm-39-52.PMC3398117.pdf
"As other investigators have noted [17-21], screen -Received: Apr21,2012 ∙Revised: May9,2012 ∙Accepted: May14,2012 Corresponding author: EScott Sills Division ofReproductive Endocrinology, Pacific Reproductive Center  (PRC-Fertility); Irvine, California 92618, USA Tel:+1-949-341-0100 Fax:+1-949-341-0613 E-mail: dr.sills@prc-ivf.com This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/7a/cerm-39-52.PMC3398117.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.52 Clin Exp Reprod Med 2012;39(2):52-57 54Fuse software (BlueGnome, Ltd.) was used for analysis of microarray  data on chromatin loss/gain across all 24 chromosomes.",OADS,/arxiv_data1/oa_pdf/a7/7a/cerm-39-52.PMC3398117.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.52 Clin Exp Reprod Med 2012;39(2):52-57 56tation rates without sacrificing pregnancy rates.,Non-OADS,/arxiv_data1/oa_pdf/a7/7a/cerm-39-52.PMC3398117.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  58 ORIGINALARTICLE http://dx.doi.org/10.5653/cerm.2012.39.2.58 pISSN2233-8233 ·eISSN2233-8241 ClinExpReprodMed2012;39(2):58-67 Function of the pentose phosphate pathway and its  key enzyme, transketolase, in the regulation of the  meiotic cell cycle in oocytes Yunna Kim1, Eun-Young Kim1, You-Mi Seo1, Tae Ki Yoon2, Woo-Sik Lee2, Kyung-Ah Lee1,2 1Department of Biomedical Science, College of Life Science, CHA University; 2CHA Research Institute, Fertility Center, CHA General Hospital, Seoul, Korea Objective:  Previously, we identified that transketolase ( Tkt), an important enzyme in the pentose phosphate pathway, is highly expressed at 2  hours of spontaneous maturation in oocytes.",Non-OADS,/arxiv_data1/oa_pdf/b9/c3/cerm-39-58.PMC3398118.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/c3/cerm-39-58.PMC3398118.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.58 Clin Exp Reprod Med 2012;39(2):58-67 60the SuperScript Preamplification System Protocol (Gibco-BRL, Grand  Island, NY , USA).",OADS,/arxiv_data1/oa_pdf/b9/c3/cerm-39-58.PMC3398118.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.58 Clin Exp Reprod Med 2012;39(2):58-67 62Results 1.,OADS,/arxiv_data1/oa_pdf/b9/c3/cerm-39-58.PMC3398118.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.58 Clin Exp Reprod Med 2012;39(2):58-67 64scripts ( Gpi1, G6pd2, Rpe, Rpia , and Taldo ) in the pathway was not af - fected, but Prps1  and Rbks transcripts were dramatically decreased  (Figure 6).",OADS,/arxiv_data1/oa_pdf/b9/c3/cerm-39-58.PMC3398118.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.58 Clin Exp Reprod Med 2012;39(2):58-67 66has an effect on oocyte maturation [9].,OADS,/arxiv_data1/oa_pdf/b9/c3/cerm-39-58.PMC3398118.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  68 ORIGINALARTICLE http://dx.doi.org/10.5653/cerm.2012.39.2.68 pISSN2233-8233 ·eISSN2233-8241 ClinExpReprodMed2012;39(2):68-72 Stimulated intrauterine insemination in women with  unilateral tubal occlusion Gwang Yi1, Byung Chul Jee1-3, Chang Suk Suh1-3, Seok Hyun Kim2,3 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam; 2Department of Obstetrics and Gynecology, Seoul  National University College of Medicine; 3Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul,  Korea Objective:  To investigate the value of stimulated intrauterine insemination (IUI) in women with unilateral tubal occlusion.",Non-OADS,/arxiv_data1/oa_pdf/d5/43/cerm-39-68.PMC3398119.pdf
"Received: May3,2012 ∙Revised: Jun7,2012 ∙Accepted: Jun18,2012 Corresponding author: Byung ChulJee Department ofObstetrics andGynecology, Seoul National University Bundang  Hospital, Seoul National University College ofMedicine, 82Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 463-707, Korea  Tel:+82-31-787-7254, Fax:+82-31-787-4054, E-mail: blasto@snubh.org This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/43/cerm-39-68.PMC3398119.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.68 Clin Exp Reprod Med 2012;39(2):68-72 70lateral tubal occlusion than those with unexplained infertility.,Non-OADS,/arxiv_data1/oa_pdf/d5/43/cerm-39-68.PMC3398119.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.68 Clin Exp Reprod Med 2012;39(2):68-72 72fowobi O, et al.",OADS,/arxiv_data1/oa_pdf/d5/43/cerm-39-68.PMC3398119.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  73 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2012.39.2.73 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2012;39(2):73-80 Effects of hypoxia inducible factors-1α on autophagy  and invasion of trophoblasts Jong-Ho Choi1, Hyun-Jung Lee2, Tae-Hyun Yang1, Gi Jin Kim1,2 1Department of Biomedical Science; 2CHA Placenta Institute, CHA University, Seoul, Korea Objective:  This study was undertaken to determine the effect of hypoxia inducible factor (HIF)-1α on the cell death, autophagy, and invasion  of trophoblasts.",Non-OADS,/arxiv_data1/oa_pdf/ae/28/cerm-39-73.PMC3398120.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/28/cerm-39-73.PMC3398120.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.73 Clin Exp Reprod Med 2012;39(2):73-80 74of pregnancy, normoxic conditions were restored when the mater - nal-fetal blood flow increased with the invasion of trophoblasts into  the endometrium, and then the trophoblast invasion ceased.",Non-OADS,/arxiv_data1/oa_pdf/ae/28/cerm-39-73.PMC3398120.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.73 Clin Exp Reprod Med 2012;39(2):73-80 76cytoplasm were increased in proportion to the extent of time of hy - poxic conditions (Figure 2B).,OADS,/arxiv_data1/oa_pdf/ae/28/cerm-39-73.PMC3398120.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.73 Clin Exp Reprod Med 2012;39(2):73-80 78are induced by hypoxia, regulate the invasion of JEG3, a choriocarci - noma cell line [20].",Non-OADS,/arxiv_data1/oa_pdf/ae/28/cerm-39-73.PMC3398120.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.73 Clin Exp Reprod Med 2012;39(2):73-80 8023.,OADS,/arxiv_data1/oa_pdf/ae/28/cerm-39-73.PMC3398120.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  81 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2012.39.2.81 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2012;39(2):81-86 Prooxidant-antioxidant balance and  malondialdehyde over time in adult rats after tubal  sterilization and vasectomy Azita Faramarzi1, Behjat Seifi1, Hamid Reza Sadeghipour1, Alireza Shabanzadeh1, Mitra Ebrahimpoor2 1Department of Physiology, School of Medicine; 2Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical  Science, Tehran, Iran Objective:  Sterilization (tubal sterilization and vasectomy) is a widely applied contraceptive method worldwide.",Non-OADS,/arxiv_data1/oa_pdf/66/96/cerm-39-81.PMC3398121.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/96/cerm-39-81.PMC3398121.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.81 Clin Exp Reprod Med 2012;39(2):81-86 82tial fibrosis of the testicles [15] are caused by oxidative stress.,Non-OADS,/arxiv_data1/oa_pdf/66/96/cerm-39-81.PMC3398121.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.81 Clin Exp Reprod Med 2012;39(2):81-86 84and 6 months after the operation as compared to the sham groups  (p<0.05) (Figure 3B).,OADS,/arxiv_data1/oa_pdf/66/96/cerm-39-81.PMC3398121.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.81 Clin Exp Reprod Med 2012;39(2):81-86 8624.,OADS,/arxiv_data1/oa_pdf/66/96/cerm-39-81.PMC3398121.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  87 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2012.39.2.87 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2012;39(2):87-93 Lin28  regulates the expression of neuropeptide Y  receptors and oocyte-specific homeobox genes in  mouse embryonic stem cells Geon Tae Park*, You-Mi Seo*, Su-Yeon Lee, Kyung-Ah Lee Department of Biomedical Science, College of Life Science, CHA University, Seoul, Korea Objective:  Lin28  has been known to control the proliferation and pluripotency of embryonic stem cells.",Non-OADS,/arxiv_data1/oa_pdf/0a/95/cerm-39-87.PMC3398122.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/95/cerm-39-87.PMC3398122.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.87 Clin Exp Reprod Med 2012;39(2):87-93 88widely expressed in early-stage embryos, with expression decreasing  and becoming restricted to a few tissues such as skeletal and cardiac  muscles [7].",Non-OADS,/arxiv_data1/oa_pdf/0a/95/cerm-39-87.PMC3398122.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.2.87 Clin Exp Reprod Med 2012;39(2):87-93 90due to insufficient gene information and the rest of the genes (up- regulated, 19; down-regulated, 5) are listed in Table 2.",OADS,/arxiv_data1/oa_pdf/0a/95/cerm-39-87.PMC3398122.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.2.87 Clin Exp Reprod Med 2012;39(2):87-93 92the possibility that the upregulation of the Npyr family by Lin28  RNAi  is through indirect regulation.,Non-OADS,/arxiv_data1/oa_pdf/0a/95/cerm-39-87.PMC3398122.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.103 pISSN 2093-3665   eISSN 2093-3673 Protective eﬃ   cacy of an Ecklonia cava extract  used to treat transient focal ischemia of the rat brain Jeong Hwan Kim1, Nam Seob Lee1, Y eong Gil Jeong1, Je-Hun Lee1, Eun Ji Kim2, Seung Yun Han1 1Department of Anatomy, Myunggok Research Institute, 2Department of Pathology, Konyang University College of Medicine, Daejeon, Korea  Abstract:  Phlorotannins (marine algal polyphenols) have been reported to exhibit benefi  cial biological activities, serving as  both antioxidants and anti-infl  ammatory agents.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Anat Cell Biol 2012;45:103-113 Jeong Hwan Kim, et al 104 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.103diminish ROS levels per se or that activate enzymes with  antioxidant properties may inhibit the rise in intracellular calcium ([Ca 2+]i), thus preventing apoptotic neuronal death.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Attenuation of focal brain ischemia by Ecklonia cava extract  http://dx.doi.org/10.5115/acb.2012.45.2.103Anat Cell Biol 2012;45:103-113 105 www.acbjournal.orginjected, and 50 mg/kg ECP-injected.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Anat Cell Biol 2012;45:103-113 Jeong Hwan Kim, et al 106 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.103in distilled water.",OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
Attenuation of focal brain ischemia by Ecklonia cava extract  http://dx.doi.org/10.5115/acb.2012.45.2.103Anat Cell Biol 2012;45:103-113 107 www.acbjournal.orgthe number of separate experiments conducted.,Non-OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Anat Cell Biol 2012;45:103-113 Jeong Hwan Kim, et al 108 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.103vs.",OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Attenuation of focal brain ischemia by Ecklonia cava extract  http://dx.doi.org/10.5115/acb.2012.45.2.103Anat Cell Biol 2012;45:103-113 109 www.acbjournal.orgEffects of ECP on neuronal viability in the context of  H2O2-induced oxidative stress  To further understand the neuroprotective mechanisms  of ECP , we explored whether ECP treatment protected differentiated SH-SY5Y neuronal cells from H 2O2-induced  oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Anat Cell Biol 2012;45:103-113 Jeong Hwan Kim, et al 110 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.103Recently, knowledge of the beneficial roles played by  polyphenols derived from terrestrial plants in protection from neurodegenerative diseases such as stroke has greatly increased, but only very limited information is available on the polyphenol components of marine plants.",OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
Attenuation of focal brain ischemia by Ecklonia cava extract  http://dx.doi.org/10.5115/acb.2012.45.2.103Anat Cell Biol 2012;45:103-113 111 www.acbjournal.orgischemia.,Non-OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Anat Cell Biol 2012;45:103-113 Jeong Hwan Kim, et al 112 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.103References 1.",OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
Attenuation of focal brain ischemia by Ecklonia cava extract  http://dx.doi.org/10.5115/acb.2012.45.2.103Anat Cell Biol 2012;45:103-113 113 www.acbjournal.orgSignal Transduction Group.,Non-OADS,/arxiv_data1/oa_pdf/6d/e4/acb-45-103.PMC3398172.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.114 pISSN 2093-3665   eISSN 2093-3673 Arginine vasopressin (AVP) expressional changes in the hypothalamic paraventricular and supraoptic nuclei of stroke-prone spontaneously hypertensive rats Sun Shin Yi1, Hyun-Jin Kim2, Seon-Gil Do2, Y oon-Bok Lee3, Hee Jin Ahn1, In Koo Hwang4, Y eo Sung  Yo on4 1Department of Biomedical Laboratory Science, College of Biomedical Sciences, Soonchunhyang University, Asan, 2Life Science Research Institute, Unigen  Inc., Cheonan, 3Department of Laboratory Animal Research, Central Research Institute, Dr. Chung’s Food Co. Ltd., Cheongju, 4Department of Anatomy  and Cell Biology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seou l, Korea  Abstract:  Arginine vasopressin (AVP) is a neuropeptide with vasocons trictive, antidiuretic, cardiovascular regulative and  hepatic glycogenolysis eff  ects, that also aff  ects other behaviors including modulating learning.",Non-OADS,/arxiv_data1/oa_pdf/ea/85/acb-45-114.PMC3398173.pdf
Th e changes of AVP in stroke-prone SHR http://dx.doi.org/10.5115/acb.2012.45.2.114Anat Cell Biol 2012;45:114-120 115 www.acbjournal.orgAVP .,Non-OADS,/arxiv_data1/oa_pdf/ea/85/acb-45-114.PMC3398173.pdf
"Anat Cell Biol 2012;45:114-120 Sun Shin Yi, et al 116 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.114CCA CAC AGA GTA CTT-3' [15], respectively.",OADS,/arxiv_data1/oa_pdf/ea/85/acb-45-114.PMC3398173.pdf
"Th e changes of AVP in stroke-prone SHR http://dx.doi.org/10.5115/acb.2012.45.2.114Anat Cell Biol 2012;45:114-120 117 www.acbjournal.orgIndividual images were of 512×512 pixels (256 gray levels),  which corresponded to a tissue area of 140×140 μm (40× primary magnifi  cation).",OADS,/arxiv_data1/oa_pdf/ea/85/acb-45-114.PMC3398173.pdf
"Anat Cell Biol 2012;45:114-120 Sun Shin Yi, et al 118 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.114SHRs [19] and these two strains differ in terms of stroke  susceptibility due to an “extra” hypertensive gene and other factors that make SHRSP rats more susceptible to stroke [16].",Non-OADS,/arxiv_data1/oa_pdf/ea/85/acb-45-114.PMC3398173.pdf
"Th e changes of AVP in stroke-prone SHR http://dx.doi.org/10.5115/acb.2012.45.2.114Anat Cell Biol 2012;45:114-120 119 www.acbjournal.organd RT-qPCR gradually increased with age, although no  significant differences were observed between the PM 8 and PM 12 groups.",Non-OADS,/arxiv_data1/oa_pdf/ea/85/acb-45-114.PMC3398173.pdf
"Anat Cell Biol 2012;45:114-120 Sun Shin Yi, et al 120 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.11412.",OADS,/arxiv_data1/oa_pdf/ea/85/acb-45-114.PMC3398173.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.121 pISSN 2093-3665   eISSN 2093-3673 Purkinje cells loss in oﬀ  spring due to maternal  morphine sulfate exposure: a morphometric study Mohammad Jafar Golalipour1, Soraya Ghafari2 1Gorgan Congenital Malformations Research Center, Department of Anatomical Sciences, 2Department of Anatomical Sciences, Faculty of Medicine,  Golestan University of Medical Sciences, Gorgan, Iran  Abstract:  Th e toxic eff  ects of morphine sulfate in the adult cerebral cortex and one-day neonatal cerebellum have been studied.",Non-OADS,/arxiv_data1/oa_pdf/3b/5f/acb-45-121.PMC3398174.pdf
Anat Cell Biol 2012;45:121-127 Mohammad Jafar Golalipour and Soraya Ghafari 122 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.121cerebellum layers of adult rats [12].,Non-OADS,/arxiv_data1/oa_pdf/3b/5f/acb-45-121.PMC3398174.pdf
Morphine and cerebellar development  http://dx.doi.org/10.5115/acb.2012.45.2.121Anat Cell Biol 2012;45:121-127 123 www.acbjournal.orgexperimental group were randomly selected and scarified  quickly with chloroform anesthesia.,Non-OADS,/arxiv_data1/oa_pdf/3b/5f/acb-45-121.PMC3398174.pdf
"Anat Cell Biol 2012;45:121-127 Mohammad Jafar Golalipour and Soraya Ghafari 124 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.121density of Purkinje cells, soma area, perimeter and diameter of  Purkinje cells in the apex and depth of folium, were measured at high magnification (100× objective) (Figs.",OADS,/arxiv_data1/oa_pdf/3b/5f/acb-45-121.PMC3398174.pdf
Morphine and cerebellar development  http://dx.doi.org/10.5115/acb.2012.45.2.121Anat Cell Biol 2012;45:121-127 125 www.acbjournal.orgexposure during gestation reduces Purkinje cells in one-day- old mice offspring [13].,Non-OADS,/arxiv_data1/oa_pdf/3b/5f/acb-45-121.PMC3398174.pdf
"Anat Cell Biol 2012;45:121-127 Mohammad Jafar Golalipour and Soraya Ghafari 126 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.121periods In conclusion, this study reveals that morphine administra- tion before and during gestational and lactation period causes Purkinje cell loss and reductio n of the size and thickness of  PCL of the cerebellar cortex in 18- and 32-day-old infant mice.",Non-OADS,/arxiv_data1/oa_pdf/3b/5f/acb-45-121.PMC3398174.pdf
Morphine and cerebellar development  http://dx.doi.org/10.5115/acb.2012.45.2.121Anat Cell Biol 2012;45:121-127 127 www.acbjournal.orgaddicts: hypoxic brain damage after chronic intravenous drug  abuse.,Non-OADS,/arxiv_data1/oa_pdf/3b/5f/acb-45-121.PMC3398174.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.128 pISSN 2093-3665   eISSN 2093-3673 Three types of the serial segmented images suitable for surface reconstruction Dong Sun Shin1, Jin Seo Park2, Min Suk Chung1 1Department of Anatomy, Ajou University School of Medicine, Suwon, 2Department of Anatomy, Dongguk University College of Medicine, Gyeongju,  Korea Abstract:  Stereoscopic surface models of human organs can be manipulated in real time.",Non-OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
Th ree types of the serial segmented images http://dx.doi.org/10.5115/acb.2012.45.2.128Anat Cell Biol 2012;45:128-135 129 www.acbjournal.orgprograms without extra programming [4-7].,OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
"Anat Cell Biol 2012;45:128-135 Dong Sun Shin, et al 130 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.128Unlike the outlined images, the white-fi  lled images excluded  the sectioned images (Fig.",OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
Th ree types of the serial segmented images http://dx.doi.org/10.5115/acb.2012.45.2.128Anat Cell Biol 2012;45:128-135 131 www.acbjournal.orgConversion of color-fi  lled images into outlined images  (Photoshop) This procedure was the same as above for the outlined  images converted from the white-filled images.,OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
"Anat Cell Biol 2012;45:128-135 Dong Sun Shin, et al 132 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.128With the Maya software, the surface models of the  chosen structures were displayed with their transparency adjusted to show various scenes (Fig.",OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
"Th ree types of the serial segmented images http://dx.doi.org/10.5115/acb.2012.45.2.128Anat Cell Biol 2012;45:128-135 133 www.acbjournal.orgfiles due to the highly organized PSD files, even when the  sectioned images were discarded.",OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
"Anat Cell Biol 2012;45:128-135 Dong Sun Shin, et al 134 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.128the timeline panel, which provides a glance at the layers  (structures) and frames (extent of structures’ outlines), is used to detect any mistakes and to plan the surface reconstruction (Fig.",OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
Th ree types of the serial segmented images http://dx.doi.org/10.5115/acb.2012.45.2.128Anat Cell Biol 2012;45:128-135 135 www.acbjournal.orga high-resolution spatial/symbolic model of the inner organs  based on the Visible Human.,OADS,/arxiv_data1/oa_pdf/c3/70/acb-45-128.PMC3398175.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.136 pISSN 2093-3665   eISSN 2093-3673 Four-headed biceps brachii, three-headed coracobrachialis muscles associated with arterial and nervous anomalies  in the upper limb Mehmet Mutlu Catli, Umut Ozsoy, Y asemin Kaya, Arzu Hizay, Fatos Belgin Yildirim, Levent Sarikcioglu Department of Anatomy, Faculty of Medicine, Akdeniz University, Antalya, Turkey  Abstract:  A four-headed biceps brachii muscle and three-headed coracobrachialis muscle, high-originated radial artery and  communication between the median and musculocutaneous nerves have been well documented in the available literature.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/acb-45-136.PMC3398176.pdf
Multiple variations in the upper limb  http://dx.doi.org/10.5115/acb.2012.45.2.136Anat Cell Biol 2012;45:136-139 137 www.acbjournal.orgheads of the biceps brachii muscle and finally joined to  the musculocutaneous nerve at the level of lower third of the humerus (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/c4/acb-45-136.PMC3398176.pdf
"Anat Cell Biol 2012;45:136-139 Mehmet Mutlu Catli, et al 138 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.136Niedenführ et al.",OADS,/arxiv_data1/oa_pdf/a7/c4/acb-45-136.PMC3398176.pdf
Multiple variations in the upper limb  http://dx.doi.org/10.5115/acb.2012.45.2.136Anat Cell Biol 2012;45:136-139 139 www.acbjournal.orgnot only for anatomist but also for clinicians.,Non-OADS,/arxiv_data1/oa_pdf/a7/c4/acb-45-136.PMC3398176.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.73 pISSN 2093-3665   eISSN 2093-3673 From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers Fariz Nurwidya, Fumiyuki Takahashi, Kunihiko Minakata, Akiko Muraka mi, Kazuhisa Takahashi  Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan Abstract:  Hypoxia, defi  ned as a decrease of tissue oxygen levels, repres ents a fundamental pathophysiological condition in  the microenvironment of solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/99/2b/acb-45-73.PMC3398177.pdf
"Anat Cell Biol 2012;45:73-78 Fariz Nurwidya, et al 74 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.73to the classical tumor phenotypes of upregulated glycolysis  and angiogenesis, leading to widespread interest in the HIF system as a target in cancer therapeutics [11].",Non-OADS,/arxiv_data1/oa_pdf/99/2b/acb-45-73.PMC3398177.pdf
"Role of HIF-1 α in cancer progression http://dx.doi.org/10.5115/acb.2012.45.2.73Anat Cell Biol 2012;45:73-78 75 www.acbjournal.orgapoptosis, and angiogenesis [31].",Non-OADS,/arxiv_data1/oa_pdf/99/2b/acb-45-73.PMC3398177.pdf
"Anat Cell Biol 2012;45:73-78 Fariz Nurwidya, et al 76 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.73multiplies the cell death signal initiated by doxorubicin, and  inhibits cellular defensive mechanisms and angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/99/2b/acb-45-73.PMC3398177.pdf
Role of HIF-1 α in cancer progression http://dx.doi.org/10.5115/acb.2012.45.2.73Anat Cell Biol 2012;45:73-78 77 www.acbjournal.org1 mediates adaptation to hypoxia by actively downregulating  mitochondrial oxygen consumption.,Non-OADS,/arxiv_data1/oa_pdf/99/2b/acb-45-73.PMC3398177.pdf
"Anat Cell Biol 2012;45:73-78 Fariz Nurwidya, et al 78 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.7338.",OADS,/arxiv_data1/oa_pdf/99/2b/acb-45-73.PMC3398177.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.79 pISSN 2093-3665   eISSN 2093-3673 Reappraisal of intergender diﬀ  erences in  the urethral striated sphincter explains why a completely circular arrangement is diﬃ   cult  in females: a histological study using human fetuses Hiroshi Masumoto1, Atsushi Takenaka2, Jose Francisco Rodríguez-Vázquez3, Gen Murakami4, Akio  Matsubara5  1Department of Urology, National Hospital Organizati on Higashi-Hiroshima Medical  Center, Higashi-Hiroshima, 2Department of Urology, Tottori  University School of Medicine, Y onago, Japan, 3Department of Anatomy and Embryology II, Faculty of Medicine, Universidad Complutense, Madrid, Spain,  4Division of Internal Medicine, Iwamizawa Kojin-kai Hospital, Iwamizawa, 5Department of Urology, Graduate School of Biomedical Sciences, Hiroshima  University, Hiroshima, Japan    Abstract:  To investigate why the development of a completely circular striated sphincter is so rare, we examined histological  sections of 11 female and 11 male mid-term human fetuses.",Non-OADS,/arxiv_data1/oa_pdf/d9/ea/acb-45-79.PMC3398178.pdf
"Anat Cell Biol 2012;45:79-85 Hiroshi Masumoto, et al 80 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.79in the process of descent to the future vestibulum.",OADS,/arxiv_data1/oa_pdf/d9/ea/acb-45-79.PMC3398178.pdf
Development of the rhabdosphincter http://dx.doi.org/10.5115/acb.2012.45.2.79Anat Cell Biol 2012;45:79-85 81 www.acbjournal.orgsome were stained with azan (red and blue) or azocarmine  (orange).,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/acb-45-79.PMC3398178.pdf
"Anat Cell Biol 2012;45:79-85 Hiroshi Masumoto, et al 82 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.79lower than that in Fig.",OADS,/arxiv_data1/oa_pdf/d9/ea/acb-45-79.PMC3398178.pdf
"Development of the rhabdosphincter http://dx.doi.org/10.5115/acb.2012.45.2.79Anat Cell Biol 2012;45:79-85 83 www.acbjournal.orginferior to a postero-anterior course (i.e., a horizontal shift  ) at  the future prostatic colliculus, i.e., the opening of the Wolffi   an  and Müllerian ducts into the urogenital sinus (Figs.",Non-OADS,/arxiv_data1/oa_pdf/d9/ea/acb-45-79.PMC3398178.pdf
"Anat Cell Biol 2012;45:79-85 Hiroshi Masumoto, et al 84 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.79remained constant during the stages examined.",OADS,/arxiv_data1/oa_pdf/d9/ea/acb-45-79.PMC3398178.pdf
"Development of the rhabdosphincter http://dx.doi.org/10.5115/acb.2012.45.2.79Anat Cell Biol 2012;45:79-85 85 www.acbjournal.orgG, Radmayr C. Fetal development of the female external urinary  sphincter complex: an anatomical and histological study.",Non-OADS,/arxiv_data1/oa_pdf/d9/ea/acb-45-79.PMC3398178.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.86 pISSN 2093-3665   eISSN 2093-3673 Vasculosyncytial membrane in relation to syncytial knots complicates the placenta in preeclampsia: a histomorphometrical study K. Devi Sankar1, P .",Non-OADS,/arxiv_data1/oa_pdf/f5/da/acb-45-86.PMC3398179.pdf
Vasculo-syncytial membra ne and syncytial knot http://dx.doi.org/10.5115/acb.2012.45.2.86Anat Cell Biol 2012;45:86-91 87 www.acbjournal.orgvascular development ultimately results in the alteration of  villous morphology in PE when compared with normal [11].,Non-OADS,/arxiv_data1/oa_pdf/f5/da/acb-45-86.PMC3398179.pdf
"Anat Cell Biol 2012;45:86-91 K. Devi Sankar, et al 88 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.86Results In the present study, 84 (42 each from control and  PE) placentas were investigated morphologically and histologically.",OADS,/arxiv_data1/oa_pdf/f5/da/acb-45-86.PMC3398179.pdf
Vasculo-syncytial membra ne and syncytial knot http://dx.doi.org/10.5115/acb.2012.45.2.86Anat Cell Biol 2012;45:86-91 89 www.acbjournal.org(Table 2).,OADS,/arxiv_data1/oa_pdf/f5/da/acb-45-86.PMC3398179.pdf
"Anat Cell Biol 2012;45:86-91 K. Devi Sankar, et al 90 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.86only in the cases of PE placenta, in which the VSM thickness  was also increased.",Non-OADS,/arxiv_data1/oa_pdf/f5/da/acb-45-86.PMC3398179.pdf
Vasculo-syncytial membra ne and syncytial knot http://dx.doi.org/10.5115/acb.2012.45.2.86Anat Cell Biol 2012;45:86-91 91 www.acbjournal.orgof the human placenta.,Non-OADS,/arxiv_data1/oa_pdf/f5/da/acb-45-86.PMC3398179.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.92 pISSN 2093-3665   eISSN 2093-3673 Protective eﬀ  ects of Ginkgo biloba extract (EGB  761) on astrocytes of rat hippocampus after exposure with scopolamine Mehrdad Jahanshahi1, EmseGol Nikmahzar2, Negin Y adollahi3, Kamyar Ramazani3 1Neuroscience Research Center, Department of Anatomy, Golestan University of Medical Sciences, 2Neuroscience Research Center, Golestan University of  Medical Sciences, 3Golestan University of Medical Sciences, Gorgan, Iran Abstract:  Th e regular extract of Ginkgo biloba  has been shown to possess neuroprotective properties in disorders like hypoxia,  ischemia, seizure activity and peripheral nerve damage.",Non-OADS,/arxiv_data1/oa_pdf/e6/6c/acb-45-92.PMC3398180.pdf
Ginkgo biloba extract and hippocampus astrocytes http://dx.doi.org/10.5115/acb.2012.45.2.92Anat Cell Biol 2012;45:92-96 93 www.acbjournal.orgscopola mine injection was recovered to normal levels by the  administration of wild ginseng [2].,Non-OADS,/arxiv_data1/oa_pdf/e6/6c/acb-45-92.PMC3398180.pdf
"Anat Cell Biol 2012;45:92-96 Mehrdad Jahanshahi, et al 94 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.92P<0.05 was considered signifi  cant.",OADS,/arxiv_data1/oa_pdf/e6/6c/acb-45-92.PMC3398180.pdf
"Ginkgo biloba extract and hippocampus astrocytes http://dx.doi.org/10.5115/acb.2012.45.2.92Anat Cell Biol 2012;45:92-96 95 www.acbjournal.orgIt seems in all areas of the hippocampus, an 80 mg/kg dose  of G. biloba  extract had a greater eff  ect than 40 mg/kg dose  of Ginkgo .",Non-OADS,/arxiv_data1/oa_pdf/e6/6c/acb-45-92.PMC3398180.pdf
"Anat Cell Biol 2012;45:92-96 Mehrdad Jahanshahi, et al 96 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.92(ventral part), thalamus (paraventricular nucleus), amygdala  (central nucleus) and dentate gyrus (EGb761, 5 mg/kg), bed nucleus of the stria terminalis (BNST) lateral division (dorsal) (EGb761, 2/5 and 5 mg/kg) [16].",Non-OADS,/arxiv_data1/oa_pdf/e6/6c/acb-45-92.PMC3398180.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2012.45.2.97 pISSN 2093-3665   eISSN 2093-3673 Diﬀ erential expression levels of synaptophysin  through developmental stages in hippocampal region of mouse brain Hee-Jang Pyeon1, Y oung-Il Lee2 Departments of 1NanoBio Medical Science and 2Anatomy, Dankook University College of Medicine, Cheonan, Korea Abstract:  Th e formation of neural synapses according to the development and growth of neurite were usually studied with  various markers.",OADS,/arxiv_data1/oa_pdf/6b/a3/acb-45-97.PMC3398181.pdf
"Anat Cell Biol 2012;45:97-102 Hee-Jang Pyeon and Y oung-Il Lee 98 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.97In our previous study, we investigated different synap- togenic patterns among the various regions of develo ping cerebral cortex and reported diff  erential expres sion levels of  synaptic marker (synaptophysin) between superficial and deep layers of cerebral cortex according to the developmental stages [8].",OADS,/arxiv_data1/oa_pdf/6b/a3/acb-45-97.PMC3398181.pdf
"Synaptophysin expressions in the developing hippocampal region http://dx.doi.org/10.5115/acb.2012.45.2.97Anat Cell Biol 2012;45:97-102 99 www.acbjournal.orgneurons were counter-stained with DAPI (ABBOT Molecular,  Des Plaines, IL, USA) and immediately inspected with the laser con-focal microscope system.",OADS,/arxiv_data1/oa_pdf/6b/a3/acb-45-97.PMC3398181.pdf
"Anat Cell Biol 2012;45:97-102 Hee-Jang Pyeon and Y oung-Il Lee 100 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.97Immunofl  uorescence fi  ndings of synaptophysin in  the layers of hippocampal region (hippocampus and subiculum) In the embryonic and neonatal group, synaptophysin  immunoreactivities following neural processes extended perpendicular between pyramidal cell layer and lacunosum molecular layer through radiatum layer (Fig.",OADS,/arxiv_data1/oa_pdf/6b/a3/acb-45-97.PMC3398181.pdf
Synaptophysin expressions in the developing hippocampal region http://dx.doi.org/10.5115/acb.2012.45.2.97Anat Cell Biol 2012;45:97-102 101 www.acbjournal.orgalso various among the groups of developmental stages.,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/acb-45-97.PMC3398181.pdf
Anat Cell Biol 2012;45:97-102 Hee-Jang Pyeon and Y oung-Il Lee 102 www.acbjournal.org http://dx.doi.org/10.5115/acb.2012.45.2.97the adult group although the background intensities in adult  group were included for the morphological calculations and statistical analyses.,OADS,/arxiv_data1/oa_pdf/6b/a3/acb-45-97.PMC3398181.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 2032 Journal of Investigative Dermatology (2012), Volume 132VA Kinsler et al.",Non-OADS,/arxiv_data1/oa_pdf/85/d8/jid201295a.PMC3398254.pdf
"A comparison of the predicted protein sequences of human and mouse kazrin (as published on the USCS GenomeBrowser; http://genome.ucsc.edu/) revealed that the proteinsencoded by exons 2–8 of mouse (accession numberNP_001103155.1) and human (accession number NP_056024.1) kazrinA are over 90% identical, but there issignificant divergence in exon 1 (Figure 1e).",OADS,/arxiv_data1/oa_pdf/50/fd/jid2012110a.PMC3398255.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.jidonline.org 1987MK Chhatriwala et al.",Non-OADS,/arxiv_data1/oa_pdf/50/fd/jid2012110a.PMC3398255.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4e/d9/els016.PMC3398257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/c3/f3/els022.PMC3398258.pdf
The significance of overlap/enrichment was calculated using the hypergeometric test implemented on the website (http://www.broadinstitute.org/gsea/msigdb/).,OADS,/arxiv_data1/oa_pdf/4a/26/srep00515.PMC3398386.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4a/26/srep00515.PMC3398386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kaczkowski, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/26/srep00515.PMC3398386.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311406140692012doi:10.1093/jxb/ers063Advance Access publication 28 March, 2012 Lu¨ et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/57/ers063.PMC3398443.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/c0/57/ers063.PMC3398443.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311407140832012doi:10.1093/jxb/ers088Advance Access publication 26 March, 2012 Romero et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/9a/ers088.PMC3398444.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/d4/9a/ers088.PMC3398444.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311408540942012doi:10.1093/jxb/ers092Advance Access publication 3 April, 2012 Ferna´ ndez Go´ mez and Wilson Non-destructive staging of barley reproductive developmentJournal of Experimental Botany , Page 1 of 10 doi:10.1093/jxb/ers092 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) RESEARCH PAPER Non-destructive staging of barley reproductive development for molecular analysis based upon external morphology Jose´Ferna ´ndez Go ´mez and Zoe A Wilson* School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leicestershire, LE12 5RD, UK * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/ad/9e/ers092.PMC3398445.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ad/9e/ers092.PMC3398445.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311412341312012doi:10.1093/jxb/ers094Advance Access publication 26 March, 2012 Vergara et al.",Non-OADS,/arxiv_data1/oa_pdf/bf/65/ers094.PMC3398446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/bf/65/ers094.PMC3398446.pdf
Sequence analysis of promoter regions Sequences of 1000 bp upstream from the transcription start site of the selected genes were download from the V. vinifera genomic database GENOSCOPE (http://www.genoscope.cns.fr).,OADS,/arxiv_data1/oa_pdf/bf/65/ers094.PMC3398446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311413341422012doi:10.1093/jxb/ers097Advance Access publication 26 March, 2012 Janicka-Russak et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/a8/ers097.PMC3398447.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/b5/a8/ers097.PMC3398447.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311415141642012doi:10.1093/jxb/ers098Advance Access publication 26 March, 2012 Zhang et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/09/ers098.PMC3398448.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/dc/09/ers098.PMC3398448.pdf
Results Sequence and gene structure of evolutionarily representative plant RTHs RTHs from other evolutionarily representative plant species could be retrieved from phytozome (http://www.phytozome.net/); their sequences are not shown in this study.,OADS,/arxiv_data1/oa_pdf/dc/09/ers098.PMC3398448.pdf
"On pairwise sequence alignment of RTHs and RTE1 (http://www.ebi.ac.uk/Tools/psa/emboss_needle/), RTE1 had the highest sequence iden-tity with and similarity to OsRTH1, and the lowest with AtRTH, OsRTH3, and RTHs of lower plants (Fig.",OADS,/arxiv_data1/oa_pdf/dc/09/ers098.PMC3398448.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311419142122012doi:10.1093/jxb/ers103Advance Access publication 17 April, 2012 Marraccini et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/68/ers103.PMC3398449.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/bd/68/ers103.PMC3398449.pdf
"GenBank (GB) and SGN (http://solgenomics.net, Mueller et al., 2005) accession numbers of ESTs and contigs containing the sequenced peptides are indicated.",OADS,/arxiv_data1/oa_pdf/bd/68/ers103.PMC3398449.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311421342182012doi:10.1093/jxb/ers106Advance Access publication 2 April, 2012 Boot et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/28/ers106.PMC3398450.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a2/28/ers106.PMC3398450.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311423342412012doi:10.1093/jxb/ers107Advance Access publication 17 April, 2012 Ogrocka´ et al.",Non-OADS,/arxiv_data1/oa_pdf/76/a6/ers107.PMC3398451.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/76/a6/ers107.PMC3398451.pdf
analysis (http://signal.salk.,OADS,/arxiv_data1/oa_pdf/76/a6/ers107.PMC3398451.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311421942322012doi:10.1093/jxb/ers109Advance Access publication 17 April, 2012 Yin et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/31/ers109.PMC3398452.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a1/31/ers109.PMC3398452.pdf
"The transgenic lines proDR5:GUS and pro cycB:GUS expressing GUS under the control of the DR5 (a synthetic auxin response element) and cyclin B ( cycB) promoters, respectively, were purchased from NASC (European Arabidopsis Stock Centre, http://arabidopsis.info/).",Non-OADS,/arxiv_data1/oa_pdf/a1/31/ers109.PMC3398452.pdf
"Data pre-processing and differential expression analysis of the gene expression data were done in R (version 2.10.0; Bioconductor, http://bioconductor.org/).",OADS,/arxiv_data1/oa_pdf/a1/31/ers109.PMC3398452.pdf
Probe annotation was according to Agilent’s web instructions (https://earray.chem.agilent.com/).,OADS,/arxiv_data1/oa_pdf/a1/31/ers109.PMC3398452.pdf
"Differential expressed kinases in upregulated genes Gene ID Name FamilyaFold change AC Fold change AB AT4G04490 CRK36 Cysteine-rich receptor-like protein kinase 3.27 0.72 AT5G48740 Leucine-rich repeat protein kinase family protein 2.79 1.76 AT1G70250 Transmembrane receptor protein serine/threonine kinase activity 2.5 1.27 AT5G10930 CIPK5 CBL-interacting protein kinase 5 2.39 1.63 AT5G01820 CIPK14 CBL-interacting protein kinase 14 2.27 2.07 aGene information was from TAIR10 (The Arabidopsis Information Resource, http://www.arabidopsis.org/).",Non-OADS,/arxiv_data1/oa_pdf/a1/31/ers109.PMC3398452.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311414341502012doi:10.1093/jxb/ers110Advance Access publication 17 April, 2012 Kai et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/0e/ers110.PMC3398453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/8e/0e/ers110.PMC3398453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311424342612012doi:10.1093/jxb/ers112Advance Access publication 10 May, 2012 Montesinos et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/ac/ers112.PMC3398454.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7c/ac/ers112.PMC3398454.pdf
"Generation of antibodies Rabbit antibodies against different Arabidopsis p24 proteins were generated by Eurogentec (Belgium, http://www.eurogentec.com) using as antigen peptides corresponding either to the N- or to the C-terminus of the indicated proteins: p24 d5-Ct (YLKRYFH- KKKLI), p24d 5-Nt (IWLTIPTTGG), p24 b2-Nt (IRFVIDREE), and p24 b2-Ct (LFERKLGMSRV).",Non-OADS,/arxiv_data1/oa_pdf/7c/ac/ers112.PMC3398454.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311429143012012doi:10.1093/jxb/ers118Advance Access publication 2 May, 2012 Richet et al.",Non-OADS,/arxiv_data1/oa_pdf/81/f0/ers118.PMC3398455.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/81/f0/ers118.PMC3398455.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311431543202012doi:10.1093/jxb/ers127Advance Access publication 2 May, 2012 Liu et al.",Non-OADS,/arxiv_data1/oa_pdf/40/f7/ers127.PMC3398456.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/f7/ers127.PMC3398456.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany 6311430343132012doi:10.1093/jxb/ers128Advance Access publication 4 May, 2012 Grantz and Vu Ozone, jasmonate, and ethylene in cottonJournal of Experimental Botany , Page 1 of 11 doi:10.1093/jxb/ers128 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) RESEARCH PAPER Root and shoot gas exchange respond additively to moderate ozone and methyl jasmonate without induction of ethylene: ethylene is induced at higher O 3concentrations D.A.",Non-OADS,/arxiv_data1/oa_pdf/7f/6e/ers128.PMC3398457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.Journal of Experimental Botany, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7f/6e/ers128.PMC3398457.pdf
Cy3-labeled cDNA was obtained according to the Nimblegen arrayuser’s guide ( http://www.nimblegen.com/products/lit/NG_Expression _Guide_v5p1.pdf ).,OADS,/arxiv_data1/oa_pdf/48/34/mBio.00079-12.PMC3398534.pdf
Genes with a /H110222.5-fold signal dif- ference and a Bayesian Pvalue of /H110210.001 ( http://cybert.microarray.ics.uci .edu) were selected to be signiﬁcantly regulated.Flow cytometric analysis.,OADS,/arxiv_data1/oa_pdf/48/34/mBio.00079-12.PMC3398534.pdf
http://dx.doi.org/10.1371/journal.ppat .1001247 .,Non-OADS,/arxiv_data1/oa_pdf/48/34/mBio.00079-12.PMC3398534.pdf
http://dx.doi.org/10.1371/journal.pone.0021133 .,Non-OADS,/arxiv_data1/oa_pdf/48/34/mBio.00079-12.PMC3398534.pdf
50:p:2357. http://dx.doi.org/10.3791/2357 .,Non-OADS,/arxiv_data1/oa_pdf/48/34/mBio.00079-12.PMC3398534.pdf
http://dx.doi.org/10.1186/gb -2002-3-7-research0034 .,Non-OADS,/arxiv_data1/oa_pdf/48/34/mBio.00079-12.PMC3398534.pdf
http://imagej.nih.gov/ij/ .,OADS,/arxiv_data1/oa_pdf/48/34/mBio.00079-12.PMC3398534.pdf
"http://dx.doi.org/10.1128/mBio.00150 -11 2.Pica N, et al.",OADS,/arxiv_data1/oa_pdf/12/1c/mBio.00138-12.PMC3398535.pdf
"http://dx.doi.org/10.1371/journal.pone.0028001 10.Corti D, et al.",OADS,/arxiv_data1/oa_pdf/12/1c/mBio.00138-12.PMC3398535.pdf
"Motif A of S. en- terica PanM was determined from an alignment with E. coli PanM using the software program ClustalW ( http://www.ebi.ac.uk/Tools/msa /clustalw2 ), based on the E. coli PanM motif A established by others (16).",OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00158-12.PMC3398536.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Catecholamine modulation of impulsivity D Economidou et al 2066 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/58/13/npp201253a.PMC3398724.pdf
"Available at: http://www.heart.org/HEARTORG/ HealthcareResearch/GetWithTheGuidelinesHFStroke/Get-With TheGuidelineHFStroke_UCM_001099_SubHomePage.jsp (accessed December 19, 2011).",Non-OADS,/arxiv_data1/oa_pdf/1f/48/cee-0002-0026.PMC3398824.pdf
"Available at: http://www.heart.org/HEARTORG/ HealthcareResearch/GetWithTheGuidelinesHFStroke/GetWithTheGuidelinesStrokeHomePage/Get-With-The-Guidelines-Stroke-RecognitionCriteria_UCM_310337_Article.jsp (accessed June 18, 2012)   15 Pollack MM, Katz RW, Ruttimann UE, Getson PR: Improving the outcome and efficiency of inten- sive care: the impact of an intensivist.",Non-OADS,/arxiv_data1/oa_pdf/1f/48/cee-0002-0026.PMC3398824.pdf
"I hope you will enjoy these commentaries and that they will entice you to read the original articles.Rho GTPases Central regulators of cell migration Michael J. Williams Uppsala University; Uppsala, Sweden Correspondence to: Michael J. Williams; Email: michael.williams@neuro.uu.se Submitted: 04/01/12; Accepted: 04/01/12http://dx.doi.org/10.4161/sgtp.20335References 1.",Non-OADS,/arxiv_data1/oa_pdf/83/b5/sgtp-3-1.PMC3398910.pdf
Biochimie  1988; 70:865-8; PMID:3145021; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/b5/sgtp-3-1.PMC3398910.pdf
Cell 1995; 81:53-62; PMID:7536630;  http://dx.doi.org/10.1016/0092-8674(95)90370-4.3.,OADS,/arxiv_data1/oa_pdf/83/b5/sgtp-3-1.PMC3398910.pdf
Cell Commun Signal 2010; 8:23; PMID:20822528; http://dx.doi.org/10.1186/1478- 811X-8-23.,OADS,/arxiv_data1/oa_pdf/83/b5/sgtp-3-1.PMC3398910.pdf
Cell 1992; 70:389-99; PMID:1643657; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/b5/sgtp-3-1.PMC3398910.pdf
FEBS Lett 2008; 582:2093-101; PMID:18460342; http://dx.doi.org/10.1016/j.febslet.2008.04.039.,OADS,/arxiv_data1/oa_pdf/83/b5/sgtp-3-1.PMC3398910.pdf
"25Subsequent studies with LARG, PDZ-RhoGEF, and p63RhoGEF have all found Val 43 of RhoA hydrophobically engages either a Lys or Arg residue of the *Correspondence to: Shawn M. Ellerbroek; Email: shawn.ellerbroek@wartburg.edu Submitted: 12/13/11; Revised: 01/19/12; Accepted: 02/01/12 http://dx.doi.org/10.4161/sgtp.19557RESEARCH PAPER Small GTPases 3:1, 15 –22; January/February/March 2012; G2012 Landes Bioscience www.landesbioscience.com Small GTPases 15",Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Cell 1985; 41:31-40; PMID:3888408; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Cell 2004; 116:167-79; PMID:14744429; http://dx.doi.org/10.1016/S0092-8674(04)00003-0 3.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Cell Sci 2004; 117:1301-12; PMID:15020670; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Annu Rev Cell Dev Biol 2005; 21:247-69; PMID:16212495; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Exp Cell Res 2004; 301:43-9; PMID:15501444; http://dx.doi.org/ 10.1016/j.yexcr.2004.08.012 7.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Cell Biol 2001; 154:147- 60; PMID:11448997; http://dx.doi.org/10.1083/jcb.200103048 8.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Science 2003; 302:1775-9; PMID: 14657501; http://dx.doi.org/10.1126/science.1090772 9.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Nat Rev Cancer 2001; 1:162-8; PMID: 11905808; http://dx.doi.org/10.1038/35101096 10.,Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Cell Signal 2009; 21:1522-31; PMID: 19477269; http://dx.doi.org/10.1016/j.cellsig.2009.05.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Cancer Res2004; 64:8694-701; PMID:15574779; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Genes Dev 2005; 19:1974-9; PMID: 16107613; http://dx.doi.org/10.1101/gad.131080514.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Biol Chem 1998; 273:18943-9; PMID: 9668072; http://dx.doi.org/10.1074/jbc.273.30.18943 15.,Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Histochem Cytochem 1995; 43:471-80; PMID:7537292; http://dx.doi.org/10.1177/43.5.7537292 16.,Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Cell Biol 2001; 152: 111-26; PMID:11149925; http://dx.doi.org/10.1083/ jcb.152.1.111 17.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Trends Cell Biol 2001; 11:471-7; PMID: 11719051; http://dx.doi.org/10.1016/S0962-8924(01) 02153-5 18.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Biol Chem 1996; 271:13556-60; PMID:8662891; http://dx.doi.org/10.1074/jbc.271.23.13556 19.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
FEBS Lett 1995;377:243-8; PMID:8543060; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Cell Biol 2011; 193:655-65; PMID:21576392; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Oncogene 2010; 29:2441-8; PMID:20101212; http://dx.doi.org/10.1038/onc.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Nat Rev Mol Cell Biol 2005; 6:167-80; PMID: 15688002; http://dx.doi.org/10.1038/nrm158725.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Nat Struct Biol 2002; 9:468-75; PMID:12006984; http://dx.doi.org/10.1038/nsb796 26.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Biol Chem 2004; 279:47352-62; PMID:15331592;http://dx.doi.org/10.1074/jbc.M406056200 27.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
The molecular basis of RhoA specificity inthe guanine nucleotide exchange factor PDZ-RhoGEF.J Biol Chem 2006; 281:32891-7; PMID:16954208; http://dx.doi.org/10.1074/jbc.M606220200 28.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Science 2007; 318: 1923-7; PMID:18096806; http://dx.doi.org/10.1126/ science.1147554 29.,Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Biol Chem 2002; 277:42964-72; PMID:12221096; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
EMBO J 1999; 18:578-85; PMID: 9927417; http://dx.doi.org/10.1093/emboj/18.3.578 31.,Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
J Biol Chem 2003; 278:19023-31; PMID:12654918; http://dx.doi.org/10.1074/jbc.M213066200 32.,OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
Naunyn Schmiedebergs Arch Pharmacol 2004; 369:540-6; PMID:15069594;http://dx.doi.org/10.1007/s00210-004-0926-5 35.,Non-OADS,/arxiv_data1/oa_pdf/56/48/sgtp-3-15.PMC3398911.pdf
"Do not distribute.www.landesbioscience.com  Small GTP ases  71Small GTPases 3:1, 71–72; January/February/March 2012; © 2012 Landes Bioscience EDITOR’S CAORNER EDITOR’S CORNER In this issue of Small GTPases Elaine L. Ellerton Landes Bioscience; Austin, TX USA Correspondence to: Elaine L. Ellerton; Email: elaine@landesbioscience.com Submitted: 02/27/12; Accepted: 02/27/12http://dx.doi.org/10.4161/sgtp.19937Tiam1 Drives Polarized Protrusion Outgrowth   pp.",Non-OADS,/arxiv_data1/oa_pdf/a3/d9/sgtp-3-2.PMC3398912.pdf
"Do not distribute.Endosomal trafficking pathway regulated by ARA6, a RAB5 GTPase unique to plants Kazuo Ebine,1,†Naoto Miyakawa,1Masaru Fujimoto,1Tomohiro Uemura,1Akihiko Nakano1,2and Takashi Ueda1,* 1Department of Biological Sciences; Graduate School of Science; The University of Tokyo; Bunkyo-ku, Tokyo Japan;2Molecular Membrane Biology Laboratory; RIKEN Advanced Science Institute; Wako, Saitama Japan †Current affiliation: Department of Parasitology; National Institute of Infectious Diseases; Shinjuku-ku, Tokyo Japan Keywords: Rab5, ARA6, SNARE, Arabidopsis thaliana , endosome, stress response Submitted: 09/08/11Revised: 10/01/11Accepted: 10/04/11 http://dx.doi.org/10.4161/sgtp.18299 *Correspondence to: Takashi Ueda; Email: tueda@biol.s.u-tokyo.ac.jp Commentary to: Ebine K, Fujimoto M, Okatani Y, Nishiyama T, Goh T, Ito E. A membrane trafficking pathway regulated by the plant-specific RAB GTPase ARA6.",Non-OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
"Nat Cell Biol 2011; 13:853– 9; PMID:21666683; http://dx.doi.org/10.1038/ncb2270Lineage-specific expansion, followed by functional diversification of key components that act in membrane trafficking, is thought to contributeto lineage-specific diversification of organelles and membrane trafficking pathways.",OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
J Plant Res 2009; 122:21-30; PMID:19082690; http://dx.doi.org/10.1007/s10265-008-0200-x 2.,Non-OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
"Evolution of the eukaryotic membrane-trafficking system: origin, tempo and mode.J Cell Sci 2007; 120:2977-85; PMID:17715154;http://dx.doi.org/10.1242/jcs.013250 3.",OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Mol Membr Biol2010; 27:469-89; PMID:21067450; http://dx.doi.org/10.3109/09687688.2010.521201 4.,Non-OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
J Mol Biol2001; 313:889-901; PMID:11697911; http://dx.doi.org/10.1006/jmbi.2001.5072 5.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Microbes Infect 2008; 10:462-70; PMID:18468471; http://dx.doi.org/10.1016/j.micinf.2008.01.017 6.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
J Mol Biol2000; 301:1077-87; PMID:10966806; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Exp Parasitol 2005; 110:244-52; PMID:15955319; http://dx.doi.org/10.1016/j.exppara.2005.02.021 9.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
J Eukaryot Microbiol 2010; 57:389-99; PMID:20738463; http://dx.doi.org/10.1111/j.1550- 7408.2010.00503.x 10.,Non-OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
EMBO J 2001; 20:4730-41; PMID:11532937; http://dx.doi.org/10.1093/emboj/20.17.4730 11.,Non-OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Cell 2007; 19:3504-15; PMID:18055610; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Cell 2007; 19:1295-312; PMID:17468262; http://dx.doi.org/10.1105/tpc.106.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant J 2004; 40:783-9; PMID:15546360; http://dx.doi.org/ 10.1111/j.1365-313X.2004.02249.x 14.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Cell 2003; 15:1057-70; PMID:12724533; http://dx.doi.org/10.1105/tpc.009779 17.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
J Cell Sci 2004; 117:943-54; PMID:14762108; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Physiol 2007; 144:6-17; PMID: 17369437; http://dx.doi.org/10.1104/pp.106.092973 19.,Non-OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Cell Struct Funct 2004; 29:49-65;PMID:15342965; http://dx.doi.org/10.1247/csf.29.49 20.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Mol Biol 2000; 42:923-36; PMID:10890538; http://dx.doi.org/ 10.1023/A:100644971523622.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Physiol 2009;149:916-28; PMID:19036832; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Nat Cell Biol 2011; 13:853-9; PMID:21666683; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Proc Natl Acad Sci USA 2000;97:6896-901; PMID:10823923; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Cell 2002; 14:465-77; PMID:11884687; http://dx.doi.org/ 10.1105/tpc.010371 26.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Cell 2009; 21:2859-77; PMID:19794113; http://dx.doi.org/10.1105/tpc.109.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Plant Cell 2010; 22:3076-92; PMID:20884800; http://dx.doi.org/10.1105/tpc.110.077768 29.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
CurrOpin Plant Biol 2011; 14:332-9; PMID:21507708;http://dx.doi.org/10.1016/j.pbi.2011.03.017 30.,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
Trends CellBiol 2008; 18:199-209; PMID:18396047; http://dx.doi.org/10.1016/j.tcb.2008.03.002 www.landesbioscience.com Small GTPases 27,OADS,/arxiv_data1/oa_pdf/42/32/sgtp-3-23.PMC3398913.pdf
"Do not distribute.The taming of a Rab GTPase by Legionella pneumophila M. Ramona Neunuebel and Matthias P. Machner* Cell Biology and Metabolism Program; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; Bethesda, MD USA Keywords: Legionella, Rab1, GEF, GAP, AMPylation, de-AMPylation, phosphocholination Submitted: 09/07/11Revised: 11/04/11Accepted: 11/08/11 http://dx.doi.org/10.4161/sgtp.18704 *Correspondence to: Matthias P. Machner; Email: machnerm@mail.nih.gov Commentary to: Neunuebel MR, Chen Y, Gaspar AH, Backlund PS, Jr., Yergey A, Machner MP.",Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Cell Host Microbe 2009; 5:593-601; PMID:19527886; http://dx.doi.org/10.1016/j.chom.2009.05.014 2.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
MicrobiolMol Biol Rev 2007; 71:636-52; PMID:18063721;http://dx.doi.org/10.1128/MMBR.00023-07 3.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Physiol Rev2011; 91:119-49; PMID:21248164; http://dx.doi.org/ 10.1152/physrev.00059.2009 4.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Nat Rev Mol Cell Biol 2009; 10:513-25; PMID:19603039; http://dx.doi.org/10.1038/nrm2728 5.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Annu Rev Cell Dev Biol 2010; 26:261-83; PMID:20929312; http://dx.doi.org/10.1146/annurev-cellbio-100109-1040346.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Traffic 2009; 10:76-87; PMID:18980612; http://dx.doi.org/ 10.1111/j.1600-0854.2008.00851.x 7.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Nature 2007; 450:365-9; PMID:17952054; http://dx.doi.org/10.1038/nature06336 9.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Cell Microbiol 2006; 8:793- 805; PMID:16611228; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Infect Immun 2004; 72:3048-53; PMID:15102819; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Nat Cell Biol 2002; 4:945-54; PMID:12447391; http://dx.doi.org/10.1038/ncb883 12.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
J Exp Med 2004; 199:1201- 11; PMID:15117975; http://dx.doi.org/10.1084/jem.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Dev Cell 2006; 11:47-56; PMID:16824952; http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Biosci Rep 2011; 31:159-68; PMID: 21250943; http://dx.doi.org/10.1042/BSR20100112 17.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Science 2004; 303:1358-61;PMID:14988561; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Science 2011; 333:453-6; PMID:21680813; http://dx.doi.org/10.1126/science.120719319.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Science 2010; 329:946-9; PMID:20651120; http://dx.doi.org/10.1126/science.1192276 20.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Nature 2011; 475: 506-9; PMID:21734656; http://dx.doi.org/10.1038/ nature10307 21.,Non-OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
Nature 2011; PMID:21822290; http://dx.doi.org/10.1038/nature10335 24.,OADS,/arxiv_data1/oa_pdf/62/81/sgtp-3-28.PMC3398914.pdf
"Do not distribute.KRAS mutant colorectal tumors Past and present Toni M. Brand and Deric L. Wheeler* Department of Human Oncology; University of Wisconsin School of Medicine and Public Health; Madison, WI USA Keywords: KRAS, EGFR, cetuximab, GTPase, resistance, metastatic colorectal cancer Abbreviations: ADCC, antibody dependent cellular cytotoxicity; ASCO, America Society for Clinical Oncology; BRAF, v-Raf murine sarcoma viral oncogene homolog B1; CRC, colorectal cancer;EGFR, epidermal growth factor receptor;FDA, Food and Drug Administration;GAPs, GTPase activating proteins; GEFs,guanosine nucleotide exchange factors;GRB2, growth-factor-receptor boundp r o t e i n2 ;G T P ,g u a n o s i n et r i p h o s p h a t e ; HGFR, hepatocyte growth factor receptor; IGF-1R, insulin-like growth factor receptortype 1; IHC, immunohistochemistry;KRAS, V-Ki-ras2 Kirsten rat sarcoma viraloncogene homolog; MAPK, mitogen-activated protein kinase; mABs, monoclonalantibodies; mCRC, metastatic colon cancer;MEK, mitogen-activated protein kinase kinase; MET, hepatocyte growth factor receptor; PI3K, phosphoinositide 3-kinase;PTEN, phosphatase and tensin homologuedeleted in chromosome 10; RTKs, receptortyrosine kinases; SFKs, Src family kinases;SHC, SH-2 containing protein; SOS, son ofsevenless homolog 1; STAT, signaltransducer and activator of transcription Submitted: 09/06/11 Revised: 11/09/11Accepted: 11/12/11 http://dx.doi.org/10.4161/sgtp.18751 *Correspondence to: Deric L. Wheeler; Email: dlwheeler@wisc.edu Commentary to: Dunn EF, Iida M, Myers RA, Campbell DA, Hintz KA, Armstrong EA, et al.",Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Oncogene 2011; 30:561 – 74; PMID:20956938; http://dx.doi.org/10.1038/onc.2010.430The treatment of metastatic colorectal cancer (mCRC) remains one of the largest hurdles in cancer therapeutics to date.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
CA Cancer J Clin 2010; 60:277-300; PMID: 20610543; http://dx.doi.org/10.3322/caac.20073 2.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Br J Cancer 2010; 103:1765-72; PMID:21139621; http://dx.doi.org/10.1038/sj.bjc.6606008 3.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nat Rev Mol Cell Biol 2006; 7:505-16; PMID:16829981; http://dx.doi.org/10.1038/nrm1962 4.,OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nat Rev Mol Cell Biol 2001; 2:127-37; PMID:11252954; http://dx.doi.org/10.1038/35052073 5.,OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Eur J Cancer 2001; 37(Suppl 4):S9-15;PMID:11597399; http://dx.doi.org/10.1016/S0959- 8049(01)00231-3 6.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Cancer Cell 2005; 7:301-11; PMID:15837620; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Cancer Sci 2007;98:1275-80; PMID:17498200; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Clin Cancer Res 2007; 13:1552-61; PMID: 17332301; http://dx.doi.org/10.1158/1078-0432.CCR- 06-1726 9.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nat Rev Drug Discov 2006; 5:987-8; PMID:17201026; http://dx.doi.org/10.1038/nrd2204 10.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
CritRev Oncol Hematol 2001; 38:17-23; PMID:11255078; http://dx.doi.org/10.1016/S1040-8428(00)00134-7 11.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
N Engl J Med 2004; 351:337-45; PMID:15269313; http://dx.doi.org/10.1056/NEJMoa033025 12.,OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
"Van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chang C h i e nC R ,M a k h s o nA ,e ta l .C e t u x i m a ba n dc h e m o -therapy as initial treatment for metastatic colorectal cancer.N Engl J Med 2009; 360:1408-17; PMID:19339720; http://dx.doi.org/10.1056/NEJMoa0805019 13.",Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
J Clin Oncol 2005; 23:1803-10; PMID:15677699;http://dx.doi.org/10.1200/JCO.2005.08.037 15.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nat Rev Clin Oncol 2009; 6:519-27; PMID:19636327; http://dx.doi.org/10.1038/nrclinonc.2009.111 16.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nat Rev Cancer 2007; 7:295-308; PMID:17384584; http://dx.doi.org/ 10.1038/nrc210917.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nature 1993; 366:643-54; PMID: 8259209; http://dx.doi.org/10.1038/366643a0 18.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Oncogene 1999; 18:1303-12; PMID:10022812; http://dx.doi.org/10.1038/sj.onc.1202425 19.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nature1987; 327:293-7; PMID:3587348; http://dx.doi.org/ 10.1038/327293a0 20.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Cancer Res 2007; 67:2643-8; PMID:17363584;http://dx.doi.org/10.1158/0008-5472.CAN-06-4158 23.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Mol Cancer Ther 2005; 4: 677-85; PMID:15827342; http://dx.doi.org/10.1158/ 1535-7163.MCT-04-0297 25.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Cancer Treat Rev 2010;36:S1-5; PMID:21129603; http://dx.doi.org/10.1016/ S0305-7372(10)70012-8 26.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nature 2010; 464:431-5; PMID: 20130576; http://dx.doi.org/10.1038/nature08833 29.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nature 2006; 439:358-62; PMID: 16273091; http://dx.doi.org/10.1038/nature04304 30.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Cancer Res 2011; 71:445-53; PMID:21118963; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Nat Med 1999; 5:810-6; PMID: 10395327; http://dx.doi.org/10.1038/10533 32.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Semin Oncol 2003; 30:105-16; PMID:14613031; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
J Clin Oncol 2004; 22:4456- 62; PMID:15483017; http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Invest New Drugs 2011; 29:1021-8; PMID:20127139; http://dx.doi.org/10.1007/s10637- 010-9392-8 35.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
J Clin Oncol 2010;28:4240-6; PMID:20713879; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Clin Cancer Res 2011; 17:472-82; PMID:21098338; http://dx.doi.org/10.1158/1078-0432.CCR-10-0568 44.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Cancer Res 2008; 68:8322-32; PMID:18922904; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Clin Colorectal Cancer 2010; 9:89-94; PMID:20378502; http://dx.doi.org/10.3816/CCC.,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
Oncogene 2011; 30:561-74; PMID:20956938; http://dx.doi.org/ 10.1038/onc.2010.43047.,OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
JAMA 2010; 304:1812-20; PMID: 20978259; http://dx.doi.org/10.1001/jama.2010.1535 www.landesbioscience.com Small GTPases 39,Non-OADS,/arxiv_data1/oa_pdf/5c/40/sgtp-3-34.PMC3398915.pdf
"Subsequently, upon inactivation of GSK3β , APC together with Dlg1 regulates microtubule *Correspondence to: Saskia I. J. Ellenbroek and John G. Collard; Email: s.ellenbroek@nki.nl and j.collard@nki.nl Submitted: 09/07/11; Revised: 01/01/12; Accepted: 01/16/12 http://dx.doi.org/10.4161/sgtp.19379Small GTPases 3:1, 4 –14; January/February/March 2012; G2012 Landes Bioscience 4 Small GTPases Volume 3 Issue 1",Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Cell 2001; 106:489-98; PMID:11525734; http://dx.doi.org/10.1016/S0092-8674(01)00471-8 3.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nature 2003; 421:753-6; PMID:12610628;http://dx.doi.org/10.1038/nature01423 4.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Cell Biol 2005; 170:895-901; PMID:16157700; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Clin Invest 1996; 97:162-71; PMID:8550829; http://dx.doi.org/10.1172/JCI118385 7.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
"Goode BL, Drubin DG, Barnes G. Functional coopera- tion between the microtubule and actin cytoskeletons.Curr Opin Cell Biol 2000; 12:63-71; PMID:10679357;http://dx.doi.org/10.1016/S0955-0674(99)00058-7 8.",OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Annu Rev Cell Dev Biol 2005; 21:247-69;PMID:16212495; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Mammalian Rho GTPases: new insights into their functions from in vivo studies.Nat Rev Mol Cell Biol 2008; 9:690-701; PMID:18719708; http://dx.doi.org/10.1038/nrm2476 11.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
TrendsCell Biol 2006; 16:522-9; PMID:16949823; http://dx.doi.org/10.1016/j.tcb.2006.08.006 12.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Cell Biol 2011; 193:381- 96; PMID:21482721; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Blood 2006; 108:2814-20; PMID: 16809619; http://dx.doi.org/10.1182/blood-2006-01- 010363 14.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Dev Biol 2004; 265:23-32; PMID: 14697350; http://dx.doi.org/10.1016/j.ydbio.2003.06.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Science 2003; 302:1775-9; PMID: 14657501; http://dx.doi.org/10.1126/science.1090772 16.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Cell Biol 2010; 191:585-98; PMID:21041448;http://dx.doi.org/10.1083/jcb.201002151 17.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Cell Biol2007; 176:863-75; PMID:17353362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Cell Biol 2005; 170:1029-37; PMID:16186252; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nat Cell Biol 2005; 7:270-7; PMID:15723051; http://dx.doi.org/10.1038/ncb1227 21.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Curr Biol 2007; 17:1623-34; PMID:17825562; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nat Cell Biol 2006; 8:227-37; PMID:16474385; http://dx.doi.org/10.1038/ncb1368 23.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
NatCell Biol 2005; 7:262-9; PMID:15723052; http://dx.doi.org/10.1038/ncb1226 24.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nature 2002; 417:867-71; PMID:12075356; http://dx.doi.org/10.1038/nature00848 25.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Methods Enzymol 2008; 439:111-29; PMID:18374160; http://dx.doi.org/ 10.1016/S0076-6879(07)00409-0 27.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Biol Chem 2007; 282:35666-78; PMID:17932039; http://dx.doi.org/10.1074/jbc.M70357120028.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nat Rev Mol CellBiol 2003; 4:938-47; PMID:14685172; http://dx.doi.org/10.1038/nrm1260 29.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Curr Biol 2006; 16:2259-64; PMID:17113391; http://dx.doi.org/10.1016/j.cub.2006.09.065 30.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nature 1995; 375: 338-40; PMID:7753201; http://dx.doi.org/10.1038/375338a0 31.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J CellBiol 1999; 144:1235-44; PMID:10087266; http://dx.doi.org/10.1083/jcb.144.6.1235 32.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nature2009; 461:104-8; PMID:19693014; http://dx.doi.org/ 10.1038/nature08241 33.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Curr Opin Cell Biol 2005; 17:517-23; PMID:16099152; http://dx.doi.org/10.1016/j.ceb.2005.08.004 34.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Dev Cell 2006; 11:21-32; PMID:16824950; http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Cell Biol 2003; 161:845-51; PMID:12796474; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Biol Chem 2004; 279:6196-203; PMID:14645234; http://dx.doi.org/10.1074/jbc.M307261200 39.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nat Cell Biol 2003; 5:599-609; PMID: 12833063; http://dx.doi.org/10.1038/ncb0703-599 40.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Cell 2002; 109:873-85; PMID:12110184; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Dev Cell 2004; 7:871-83; PMID:15572129; http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Mol Biol Cell 2010; 21:3518-28; PMID:20719958; http://dx.doi.org/10.1091/mbc.E09-08-0709 44.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Science 2000; 289:1194-7; PMID:10947987; http://dx.doi.org/10.1126/science.289.5482.1194 45.,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nat Cell Biol 2003; 5:211-5; PMID:12598901; http://dx.doi.org/10.1038/ncb937 46.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Nat Cell Biol 2002; 4:294-301; PMID:11912491; http://dx.doi.org/ 10.1038/ncb77347.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Biol Chem 1998; 273:34954-60; PMID: 9857026; http://dx.doi.org/10.1074/jbc.273.52.34954 48.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Bio- chem Biophys Res Commun 2011; 408:322-8; PMID: 21513698; http://dx.doi.org/10.1016/j.bbrc.2011.04.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Biol Chem 1999; 274: 1401-6; PMID:9880513; http://dx.doi.org/10.1074/ jbc.274.3.1401 50.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Biol Chem 1995; 270:30241-4; PMID:8530437; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Biol Chem 2001; 276:1677-80; PMID: 11058583; http://dx.doi.org/10.1074/jbc.C000635200 52.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Neuron 2006; 51:727-39; PMID:16982419; http://dx.doi.org/10.1016/j.neuron.2006.07.020 53.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
Methods Enzymol 2006; 407:269-81; PMID:16757331; http://dx.doi.org/ 10.1016/S0076-6879(05)07023-0 54.,OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
J Biol Chem 2004; 279:30092-8; PMID:15138270; http://dx.doi.org/10.1074/jbc.M401192200 14 Small GTPases Volume 3 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/25/fd/sgtp-3-4.PMC3398916.pdf
"Tam Embryology Unit; Children ’s Medical Research Institute and Sydney Medical School; The University of Sydney; Sydney, NSW Australia Keywords: embryo, endoderm, epithelium, differentiation, organogenesis, polarity, cytoskeleton Submitted: 10/31/11 Revised: 11/17/11 Accepted: 11/21/11http://dx.doi.org/10.4161/sgtp.18820 *Correspondence to: David A.F.",Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Development 2011; 138:4511 –22; PMID:21903671; http://dx.doi.org/10.1242/dev.063867The embryonic foregut of the mouse embryo is lined by a layer of endoderm cells whose architecture changes during development.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Cell 2004; 6:845-54; PMID:15177032; http://dx.doi.org/10.1016/j.devcel.2004.05.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Dyn 2007; 236:2767-78; PMID: 17849438; http://dx.doi.org/10.1002/dvdy.21309 3.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Curr Biol 2000; 10:758-65; PMID:10898977; http://dx.doi.org/10.1016/S0960-9822(00)00571-6 4.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Dyn 2009; 238:3111-25; PMID:19924810; http://dx.doi.org/10.1002/dvdy.22157 5.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Development 2011; 138:4511-22; PMID: 21903671; http://dx.doi.org/10.1242/dev.063867 6.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Curr Biol 2004; 14:2052-6; PMID:15556869; http://dx.doi.org/10.1016/j.cub.2004.11.011 7.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Mol Biol Cell 2011; 22:2119-30; PMID:21508312; http://dx.doi.org/10.1091/mbc.E10-12-0969 8.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
J Biol Chem 2005; 280:33055- 65; PMID:16046391; http://dx.doi.org/10.1074/jbc.M507362200 9.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Exp Cell Res 2007; 313:3673-9; PMID:17850788; http://dx.doi.org/10.1016/j.yexcr.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Mol Cell Biol 2009; 29:1035-49;PMID:19064640; http://dx.doi.org/10.1128/MCB.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Genes Dev 2001; 15:1796-807; PMID:11459829; http://dx.doi.org/10.1101/gad.89430113.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Mech Dev 1999; 89:115-24; PMID: 10559486; http://dx.doi.org/10.1016/S0925-4773(99) 00213-0 14.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Neuron 1999; 22:667-76; PMID:10230788; http://dx.doi.org/10.1016/S0896-6273(00) 80727-8 15.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Mol Cell Biol 2010; 30:1329-40; PMID: 20065035; http://dx.doi.org/10.1128/MCB.00795-09 16.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Nat Cell Biol 2011; 13:952-7; PMID:21785423; http://dx.doi.org/10.1038/ ncb2291 18.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Cell 2009; 139:791- 801; PMID:19914171; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
J Neurosci 2011; 31:13921-35; PMID:21957254; http://dx.doi.org/10.1523/JNEUROSCI.3343-11.2011 21.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Annu Rev Cell Dev Biol2004; 20:781-810; PMID:15473860; http://dx.doi.org/10.1146/annurev.cellbio.20.010403.113126 22.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Development 2005; 132:2599-609; PMID: 15857914; http://dx.doi.org/10.1242/dev.01842 23.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Biol 2009; 330:286-304; PMID:19358838; http://dx.doi.org/10.1016/j.ydbio.2009.03.026 24.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
BMC Dev Biol 2007; 7:4; PMID:17222338; http://dx.doi.org/ 10.1186/1471-213X-7-425.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Cell 2009; 17:290-8; PMID:19686689; http://dx.doi.org/10.1016/j.devcel.2009.06.005 26.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
J Cell Biochem 2009; 108:295-303; PMID:19562671; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Cancer Res 2006;66:7578-88; PMID:16885357; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Biol 2007; 306:121-33; PMID:17433286; http://dx.doi.org/10.1016/j.ydbio.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Am JPhysiol Renal Physiol 2011; 300:F549-60; PMID: 20534871; http://dx.doi.org/10.1152/ajprenal.00566.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Dyn 2005; 232:685-94; PMID:15712202; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Mol Cell Endocrinol 2010; 323:35-54; PMID: 20026174; http://dx.doi.org/10.1016/j.mce.2009.12.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Endocrinology 2003; 144: 3618-24; PMID:12865344; http://dx.doi.org/10.1210/ en.2003-0393 33.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Dev Biol 2006;290:44-56; PMID:16364283; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Nat Rev Mol Cell Biol 2007; 8:633-44; PMID:17643125; http://dx.doi.org/10.1038/nrm2222 36.,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
Biophys J 2009; 97: 1873-82; PMID:19804717; http://dx.doi.org/10.1016/j.bpj.2009.07.050 44 Small GTPases Volume 3 Issue 1,OADS,/arxiv_data1/oa_pdf/76/b0/sgtp-3-40.PMC3398917.pdf
"Do not distribute.Control of Rho GTPase function by BAR-domains Bart-Jan de Kreuk and Peter L. Hordijk* Department of Molecular Cell Biology; Sanquin Research and Landsteiner Laboratory; Academic Medical Center; University of Amsterdam; Amsterdam, The Netherlands Keywords: Rho GTPase, BAR, RhoGAP, RhoGEF, cytoskeleton, migration Submitted: 11/03/11 Revised: 12/02/11 Accepted: 12/06/11http://dx.doi.org/10.4161/sgtp.18960 *Correspondence to: Peter L. Hordijk; Email: p.hordijk@sanquin.nl Commentary to: de Kreuk BJ, Nethe M,Fernandez-Borja M, Anthony EC, Hensbergen PJ,Deelder AM, et al.",Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Cell Sci 2011;124:2375 –88; PMID:21693584; http://dx.doi.org/ 10.1242/jcs.080630Cytoskeletal dynamics are key to the establishment of cell polarity and the consequent coordination of protru- sion and contraction that drives cellmigration.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Annu Rev Cell Dev Biol 2005; 21:247-69; PMID:16212495; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Nat Rev Mol Cell Biol 2005; 6:167-80; PMID:15688002; http://dx.doi.org/10.1038/nrm1587 4.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Trends Cell Biol 2004; 14:377-85; PMID:15246431; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Nat Rev Mol Cell Biol 2011; 12:493-504; PMID:21779026; http://dx.doi.org/10.1038/nrm3153 6.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Trends Cell Biol 2007; 17:246-50; PMID:17363257; http://dx.doi.org/10.1016/j.tcb.2007.03.001 7.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Mol Biol Cell 2004; 15:256-67; PMID: 14617821; http://dx.doi.org/10.1091/mbc.E03-01-0019 8.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Dev Cell 2002; 2:411-23; PMID:11970892; http://dx.doi.org/10.1016/S1534-5807(02) 00145-4 9.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Nature 1996; 382:177-9; PMID:8700210; http://dx.doi.org/10.1038/382177a0 10.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
"Biochem J 2003; 371:233-41; PMID: 12564953; http://dx.doi.org/10.1042/BJ20030139 11. de Kreuk BJ, Nethe M, Fernandez-Borja M, Anthony EC, Hensbergen PJ, et al.",OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Cell Sci 2011; 124:2375- 88; PMID:21693584; http://dx.doi.org/10.1242/jcs.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
EMBO J 2011;30:3501-15; PMID:21878992; http://dx.doi.org/10.1038/emboj.2011.266 13.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Cell2009; 137:191-6; PMID:19379681; http://dx.doi.org/10.1016/j.cell.2009.04.01014.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Curr Biol 1997; 7:479-87; PMID:9210375; http://dx.doi.org/10.1016/ S0960-9822(06)00219-3 15.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Cell 2004; 118: 203-16; PMID:15260990; http://dx.doi.org/10.1016/ j.cell.2004.06.027 16.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Cancer Res 2010; 70:8347-56; PMID:20940394; http://dx.doi.org/10.1158/0008-5472.CAN-09-4149 17.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Neurosci 2008;28:8316-25; PMID:18701694; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Nature 2000; 408:732-5; PMID:11130076; http://dx.doi.org/ 10.1038/35047107 23.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Cell Sci 2008; 121:379-90; PMID:18198193; http://dx.doi.org/10.1242/jcs.01027224.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Cell Sci 2005; 118:5393- 403; PMID:16280553; http://dx.doi.org/10.1242/jcs.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Biochem Biophys Res Commun 2010; 401:527-32; PMID:20875796; http://dx.doi.org/10.1016/j.bbrc.2010.09.087 27.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Biol Cell 2007; 99:67-86; PMID:17222083; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Cell 2009; 138:990-1004; PMID:19737524; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Cell 2001; 107:209-21; PMID:11672528; http://dx.doi.org/10.1016/S0092-8674(01)00530-X www.landesbioscience.com Small GTPases 51,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Nat Cell Biol 2002; 4:970-5; PMID:12447388; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Biol Chem 2000; 275:36885-91; PMID:10967100; http://dx.doi.org/10.1074/jbc.M004069200 38.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Biol Chem 2001; 276:35060-70; PMID:11431473; http://dx.doi.org/ 10.1074/jbc.M103540200 39.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Cell 2006; 125:535-48; PMID:16678097; http://dx.doi.org/10.1016/j.cell.2006.02.045 40.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Biol Chem 2010; 285:12308-20; PMID:20080965; http://dx.doi.org/10.1074/jbc.M109.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Cell Biol 2009; 184:721-36; PMID:19273615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Biochem Soc Trans 2009; 37:1061-5; PMID: 19754452; http://dx.doi.org/10.1042/BST037106143.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Mol Biol Cell 2011; 22:4380-9; PMID: 21965292; http://dx.doi.org/10.1091/mbc.E10-12-0936 46.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Nature 1998; 392:923-6; PMID:9582072; http://dx.doi.org/10.1038/31940 47.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Curr Biol 2009; 19:1133-9; PMID:19481455; http://dx.doi.org/10.1016/j.cub.2009.05.022 48.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Neuron 2002; 33: 789-804; PMID:11879655; http://dx.doi.org/10.1016/ S0896-6273(02)00601-3 49.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Cell Biol 2001; 152:971-84; PMID: 11238453; http://dx.doi.org/10.1083/jcb.152.5.971 50.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Biochem J 2002; 367:57-65; PMID:12093360; http://dx.doi.org/10.1042/BJ2002082951.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Nature 2001; 411:701-6; PMID:11395774; http://dx.doi.org/10.1038/35079621 53.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Mol Biol Cell 2007; 18:1242-52; PMID:17267693;http://dx.doi.org/10.1091/mbc.E06-06-0510 54.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Mol Cell 2011; 42:650-61; PMID:21658605; http://dx.doi.org/10.1016/j.molcel.2011.03.032 55.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
Methods Enzymol 2005; 404: 537-45; PMID:16413298; http://dx.doi.org/10.1016/S0076-6879(05)04047-4 56.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
J Cell Biol 2010; 189:661-9; PMID:20479467; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/71/f6/sgtp-3-45.PMC3398918.pdf
"Bourguignon Department of Medicine; University of California at San Francisco; and Endocrine Unit (111N2); VA Medical Center; San Francisco, CA USA Keywords: hyaluronan, CD44, miRNAs, RhoGTPases, cytoskeleton, tumor progression Submitted: 11/10/11 Revised: 12/15/11Accepted: 12/19/11http://dx.doi.org/10.4161/sgtp.19110 Correspondence to: Lilly Y.W.",Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Oncogene 2012; 31:149– 60; PMID:21685938; http://dx.doi.org/10.1038/onc.2011.222Ahallmark of all solid tumor malig- nancies is the ability to invade the surrounding tissue and/or metastasize to distant sites.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Cancer Metastasis Rev 2005; 24:35-45; PMID:15785871; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Curr Opin Cell Biol 2000; 12:581-6; PMID:10978893; http://dx.doi.org/ 10.1016/S0955-0674(00)00135-6 4.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Chem Rev 2006; 106:818-39; PMID:16522010; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Biol Chem2002; 277:4593-6; PMID:11717318; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Semin Cancer Biol 2008; 18:251-9; PMID:18450475; http://dx.doi.org/10.1016/j.semcancer.2008.03.007 7.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
"Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis.Trends Immunol 2001; 22:317-21; PMID:11377291; http://dx.doi.org/10.1016/S1471-4906(01)01936-6 9.",OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Cell Sci 2008; 121:925-32; PMID:18354082; http://dx.doi.org/10.1242/jcs.022038 10.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Science 1998; 279:509-14; PMID:9438836; http://dx.doi.org/10.1126/science.279.5350.509 11.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Oncogene 2009;28:2219-30; PMID:19421144; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
"Cell Motil Cytoskeleton 1999; 43:269-87; PMID:10423269; http://dx.doi.org/10.1002/(SICI) 1097-0169(1999)43:4 ,269::AID-CM1 .3.0.CO;2-514.",OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
APMIS 2007; 115:1090-106; PMID: 18042145; http://dx.doi.org/10.1111/j.1600-0463.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
RNA 2004;10:1957-66; PMID:15525708; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Biol Chem 2007; 282:32773-9; PMID:17724023; http://dx.doi.org/10.1074/jbc.M705054200 17.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Virus Res 2004; 102:3-9;PMID:15068874; http://dx.doi.org/10.1016/j.virusres.2004.01.009 18.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Int J Cancer 2009; 125:1407-13; PMID:19536818; http://dx.doi.org/10.1002/ijc.24522 58 Small GTPases Volume 3 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Biol Chem 2010; 285:7986-94; PMID:20075075; http://dx.doi.org/10.1074/jbc.M109.062877 20.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Nature 2007; 449:682-8; PMID: 17898713; http://dx.doi.org/10.1038/nature06174 21.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Biol Chem 2010; 285:36721-35; PMID:20843787; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Nat Biotechnol 2010; 28:341-7; PMID:20351690; http://dx.doi.org/10.1038/nbt.1618 23.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Biol Chem 2005; 280:20310-5; PMID: 15784621; http://dx.doi.org/10.1074/jbc.M50073720024.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Oncogene 2012; 31:149-60; PMID:21685938; http://dx.doi.org/10.1038/onc.2011.222 25.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Breast Cancer Res 2010;12:201; PMID:20346098; http://dx.doi.org/10.1186/bcr2484 26.,Non-OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Oncogene 2007; 26:2799- 803; PMID:17072344; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
Oncogene 2008; 27:2128-36; PMID:17968323; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Biol Chem 2009; 284:26533-46; PMID:19633292; http://dx.doi.org/ 10.1074/jbc.M109.027466 30.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
J Biol Chem 2008; 283: 17635-51; PMID:18441325; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/df/4a/sgtp-3-53.PMC3398919.pdf
"Do not distribute.Rac-ing to the plasma membrane The long and complex work commute of Rac1 during cell signaling Xosé R. Bustelo,* Virginia Ojeda, María Barreira, Vincent Sauzeau†and Antonio Castro-Castro Centro de Investigación del Cáncer; Instituto de Biología Molecular y Celular del Cáncer; CSIC —University of Salamanca; Campus Unamuno; Salamanca, Spain †Current address: L ’Institut du Thorax-UMR 915; Nantes, France Keywords: coronin, Rac1, F-actin, cytoskeleton, lipid rafts, β-Pix, ArhGEF7, Pak, RhoGDI Submitted: 11/05/11 Revised: 12/16/11 Accepted: 12/19/11http://dx.doi.org/10.4161/sgtp.19111 *Correspondence to: Xosé R. Bustelo; Email: xbustelo@usal.es Commentary to: Castro-Castro A, Ojeda V,Barreira M, Sauzeau V, Navarro-Lérida I, Muriel O,et al.",Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
"EMBO J 2011; 30:3913 –27; PMID:21873980; http://dx.doi.org/10.1038/emboj.2011.310The functional cycle of the Rac1 GTPase involves a large number of steps, including post-translational pro- cessing, cytosolic sequestration byRhoGDIs, translocation to specific sub- cellular localizations, activation by GDP/ GTP exchange, inactivation by GTPhydrolysis, and re-formation of cytosolicRac1/RhoGDI inhibitory complexes.Here, we summarize the current know-ledge about the regulation of those steps.In addition, we discuss a recently descri-bed, cytoskeletal-dependent feed-back loop that favors the efficient translocation and activation of Rac subfamily proteinsduring cell signaling.",Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Bioessays 2007; 29:356-70;PMID:17373658; http://dx.doi.org/10.1002/bies.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
J Cell Biol 2008; 181:485- 96; PMID:18443222; http://dx.doi.org/10.1083/jcb.200801047 3.,Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Mol Cell 2011; 42:50-61; PMID: 21474067; http://dx.doi.org/10.1016/j.molcel.2011.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Cell Signal 1998; 10: 167-72; PMID:9607139; http://dx.doi.org/10.1016/ S0898-6568(97)00120-4 5.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
J Biol Chem 2008; 283:25150-63; PMID:18614539; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Cell Adh Migr 2011;5:11-5; PMID:20798596; http://dx.doi.org/10.4161/ cam.5.1.13196 8.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
J Clin Invest 2011;121:628-39; PMID:21266780; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Mol Biol Cell 2005; 16:1606-16; PMID: 15659645; http://dx.doi.org/10.1091/mbc.E04-11-0960 10.,Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
GDIs: central regulatory molecules in Rho GTPase activation.Trends Cell Biol 2005; 15:356-63; PMID:15921909;http://dx.doi.org/10.1016/j.tcb.2005.05.001 11.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Cell 2007; 129:865-77; PMID:17540168; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Cell 2003; 115:851-62; PMID:14697203; http://dx.doi.org/10.1016/S0092- 8674(03)01014-6 14.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
"J Biol Chem 2003; 278:37916-25; PMID:12805377; http://dx.doi.org/10.1074/jbc.M301437200 16. ten Klooster JP, Jaffer ZM, Chernoff J, Hordijk PL.",OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
J Cell Biol 2006; 172: 759-69; PMID:16492808; http://dx.doi.org/10.1083/jcb.200509096 17.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
J Biol Chem 2000; 275:423-8; PMID:10617634; http://dx.doi.org/ 10.1074/jbc.275.1.423 www.landesbioscience.com Small GTPases 65,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Nat Cell Biol 2010; 12:1078-85; PMID:20935639; http://dx.doi.org/10.1038/ncb2112 19.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Nat Commun 2011;2:259; PMID:21448158; http://dx.doi.org/10.1038/ ncomms1243 21.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Science 2006; 314:1458-61; PMID: 17095657; http://dx.doi.org/10.1126/science.1134389 22.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Science 2008;319:210-3; PMID:18187657; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Nat Cell Biol 2007; 9:1381-91; PMID:18026091; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Nat Cell Biol 2005; 7:901-8; PMID:16113676; http://dx.doi.org/10.1038/ ncb1293 26.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Cell 2008; 134:135-47; PMID:18614017;http://dx.doi.org/10.1016/j.cell.2008.05.034 27.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Traffic 2010; 11:198-209; PMID:19961560; http://dx.doi.org/10.1111/j.1600- 0854.2009.01015.x 28.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Mol Cell 2004; 15:117-27; PMID:15225553; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
J Biol Chem 2003; 278:39413-21; PMID:12888567; http://dx.doi.org/ 10.1074/jbc.M302083200 31.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Mol Biol Cell 2009; 20:2049-59; PMID:19211846; http://dx.doi.org/10.1091/mbc.E07-12-1248 32.,Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
EMBO J 2011; 30:3913-27; PMID:21873980; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Bioessays 2005; 27:625-32; PMID: 15892111; http://dx.doi.org/10.1002/bies.20235 34.,Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
Mol Cell1998; 1:183-92; PMID:9659915; http://dx.doi.org/ 10.1016/S1097-2765(00)80019-2 66 Small GTPases Volume 3 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/92/32/sgtp-3-60.PMC3398920.pdf
"McCarty Departments of Biomedical Engineering and Cell and Developmental Biology; School of Medicine; Oregon Health & Science University; Portland, OR USA Keywords: actin, cytoskeleton, GEF, P-Rex1, Rac1, rapamycin, Rheb, S6K1, TIAM1, TSC2 Submitted: 11/04/11Accepted: 12/21/11 http://dx.doi.org/10.4161/sgtp.19137 *Correspondence to: Joseph E. Aslan; Email: aslanj@ohsu.edu Commentary to: Aslan JE, Tormoen GW, Loren CP, Pang J, McCarty OJT.",Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
"Blood 2011; 118:3129 –36; PMID:21757621; http://dx.doi.org/10.1182/blood-2011-02-331579Small GTPase proteins regulate cyto- skeletal dynamics to orchestrate diverse cellular functions in organismal physiology, development and disease.",Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Br J Haematol 2009; 147:415-30; PMID: 19656155; http://dx.doi.org/10.1111/j.1365-2141.2009.07819.x 2.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
ArteriosclerThromb Vasc Biol 2010; 30:2341-9; PMID:21071698; http://dx.doi.org/10.1161/ATVBAHA.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
J Cell Biol 1999; 144:745-54; PMID:10037795; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
PMID:22045984; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
J Biol Chem 2005; 280:39474-84; PMID:16195235;http://dx.doi.org/10.1074/jbc.M504672200 Figure 1.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
"Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phospholipase C. Blood 2002; 100:3561-9; PMID:12411320; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
PLoSOne 2011; 6:e22117; PMID:21789221; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
J Thromb Haemost 2005; 3:1752-62; PMID:16102042; http://dx.doi.org/10.1111/j.1538-7836.2005.01429.x 10.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Nat Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025 12.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Trends Mol Med 2007; 13:252-9; PMID: 17452018; http://dx.doi.org/10.1016/j.molmed.2007.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
J Clin Invest 2011; 121:1231-41; PMID:21490404;http://dx.doi.org/10.1172/JCI44145 14.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Am JPhysiol Gastrointest Liver Physiol 2006; 291:G510-7; PMID:16710051; http://dx.doi.org/10.1152/ajpgi.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Am J PhysiolHeart Circ Physiol 2005; 288:H2861-8; PMID: 15708965; http://dx.doi.org/10.1152/ajpheart.00561.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Oncogene 2011; 30:2420-32; PMID:21258406;http://dx.doi.org/10.1038/onc.2010.61517.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Cancer Res 2011; 71:3246-56; PMID:21430067; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Cell 1996; 85:573-83; PMID: 8653792; http://dx.doi.org/10.1016/S0092-8674(00)81257-X 19.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Biochem Biophys Res Commun 1997; 233:193-9; PMID:9144421; http://dx.doi.org/10.1006/ bbrc.1997.6419 20.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Blood 2007; 109:1975-83; PMID:17110454; http://dx.doi.org/10.1182/blood- 2006-08-042192 21.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
J Mater Sci Mater Med 2007;18:2193-8; PMID:17607513; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Blood 2011; 118:3129- 36; PMID:21757621; http://dx.doi.org/10.1182/blood-2011-02-331579 24.,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
J Biol Chem 2003; 278:18833-41; PMID:12531897; http://dx.doi.org/10.1074/jbc.M20787620026.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Mol Cell 2010; 40:877-92; PMID:21172654; http://dx.doi.org/10.1016/j.molcel.2010.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Cell 2002; 108:809-21; PMID:11955434; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Mol Cell 2011; 42:50-61; PMID: 21474067; http://dx.doi.org/10.1016/j.molcel.2011.03.017 31.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Sci Signal 2009; 2:pe24; PMID:19383975; http://dx.doi.org/10.1126/scisignal.267pe24 32.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
J Biol Chem 2011; 286:24553-60; PMID:21592956; http://dx.doi.org/ 10.1074/jbc.M110.202341 33.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
Dev Cell 2010; 19:845-57; PMID:21145500; http://dx.doi.org/10.1016/j.devcel.2010.11.004 34.,OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
BiochemSoc Trans 2009; 37:217-22; PMID:19143635; http://dx.doi.org/10.1042/BST0370217 70 Small GTPases Volume 3 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/df/a5/sgtp-3-67.PMC3398921.pdf
"Do not distribute.Epigenetics 7:6, 542-550; June 2012; © 2012 Landes Bioscience REsEaRch  pap ER 542 Epigenetics  V olume 7 Issue 6*Correspondence to: Manel Esteller; Email: mesteller@idibell.cat Submitted: 04/26/12; Accepted: 04/26/12http://dx.doi.org/10.4161/epi.20523Introduction Alterations of the epigenetic landscape and single gene loci are  associated to different types of diseases.",Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nat Biotechnol 2010; 28:1057- 68; PMID:20944598; http://dx.doi.org/10.1038/nbt.1685.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
N Engl J Med  2008; 358:1148-59; PMID:18337604; http://dx.doi.org/10.1056/NEJMra072067.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nat Genet 2007; 39:457-66; PMID:17334365; http://dx.doi.org/10.1038/ng1990.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Cell 1992; 69:915-26; PMID:1606615; http://dx.doi.org/10.1016/0092-8674(92)90611-F .,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nature 1999; 402:187-91; PMID:10647011; http://dx.doi.org/10.1038/46214.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Clin Genet 2011; In press; PMID:21906047; http://dx.doi.org/10.1111/j.1399-0004.2011.01783.x.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Am J Hum Genet 2011; 88:796-804; PMID:21596365; http://dx.doi.org/10.1016/j.ajhg.2011.04.018.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
PLoS One 2011; 6:19464; PMID:21559330; http://dx.doi.org/10.1371/journal.pone.0019464.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Cell 1999; 99:247-57; PMID:10555141; http://dx.doi.org/10.1016/S0092-8674(00)81656-6.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Mutat Res 2012; 729:100-5; PMID:22032830; http://dx.doi.org/10.1016/j.mrfmmm.2011.10.007.12.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Hum Mol Genet 2008; 17:690-709; PMID:18029387; http://dx.doi.org/10.1093/hmg/ddm341.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Epigenetics 2010; 5:427-43; PMID:20448464; http://dx.doi.org/10.4161/epi.5.5.11999.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Hum Mol Genet 2002; 11:3191-8; PMID:12444103; http://dx.doi.org/10.1093/hmg/11.25.3191.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Hum Mutat 2000; 16:509-17; PMID:11102980; http://dx.doi.org/10.1002/1098-1004(200012)16:6<509::AID-HUMU8>3.0.CO;2-V. 17.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Hum Mutat 2005; 25:56-63; PMID:15580563; http://dx.doi.org/10.1002/humu.20113.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Genome Res 2009; 19:1639-45; PMID:19541911; http://dx.doi.org/10.1101/gr.092759.109.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Hum Mol Genet 2000; 9:2575-87; PMID:11063717; http://dx.doi.org/10.1093/hmg/9.18.2575.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nat Genet 2009; 41:1350-3; PMID:19881528; http://dx.doi.org/10.1038/ng.471.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nat Genet 2009; 41:178-86; PMID:19151715; http://dx.doi.org/10.1038/ng.298.22.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
PLoS One 2007; 2:603; PMID:17622348; http://dx.doi.org/10.1371/journal.pone.0000603.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Cell 2007; 129:823-37; PMID:17512414; http://dx.doi.org/10.1016/j.cell.2007.05.009.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nature 2001; 410:120-4; PMID:11242054; http://dx.doi.org/10.1038/35065138.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Genes Dev 2005; 19:431-5; PMID:15681608; http://dx.doi.org/10.1101/gad.1263005.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Mol Cell Biol 2006; 26:9185-95; PMID:17030614; http://dx.doi.org/10.1128/MCB.01529-06.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Genes Dev 2006; 20:1848-67; PMID:16847345; http://dx.doi.org/10.1101/gad.1422906.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nucleic Acids Res 2011; 39:104-18; PMID:20841325; http://dx.doi.org/10.1093/nar/gkq774.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
EMBO J 2003; 22:1599-607; PMID:12660166; http://dx.doi.org/10.1093/emboj/cdg160.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Hum Mol Genet 2006; 15:1375-85; PMID:16543361; http://dx.doi.org/10.1093/hmg/ddl059.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
J Mol Biol 2011; 409:758-72; PMID:21549127; http://dx.doi.org/10.1016/j.jmb.2011.04.050.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Development 2006; 133:1183-92; PMID:16501171; http://dx.doi.org/10.1242/dev.02293.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nature 2007; 448:714-7; PMID:17687327; http://dx.doi.org/10.1038/nature05987.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
BMC Bioinformatics  2009; 10:232; PMID:19635165; http://dx.doi.org/10.1186/1471-2105-10-232.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Bioinformatics 2009; 25:2078-9; PMID:19505943; http://dx.doi.org/10.1093/bioin-formatics/btp352.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Bioinformatics 2010; 26:841-2; PMID:20110278; http://dx.doi.org/10.1093/bioinformatics/btq033.39.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Immunol Rev 2009; 228:132-48; PMID:19290925; http://dx.doi.org/10.1111/j.1600-065X.2008.00748.x.,Non-OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Mol Cell 2011; 44:17-28; PMID:21924933; http://dx.doi.org/10.1016/j.molcel.2011.08.026.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Cell 2011; 146:1029-41; PMID:21925323; http://dx.doi.org/10.1016/j.cell.2011.08.016.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Nucleic Acids Res 2010; 38:4246-53; PMID:20223770; http://dx.doi.org/10.1093/nar/gkq147.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
Genome Res 2012; 22:1128-38 PMID:22466170; http://dx.doi.org/10.1101/gr.133728.111.,OADS,/arxiv_data1/oa_pdf/42/99/epi-7-542.PMC3398983.pdf
"Do not distribute.www.landesbioscience.com  Epigenetics  635Epigenetics 7:6, 635-651; June 2012; © 2012 Landes Bioscienc e REsEaRch  pap ER REsEaRch  pap ER *Correspondence to: Franz Varga; Email: franz.varga@osteologie.at Submitted: 11/26/11; Revised: 03/22/12; Accepted: 03/26/12http://dx.doi.org/10.4161/epi.20163Introduction Methylation of cytosine-guanine dinucleotides (CpGs) on DNA  is an important epigenetic mechanism involved in the selective regulation of gene expression and in the stabilization of chroma-tin.",Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 1986; 321:209-13; PMID:2423876; http://dx.doi.org/10.1038/321209a0.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 2007; 449:1073-7; PMID:17960246; http://dx.doi.org/10.1038/nature06251.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Hum Mol Genet 2000; 9:2395-402; PMID:11005794; http://dx.doi.org/10.1093/hmg/9.16.2395.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 1999; 397:579-83; PMID:10050851; http://dx.doi.org/10.1038/17533.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 2007; 445:671-5; PMID:17268471; http://dx.doi.org/10.1038/nature05515.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell 2008; 135:1201-12; PMID:19109892; http://dx.doi.org/10.1016/j.cell.2008.11.042.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell 2011; 145:423-34; PMID:21496894; http://dx.doi.org/10.1016/j.cell.2011.03.022.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 2010; 466:1129-33; PMID:20639862; http://dx.doi.org/10.1038/nature09303.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell Cycle 2011; 10:2428-36; PMID:21750410; http://dx.doi.org/10.4161/cc.10.15.16930.12.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell Cycle 2009; 8:1526-31; PMID:19377292; http://dx.doi.org/10.4161/cc.8.10.8500.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 2011; 473:398-402; PMID:21460836; http://dx.doi.org/10.1038/nature10008.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 2011; 473:389-93; PMID:21451524; http://dx.doi.org/10.1038/nature09934.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Stem Cells 2006; 24:2549-56; PMID:16840553; http://dx.doi.org/10.1634/stemcells.2005-0427.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nat Biotechnol 2007; 25:84-90; PMID:17211407; http://dx.doi.org/10.1038/nbt1272.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell T ransplant 1996; 5:131-43; PMID:8689027; http://dx.doi.org/10.1016/0963-6897(95)02040-3.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Biochem Biophys Res Commun 1981; 98:614-20; PMID:6261745; http://dx.doi.org/10.1016/0006-291X(81)91158-X.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Bioorg Chem 2004; 32:234-43; PMID:15210338; http://dx.doi.org/10.1016/j.bioorg.2004.04.005.22.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Science 1999; 284:143-7; PMID:10102814; http://dx.doi.org/10.1126/science.284.5411.143.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Cell Physiol 2007; 211:253-60; PMID:17167770; http://dx.doi.org/10.1002/jcp.20933.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Cell Biochem 2006; 99:1233-9; PMID:16795049; http://dx.doi.org/10.1002/jcb.20958.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Biol Chem 2003; 278:34387-94; PMID:12815054; http://dx.doi.org/10.1074/jbc.M211386200.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Rev Endocr Metab Disord 2006; 7:1-16; PMID:17051438; http://dx.doi.org/10.1007/s11154-006-9001-5.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Gene 2006; 366:51-7; PMID:16314053; http://dx.doi.org/10.1016/j.gene.2005.10.011.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Cell Biol 1983; 96:191-8; PMID:6826647; http://dx.doi.org/10.1083/jcb.96.1.191.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Bone 1996; 18:591-9; PMID:8806001; http://dx.doi.org/10.1016/8756-3282(96)00068-3.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Cell Biol 1983; 96:191-8; PMID:6826647; http://dx.doi.org/10.1083/jcb.96.1.191.Software) while p ≤ 0.05 was considered as significant.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 2011; 473:343-8; PMID:21490601; http://dx.doi.org/10.1038/nature10066.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nature 2011; 473:394-7; PMID:21552279; http://dx.doi.org/10.1038/nature10102.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell 2011; 145:423-34; PMID:21496894; http://dx.doi.org/10.1016/j.cell.2011.03.022.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Endocr Rev 2000; 21:115-37; PMID:10782361; http://dx.doi.org/10.1210/er.21.2.115.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Bone Miner Res 1999; 14:893-903; PMID:10352097; http://dx.doi.org/10.1359/jbmr.1999.14.6.893.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Bone Miner Res 2001; 16:1772-9; PMID:11585340; http://dx.doi.org/10.1359/jbmr.2001.16.10.1772.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Haematologica 2012; 97:324; PMID:22383741; http://dx.doi.org/10.3324/haematol.2012.064410.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nucleic Acids Res 2001; 29:45; PMID:11328886; http://dx.doi.org/10.1093/nar/29.9.e45.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
BMC Cancer 2008; 8:222; PMID:18673580; http://dx.doi.org/10.1186/1471-2407-8-222.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Calcif Tissue Int 1997; 61:404-11; PMID:9351883; http://dx.doi.org/10.1007/s002239900356.45.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
FEBS J 2008; 275:5217-35; PMID:18803665; http://dx.doi.org/10.1111/j.1742-4658.2008.06658.x.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell Death Differ 2003; 10:211-7; PMID:12700649; http://dx.doi.org/10.1038/sj.cdd.4401132.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nat Rev Mol Cell Biol 2010; 11:607-20; PMID:20683471; http://dx.doi.org/10.1038/nrm2950.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Science 2009; 324:929-30; PMID:19372393; http://dx.doi.org/10.1126/sci-ence.1169786.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Science 2009; 324:930-5; PMID:19372391; http://dx.doi.org/10.1126/sci-ence.1170116.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Mol Pharmacol 2011; 80:174-82; PMID:21505039; http://dx.doi.org/10.1124/mol.110.070896.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Hum Mol Genet 2000; 9:2395-402; PMID:11005794; http://dx.doi.org/10.1093/hmg/9.16.2395.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Mol Cell Biol 2008; 28:215-26; PMID:17967891; http://dx.doi.org/10.1128/MCB.01073-07.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Genes Dev 2004; 18:1035-46; PMID:15105378; http://dx.doi.org/10.1101/gad.1176104.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cell Stem Cell 2011; 8:200-13; PMID:21295276; http://dx.doi.org/10.1016/j.stem.2011.01.008.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Blood 2009; 114:144-7; PMID:19420352; http://dx.doi.org/10.1182/blood-2009-03-210039.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nat Rev Cancer 2011; 11:535; PMID:21779006; http://dx.doi.org/10.1038/nrc3115.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cancer Cell 2011; 20:11-24; PMID:21723200; http://dx.doi.org/10.1016/j.ccr.2011.06.001.31.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Bone 1998; 23:511-20; PMID:9855459; http://dx.doi.org/10.1016/S8756-3282(98)00139-2.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Bone 1997; 20:225-36; PMID:9071473; http://dx.doi.org/10.1016/S8756-3282(96)00367-5.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Biol Chem 2011; 286:30071-86; PMID:21652706; http://dx.doi.org/10.1074/jbc.M111.253518.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Apoptosis 2010; 15:728-37; PMID:20428952; http://dx.doi.org/10.1007/s10495-010-0462-3.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Biol Chem 2011; 286:41083-94; PMID:21917922; http://dx.doi.org/10.1074/jbc.M111.258715.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Cytogenet Cell Genet 1988; 47:192-6; PMID:3416653; http://dx.doi.org/10.1159/000132547.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
EMBO J 1998; 17:1675-87; PMID:9501089; http://dx.doi.org/10.1093/emboj/17.6.1675.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Heart Fail Rev 2008; 13:111-9; PMID:18080749; http://dx.doi.org/10.1007/s10741-007-9070-x.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Biol Chem 2003; 278:40967-72; PMID:12881513; http://dx.doi.org/10.1074/jbc.M307380200.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
FEBS Lett 2006; 580:121-6; PMID:16360153; http://dx.doi.org/10.1016/j.febs-let.2005.11.062.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Nat Biotechnol 2007; 25:84-90; PMID:17211407; http://dx.doi.org/10.1038/nbt1272.,OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
J Invest Dermatol 2010; 130:1116-25; PMID:19759548; http://dx.doi.org/10.1038/jid.2009.301.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Mol Biol Rep 2011; 38:249-59; PMID:20349282; http://dx.doi.org/10.1007/s11033-010-0102-6.,Non-OADS,/arxiv_data1/oa_pdf/c1/37/epi-7-635.PMC3398991.pdf
Robinson; Email: wrobinson@cfri.ca Submitted: 02/22/12; Revised: 03/27/12; Accepted: 03/30/12http://dx.doi.org/10.4161/epi.20221Introduction The theory that the environment can affect gene expression has  gained much attention in recent years.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nucleic Acids Res 2004; 32:38; PMID:14973332; http://dx.doi.org/10.1093/nar/gnh032.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Epigenetics 2009; 4:394-8; PMID:19755846; http://dx.doi.org/10.4161/epi.4.6.9766.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Am J Respir Crit Care Med 2009; 179:572-8; PMID:19136372; http://dx.doi.org/10.1164/rccm.200807-1097OC.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Environ Health Perspect 2008; 116:1547-52; PMID:19057709; http://dx.doi.org/10.1289/ehp.11338.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Environ Health Perspect 2010; 118:790-5; PMID:20064768; http://dx.doi.org/10.1289/ehp.0901429.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Methods 2002; 27:156-61; PMID:12095275; http://dx.doi.org/10.1016/S1046-2023(02)00069-5.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
J Nucleic Acids 2011; 2011:870726; PMID:21772996; http://dx.doi.org/10.4061/2011/870726.8.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Birth Defects Res A Clin Mol Teratol 2010; 88:575-81; PMID:20641100; http://dx.doi.org/10.1002/bdra.20670.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nat Genet 2007; 39:457-66; PMID:17334365; http://dx.doi.org/10.1038/ng1990.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Epigenomics 2009; 1:177- 200; PMID:22122642; http://dx.doi.org/10.2217/epi.09.14.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nat Rev Genet 2009; 10:691-703; PMID:19763152; http://dx.doi.org/10.1038/nrg2640.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Prog Nucleic Acid Res Mol Biol 1996; 53:283-319; PMID:8650306; http://dx.doi.org/10.1016/S0079-6603(08)60148-8.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nucleic Acids Res 2009; 37:4331-40; PMID:19458156; http://dx.doi.org/10.1093/nar/gkp393.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nature 2001; 409:860-921; PMID:11237011; http://dx.doi.org/10.1038/35057062.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nat Rev Genet 2002; 3:370-9; PMID:11988762; http://dx.doi.org/10.1038/nrg798.16.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nucleic Acids Res 1991; 19:5613-7; PMID:1945838; http://dx.doi.org/10.1093/nar/19.20.5613.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
J Mol Biol 1995; 246:401-17; PMID:7877164; http://dx.doi.org/10.1006/jmbi.1994.0095.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Science 2004; 303:1626-32; PMID:15016989; http://dx.doi.org/10.1126/sci-ence.1089670.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nat Genet 2009; 41:563-71; PMID:19377475; http://dx.doi.org/10.1038/ng.368.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
J Biomed Biotechnol 2006; 2006:71753; PMID:16877819; http://dx.doi.org/10.1155/JBB/2006/71753.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nat Genet 2005; 37:853-62; PMID:16007088; http://dx.doi.org/10.1038/ng1598.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Gene 2009; 448:151-67; PMID:19699787; http://dx.doi.org/10.1016/j.gene.2009.08.006.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Hum Mol Genet 2009; 18:3544-52; PMID:19586922; http://dx.doi.org/10.1093/hmg/ddp299.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Mamm Genome 2011; 22:722-35; PMID:21874386; http://dx.doi.org/10.1007/s00335-011-9355-1.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Genomics 2004; 84:982-90; PMID:15533715; http://dx.doi.org/10.1016/j.ygeno.2004.09.004.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Mol Cell Biol 2003; 23:3566-74; PMID:12724415; http://dx.doi.org/10.1128/MCB.23.10.3566-74.2003.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Epigenetics Chromatin 2011; 4:7; PMID:21545704; http://dx.doi.org/10.1186/1756-8935-4-7.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Epigenetics Chromatin 2011; 4:10; PMID:21749726; http://dx.doi.org/10.1186/1756-8935-4-10.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
BMC Bioinformatics 2010; 11:587; PMID:21118553; http://dx.doi.org/10.1186/1471-2105-11-587.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Bioinformatics 2004; 20:1170-7; PMID:14764558; http://dx.doi.org/10.1093/bioinformatics/bth059.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Genome Res 2004; 14:2245-52; PMID:15520288; http://dx.doi.org/10.1101/gr.2693004.36.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Ann Hum Genet 2004; 68:196-204; PMID:15180700; http://dx.doi.org/10.1046/j.1529-8817.2004.00081.x.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Mol Reprod Dev 2011; 78:150; PMID:21425205; http://dx.doi.org/10.1002/mrd.21296.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Mod Pathol 2007; 20:802-10; PMID:17483816; http://dx.doi.org/10.1038/modpathol.3800825.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
J Pathol 2007; 211:269-77; PMID:17139617; http://dx.doi.org/10.1002/path.2106.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
PLoS One 2009; 4:4941; PMID:19293934; http://dx.doi.org/10.1371/journal.pone.0004941.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Genome Res 2002; 12:1483-95; PMID:12368240; http://dx.doi.org/10.1101/gr.388902.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Oncogene 2002; 21:5388-93; PMID:12154401; http://dx.doi.org/10.1038/sj.onc.1205599.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nucleic Acids Res 1982; 10:2709-21; PMID:7079182; http://dx.doi.org/10.1093/nar/10.8.2709.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
J Biol Chem 2010; 285:9583-93; PMID:20071334; http://dx.doi.org/10.1074/jbc.M109.064956.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Nucleic Acids Res 2005; 33:6823-36; PMID:16326863; http://dx.doi.org/10.1093/nar/gki987.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Cancer Res 2007; 67:876-80; PMID:17283117; http://dx.doi.org/10.1158/0008-5472.CAN-06-2995.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Am J Clin Nutr 2010; 91:1359-67; PMID:20164316; http://dx.doi.org/10.3945/ajcn.2009.28858.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Genomics 2006; 87:580-90; PMID:16488573; http://dx.doi.org/10.1016/j.ygeno.2006.01.002.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Epidemiology 2010; 21:819-28; PMID:20805753; http://dx.doi.org/10.1097/EDE.0b013e3181f20457.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Genome Res 2010; 20:1262-70; PMID:20488934; http://dx.doi.org/10.1101/gr.106419.110.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
Eur J Hum Genet 2010; 18:1006-12; PMID:20442742; http://dx.doi.org/10.1038/ejhg.2010.63.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
BMC Genomics 2011; 12:529; PMID:22032438; http://dx.doi.org/10.1186/1471-2164-12-529.,OADS,/arxiv_data1/oa_pdf/30/a8/epi-7-652.PMC3398992.pdf
"It is only very recently, through the incredible advances of sequencing technology and the announcement of the complete human and  Correspondence to: Marguerite Blignaut; Email: mblig@sun.ac.za Submitted: 03/27/12; Accepted: 03/27/12http://dx.doi.org/10.4161/epi.20170Book review to: Morris KV, ed.",Non-OADS,/arxiv_data1/oa_pdf/f2/8d/epi-7-664.PMC3398993.pdf
"Johanna Lepeule,1,* an drea Baccarelli,1 Letizia ta rantini,2 va leria mo tta,1,2 Laura Cantone,2 au gusto a.  Litonjua,3,4   David Sparrow,5 Pantel S. vo konas5 and Joel Schwartz1,3 1Exposure, Epidemiology and ri sk Program; Department of Environmental Health; Harvard School of Public Health; Boston, ma  uSa; 2Center of mo lecular and Genetic  Epidemiology; Department of Environmental and Occupational Health; Ca’ Granda Ospedale  ma ggiore Policlinico  irC CS Foundation;  un iversità degli Studi di  mi lano;   mi lan,  it aly; 3Channing Laboratory; Brigham and wo men’s Hospital; Harvard me dical School; Boston, ma  uSa; 4Division of Pulmonary and Critical Care me dicine;   Brigham and  wo men’s Hospital; Harvard  me dical School; Boston,  ma   uSa; 5va Normative ag ing Study; ve terans aff airs Boston Healthcare System   and the Department of  me dicine; Boston  un iversity School of  me dicine; Boston,  ma   uSa *Correspondence to: Johanna Lepeule; Email: jlepeule@hsph.harvard.edu Submitted: 05/07/12; Accepted: 05/07/12http://dx.doi.org/10.4161/epi.20942It has come to the attention of the authors that Table 5  was not included in Epigenetics  Volume 7, Issue 3 in the manuscript: Lepeule  J, Baccarelli A, Tarantini L, Motta V, Cantone L, Litonjua AA, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/bf/epi-7-667.PMC3398994.pdf
"*Correspondence to: Karl T. Kelsey Email: karl_kelsey@brown.edu Submitted: 05/15/12; Accepted: 05/15/12http://dx.doi.org/10.4161/epi.20943Authors Scott M. Langevin and E. Andres Houseman contributed equally and should be listed as joint first authors in Epigenetics  Volume 6, Issue 7 in the manuscript: Langevin SM, Houseman EA, Christensen BC, Wiencke JK, Nelson HH, Karagas MR, et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/fb/epi-7-668.PMC3398995.pdf
"nl, Clemens Löwik; e-mail: c.w.g.m.lowik@lumc.nl, URL: http://www.lumc.nl",Non-OADS,/arxiv_data1/oa_pdf/65/95/11307_2011_Article_522.PMC3399070.pdf
BMC Psychiatry 11:109. http://www.biomedcentral.com/1471- 1244X/1411/1109 11.,Non-OADS,/arxiv_data1/oa_pdf/5d/22/127_2011_Article_441.PMC3399078.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/05/bb/ima-3-1.PMC3399098.pdf
(2004)	is	the	sole	record	of	a	fungal	pathogen	 on	 this	host	in	the	Brazilian	database	(http://pragawall.cenargen.,OADS,/arxiv_data1/oa_pdf/05/bb/ima-3-1.PMC3399098.pdf
"Beltsville,	 MD:	 Systematic	 Mycology	 and	Microbiology	 Laboratory,	 ARS,	 USDA;	http://nt.ars-grin.gov/fungaldatabasews/.",Non-OADS,/arxiv_data1/oa_pdf/05/bb/ima-3-1.PMC3399098.pdf
Available	 at	http://nt.ars-grin.gov/ fungaldatabases/index.cfm.,OADS,/arxiv_data1/oa_pdf/05/bb/ima-3-1.PMC3399098.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/37/fa/ima-3-15.PMC3399099.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c0/ca/ima-3-25.PMC3399100.pdf
"The	alignments,	 together	with	the	trees	from	the	Bayesian	 analyses	 (Figs	2–3),	have	been	deposited	 in	TreeBASE	 (http://purl.org/phylo/treebase/phylows/study/TB2:S12709).",OADS,/arxiv_data1/oa_pdf/c0/ca/ima-3-25.PMC3399100.pdf
"Primers	used	were:	(a)	for	 the	5’	part	of	LSU:	LR3	and	LR5	(Vilgalys	&	Hester	1990),	 and	forward	primer	LROR	(http://www.biology.duke.edu/ fungi/mycolab/primers.htm#Large	 subunit	RNA	(25-28S)	 primer	sequences )	or	LCa1	(primer	designed	 for	this	study:	 5’–GTCCGAGTTGTAGATGAG–3’);	 (b)	for	amplification	 of	 5.8S-ITS2	 part	of	ITS	region	see	Table	2;	(c)	for	the	ATP6:	 ATP6-2	and	 ATP6-3	(Kretzer	&	Bruns	1999).",Non-OADS,/arxiv_data1/oa_pdf/c0/ca/ima-3-25.PMC3399100.pdf
"The	first	LSU	dataset	 was	submitted	 to	the	 Cyberinfrastructure	 for	Phylogenetic	 Research	 (CIPRES	 Science	 Gateway:	 http://www.phylo.org/)	 for	preliminary	 analysis	with	RAxML	v.	7.2.8	(Stamatakis	 2006,	Stamatakis	et al.",OADS,/arxiv_data1/oa_pdf/c0/ca/ima-3-25.PMC3399100.pdf
"2008)	via	a	Web	server	available	at	the	Vital-IT	Unit	at	Swiss	 Institute	of	Bioinformatics	 (http://phylobench.vital-it.ch/raxml- bb/index.php),	 executing	 100	rapid	bootstrap	 replicates	 employing	 a	GTRMIX	model	(switching	 from	GAMMA	to	CAT	 for	rapid	bootstrapping);	 thereafter	 a	thorough	 ML	search	 was	conducted	 under	the	GAMMA	model.",OADS,/arxiv_data1/oa_pdf/c0/ca/ima-3-25.PMC3399100.pdf
"2000),	and	Zimbabwe	 (Sharpe	&	Wursten,	http://www.vumba-nature.com).Comments:	 This	species	is	quite	distinct	in	the	deep	orange	 to crimson colour, especially towards the cap centre, which clearly	contrasts	 with	the	pale	bright	yellow	folds.",Non-OADS,/arxiv_data1/oa_pdf/c0/ca/ima-3-25.PMC3399100.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/f1/bd/ima-3-39.PMC3399101.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/00/11/ima-3-45.PMC3399102.pdf
species complex  (Table	1)	were	aligned	using	MAFFT	(http://timpani.genome.,OADS,/arxiv_data1/oa_pdf/00/11/ima-3-45.PMC3399102.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/e6/20/ima-3-59.PMC3399103.pdf
"MATeRIAls AND MeTHODs Fungal isolates The	provenance	 of	fungal	isolates	examined	 in	this	study	is	 detailed	in	Table	1	and	these	cultures	are	available	from	the	 Agricultural	 Research	 Service	Culture	Collection	 (NRRL),	 Peoria,	Illinois	( http://nrrl.ncaur.usda.gov).",Non-OADS,/arxiv_data1/oa_pdf/e6/20/ima-3-59.PMC3399103.pdf
"DNA	sequencing	 was	performed	 on	 both	template	strands	using	dye	terminator	 technology	 (v3.1)	 and	an	ABI	3730	sequencer,	 both	from	Applied	Biosystems	 (http://www.appliedbiosystems.com/).",OADS,/arxiv_data1/oa_pdf/e6/20/ima-3-59.PMC3399103.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/02/e8/ima-3-81.PMC3399104.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/93/16/ima-3-87.PMC3399105.pdf
"This	could	pave	the	way	for	increased	 funding	of	international	 collaboration,	increased	global	visibility,	and	higher	priority	among	decision	makers	all	over	the	world.Article info: Submitted:	28	May	2012;	 Accepted:	12	June	2012;  Published:	22	June	2012.Key words:  biodiversitybiomass	conversionfungal enzymesglobal challengesnew biological solutionssecretomicsteachingtraining INTRoDuCTIoN Horizon 2020 	is	a	visionary	 document	 for	the	European	 common	 research	 programme	 2014–2020	 (http://ec.europa.",Non-OADS,/arxiv_data1/oa_pdf/93/16/ima-3-87.PMC3399105.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/87/4e/ima-3-9.PMC3399106.pdf
"Beltsville,	 MD:	 Systematic	 Mycology	 and	Microbiology	 Laboratory,	 ARS,	USDA;	 http://nt.ars-grin.gov/fungaldatabases/ Garces	Orejuela	CG	(1944)	New	or	heretofore	 unreported	 species	 of	the	higher	ascomycetes	 from	Colombia	 and	Venezuela.",Non-OADS,/arxiv_data1/oa_pdf/87/4e/ima-3-9.PMC3399106.pdf
"Brasilia:		Laboratório	 de	Quarentena	 Vegetal,	Embrapa	 Recursos	 Genéticos	 e	Biotecnologia;	 http://pragawall.table 1.",Non-OADS,/arxiv_data1/oa_pdf/87/4e/ima-3-9.PMC3399106.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/48/45/ima-3-93.PMC3399107.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/ef/e7/ima-3-99.PMC3399108.pdf
Data have been deposited as entries UVBAD5 UVP 0001 and TRP4P6 UVP 0001 in the RNA Mapping Database (http://rmdb.stanford.edu).,OADS,/arxiv_data1/oa_pdf/1a/fe/srep00517.PMC3399121.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1a/fe/srep00517.PMC3399121.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kladwang, W., Hum, J.",Non-OADS,/arxiv_data1/oa_pdf/1a/fe/srep00517.PMC3399121.pdf
"The additional databases mined included Uniprot (The Uniprot Consortium, 2012), Phytozome2(Goodstein et al., 2012), and JGI3for multiple species, Solgenomics4(Bombarely et al., 2011) and PGSC5(Potato Genome Sequencing Consortium, 2011) for Solanaceae , The Arabidopsis Information Resource6(Lamesch 1http://string-db.org/ 2http://www.phytozome.net/ 3http://genome.jgi.doe.gov/ 4http://solgenomics.net/ 5http://potatogenomics.plantbiology.msu.edu/ 6http://www.arabidopsis.orget al., 2012) for Arabidopsis, and COSMOSS7(Lang et al., 2005) forPhyscomitrella .",OADS,/arxiv_data1/oa_pdf/32/35/fpls-03-00159.PMC3399122.pdf
"For Exo70, which is more 7http://www.cosmoss.org/ Frontiers in Plant Science | Plant Trafﬁc and Transport July 2012 | Volume 3 | Article 159 | 2",Non-OADS,/arxiv_data1/oa_pdf/32/35/fpls-03-00159.PMC3399122.pdf
"SUPPLEMENTARY MATERIAL The Supplementary Material for this article can be found online at https://www.frontiersin.org/articles/10.3389/fpls.2012.00159/full Cvrckova_S1.xls | List of the 392 exocyst subunit sequences analyzed, including database accession numbers, phylogenetic classiﬁcation and domain composition (Microsoft Excel ﬁle).",OADS,/arxiv_data1/oa_pdf/32/35/fpls-03-00159.PMC3399122.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Dutta, S. & Wakabayashi, K. Tuning Charge and Spin Excitations in Zigzag Edge Nanographene Ribbons.",Non-OADS,/arxiv_data1/oa_pdf/57/08/srep00519.PMC3399123.pdf
"This is an open access article, published under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5).",Non-OADS,/arxiv_data1/oa_pdf/1b/10/JVR-03-001.PMC3399132.pdf
Methods Glycosyl hydrolase family 70 sequences .The DNA and amino acid sequences of glycosyl hydrolase family 70 proteins used in this study were obtained from GenBankat NCBI (http://www.ncbi.nlm.nih.gov/) with cross-reference to Pfam (http:// pfam.sanger.ac.uk/).,OADS,/arxiv_data1/oa_pdf/f9/86/srep00518.PMC3399136.pdf
"Sequencing analyses of unknown streptococcal gtfgenes was performed as described previously 18,30, and the sequences were deposited in the DNA Data Bank of Japan (http://sakura.ddbj.nig.ac.jp/sakura_en.html).",OADS,/arxiv_data1/oa_pdf/f9/86/srep00518.PMC3399136.pdf
"Homology and protein family search .Motifs from GTFs were analyzed by homology and protein family searches using BLAST in NCBI and SYSTERS Protein Family Database in Max Plank Institute for Molecular Genetics, Computational Molecular Biology (http://systers.molgen.mpg.de/), respectively.",OADS,/arxiv_data1/oa_pdf/f9/86/srep00518.PMC3399136.pdf
Phylogenetic analysis .Sequence alignment was performed using ClustalX software version 1.8331(http://bips.u-strasbg.fr/fr/Documentation/ClustalX/#G).,OADS,/arxiv_data1/oa_pdf/f9/86/srep00518.PMC3399136.pdf
oralis Uo5 genome (GenBank: FR720602.1) were analysed using BLAST (NCBI; http://www.ncbi.nlm.nih.gov/BLAST/).,OADS,/arxiv_data1/oa_pdf/f9/86/srep00518.PMC3399136.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f9/86/srep00518.PMC3399136.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Hoshino, T., Fujiwara, T. & Kawabata, S. Evolution of Cariogenic Character in Streptococcus mutans : Horizontal Transmission of Glycosyl Hydrolase Family 70 Genes.",Non-OADS,/arxiv_data1/oa_pdf/f9/86/srep00518.PMC3399136.pdf
"2012, 9      http://www.medsci.org  339  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(5):339-352. doi: 10.7150/ ijms.4414   Research Paper   BioShuttle Mobility in Living Cells Studied with High -Resolution FCS & CLSM  Methodologies   Klaus Braun1, Marcel Beining2, Manfred Wiessler1, Twan Lammers3, Rüdiger Pipkorn4, Ute Hennrich1,  Kiyoshi Nokihara5, Wolfhard Semmler1, Jürgen Debus6, Waldemar Waldeck2   1.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  340  functional groups via disulfide bridge formation, for  transport across the cell membrane.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9      http://www.medsci.org  341  Material & Methods   Cell culture   Cells lines [HeLa and HeLa S3 (suspension cu l- ture), MCF7 and TP366 cells] were m aintained in  DMEM (RPMI1640 for HeLa S3) medium without  phenol red and with 10 % fetal calf serum at 37°C in a  humid atmosphere with 5 % CO 2 and passaged twice  in a week.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"A diffusion model was fitted to the data to  calculate 1) the diffusion coefficient, 2) the number o f  particles, and 3) the triplet states, using the cu s- tom-made software Quickfit 2  (http://download.cnet.com/QuickFit/3000 -18541_4 - 10626451.html).",OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  342  Optimizing Fluorescence correlation spe c- troscopy (FCS) measurements   Determination of the stability of measure ments   For the determination of the stability of the FCS  measurements, n = 60 measurements of Alexa Fluor®  488 were conducted.",OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9      http://www.medsci.org  343  Influence of laser intensity on diffusion time   In order to receive adequate correlation fun c- tions, sufficient fluorescence signal intensities are  needed.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9      http://www.medsci.org  344    Figure 4. the graphs display the dependency of different FFM parameters on the measuring depth with CPP -Rd110 A [20 nM] without  (A)  and with NP40 detergent (B) [0.02  %].",OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  345  Contemplation of the BioShuttle measur e- ment studies   The summarized parameters achieved by the i n- struments’ calibration procedures can be considered  as a complex but helpful analysis platform.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
(The software  used was allocated at http://fiji.sc/wiki/index.,OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
The specific non -interacting spectra are  shown in the atto -tec’s website http://www.atto -  tec.com .,OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  346    Figure 6. illustrates the Z -scan through a HeLa S3 cell 1 h after incubation with CPP -Rd110 BioShuttle A [200 nM].",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  347  to647N) -CPP -SS-NLS -(Atto488) -BioShuttle scheme  (Figure 1, B).",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  348  acid (PNA) complementary to CtsB mRNA was used  in the design of BioShuttle C, to serve as an anchor  inside treated cells by formation of CtsB mRNA/   CtsB -PNA hybrids.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  349      Figure 9. shows confocal FFM images of HeLa  (left), MCF7 (middle), and TP366 (right) cell lines 24 h after incubation with   CtsB-PNA-BioShuttle C. All investigated cell lines show the successful uptake of CtsB-BioShuttle C as shown by the cytoplasm located  fluorescence signals.",OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  350  as a meaningful parameter, as proven in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  351  Macromolecules Department, DKFZ and Mario Koch,  Central Peptide Synthesis Unit, DKFZ for their e n- couragement.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9    http://www.medsci.org  352  57.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/ijmsv09p0339.PMC3399214.pdf
"2012, 9      http://www.medsci.org  353  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(5):353-360. doi: 10.7150/ ijms.4276   Research Paper   Analysis of the  Mineral Composition of the Human Calcified Cartilage Zone   Ying Zhang, Fuyou Wang, Hongbo Tan,  Guangxing Chen,  Lin Guo,  Liu Yang  Center for Joint Surgery, Southwest Hospital, Third Military Medical University, Chongqing , 400038, China     Corresponding author : Dr. Liu Yang , Center for Joint Surgery, Southwest Hospital,  Third Military Medical University,  Chongqing , 400038, China .",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
This is an open -access article distri buted under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9    http://www.medsci.org  354  such as osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9    http://www.medsci.org  355  121-MB amino acid analyzer.",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9    http://www.medsci.org  356  1), 19 amino acids accounted for 61.39% ± 0.38% of the  articular cartilage dry weight, 20.16% ± 0.96% of the  calcification layer and 13.69% ± 0.45% of the sub- chondral bo ne.",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9      http://www.medsci.org  357      Fig.",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9    http://www.medsci.org  358    Fig.3 Quantitative analysis of the calcified cartilage zone (CCZ) inorganic constituents using X-ray diffraction  (XRD): (A) XRD pattern of  the hydroxyapatite ceramic (HAC ) standard sample.",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9    http://www.medsci.org  359  different  (2).",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9    http://www.medsci.org  360  Foundation of China (201104756).",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ijmsv09p0353.PMC3399215.pdf
"2012, 9      http://www.medsci.org  361  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(5):361-369. doi: 10.7150/ ijms.4629   Research Paper   Knowledge of and Attitude to Nuclear Power among Residents around  Tianwan Nuclear Power Plant in Jiangsu of China   Ningle Yu*, Yimei Zhang*, Jin Wang*, Xingjiang Cao, Xiangyong Fan, Xiaosan Xu, Furu Wang  JiangSu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing 210029, China    * Contributed equally .",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  362  portant impact factor on public acceptance.",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  363  Potential participants were given prior  information  about the purpose of the study.",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  364  However, we failed to find any significant correlation  between different marital status or distance away  from the plant and the level of knowledge of radiation  (see Table 2).",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  365  power is an economical, safe and clean energy source.",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  366  Table 4.",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  367  while 88.0% people sai d they usually not easy to o b- tain relevant knowledge, even 25.5% people unable to  get it.",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  368  For different age groups, educational level, fa m- ily income and distance away from the plant, the  mean score was also different, respectively.",OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9    http://www.medsci.org  369  ferent distances group, which suggested the distance  away from the nuclear power plant could not affect  the demands for relevant knowledge of nuclear po w- er.",Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
http://www.census.gov/srd/papers/   pdf/sm95 -06.pdf .,OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
Designing and   conducting Health Systems Research  projects ; Ottawa: Programme on  Health Systems  Research and Development of the  World Health Orga n- isation ; Health  Sciences Division of the International  Development R e- search Centre (IDRC)  and Geneva ; 1991   http://www.idrc.ca/en/ev -56606 -201-1- DO_TOPIC.html.,Non-OADS,/arxiv_data1/oa_pdf/59/7d/ijmsv09p0361.PMC3399216.pdf
"2012, 9      http://www.medsci.org  370  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(5):370-379. doi: 10.7150/ ijms.4395   Research Paper   18α-Glycyrrhetinic Acid Down -Regulates Expression of Type I and III Col- lagen via  TGF-Β1/Smad Signaling  Pathway in Human and Rat Hepatic  Stellate Cells   Lei Zong1,2, Ying Qu1, Ming -yi Xu1, Yu-wei Dong1, Lun -gen Lu1  1.",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  371  rhosis.",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  372  Shuzo Co., Ltd, Japan) and real time PCR Master Mix  (SYBR Green) Kit (Toyobo Co., Ltd. Japan).",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  373  NIH Image J (developed by Wayne Rasband, National  Institutes of Health, Bethesda, MD, USA).",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  374  COL3A1, and Smad7 was 0.79, 0.75, 0.62, and 1.42,  respectively, at 24 h after treatment ( P<0.05), and 0.47,  0.32, 0.36, and 1.95, respectively, at 48 h after trea t-ment ( P<0.01) (Fig 2).",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  375    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  376  reduced at 24 h and 48 h, while that of phosphoryl a- tion of Smad2 remained unchang ed (Fig 4).",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  377    Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  378  to DNA either directly or with the help of other pr o- teins, regulating collagen I and III expression.",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9    http://www.medsci.org  379  Science Foundation of China (No:30871162 &  81070345 ), the National Key Technologies Research  and Development Program of Ch ina during the 11th  Five -year Plan Period (2008ZX10002 -006),  Science and  Technology Commission of Shanghai Municipality  (No:09XD1403200 & 10411955300 ).",Non-OADS,/arxiv_data1/oa_pdf/b7/27/ijmsv09p0370.PMC3399217.pdf
"2012, 9      http://www.medsci.org  380  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(5):380-386. doi: 10.7150/ ijms.4641   Research Paper   Analysis on the Pathogenesis of Symptomatic Pulmonary Embolism with   Human Genomics   Hao Wang1*, Qianglin Duan1*, Lemin Wang 1 , Zhu Gong 1, Aibin Liang 2, Qiang Wang 1, Haoming Song 1 ,  Fan Yang3, Yanli Song4   1.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"2012, 9    http://www.medsci.org  381  regions, such as Japan, Thailand, Singapore, Taiwan,  the number of repor ted PE cases is also increasing   (4-8).",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"2012, 9    http://www.medsci.org  382  lowing the manufacturer's instructions.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"2012, 9    http://www.medsci.org  383      Fig.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"2012, 9    http://www.medsci.org  384    Fig.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"2012, 9    http://www.medsci.org  385  Discussion   Two  genes with down -regulated expressions are  closely related to the T cell mediated immun ity ac- cording to GO analysi s (with high value of Enric h- ment).",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"2012, 9    http://www.medsci.org  386  [8] Leizorovicz A.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"http://www.wrongdiagnosis.com/p/   pulmona ry_embolism/stats -country.htm   [11] Hyers, TM.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/ijmsv09p0380.PMC3399218.pdf
"2012, 9      http://www.medsci.org  387  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(5):387-390. doi: 10.7150/ ijms.3383   Case Report   A Large Amniocele with Protruded Umbilical Cord Diagnosed by 3D Ultra- sound   Yun Sung Jo1, Min Jeong Kim2, Gui Se Ra Lee1, Sa Jin Kim2   1.",Non-OADS,/arxiv_data1/oa_pdf/4b/79/ijmsv09p0387.PMC3399219.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/79/ijmsv09p0387.PMC3399219.pdf
"2012, 9    http://www.medsci.org  388  cells/mm3 and a C -reactive protein of 1.34 mg/dL.",Non-OADS,/arxiv_data1/oa_pdf/4b/79/ijmsv09p0387.PMC3399219.pdf
"2012, 9    http://www.medsci.org  389    Fig.",Non-OADS,/arxiv_data1/oa_pdf/4b/79/ijmsv09p0387.PMC3399219.pdf
"2012, 9    http://www.medsci.org  390  7.",Non-OADS,/arxiv_data1/oa_pdf/4b/79/ijmsv09p0387.PMC3399219.pdf
"2012, 8      http://www.biolsci.org  913  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2012; 8(6):913-934. doi: 10.7150/ ijbs.3697  Review  Honey - A Novel Antidiabetic Agent    Omotayo  O. Erejuwa  , Siti A. Sulaiman,  Mohd  S. Ab  Wahab    Department of Pharmacology, School of Medical Sciences, U niversiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, M a- laysia .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  914  particular plant (monofloral honey) or no dominant  pollen type in the sample (multifloral h oney) [6, 7] .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  915  ridase -related transport system appears to be corro b- orated by a study which showed that the greatest a b- sorption of fructose occurred when equal amounts of  fructose and glucose were given sim ultaneously [53].",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  916  to improve intestinal morphology [72-74] or its ga s- troprotective effect [70, 71] , these GIT effects of honey  might promote healing and enhance GIT health in  diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8      http://www.biolsci.org  917    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  918  intestinal absorption of calorie resulting from i n- creased intestinal calorie extraction by pathogenic gut  microbiota, urinary excretion of honey metabolites  [38, 39, 79, 96 -98].",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  919  subjects [120]  or no change in body weight in ove r- weight or obese subjects [121] .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  920  that honey supplementation in non -diabetic rats did  not alter the serum concentrations of glucose and  fructosamine [66].",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  921  type 2 diabetic patients for 8 weeks significantly r e- duced TG, TC, LDL cholesterol, LDL/HDL ratio   and increased HDL cholesterol compared with  baseline data [120] .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  922  or obese human subjects, Yaghoobi  et al.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  923  study design related issues [82, 120, 130] .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  924  Antidiabetic effect of honey: Potential  mechanisms of action based on the  non-antioxidant constituents in honey     Considering that honey is reported to contai n at  least 181 substances [8], the exact mechanism of its  antidiabetic effect is complex and therefore will n e- cessitate detailed investigation [16].",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  925  damage and thus enhance insulin secretion resulting  in improved glycemic control [17-19, 62] .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  926  apy [17-19, 62, 66] .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  927  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  928  solutions containing artificial honey or  natural honey for 15 days  Natural honey: ↓ TC, ↓ LDL cholesterol,  ↓ CRP   Statistically insignificant parameters (Honey versus baseline within the first 3 hours)    Artificial honey: ↑ TC, ↑ LDL cholesterol,  ↑ TG    Natural hon ey: ↓ TC, ↓ LDL cholesterol,  ↓ TG   Type 2 diabetic patients dextrose (70 g),  sucrose (30 g) or natural honey  (60%, 30  or 90 g)  Statistically significant parameter (Honey versus dextrose within the first 3 hours)   ↓ Glucose   Statistically insignificant parameters (Honey versus sucrose within the first 3 hours)   ↓ Glucose, ↑ Insulin  [22, 139]   Type 2 diabe tic patients administered  honey (ﬁrst 2 weeks, 1 g/kg/day; s e- cond 2 weeks, 1.5 g/kg/day; third 2  weeks, 2 g/kg/day; and last 2 weeks, 2.5  g/kg/day) orally for 8 weeks  Statistically significant parameters (versus baseline)   ↓ Glucose, ↑ Glycosylated hemoglo bin, ↓ TC, ↓ LDL cholesterol,   ↑ HDL cholesterol, ↓ TG, ↓ LDL/HDL ratio, ↓ Body weight   Statistically significant parameters  (versus control)   ↓ Glucose, ↓ LDL/HDL ratio, ↓ Body weight  [120]   ↑ = increased, ↓ = reduced, ↔ = no significant effect, TC = total cholesterol, TG = triglycerides, HDL = high -density lipoprotein, LDL =  low-density lipoprotein, VLDL = very low -dens ity lipoprotein, AST = aspartate transaminase, ALT = alanine transaminase, ALP = alkaline  phosphatase, LDH = lactic acid dehydrogenase, CK = creatinine kinase, GR = glutathione reductase, CRP = C -reactive proteins, MCP -1 =  monocyte chemoattractant protein -1, Hs -CRP = high -sensiti vity C -reactive protein.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  929  of ≤ 7.0% [223, 224] .",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  930  including increased ins ulin secretion.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
http://www.bee -hexagon.net   5.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
http://www.medbio.info   30.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
http://www.reboundhealth.com/cms/topic -carbohydrates.html   31.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  931  46.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
http://www.biosite.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
http://www.chemblink.com   86.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
http://www.extrasynthese.com   87.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
http://www.carbosynth.com   88.,Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  932  98.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  933  148.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
"2012, 8    http://www.biolsci.org  934  201.",Non-OADS,/arxiv_data1/oa_pdf/15/68/ijbsv08p0913.PMC3399220.pdf
Available from:   http://www.whoiran.org/Newsletter/NewsLetter- V4N3and4E.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/72/IJPVM-3-79.PMC3399286.pdf
Available from:  URL:  http://www.blackwellreference.com/public/tocnode?,Non-OADS,/arxiv_data1/oa_pdf/73/72/IJPVM-3-79.PMC3399286.pdf
Available from: http://www.Who  int/inffs/en/fact 164 htm [Last accessed on 2012].,OADS,/arxiv_data1/oa_pdf/43/ae/IJPVM-3-89.PMC3399298.pdf
Hepatitis C.  Available from: http://www.vahepatitisc.com.,Non-OADS,/arxiv_data1/oa_pdf/18/32/IJPVM-3-102.PMC3399306.pdf
1997; 21-25 july Availa- ble from:   http://www.who.int/entity/healthpromotion/conferen ces/previous/jakarta/declaration/en/ [Last cited on  2011 Mar 10].,Non-OADS,/arxiv_data1/oa_pdf/22/3d/IJPVM-3-191.PMC3399308.pdf
World Health Organization;  1986; Available from:   http://www.who.int/entity/healthpromotion/conferen ces/previous/ottawa/en/ [Last cited on 2010 Sept  20].,Non-OADS,/arxiv_data1/oa_pdf/22/3d/IJPVM-3-191.PMC3399308.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/83/ijbsv08p0935.PMC3399316.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/23/ijbsv08p0945.PMC3399317.pdf
http://www.moh.gov.cn/publicfiles/busin ess/   cmsresources/zwgkzt/cmsrsdocument/doc3242.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/23/ijbsv08p0945.PMC3399317.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/95/ijbsv08p0953.PMC3399318.pdf
Data analysis   The scanned images obtained were first assessed   by visual i nspection and then analyzed using Aff y- metrix GeneChip® Command Console™ (AGCC)   software  (http://www.affymetrix.com/browse/   products.jsp?productId=131429&navMode=34000&   navAction=jump&aId=productsNav ).,OADS,/arxiv_data1/oa_pdf/20/95/ijbsv08p0953.PMC3399318.pdf
"The expression  flags (indicators of expressed genes) we re also dete r- mined using Affymetrix® Expression Console™  software  (http://www.affymetrix.com/browse/   level_seven_software_products_only.jsp?productId=   131414&categoryId=35623 ) application  MAS 5.0 alg o- rithm as “present,” “marginal,” and “absent” calls.",OADS,/arxiv_data1/oa_pdf/20/95/ijbsv08p0953.PMC3399318.pdf
This  system is freely available at  http://bioinfo.bti.cornell.edu/tool/MetGenMAP.,OADS,/arxiv_data1/oa_pdf/20/95/ijbsv08p0953.PMC3399318.pdf
http://www.biolsci.org/v0 8p0953s1.xls  Acknowledgements   We are grateful to Professor Ye GY for kindly  providing KMD and Xiushui rice seeds.,Non-OADS,/arxiv_data1/oa_pdf/20/95/ijbsv08p0953.PMC3399318.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d9/1f/ijbsv08p0964.PMC3399319.pdf
A copy of theJava code for the simulation and the simulator is accessible onlineathttp://www.cs.york.ac.uk/immunesims/frontiers.,Non-OADS,/arxiv_data1/oa_pdf/d3/aa/fimmu-03-00172.PMC3399454.pdf
"The PP simulator,the documented Java source code, all tools created for the visual-ization of PP formation and statistical analysis of the model arefreely available for download from the web ( http://www.cs.york.",OADS,/arxiv_data1/oa_pdf/d3/aa/fimmu-03-00172.PMC3399454.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2012 |  64  | e3462 | Page 1 of 6Video Article Derivation of Glial Restricted Precursors from E13 mice André W. Phillips1,2, Sina Falahati1,2, Roshi DeSilva1,3, Irina Shats2, Joel Marx1, Edwin Arauz1, Douglas A. Kerr4, Jeffrey D. Rothstein2,5, Michael V. Johnston1,2,6, Ali Fatemi1,2,6 1Hugo W. Moser Research Institute at Kennedy Krieger, Johns Hopkins University 2Department of Neurology, Johns Hopkins School of Medicine 3University of Maryland 4Experimental Neurology, Biogen Idec 5The Brain Science Institute, Johns Hopkins School of Medicine 6Department of Pediatrics, Johns Hopkins School of Medicine Correspondence to: André W. Phillips at phillipsa@kennedykrieger.org URL: http://www.jove.com/video/3462 DOI: doi:10.3791/3462 Keywords: Neuroscience, Issue 64, Physiology, Medicine, periventricular leukomalacia, oligodendrocytes, glial restricted precursors, spinal cord, cell culture Date Published: 6/20/2012 Citation: Phillips, A.W., Falahati, S., DeSilva, R., Shats, I., Marx, J., Arauz, E., Kerr, D.A., Rothstein, J.D., Johnston, M.V., Fatemi, A. Derivation of Glial Restricted Precursors from E13 mice.",Non-OADS,/arxiv_data1/oa_pdf/45/21/jove-64-3462.PMC3399460.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/3462/ Protocol Introduction In this protocol we show how to extract, select and plate glial restricted precursor (GRP) cells from the spinal cord of E13 mouse fetuses.",Non-OADS,/arxiv_data1/oa_pdf/45/21/jove-64-3462.PMC3399460.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2012 |  61  | e3890 | Page 1 of 8Video Article On-chip Isotachophoresis for Separation of Ions and Purification of Nucleic Acids Giancarlo Garcia-Schwarz1, Anita Rogacs1, Supreet S. Bahga1, Juan G. Santiago1 1Mechanical Engineering, Stanford University Correspondence to: Juan G. Santiago at juan.santiago@stanford.edu URL: http://www.jove.com/video/3890 DOI: doi:10.3791/3890 Keywords: Bioengineering, Issue 61, Isotachophoresis, electrokinetics, microfluidics, sample preparation Date Published: 3/2/2012 Citation: Garcia-Schwarz, G., Rogacs, A., Bahga, S.S., Santiago, J.G.",Non-OADS,/arxiv_data1/oa_pdf/27/77/jove-61-3890.PMC3399465.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3890/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/27/77/jove-61-3890.PMC3399465.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2012 |  60  | e3300 | Page 1 of 7Video Article T-maze Forced Alternation and Left-right Discrimination Tasks for Assessing Working and Reference Memory in Mice Hirotaka Shoji1,2, Hideo Hagihara1, Keizo Takao3, Satoko Hattori1,2,3, Tsuyoshi Miyakawa1,2,3 1Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University 2Japan Science and Technology Agency, Core Research for Evolutionary Science and Technology (CREST) 3Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, National Institutes of Natural Sciences URL: http://www.jove.com/video/3300 DOI: doi:10.3791/3300 Keywords: Neuroscience, Issue 60, T-maze, learning, memory, behavioral flexibility, behavior, mouse Date Published: 2/26/2012 Citation: Shoji, H., Hagihara, H., Takao, K., Hattori, S., Miyakawa, T. T-maze Forced Alternation and Left-right Discrimination Tasks for Assessing Working and Reference Memory in Mice.",Non-OADS,/arxiv_data1/oa_pdf/7b/33/jove-60-3300.PMC3399492.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3300/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/33/jove-60-3300.PMC3399492.pdf
"The application used for acquiring and analyzing the behavioral data (Image TM) is based on the public domain Image J program (developed by Wayne Rasband at the National Institute of Mental Health and available at http://rsb.info.nih.gov/ij/ ), which was modified by Tsuyoshi Miyakawa (available through O'HARA & Co., Tokyo, Japan).",OADS,/arxiv_data1/oa_pdf/7b/33/jove-60-3300.PMC3399492.pdf
"The data of strains already published in the research article are included in the ""Mouse Behavioral Phenotype Database"" as a public database (URL: http://www.mouse- phenotype.org/ ).",OADS,/arxiv_data1/oa_pdf/7b/33/jove-60-3300.PMC3399492.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2012 |  60  | e3448 | Page 1 of 13Video Article Quantitative and Automated High-throughput Genome-wide RNAi Screens in C. elegans Barbara Squiban1, Jérôme Belougne1, Jonathan Ewbank1, Olivier Zugasti1 1Centre d’Immunologie de Marseille-Luminy, Université de la Méditerranée Correspondence to: Olivier Zugasti at zugasti@ciml.univ-mrs.fr URL: http://www.jove.com/video/3448 DOI: doi:10.3791/3448 Keywords: Molecular Biology, Issue 60, C. elegans , fluorescent reporter, Biosort, LIMS, innate immunity, Drechmeria coniospora Date Published: 2/27/2012 Citation: Squiban, B., Belougne, J., Ewbank, J., Zugasti, O. Quantitative and Automated High-throughput Genome-wide RNAi Screens in C. elegans .",Non-OADS,/arxiv_data1/oa_pdf/70/d7/jove-60-3448.PMC3399495.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3448/ Protocol The protocol as described below is divided into steps on five successive days (Fig.,Non-OADS,/arxiv_data1/oa_pdf/70/d7/jove-60-3448.PMC3399495.pdf
"The C. elegans  Research Community, eds., http://www.wormbook.org.",Non-OADS,/arxiv_data1/oa_pdf/70/d7/jove-60-3448.PMC3399495.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2012 |  60  | e3679 | Page 1 of 10Video Article Preparing Individual Drosophila  Egg Chambers for Live Imaging Timothy T. Weil1, Richard M. Parton1, Ilan Davis1 1Department of Biochemistry, University of Oxford Correspondence to: Ilan Davis at ilan.davis@bioch.ox.ac.uk URL: http://www.jove.com/video/3679 DOI: doi:10.3791/3679 Keywords: Molecular Biology, Issue 60, Drosophila  oocytes, wide-field microscopy, cytoskeleton, RNA injection, mRNA localization Date Published: 2/27/2012 Citation: Weil, T.T., Parton, R.M., Davis, I.",Non-OADS,/arxiv_data1/oa_pdf/91/4a/jove-60-3679.PMC3399498.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3679/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/91/4a/jove-60-3679.PMC3399498.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2012 |  60  | e3774 | Page 1 of 5Video Article Preterm EEG: A Multimodal Neurophysiological Protocol Susanna Stjerna1, Juha Voipio2, Marjo Metsäranta3, Kai Kaila2,4, Sampsa Vanhatalo1 1Department of Children's Clinical Neurophysiology, Helsinki University Hospital, University of Helsinki 2Department of Biosciences, University of Helsinki 3Department of Pediatrics, Helsinki University Hospital, University of Helsinki 4Neuroscience Center, University of Helsinki Correspondence to: Sampsa Vanhatalo at sampsa.vanhatalo@helsinki.fi URL: http://www.jove.com/video/3774 DOI: doi:10.3791/3774 Keywords: Neuroscience, Issue 60, neurophysiology, preterm baby, neonatal, EEG, evoked response, high density EEG, FbEEG, sensory evoked response, neonatal intensive care unit Date Published: 2/18/2012 Citation: Stjerna, S., Voipio, J., Metsäranta, M., Kaila, K., Vanhatalo, S. Preterm EEG: A Multimodal Neurophysiological Protocol.",Non-OADS,/arxiv_data1/oa_pdf/ee/cd/jove-60-3774.PMC3399499.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3774/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/cd/jove-60-3774.PMC3399499.pdf
"Otherwise, you will need to use head net and single electrode placement, which is demonstrated on the website of the NEMO study (see http://www.nemo-europe.com/en/educational-tools.php).",Non-OADS,/arxiv_data1/oa_pdf/ee/cd/jove-60-3774.PMC3399499.pdf
"8.Check the impedances and EEG signal quality, and prepare the scalp either by gentle mechanical rubbing or by using the so called SurePrep method as needed2,3 (http://www.helsinki.fi/science/eeg/videos/sureprep/).",Non-OADS,/arxiv_data1/oa_pdf/ee/cd/jove-60-3774.PMC3399499.pdf
"In babies with spontaneous breathing, special care is needed not to restrain breathing movements (see also http://www.nemo-europe.com/en/ educational-tools.php ).",Non-OADS,/arxiv_data1/oa_pdf/ee/cd/jove-60-3774.PMC3399499.pdf
"A faithful recording of these infraslow activities requires a DC stable recording setting that consists of a DC coupled amplifier (see Acknowledgements), Ag/AgCl electrodes, chloride-containing gel16, as well as an adequate elimination of epithelial potential (for details, see refs 2,3,8, as well as http://www.nemo-europe.com/en/educational-tools.php -> Setting up EEG hardware -> Skin prepping).",Non-OADS,/arxiv_data1/oa_pdf/ee/cd/jove-60-3774.PMC3399499.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2012 |  60  | e3643 | Page 1 of 6Video Article Identification of Protein Interacting Partners Using Tandem Affinity Purification Dalan Bailey*1, Luis Urena*1, Lucy Thorne1, Ian Goodfellow1 1Section of Virology, Department of Medicine, Imperial College London *These authors contributed equally Correspondence to: Dalan Bailey at D.Bailey@Imperial.ac.uk , Ian Goodfellow at I.Goodfellow@Imperial.ac.uk URL: http://www.jove.com/video/3643 DOI: doi:10.3791/3643 Keywords: Molecular Biology, Issue 60, TAP tagging, translation, eIF4E, proteomics, tandem affinity purification Date Published: 2/25/2012 Citation: Bailey, D., Urena, L., Thorne, L., Goodfellow, I.",Non-OADS,/arxiv_data1/oa_pdf/81/93/jove-60-3643.PMC3399501.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3643/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/81/93/jove-60-3643.PMC3399501.pdf
"Do not distribute.www.landesbioscience.com  Prion  309 Resea Rch  Pa P e R Resea Rch  Pa P e R Prion 6:3, 309-1; July/ august 2012; © 2012 Landes Bioscienc e *Correspondence to: Giuseppe Legname; Email: legname@sissa.it Submitted: 01/07/12; Revised: 03/12/12; Accepted: 03/13/12http://dx.doi.org/10.4161/pri.20026Introduction Prion diseases are fatal neurodegenerative disorders that  include Creutzfeldt-Jakob disease, fatal familial insomnia and Gerstmann-Sträussler-Scheinker disease in humans.",Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Nature 1992; 356:577-82; PMID:1373228; http://dx.doi.org/10.1038/356577a0.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Nature 1996; 380:528-31; PMID:8606772; http://dx.doi.org/10.1038/380528a0.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Mol Biol 1999; 292:797-817; PMID:10525406; http://dx.doi.org/10.1006/jmbi.1999.3108.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
EMBO J 2001; 20:694-702; PMID:11179214; http://dx.doi.org/10.1093/emboj/20.4.694.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Gene 2001; 275:1-18; PMID:11574147; http://dx.doi.org/10.1016/S0378-1119(01)00627-8.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Science 1999; 286:914-5; PMID:10577243; http://dx.doi.org/10.1126/sci-ence.286.5441.914.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
FEBS Lett 1997; 413:282-8; PMID:9280298; http://dx.doi.org/10.1016/S0014-5793(97)00920-4.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Biochem J 2003; 373:485-94; PMID:12665426; http://dx.doi.org/10.1042/BJ20021911.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Mamm Genome 2001; 12:376-9; PMID:11331946; http://dx.doi.org/10.1007/s003350010285.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Am J Pathol 2004; 164:2279-88; PMID:15161660; http://dx.doi.org/10.1016/S0002-9440(10)63784-4.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
EMBO J 2003; 22:3095-101; PMID:12805223; http://dx.doi.org/10.1093/emboj/cdg285.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Mol Cell Neurosci 2003; 23:144-55; PMID:12799144; http://dx.doi.org/10.1016/S1044-7431(03)00017-4.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Biochem Biophys Res Commun 2004; 319:1247-52; PMID:15194501; http://dx.doi.org/10.1016/j.bbrc.2004.05.115.21.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Cell 1998; 93:203-14; PMID:9568713; http://dx.doi.org/10.1016/S0092-8674(00)81572-X.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Acta Biochim Biophys Sin (Shanghai) 2009; 41:42-53; PMID:19129949; http://dx.doi.org/10.1093/abbs/gmn005.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Neuroscience 2006; 141:1375-88; PMID:16766127; http://dx.doi.org/10.1016/j.neuro-science.2006.04.068.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J BiolChem 2003; 278:28944-9; PMID:12759361; http://dx.doi.org/10.1074/jbc.M303655200.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Biol Chem 2008; 283:24202-11; PMID:18562311; http://dx.doi.org/10.1074/jbc.M804212200.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Cerebellum 2002; 1:41-55; PMID:12879973; http://dx.doi.org/10.1080/147342202753203087.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Virol 2007; 81:13794-800; PMID:17913812; http://dx.doi.org/10.1128/JVI.01502-07.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Biochemistry 1996; 35:5528-37; PMID:8611544; http://dx.doi.org/10.1021/bi952965e.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Anal Biochem 1981; 110:201-7; PMID:6163373; http://dx.doi.org/10.1016/0003-2697(81)90136-6.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Science 1995; 270:96-9; PMID:7569956; http://dx.doi.org/10.1126/science.270.5233.96.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Nature 2001; 412:739-43; PMID:11507642; http://dx.doi.org/10.1038/35089090.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Cerebellum 2002; 1:277-87; PMID:12879966; http://dx.doi.org/10.1080/147342202320883588.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Dev Neurobiol 2007; 67:670-86; PMID:17443816; http://dx.doi.org/10.1002/dneu.20366.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Dev Neurobiol 2008; 68:332-48; PMID:18085563; http://dx.doi.org/10.1002/dneu.20555.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Autophagy 2009; 5:422-4; PMID:19320049; http://dx.doi.org/10.4161/auto.5.3.7882.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Brain Pathol 2010; 20:119-32; PMID:19055638; http://dx.doi.org/10.1111/j.1750-3639.2008.00245.x.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Neurosci 2007; 27:852-9; PMID:17251426; http://dx.doi.org/10.1523/JNEUROSCI.4244-06.2007.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Mol Biol 2003; 329:323-33; PMID:12758079; http://dx.doi.org/10.1016/S0022-2836(03)00342-5.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Neurochem 2005; 95:1373-86; PMID:16313516; http://dx.doi.org/10.1111/j.1471-4159.2005.03469.x.31.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
PLoS One 2009; 4:5968; PMID:19536284; http://dx.doi.org/10.1371/journal.pone.0005968.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Cell Death Differ 2003; 10:652-61; PMID:12761574; http://dx.doi.org/10.1038/sj.cdd.4401234.,Non-OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Biol Chem 2003; 278:28944-9; PMID:12759361; http://dx.doi.org/10.1074/jbc.M303655200.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Mol Cell Neurosci 2003; 23:144-55; PMID:12799144; http://dx.doi.org/10.1016/S1044-7431(03)00017-4.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
Biochem J 2010; 425:341-51; PMID:19888917; http://dx.doi.org/10.1042/BJ20091050.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
J Virol 2000; 74:4351-60; PMID:10756050; http://dx.doi.org/10.1128/JVI.74.9.4351-60.2000.,OADS,/arxiv_data1/oa_pdf/68/70/prio-6-309.PMC3399532.pdf
"Do not distribute.www.landesbioscience.com  Prion  261 Resea Rch  Pa P e R Resea Rch  Pa P e R Prion 6:3, 261-275; July/ august 2012; © 2012 Landes Bioscienc e *Correspondence to: Caroline Piercey Åkesson; Email: carolinepiercey.akesson@nvh.no Submitted: 09/02/11; Revised: 11/29/11; Accepted: 12/29/11http://dx.doi.org/10.4161/pri.19215Introduction The transmissible spongiform encephalopathies (TSEs) are caused  by prions composed of an infectious conformer of the host-coded prion protein.",Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Infect Dis  1982; 146:657-64; PMID:6813384; http://dx.doi.org/10.1093/infdis/146.5.657.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
APMIS 2002; 110:23-32; PMID:12064252; http://dx.doi.org/10.1034/j.1600-0463.2002.100104.x.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
BMC Vet Res 2009; 5:9; PMID:19243608; http://dx.doi.org/10.1186/1746-6148-5-9.6.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Neurosci Lett 2000; 278:181-4; PMID:10653023; http://dx.doi.org/10.1016/S0304-3940(99)00934-9.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Pathol 1992; 168:413-8; PMID:1362440; http://dx.doi.org/10.1002/path.1711680412.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Pathol 2000; 191:323-32; PMID:10878556; http://dx.doi.org/10.1002/1096-9896(200007)191:3<323::AID-PATH629>3.0.CO;2-Z.11.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Adv Drug Deliv Rev 2004; 56:885-99; PMID:15063596; http://dx.doi.org/10.1016/j.addr.2003.09.008.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Annu Rev Nutr 1988; 8:329-50; PMID:3060169; http://dx.doi.org/10.1146/annurev.nu.08.070188.001553.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Int J Pharm 2007; 335:79-89; PMID:17197140; http://dx.doi.org/10.1016/j.ijpharm.2006.10.043.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Dig Dis Sci 1995; 40:967-75; PMID:7729286; http://dx.doi.org/10.1007/BF02064184.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Exp Med  2002; 196:1627-38; PMID:12486105; http://dx.doi.org/10.1084/jem.20021598.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Ann NY Acad Sci 2003; 987:15-25; PMID:12727620; http://dx.doi.org/10.1111/j.1749-6632.2003.tb06029.x.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Eur J Immunol 1986; 16:240-8; PMID:3456894; http://dx.doi.org/10.1002/eji.1830160306.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Blood 2007; 109:661-9; PMID:17003381; http://dx.doi.org/10.1182/blood-2005-12-023044.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Nat Immunol 2007; 8:1086-94; PMID:17873879; http://dx.doi.org/10.1038/ni1511.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Vaccine 2008; 26:6221-4; PMID:18852006; http://dx.doi.org/10.1016/j.vaccine.2008.09.061.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Am J Pathol 2003; 162:1103-11; PMID:12651603; http://dx.doi.org/10.1016/S0002-9440(10)63907-7.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Cell Biol 1972; 54:195-205; PMID:5040858; http://dx.doi.org/10.1083/jcb.54.2.195.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Pharm Pharmacol 1998; 50:753-60; PMID:9720624; http://dx.doi.org/10.1111/j.2042-7158.1998.tb07136.x.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Gut 1979; 20:121-5; PMID:428823; http://dx.doi.org/10.1136/gut.20.2.121.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Vet Pathol 1994; 31:340-8; PMID:8053129; http://dx.doi.org/10.1177/030098589403100307.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
PLoS One 2007; 2:1304; PMID:18074028; http://dx.doi.org/10.1371/journal.pone.0001304.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Intervirology 1982; 17:201-7; PMID:6813286; http://dx.doi.org/10.1159/000149289.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Pathol 2000; 190:495-502; PMID:10700001; http://dx.doi.org/10.1002/(SICI)1096-9896(200003)190:4<495::AID-PATH535>3.0.CO;2-T. 37.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Int J Pharm 2005; 298:293-304; PMID:15964722; http://dx.doi.org/10.1016/j.ijpharm.2005.02.042.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Vet Immunol  Immunopathol 2010; 133:33-9; PMID:19647878; http://dx.doi.org/10.1016/j.vetimm.2009.06.018.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Nature 1995; 375:151-5; PMID:7753172; http://dx.doi.org/10.1038/375151a0.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Exp Med 1986; 163:981-97; PMID:3950549; http://dx.doi.org/10.1084/jem.163.4.981.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Hum Immunol 2000; 61:729-38; PMID:10980384; http://dx.doi.org/10.1016/S0198-8859(00)00144-0.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Cell Immunol 1995; 163:157-62; PMID:7758126; http://dx.doi.org/10.1006/cimm.1995.1110.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Int Immunol 2006; 18:857-69; PMID:16581822; http://dx.doi.org/10.1093/intimm/dxl022.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Immunology 2004; 111:262-72; PMID:15009426; http://dx.doi.org/10.1111/j.0019-2805.2004.01820.x.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Int J Pharm 1999; 183:7-11; PMID:10361144; http://dx.doi.org/10.1016/S0378-5173(99)00050-2.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Exp Med 2001; 194:769-79; PMID:11560993; http://dx.doi.org/10.1084/jem.194.6.769.17.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Nat Immunol 2001; 2:361-7; PMID:11276208; http://dx.doi.org/10.1038/86373.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Nat Med 2001; 7:976-7; PMID:11533681; http://dx.doi.org/10.1038/nm0901-976.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Adv Drug Deliv Rev 2004; 56:915-20; PMID:15063598; http://dx.doi.org/10.1016/j.addr.2003.10.035.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Neurosci 2004; 24:11280-90; PMID:15601934; http://dx.doi.org/10.1523/JNEUROSCI.2864-04.2004.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Pathol 2006; 209:4-14; PMID:16575799; http://dx.doi.org/10.1002/path.1962.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Exp Med 1996; 183:237-47; PMID:8551227; http://dx.doi.org/10.1084/jem.183.1.237.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Dev Comp Immunol 2008; 32:837-49; PMID:18222542; http://dx.doi.org/10.1016/j.dci.2007.12.004.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/sci-ence.6801762.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Prion 2009; 3:139-45; PMID:19806034; http://dx.doi.org/10.4161/pri.3.3.9922.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Science 2010; 327:656-61; PMID:20133564; http://dx.doi.org/10.1126/sci-ence.1178331.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Vet Immunol Immunopathol 1991; 27:21-7; PMID:1902342; http://dx.doi.org/10.1016/0165-2427(91)90072-K. 65.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Vet Immunol Immunopathol 1993; 39:93-102; PMID:8310662; http://dx.doi.org/10.1016/0165-2427(93)90168-4.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Vet Immunol Immunopathol 1991; 28:1-16; PMID:1905075; http://dx.doi.org/10.1016/0165-2427(91)90038-E. 61.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
J Comp Pathol 2004; 130:181-94; PMID:15003476; http://dx.doi.org/10.1016/j.jcpa.2003.11.001.,OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
Brain Pathol 2009; 19:1-11; PMID:18400047; http://dx.doi.org/10.1111/j.1750-3639.2008.00150.x.,Non-OADS,/arxiv_data1/oa_pdf/f5/a1/prio-6-261.PMC3399537.pdf
"Do not distribute.Prion 6:3, 252-255; July/August 2012; © 2012 Landes Bioscience Extr A Vi Ew 252 P rion  V olume 6 i ssue 3Prion 6:3, 252-255; July/August 2012; © 2012 Landes Bioscience Keywords:  prion protein, prion diseases,  infectivity, amyloid fibrils, template- assisted mechanism, neurodegenerative diseases Abbreviations:  PrP C, normal cellular iso - form of the prion protein; PrPSc, abnor - mal, disease-associated isoform of the  prion protein; rPrP, recombinant PrP Submitted: 01/11/12Revised: 02/29/12Accepted: 03/06/12http://dx.doi.org/10.4161/pri.19930 *Correspondence to: Ilia V. Baskakov;  Email: Baskakov@umaryland.eduPrion replication occurs via a tem - plate-assisted mechanism, which  postulates that the folding pattern of a  newly recruited polypeptide chain accu - rately reproduces that of a template.",Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
J Cell Sci 2010; 123:1191-201; PMID:20356930; http://dx.doi.org/10.1242/jcs.051672.,OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
PLoS One 2009; 4:6041; PMID:19582162; http://dx.doi.org/10.1371/journal.pone.0006041.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Cell 2001; 106:171-82; PMID:11511345; http://dx.doi.org/10.1016/S0092-8674(01)00427-5.,OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Acta Neuropathol 2010; 119:177-87; PMID:20052481; http://dx.doi.org/10.1007/s00401-009-0633-x.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Trends Microbiol 2003; 11:578-84; PMID:14659690; http://dx.doi.org/10.1016/j.tim.2003.10.007.,OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
J Biol Chem 2009; 284:14386-95; PMID:19329794; http://dx.doi.org/10.1074/jbc.M900533200.,OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Nature 2007; 447:556-61; PMID:17495929; http://dx.doi.org/10.1038/nature05848.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Mol Microbiol 2010; 76:1483-99; PMID:20444092; http://dx.doi.org/10.1111/j.1365-2958.2010.07177.x.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Ann Neurol 2011; 70:532-40; PMID:22028219; http://dx.doi.org/10.1002/ana.22615.References 1.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Annu Rev Biochem 1998; 67:793-819; PMID:9759504; http://dx.doi.org/10.1146/annurev.biochem.67.1.793.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Science 2004; 305:673-6; PMID:15286374; http://dx.doi.org/10.1126/science.1100195.,OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Cell 2005; 121:195-206; PMID:15851027; http://dx.doi.org/10.1016/j.cell.2005.02.011.,OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
Nature 2003; 425:717-20; PMID:14562104; http://dx.doi.org/10.1038/nature01979.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
PLoS Pathog 2011; 7:1002419; PMID:22144901; http://dx.doi.org/10.1371/journal.ppat.1002419.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
J Mol Biol 2010; 400:908-21; PMID:20553730; http://dx.doi.org/10.1016/j.jmb.2010.05.051.,OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
PLoS Pathog 2011; 7:1001277; PMID:21347353; http://dx.doi.org/10.1371/journal.ppat.1001277.,Non-OADS,/arxiv_data1/oa_pdf/71/5f/prio-6-252.PMC3399541.pdf
"Full details of how to assemble this printer are provided under the GNU General PublicLicense software scheme (and can be downloaded from *Correspondence to: Roland Partridge; Email: Roland.Partridge@ed.ac.uk Submitted: 03/26/12; Accepted: 03/27/12 http://dx.doi.org/10.4161/org.20173Organogenesis 8:1, 22 –27; January/February/March 2012; G2012 Landes Bioscience 22 Organogenesis Volume 8 Issue 1",Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Curr Opin Neurobiol 2012; In press; PMID:22398400; http://dx.doi.org/10.1016/j.conb.2012.02.006 2.,OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
"Anat Rec1998; 253:49-57; PMID:9605360; http://dx.doi.org/10.1002/(SICI)1097-0185(199804)253:2 ,49::AID-AR8 .",Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Semin Cell Dev Biol 1997; 8:509-17; PMID: 9441956; http://dx.doi.org/10.1006/scdb.1997.0174 6.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Neuroinformatics 2003; 1:309-25; PMID:15043218;http://dx.doi.org/10.1385/NI:1:4:309 7.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Respir Res 2010; 11:162; PMID:21108827; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Organogenesis 2009; 5:211-6; PMID:20539740;http://dx.doi.org/10.4161/org.5.4.10426 11.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Organogenesis 2009;5:227-30; PMID:20539742; http://dx.doi.org/10.4161/ org.5.4.10403 12.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Med Educ 1985; 19:13-26; PMID:3969019; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Adv Health Sci Educ Theory Pract 2007; 12:491-507; PMID:16847728;http://dx.doi.org/10.1007/s10459-006-9021-7 15.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Teach Learn Med2009; 21:201-6; PMID:20183339; http://dx.doi.org/ 10.1080/10401330903014178 16.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Anat Sci Educ 2009; 2:156-9; PMID:19588481; http://dx.doi.org/10.1002/ ase.92 17.,OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
J Exp Psychol Appl 2010; 16:45-59; PMID: 20350043; http://dx.doi.org/10.1037/a0018373 18.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Cognition 2012;123:33-49; PMID:22217386; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
Biomaterials 2009; 30:5910-7; PMID:19664819;http://dx.doi.org/10.1016/j.biomaterials.2009.06.034 27.,OADS,/arxiv_data1/oa_pdf/8c/d4/org-8-22.PMC3399707.pdf
http://www.wmpho.org.uk/excesswinterdeathsinEnglandatlas/atlas.,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.nea.org.uk/excess-winter-mortality/ (accessed Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/PublicationsPolicyAnd Guidance/DH_121382 (accessed Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://winterwatch.dh.gov.uk/ (accessed Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.direct.gov.uk/en/Environmentand greenerliving/Energyandwatersaving/Energygrants/DG_10018661 (accessed Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.decc.gov.uk/en/content/cms/consultations/green_deal/green_deal.aspx (accessed Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
"Joseph Rowntree Foundation, 2011. http://www.jrf.",Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.thensmc.com/content/what-social-marketing-0 (accessed Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.nsms.org.uk/sites/default/ﬁles/Students-1d- deﬁnitions_optimised.pdf (accessed Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.snh.org.uk/pdfs/sgp/A328463.pdf (accessed Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.decc.gov.uk/assets/decc/Statistics/ fuelpoverty/2181-annual-report-fuel-poverty-stats-2011.pdf (accessed Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://kwillt.org/index.php/products (accessed Apr 2012).,OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
2011. http://www.dh.gov.uk/prod_consum_dh/ groups/dh_digitalassets/@dh/@en/documents/digitalasset/ dh_132559.pdf (accessed Apr 2012).,OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.altogetherbetter.org.uk/SharedFiles/Download.,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.healthyambitions.co.uk/Uploads/BetterForLess/ 08%20BETTER%20FOR%20LESS%20every%20contact% 20counts.pdf (accessed Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/bmjopen-2012-000922.PMC3400059.pdf
http://www.ipcc.ch/pdf/ assessment-report/ar4/wg1/ar4-wg1-spm.pdf (accessed 5 Sep 2011).24.,Non-OADS,/arxiv_data1/oa_pdf/6b/11/bmjopen-2011-000741.PMC3400060.pdf
http://www.comeunity.com/adoption/health/growth.html (accessed 20 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/6b/11/bmjopen-2011-000741.PMC3400060.pdf
"American Cancer Society, Inc. http://www.cancer.",Non-OADS,/arxiv_data1/oa_pdf/6b/11/bmjopen-2011-000741.PMC3400060.pdf
http://ah.anhuinews.com/system/2009/10/31/002379545.shtml 15.,Non-OADS,/arxiv_data1/oa_pdf/5c/1f/bmjopen-2012-000827.PMC3400061.pdf
Data sharing statement Data may be obtained from http://www.cdc.gov/brfss (2006 interview data ﬁle).,OADS,/arxiv_data1/oa_pdf/49/41/bmjopen-2011-000696.PMC3400062.pdf
http://www.cdc.gov/nchs/tutorials/ nhanes/SurveyDesign/Weighting/intro.htm (accessed 9 Nov 2011).,OADS,/arxiv_data1/oa_pdf/49/41/bmjopen-2011-000696.PMC3400062.pdf
"Atlanta, GA: Centers for Disease Control and Prevention, 2006.ftp://ftp.cdc.gov/pub/Data/Brfss/userguide.pdf (accessed 9 Nov 2011).",OADS,/arxiv_data1/oa_pdf/49/41/bmjopen-2011-000696.PMC3400062.pdf
"Washington, DC: U.S. Census Bureau, Statistical Research Division, 2005. http://www.census.gov/srd/www/byyear.html(accessed 2 May 2012).",OADS,/arxiv_data1/oa_pdf/49/41/bmjopen-2011-000696.PMC3400062.pdf
2010. http://www.cdc.gov/ nchs/data/nhis/tecdoc4.pdf (accessed 2 May 2012).,OADS,/arxiv_data1/oa_pdf/49/41/bmjopen-2011-000696.PMC3400062.pdf
"Atlanta, GA: US Department of Health and Human Services, CDC, 2007.ftp://ftp.cdc.gov/pub/Data/Brfss/2006SummaryDataQualityReport.pdf (accessed 2 May 2012).",OADS,/arxiv_data1/oa_pdf/49/41/bmjopen-2011-000696.PMC3400062.pdf
"Atlanta, GA: US Department of Health and Human Services, CDC, 2010. http://www.cdc.gov/ chronicdisease/resources/publications/AAG/brfss.htm (accessed 2 May 2012).",Non-OADS,/arxiv_data1/oa_pdf/49/41/bmjopen-2011-000696.PMC3400062.pdf
To view these ﬁles please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-000856).,Non-OADS,/arxiv_data1/oa_pdf/84/e5/bmjopen-2012-000856.PMC3400063.pdf
2011. http://www.meta-analysis-made-easy.com 10.,Non-OADS,/arxiv_data1/oa_pdf/14/52/bmjopen-2012-000828.PMC3400064.pdf
2011. http://www.cdc.gov/nchs/ nhanes.htm (accessed 7 Oct 2011).,OADS,/arxiv_data1/oa_pdf/14/52/bmjopen-2012-000828.PMC3400064.pdf
2006. http://www.cdc.gov/ nchs/nhanes/nhanes2003-2004/analytical_guidelines.htm (accessed7 Oct 2011).,OADS,/arxiv_data1/oa_pdf/14/52/bmjopen-2012-000828.PMC3400064.pdf
2011. http://apps.who.int/ghodata/ (accessed 7 Oct 2011).,OADS,/arxiv_data1/oa_pdf/14/52/bmjopen-2012-000828.PMC3400064.pdf
To view these ﬁlesplease visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001044).,OADS,/arxiv_data1/oa_pdf/98/1e/bmjopen-2012-001044.PMC3400065.pdf
"Center for Global Development, 2006. http://www.cgdev.org/content/ publications/detail/5967/ (accessed 3 Jul 2012).",Non-OADS,/arxiv_data1/oa_pdf/f0/2d/bmjopen-2011-000589.PMC3400066.pdf
2007. http://ssrn.com/ abstract ¼994997 21.,Non-OADS,/arxiv_data1/oa_pdf/f0/2d/bmjopen-2011-000589.PMC3400066.pdf
To viewthese ﬁles please visit the journal online (http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/87/bmjopen-2012-001074.PMC3400068.pdf
"METHODS Data sources Relevant primary studies were identiﬁed by searchingthe MEDLINE and EMBASE databases, the CochraneLibrary and the http://Clinicaltrials.gov database (toidentify ongoing trials yet to be reported in theliterature) until April 2011.",OADS,/arxiv_data1/oa_pdf/c6/8e/bmjopen-2011-000524.PMC3400069.pdf
To viewthese ﬁles please visit thejournal online (http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/71/bmjopen-2012-001507.PMC3400070.pdf
To view these ﬁles pleasevisit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001153).,Non-OADS,/arxiv_data1/oa_pdf/ec/2e/bmjopen-2012-001153.PMC3400071.pdf
http://project.vbook.no/project.asp?,Non-OADS,/arxiv_data1/oa_pdf/ec/2e/bmjopen-2012-001153.PMC3400071.pdf
http://project.vbook.no/project.asp?,Non-OADS,/arxiv_data1/oa_pdf/ec/2e/bmjopen-2012-001153.PMC3400071.pdf
http://www.ssb.no/ samfunnsspeilet/utg/201102/10/ 4.,Non-OADS,/arxiv_data1/oa_pdf/ec/2e/bmjopen-2012-001153.PMC3400071.pdf
"Oslo: The Norwegian Health Economics Administration (HELFO), 2011. http://www.helfo.no/statistikk/Documents/Analyserapport%20Aktivitetsstatistikk%202009.pdf 23.",Non-OADS,/arxiv_data1/oa_pdf/ec/2e/bmjopen-2012-001153.PMC3400071.pdf
"Oslo: Statistics Norway, 1994. http://www.ssb.no/kommuner/komklasse94.html 24.",OADS,/arxiv_data1/oa_pdf/ec/2e/bmjopen-2012-001153.PMC3400071.pdf
"http://ec.europa.eu/internal_market/ qualiﬁcations/policy_developments/legislation_en.htm PAGE fraction trail=5.75 6 Sandvik H, Hunskaar S, Diaz E. BMJ Open 2012; 2:e001153.",Non-OADS,/arxiv_data1/oa_pdf/ec/2e/bmjopen-2012-001153.PMC3400071.pdf
http://www.nepa.gov.jm/publications/SOE/ 2010/state-of-The-environment-report-2010-Jamaica.pdf (accessed 23 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/c4/b9/bmjopen-2012-001132.PMC3400072.pdf
2008. http://pioj.gov.jm/ Portals/0/Social_Sector/Urbanization in Jamaica.,Non-OADS,/arxiv_data1/oa_pdf/c4/b9/bmjopen-2012-001132.PMC3400072.pdf
To view these ﬁles please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001321).,Non-OADS,/arxiv_data1/oa_pdf/6e/a4/bmjopen-2012-001321.PMC3400074.pdf
This study is part of the A-CaRe 2 Move program: http://www.a-care.org/.,Non-OADS,/arxiv_data1/oa_pdf/6e/a4/bmjopen-2012-001321.PMC3400074.pdf
2010. http://globocan.iarc.fr (accessed 18 Oct 2011).,Non-OADS,/arxiv_data1/oa_pdf/6e/a4/bmjopen-2012-001321.PMC3400074.pdf
2004. http://www.aihw.gov.au/publication-detail/?,Non-OADS,/arxiv_data1/oa_pdf/89/fd/bmjopen-2012-001196.PMC3400076.pdf
2003. http://www.who.int/whr/2003/en/member_states_182-184_en.,Non-OADS,/arxiv_data1/oa_pdf/89/fd/bmjopen-2012-001196.PMC3400076.pdf
http://data.worldbank.org/indicator/NY.GNP.,OADS,/arxiv_data1/oa_pdf/89/fd/bmjopen-2012-001196.PMC3400076.pdf
2008. http://www.hciproject.org/node/1070 (accessed 20 Feb 2012).,OADS,/arxiv_data1/oa_pdf/89/fd/bmjopen-2012-001196.PMC3400076.pdf
11. http://www.mdch.state.mi.us/pha/vipf2/football.htm (accessed 22 Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/36/eb/bmjopen-2012-001149.PMC3400077.pdf
http://www.sarugby.co.za/boksmart/default.aspx (accessed 22 Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/36/eb/bmjopen-2012-001149.PMC3400077.pdf
http://www.nzrugby.co.nz/the_game/safety/rugbysmart (accessed 22 Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/36/eb/bmjopen-2012-001149.PMC3400077.pdf
http://www.rugby.com.au/LinkClick.,Non-OADS,/arxiv_data1/oa_pdf/36/eb/bmjopen-2012-001149.PMC3400077.pdf
"Cases werelinked by postcode to lower-level super output area andmedium-level super output area (MSOA), deprivationindex, ethnic origin, population density and census datausing data held on the Ofﬁce for National Statisticswebsite (http://www.statistics.gov.uk/cci/nugget.asp?id¼6).",OADS,/arxiv_data1/oa_pdf/4c/ad/bmjopen-2012-001179.PMC3400078.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e4/83/srep00516.PMC3400080.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Matsuda, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/83/srep00516.PMC3400080.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wang, Y., Panzik, J.E., Kiefer, B.",Non-OADS,/arxiv_data1/oa_pdf/f4/5e/srep00520.PMC3400081.pdf
"T o facilitate the estimation, we used the ISQoL software, which was built in the R statistical package and can be freely downloaded from http://www.stat.sinica.edu.tw/jshwang.",OADS,/arxiv_data1/oa_pdf/24/78/oemed-2011-100462.PMC3400143.pdf
"T o apply Monte Carlo simulation, we used the ISQoL software (available from http://www.stat.sinica.edu.tw/jshwang) for the estimation of lifetime survival func- tions and the calculation of EYLL and lifetime healthcare expenditures.",OADS,/arxiv_data1/oa_pdf/24/78/oemed-2011-100462.PMC3400143.pdf
2012. http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/24/78/oemed-2011-100462.PMC3400143.pdf
2011. http://www.eiu.com/index.asp?layout ¼ib3Article&article_id ¼1488232533 &pubtypeid ¼1152462500&country_id ¼1630000163&category_id ¼775133077 &rf¼0 (assessed 2 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/24/78/oemed-2011-100462.PMC3400143.pdf
"Table 1 Radiation exposure dose of workers at Fukushima Dai-ichi nuclear power plant, Japan, from March to May 2011 March April May External exposureInternal exposureTotal exposureExternal exposureInternal exposureTotal exposureExternal exposureInternal exposureTotal exposure Radiation exposed(mSv) $2 5 0 056000000 200e2 4 9 012000000 150e1 9 9 91 1 4000000 100e1 4 9 2 85 7 7000000 50e9 9 1 6 3 7 8 3 0 9203000 20e49 421 260 859 56 1 81 18 0 19 10e19 883 666 1041 276 19 310 131 1 144 <10 2241 2726 1434 3286 3588 3214 2881 3016 2854 Total 3745 3742 3742 3620 3608 3608 3030 3017 3017 Maximum exposure (mSv) 199.4 590.0 670.4 65.9 41.8 69.3 41.6 10.1 41.6 Source: Tokyo Electric Power Company, http://www.tepco.co.jp/cc/press/betu11_j/images/111031e.pdf.",Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.meti.go.jp/english/earthquake/nuclear/roadmap/ pdf/110517roadmap_NPS.pdf (accessed 8 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.iaea.org/newscenter/focus/fukushima/japan- report/ (accessed 13 Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.tepco.co.jp/ cc/press/betu11_j/images/111031e.pdf (accessed 30 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.mhlw.go.jp/shinsai_jouhou/keii.html (accessed 20 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2008. http://www.unscear.org/docs/ reports/2008/11-80076_Report_2008_Annex_D.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.nies.go.jp/health/HeatStroke/est/dl.html 11.,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.who.int/ionizing_radiation/ pub_meet/tech_brieﬁngs/potassium_iodide/en/index.html (accessed 17 Nov 2011).,OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.nsc.,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
2011. http://www.mhlw.go.jp/stf/houdou/ 2r9852000001f4ob.html PAGE fraction trail=3.75 602 Occup Environ Med 2012; 69:599e602.,Non-OADS,/arxiv_data1/oa_pdf/87/5e/oemed-2011-100587.PMC3400146.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/52/srep00514.PMC3400147.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Dambre, J., Verstraeten, D., Schrauwen, B.",Non-OADS,/arxiv_data1/oa_pdf/92/52/srep00514.PMC3400147.pdf
"2008;28(1):4-9, http://dx.doi.org/10.1016/ j.semnephrol.2007.10.001.",OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2007;49(6):763- 75, http://dx.doi.org/10.1053/j.ajkd.2007.03.013.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"1987;7(6):440-4, http://dx.doi.org/ 10.1159/000167516.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"1992;41(5):1134-42, http://dx.doi.org/10.1038/ki.1992.173.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2003;8(3):130-8, http://dx.doi.org/10.1046/j.1440-1797.2003.00153.x.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2001;87(3):240-8, http://dx.doi.org/10.1159/ 000045921.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2008;118(11):3522-30, http://dx.doi.org/ 10.1172/JCI36150.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2008;110(1):e31-6, http://dx.doi.org/10.1159/000151561.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2006;57:365-80, http://dx.doi.org/10.1146/annurev.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2005;14(10):814-21, http://dx.doi.org/10.1191/0961203305lu 2188oa.14.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
"2003;42(1):76-86, http://dx.doi.org/10.1016/S0272-6386(03)00411-6.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/cln-67-07-697.PMC3400157.pdf
